concept_id	concept_synonym_name	language_concept_id
19474116	Housing Condition, Social	4180186
19474116	Environment, Home	4180186
19474116	Housing Conditions, Social	4180186
19474117	Drought Avoidence	4180186
19474117	Resistance, Drought	4180186
19474117	Avoidence, Drought	4180186
19474117	Drought Injuries	4180186
19474117	Tolerance, Drought	4180186
19474117	Drought Tolerance	4180186
19474117	Injury, Drought	4180186
19474117	Drought Recovery	4180186
19474117	Recovery, Drought	4180186
19474117	Drought Recoveries	4180186
19474117	Drought Escapes	4180186
19474117	Drought Resistances	4180186
19474117	Drought Tolerances	4180186
19474117	Drought Injury	4180186
19474117	Drought Escape	4180186
19474117	Drought Avoidences	4180186
19474118	Meglitinide Analogues	4180186
19474118	Secretogogue, Insulin	4180186
19474118	Secretogogues, Insulin	4180186
19474118	Insulin Secretogogue	4180186
19474118	Analogues, Meglitinide	4180186
19474118	Hypoglycemic Sulfonylureas	4180186
19474118	Insulin Secretogogues	4180186
19474119	Work Environments	4180186
19474119	Environment, Workplace	4180186
19474119	Workplace Environment	4180186
19474119	Working Condition	4180186
19474119	Work Environment	4180186
19474119	Working Environment	4180186
19474119	Condition, Workplace	4180186
19474119	Workplace Environments	4180186
19474119	Workplace Condition	4180186
19474119	Working Environments	4180186
19474119	Workplace Conditions	4180186
19474119	Environment, Working	4180186
19474119	Condition, Working	4180186
19474120	Anti-IL-6 Agents	4180186
19474120	Anti-IL6 Agents	4180186
19474120	Agents, Anti-Interleukin-6	4180186
19474120	Inhibitors, Interleukin-6	4180186
19474120	Agents, Anti-IL-6	4180186
19474120	IL-6 Inhibitors	4180186
19474120	Agents, Anti-IL6	4180186
19474120	Anti-Interleukin-6 Agents	4180186
19474120	IL6 inhibitors	4180186
19474120	IL 6 Inhibitors	4180186
19474120	inhibitors, IL6	4180186
19474120	Anti IL 6 Agents	4180186
19474120	Inhibitors, IL-6	4180186
19474120	Anti IL6 Agents	4180186
19474121	CD223 Antigen	4180186
19474121	CD223 Antigens	4180186
19474121	Antigens, CD223	4180186
19474121	Lymphocyte Activation Gene 3 Proteins	4180186
19474122	Glycosyl-Albumin	4180186
19474122	Albumin, Glycated Serum	4180186
19474122	Glycated Albumin, Serum	4180186
19474122	Serum Albumin, Glycosylated	4180186
19474122	Albumin, Serum Glycated	4180186
19474122	Albumin, Glycosylated Serum	4180186
19474122	Glycoalbumin	4180186
19474122	Serum Glycated Albumin	4180186
19474122	Glycosylated Serum Albumin	4180186
19474122	Glycosyl Albumin	4180186
19474122	Serum Albumin, Glycated	4180186
19474127	Stromal Lymphopoietin, Thymic	4180186
19474127	TSLP Cytokine	4180186
19474127	Lymphopoietin, Thymic Stromal	4180186
19474127	Cytokine, TSLP	4180186
19474129	Type III Interferons	4180186
19474129	III Interferon, Type	4180186
19474129	III Interferons, Type	4180186
19474129	Type III IFN	4180186
19474129	Interferons, Lambda	4180186
19474129	III, Interferon Type	4180186
19474129	IFN-Lambda	4180186
19474129	Interferon-Lambda	4180186
19474129	Type III IFNs	4180186
19474129	Interferon Type III	4180186
19474129	Lambda Interferons	4180186
19474129	III IFN, Type	4180186
19474129	Interferons, Type III	4180186
19474129	Type III Interferon	4180186
19474129	Interferon, Type III	4180186
19474129	III IFNs, Type	4180186
19474129	IFNs, Type III	4180186
19474130	Visotrast 300	4180186
19474130	Sodium, Acetrizoate	4180186
19474130	Acid, Acetrizoic	4180186
19474130	Jodopax	4180186
19474130	Visotrast 400	4180186
19474130	Salpix	4180186
19474130	Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-	4180186
19474130	Triiotrast	4180186
19474130	Acetrizoate Sodium	4180186
19474133	2-Propenal	4180186
19474133	Aldehyde, Acrylic	4180186
19474133	Acrylaldehyde	4180186
19474133	Aldehyde, Allyl	4180186
19474133	Acrylic Aldehyde	4180186
19474133	Aldehyde, Ethylene	4180186
19474133	Acraldehyde	4180186
19474133	Aqualin	4180186
19474133	Allyl Aldehyde	4180186
19474133	Ethylene Aldehyde	4180186
19474133	2 Propenal	4180186
19474135	S 1021	4180186
19474135	Solcoseryl	4180186
19474136	Phosphate, Adenosine	4180186
19474136	Nucleotide, Adenine	4180186
19474136	Adenine Nucleotide	4180186
19474136	Adenosine Phosphates	4180186
19474136	Adenosine Phosphate	4180186
19474136	Nucleotides, Adenine	4180186
19474136	Phosphates, Adenosine	4180186
19474139	Acids, Hexanedioic	4180186
19474139	Adipic Acids	4180186
19474139	Hexanedioic Acids	4180186
19474139	Acids, Adipic	4180186
19474144	Alloid G	4180186
19474144	Alginic Acid, Barium Salt	4180186
19474144	Barium Alginate	4180186
19474144	Potassium Alginate	4180186
19474144	Sodium Alginate	4180186
19474144	Alginate, Sodium Calcium	4180186
19474144	Alginic Acid, Potassium Salt	4180186
19474144	Alginate, Potassium	4180186
19474144	Alginate, Barium	4180186
19474144	Alginate, Copper	4180186
19474144	Copper Alginate	4180186
19474144	Alginic Acid, Copper Salt	4180186
19474144	poly(Mannuronic Acid), Sodium Salt	4180186
19474144	Xantalgin	4180186
19474144	Kalrostat 2	4180186
19474144	Calcium Alginate, Sodium	4180186
19474144	Kalrostat	4180186
19474144	Alginic Acid, Sodium Salt	4180186
19474144	Alginate, Calcium	4180186
19474144	Calcium Alginate	4180186
19474144	Alginate, Sodium	4180186
19474144	Alginic Acid, Calcium Salt	4180186
19474144	Sodium Calcium Alginate	4180186
19474144	Alginate	4180186
19474144	Calginat	4180186
19474144	Kaltostat	4180186
19474144	Vocoloid	4180186
19474150	Compounds, Alum	4180186
19474152	Urgent Care Clinic	4180186
19474152	Care Centers, Urgent	4180186
19474152	Free-Standing Clinic	4180186
19474152	Clinics, Abortion	4180186
19474152	Center, Ambulatory Health	4180186
19474152	Outpatient Clinics	4180186
19474152	Ambulatory Care Facility	4180186
19474152	Abortion Center	4180186
19474152	Abortion Clinic	4180186
19474152	Ambulatory Care Facilities, Non-Hospital	4180186
19474152	Clinic, Urgent Care	4180186
19474152	Centers, Family Planning	4180186
19474152	Care Center, Urgent	4180186
19474152	Clinic, Abortion	4180186
19474152	Care Clinics, Urgent	4180186
19474152	Clinics, Free-Standing	4180186
19474152	Ambulatory Health Center	4180186
19474152	Center, Abortion	4180186
19474152	Urgent Care Clinics	4180186
19474152	Urgent Care Centers	4180186
19474152	Abortion Centers	4180186
19474152	Clinics, Free Standing	4180186
19474152	Center, Urgent Care	4180186
19474152	Care Clinic, Urgent	4180186
19474152	Centers, Ambulatory Health	4180186
19474152	Clinics, Outpatient	4180186
19474152	Health Centers, Ambulatory	4180186
19474152	Activities, Clinic	4180186
19474152	Clinic Activities	4180186
19474152	Ambulatory Health Centers	4180186
19474152	Facility, Ambulatory Care	4180186
19474152	Free-Standing Clinics	4180186
19474152	Clinic, Outpatient	4180186
19474152	Urgent Care Center	4180186
19474152	Outpatient Clinic	4180186
19474152	Centers, Abortion	4180186
19474152	Abortion Clinics	4180186
19474152	Health Center, Ambulatory	4180186
19474152	Clinics, Urgent Care	4180186
19474152	Ambulatory Care Facilities, Nonhospital	4180186
19474152	Activity, Clinic	4180186
19474152	Centers, Urgent Care	4180186
19474152	Facilities, Ambulatory Care	4180186
19474152	Center, Family Planning	4180186
19474152	Clinic, Free-Standing	4180186
19474152	Family Planning Centers	4180186
19474152	Clinic Activity	4180186
19474152	Ambulatory Care Facilities, Non Hospital	4180186
19474152	Family Planning Center	4180186
19474154	C.I.20470	4180186
19474154	C.I. 20470	4180186
19474154	C.I. Acid Black 1	4180186
19474154	C.I.-20470	4180186
19474154	2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3-((4-nitrophenyl)azo)-6-(phenylazo)-, disodium salt	4180186
19474154	Amido Black, Sodium salt	4180186
19474154	Amido Black, Dilithium salt	4180186
19474154	Black, Amido	4180186
19474155	Peptide Chloromethyl Ketones	4180186
19474155	Chloromethyl Ketones, Peptide	4180186
19474155	Ketones, Peptide Chloromethyl	4180186
19474156	Acid, Essential Amino	4180186
19474156	Amino Acid, Essential	4180186
19474156	Acids, Essential Amino	4180186
19474156	Essential Amino Acid	4180186
19474156	Essential Amino Acids	4180186
19474161	Aminohexanoic Acids	4180186
19474161	Aminohexanoates	4180186
19474161	Acids, Aminocaproic	4180186
19474161	Acid Derivatives, Aminocaproic	4180186
19474161	Acids, Aminohexanoic	4180186
19474161	Aminocaproic Acid Derivatives	4180186
19474161	Aminohexanoic Acid Derivatives	4180186
19474161	Aminocaproic Acids	4180186
19474161	Derivatives, Aminohexanoic Acid	4180186
19474161	Derivatives, Aminocaproic Acid	4180186
19474161	Acid Derivatives, Aminohexanoic	4180186
19474163	Acids, Aminohippuric	4180186
19474164	1H-Imidazole-4-carboxamide, 5-amino-	4180186
19474164	Ba 2756	4180186
19474164	Carboxamide, Aminoimidazole	4180186
19474167	2-Oxazolamine, 4,5-dihydro-5-phenyl-	4180186
19474167	Menocil	4180186
19474167	Aminoxafen	4180186
19474167	Aminoxaphen	4180186
19474168	Acids, Aminosalicylic	4180186
19474170	Isoelectric Focusing Agents	4180186
19474170	Pharmalyte	4180186
19474170	Carrier Ampholyte	4180186
19474170	Isoelectric Focusing Agent	4180186
19474170	Agent, Isoelectric Focusing	4180186
19474170	Carrier Ampholytes	4180186
19474170	Ampholytes, Carrier	4180186
19474170	Ampholines	4180186
19474170	Ampholyte	4180186
19474170	Ampholyte Mixture	4180186
19474170	Servalyte	4180186
19474170	Pharmalytes	4180186
19474170	Ampholytes	4180186
19474171	Amyloid A Precursor	4180186
19474171	Amyloid Protein SAA	4180186
19474171	Amyloid A Protein Related Serum Component	4180186
19474171	Amyloid Protein AA	4180186
19474171	Serum A Related Protein	4180186
19474171	Amyloid A Protein	4180186
19474171	Amyloid Fibril Protein AA	4180186
19474171	Serum Amyloid Protein A	4180186
19474171	Serum Amyloid A	4180186
19474171	Amyloid Serum Protein SAA	4180186
19474171	Amyloid A Protein-Related Serum Component	4180186
19474171	Amyloid-Related Serum Protein (SAA)	4180186
19474171	Amyloid Protein AA Precursor	4180186
19474176	Drugs, Anesthetic	4180186
19474176	Anesthetic Effect	4180186
19474176	Anesthetic	4180186
19474176	Anesthetic Effects	4180186
19474176	Agents, Anesthetic	4180186
19474176	Effect, Anesthetic	4180186
19474176	Anesthetic Agents	4180186
19474176	Anesthetic Drugs	4180186
19474176	Effects, Anesthetic	4180186
19474177	Angiotensin	4180186
19474178	Lymphochin	4180186
19474178	N,N-bis(2-chloroethyl)aniline	4180186
19474178	N,N-bis-(2-chloroethyl)aniline	4180186
19474178	Mustard, Aniline	4180186
19474178	Lymphoquin	4180186
19474178	Lymphocin	4180186
19474178	N,N-Di(2-Chloroethyl)aniline	4180186
19474178	Benzenamine, N,N-bis(2-chloroethyl)-	4180186
19474179	3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R-(2alpha,3alpha,4beta))-	4180186
19474179	Flagecidin	4180186
19474186	Bacterial Antibodies	4180186
19474189	Monoclonal Antibodies	4180186
19474189	Monoclonal Antibody	4180186
19474189	Antibody, Monoclonal	4180186
19474190	Viral Antibodies	4180186
19474194	Complex, Immune	4180186
19474194	Complex, Antigen-Antibody	4180186
19474194	Immune Complexes	4180186
19474194	Complexes, Immune	4180186
19474194	Antigen-Antibody Complexes	4180186
19474194	Antigen Antibody Complexes	4180186
19474194	Complexes, Antigen-Antibody	4180186
19474194	Antigen Antibody Complex	4180186
19474194	Immune Complex	4180186
19474196	B-Lymphocyte Differentiation Antigens	4180186
19474196	Plasma Cell Antigens PC 1	4180186
19474196	Blast 2 Antigen, B Cell	4180186
19474196	B Cell Blast 2 Antigen	4180186
19474196	Blast-2 Antigen, B-Cell	4180186
19474196	Differentiation Antigens, B-Lymphocyte	4180186
19474196	B-Lymphocyte Leu Antigens	4180186
19474196	Antigens, Plasma Cell, PC-1	4180186
19474196	Antigen, B-Cell Blast-2	4180186
19474196	B-Cell Differentiation Antigens	4180186
19474196	Leu Antigens, B-Lymphocyte	4180186
19474196	B-Cell Blast-2 Antigen	4180186
19474196	Antigens, B-Cell Differentiation	4180186
19474196	Antigens, Differentiation, B Lymphocyte	4180186
19474196	Leu Antigens, B Lymphocyte	4180186
19474196	Differentiation Antigens, B-Cell	4180186
19474196	Differentiation Antigens, B Cell	4180186
19474196	Antigens, B-Lymphocyte Differentiation	4180186
19474196	Differentiation Antigens, B Lymphocyte	4180186
19474196	Antigens, Differentiation, B-Cell	4180186
19474196	Plasma Cell Antigens PC-1	4180186
19474196	Antigens, B-Lymphocyte Leu	4180186
19474196	B Cell Differentiation Antigens	4180186
19474196	B Lymphocyte Differentiation Antigens	4180186
19474197	Differentiation Antigens, T-Cell	4180186
19474197	T-Lymphocyte Leu Antigens	4180186
19474197	Antigens, T6	4180186
19474197	Leu Antigens, T Lymphocyte	4180186
19474197	Antigens, Differentiation, T-Cell	4180186
19474197	Antigens, L3T4	4180186
19474197	Antigens, T-Cell Differentiation	4180186
19474197	T-Lymphocyte Differentiation Antigens	4180186
19474197	Differentiation Antigens, T-Lymphocyte	4180186
19474197	T6 Antigens	4180186
19474197	T Cell Differentiation Antigens	4180186
19474197	Leu Antigens, T-Lymphocyte	4180186
19474197	T Lymphocyte Differentiation Antigens	4180186
19474197	Antigens, T-Lymphocyte Differentiation	4180186
19474197	L3T4 Antigens	4180186
19474197	T-Cell Differentiation Antigens	4180186
19474197	Antigens, T-Lymphocyte Leu	4180186
19474197	Differentiation Antigens, T Cell	4180186
19474197	Differentiation Antigens, T Lymphocyte	4180186
19474197	Antigens, Differentiation, T Lymphocyte	4180186
19474198	Antigen, Fungal	4180186
19474198	Fungal Antigens	4180186
19474198	Fungal Antigen	4180186
19474205	Drugs, Antineoplastic	4180186
19474205	Antitumor Agent	4180186
19474205	Agents, Antitumor	4180186
19474205	Anticancer Agent	4180186
19474205	Agents, Antineoplastic	4180186
19474205	Antineoplastic	4180186
19474205	Antitumor Agents	4180186
19474205	Anticancer Agents	4180186
19474205	Drug, Antineoplastic	4180186
19474205	Agent, Cancer Chemotherapy	4180186
19474205	Drug, Chemotherapeutic Anticancer	4180186
19474205	Antineoplastic Agent	4180186
19474205	Agent, Antitumor	4180186
19474205	Agent, Antineoplastic	4180186
19474205	Drug, Antitumor	4180186
19474205	Chemotherapeutic Anticancer Agents	4180186
19474205	Antineoplastic Drug	4180186
19474205	Drug, Cancer Chemotherapy	4180186
19474205	Drugs, Cancer Chemotherapy	4180186
19474205	Antineoplastic Drugs	4180186
19474205	Chemotherapeutic Anticancer Drug	4180186
19474205	Agents, Cancer Chemotherapy	4180186
19474205	Chemotherapy Agent, Cancer	4180186
19474205	Agents, Chemotherapeutic Anticancer	4180186
19474205	Antineoplastics	4180186
19474205	Agents, Anticancer	4180186
19474205	Antitumor Drug	4180186
19474205	Cancer Chemotherapy Drug	4180186
19474205	Antitumor Drugs	4180186
19474205	Chemotherapy Drugs, Cancer	4180186
19474205	Chemotherapy Drug, Cancer	4180186
19474205	Cancer Chemotherapy Drugs	4180186
19474205	Agent, Anticancer	4180186
19474205	Cancer Chemotherapy Agent	4180186
19474205	Drugs, Antitumor	4180186
19474205	Cancer Chemotherapy Agents	4180186
19474205	Chemotherapy Agents, Cancer	4180186
19474209	Serpin F2	4180186
19474209	alpha-2 Antiplasmin	4180186
19474209	alpha 2-Plasmin Inhibitor	4180186
19474209	alpha 2 Plasmin Inhibitor	4180186
19474209	alpha(2)-Plasmin Inhibitor	4180186
19474209	alpha 2 Antiplasmin	4180186
19474211	Antistreptolysin O	4180186
19474213	Anti-Venin	4180186
19474213	Anti Venin	4180186
19474213	Anti Venoms	4180186
19474213	Anti-Venins	4180186
19474213	Antivenom	4180186
19474213	Antivenin	4180186
19474213	Anti-Venoms	4180186
19474213	Anti-Venom	4180186
19474213	Anti Venom	4180186
19474213	Antivenoms	4180186
19474213	Anti Venins	4180186
19474217	Barrier, Architectural	4180186
19474217	Facility Accesses	4180186
19474217	Ramp	4180186
19474217	Barriers, Physical	4180186
19474217	Access, Facility	4180186
19474217	Architectural Barrier	4180186
19474217	Physical Barriers	4180186
19474217	Facility Access	4180186
19474217	Barrier, Physical	4180186
19474217	Physical Barrier	4180186
19474217	Architectural Barriers	4180186
19474217	Barriers, Architectural	4180186
19474217	Ramps	4180186
19474217	Accessibility, Architectural	4180186
19474217	Accesses, Facility	4180186
19474219	Arecaline	4180186
19474219	Arecholin	4180186
19474219	Arecholine	4180186
19474219	3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester	4180186
19474219	Arecolin	4180186
19474219	Methylarecaidin	4180186
19474220	Armine	4180186
19474220	Ethyl-p-Nitrophenyl Ethylphosphonate	4180186
19474221	Acid, p-Aminophenylarsonic	4180186
19474221	4-Aminobenzenearsonic Acid	4180186
19474221	Arsenilate, Sodium	4180186
19474221	Acid, 4-Aminobenzenearsonic	4180186
19474221	4 Aminobenzenearsonic Acid	4180186
19474221	Acid, Arsanilic	4180186
19474221	Atoxyl	4180186
19474221	Arsanilate, Sodium	4180186
19474221	p-Aminophenylarsonic Acid	4180186
19474221	Sodium Arsanilate	4180186
19474221	p Aminophenylarsonic Acid	4180186
19474221	Sodium Arsenilate	4180186
19474222	Acetic acid, 2,2'-(((4-(aminocarbonyl)phenyl)arsinidene)bis(thio))bis-	4180186
19474222	Thioarsenite	4180186
19474222	Caparsolate	4180186
19474222	Thiacetarsamide	4180186
19474223	2,7-Naphthalenedisulfonic acid, 3,6-bis((2-arsonophenyl)azo)-4,5-dihydroxy-	4180186
19474224	Phenol, 4,4'-(1,2-diarsenediyl)bis(2-amino)-, dihydrochloride	4180186
19474224	Salvarsan	4180186
19474224	Arsenobenzol, Sodium	4180186
19474224	Arsenobenzol	4180186
19474224	Sodium Arsenobenzol	4180186
19474228	Astringent	4180186
19474228	Effect, Astringent	4180186
19474228	Astringent Effects	4180186
19474228	Astringent Effect	4180186
19474228	Effects, Astringent	4180186
19474231	Auditory Fatigues	4180186
19474231	Fatigues, Auditory	4180186
19474231	Fatigue, Auditory	4180186
19474231	Temporary Threshold Shift, Auditory	4180186
19474232	Acid, Aurintricarboxylic	4180186
19474232	Ammonium Aurintricarboxylate	4180186
19474232	Aurintricarboxylic Acid, Calcium (1:3) Salt	4180186
19474232	Aluminon	4180186
19474232	Acid, Aurin Tricarboxylic	4180186
19474232	Aurintricarboxylic Acid, Triammonium Salt	4180186
19474232	Aurintricarboxylate	4180186
19474232	Aurintricarboxylic Acid, Calcium (2:3) Salt	4180186
19474232	Aurintricarboxylic Acid, Trisodium Salt	4180186
19474232	Aurin Tricarboxylic Acid	4180186
19474232	Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy-	4180186
19474233	Aurovertin	4180186
19474234	Autoantibody	4180186
19474235	Processing, Automatic Information	4180186
19474235	Data Processing, Computer	4180186
19474235	Processing, Computer Data	4180186
19474235	Information Processing, Automatic	4180186
19474235	Optical Readers	4180186
19474235	Processing, Automatic Data	4180186
19474235	Data Processing, Automatic	4180186
19474235	Bar Code	4180186
19474235	Information Processing	4180186
19474235	Codes, Bar	4180186
19474235	Bar Codes	4180186
19474235	Optical Reader	4180186
19474235	Data Processing, Electronic	4180186
19474235	Automatic Information Processing	4180186
19474235	Computer Data Processing	4180186
19474235	Processing, Electronic Data	4180186
19474235	Processing, Information	4180186
19474235	Automatic Data Processing	4180186
19474239	Azo Dyes	4180186
19474239	Dyes, Azo	4180186
19474239	Dye, Azo	4180186
19474239	Compounds, Azo	4180186
19474239	Azo Dye	4180186
19474240	Stains, Azure	4180186
19474240	Stain, Giemsa	4180186
19474240	Giemsa-11	4180186
19474240	Giemsa 11	4180186
19474240	Giemsa Stain	4180186
19474244	BayR5417	4180186
19474244	Bay-K-8644, (+-)-Isomer	4180186
19474244	Bay-K-8644, (-)-Isomer	4180186
19474244	BK-8644	4180186
19474244	BK8644	4180186
19474244	BK 8644	4180186
19474244	R5417, Bay	4180186
19474244	Bay-K-8644	4180186
19474244	Bay-R-5417	4180186
19474244	Bay K8644	4180186
19474244	BayK8644	4180186
19474244	Bay-K-8644, (+)-Isomer	4180186
19474244	Bay R 5417	4180186
19474244	Bay K 8644	4180186
19474244	Bay R5417	4180186
19474244	Bay-K8644	4180186
19474245	Methetharimide	4180186
19474245	2,6-Piperidinedione, 4-ethyl-4-methyl-	4180186
19474245	Ethylmethylglutarimide	4180186
19474245	Megimide	4180186
19474246	Bence Jones Protein Den	4180186
19474246	Protein, Bence Jones	4180186
19474246	Jones Protein, Bence	4180186
19474246	Bence Jones Protein SUT	4180186
19474248	Benzodiazepine	4180186
19474248	Benzodiazepine Compounds	4180186
19474252	Auramine	4180186
19474252	Benzenamine, 4,4'-carbonimidoylbis(N,N-dimethyl)-, monohydrochloride	4180186
19474252	Auramine O	4180186
19474253	Viologen, Benzyl	4180186
19474253	4,4'-Bipyridinium, 1,1'-bis(phenylmethyl)-	4180186
19474254	alpha Aminotoluene	4180186
19474254	alpha-Aminotoluene	4180186
19474254	Phenylmethylamine	4180186
19474256	Dihydrochloride, Betazole	4180186
19474256	Lilly 96791	4180186
19474256	Histalog	4180186
19474256	Ametazole	4180186
19474256	Betazole Dihydrochloride	4180186
19474256	Monohydrochloride, Betazole	4180186
19474256	1H-Pyrazole-3-ethanamine	4180186
19474256	Betazole Monohydrochloride	4180186
19474257	Compounds, Bethanechol	4180186
19474260	Furo(3,4-e)-1,3-benzodioxol-8(6H)-one, 6-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (R-(R*,S*))-	4180186
19474260	6-(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)furo(3,4-e)1,3-benzodioxol-8(6H)one	4180186
19474266	Phenol, 2,2'-thiobis(4,6-dichloro)-	4180186
19474266	Bitin	4180186
19474267	Bank, Blood	4180186
19474267	Blood Bank	4180186
19474267	Banks, Blood	4180186
19474268	Blood Coagulation Factor	4180186
19474268	Factor, Blood Coagulation	4180186
19474268	Clotting Factor	4180186
19474268	Factors, Clotting	4180186
19474268	Coagulation Factor, Blood	4180186
19474268	Factors, Coagulation	4180186
19474268	Factors, Blood Coagulation	4180186
19474268	Clotting Factors	4180186
19474268	Coagulation Factors	4180186
19474268	Coagulation Factor	4180186
19474268	Coagulation Factors, Blood	4180186
19474268	Factor, Coagulation	4180186
19474268	Factor, Clotting	4180186
19474270	Bombesin Dihydrochloride	4180186
19474270	Dihydrochloride, Bombesin	4180186
19474270	5-oxoPro-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-MetNH2	4180186
19474270	Bombesin 14	4180186
19474271	Bongkrekate	4180186
19474271	Flavotoxin A	4180186
19474271	2,4,8,10,14,18,20-Docosaheptaenedioic acid, 20-(carboxymethyl)-6-methoxy-2,5,17-trimethyl-, (R-(R*,S*-(E,Z,Z,E,E,Z,E)))-	4180186
19474272	Book Ornamentations	4180186
19474272	Ornamentation, Book	4180186
19474272	Ornamentations, Book	4180186
19474274	Antitoxin, Botulism	4180186
19474274	Botulism Antitoxin	4180186
19474274	Trivalent Equine Botulinum Antitoxin	4180186
19474274	Antitoxin, Botulinum	4180186
19474275	Botulin	4180186
19474275	Botulinum Neurotoxin	4180186
19474275	Toxins, Clostridium botulinum	4180186
19474275	Neurotoxins, Botulinum	4180186
19474275	Toxin, Botulinum	4180186
19474275	Clostridium botulinum Toxins	4180186
19474275	Toxins, Botulinum	4180186
19474275	Neurotoxin, Botulinum	4180186
19474275	Botulinum Toxin	4180186
19474275	Botulinum Neurotoxins	4180186
19474276	Bradykinin Hydrochloride	4180186
19474276	Bradykinin Acetate, (9-D-Arg)-Isomer	4180186
19474276	Bradykinin, (2-D-Pro-7-D-Pro)-Isomer	4180186
19474276	Bradykinin, (9-D-Arg)-Isomer	4180186
19474276	Bradykinin, (6-D-Ser)-Isomer	4180186
19474276	Bradykinin Triacetate	4180186
19474276	Bradykinin, (8-D-Phe)-Isomer	4180186
19474276	Bradykinin, (5-D-Phe)-Isomer	4180186
19474276	Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg	4180186
19474276	Bradykinin, (1-D-Arg)-Isomer	4180186
19474276	Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer	4180186
19474276	Bradykinin, (3-D-Pro)-Isomer	4180186
19474276	Bradykinin Diacetate	4180186
19474276	Bradykinin, (2-D-Pro)-Isomer	4180186
19474276	Bradykinin, (7-D-Pro)-Isomer	4180186
19474276	Arg Pro Pro Gly Phe Ser Pro Phe Arg	4180186
19474276	Bradykinin, (5-D-Phe-8-D-Phe)-Isomer	4180186
19474276	Bradykinin, (3-D-Pro-7-D-Pro)-Isomer	4180186
19474279	NSD-1055	4180186
19474279	NSD 1055	4180186
19474279	NSD1055	4180186
19474279	Phenol, 5-((aminooxy)methyl)-2-bromo-	4180186
19474281	Isobutyl alpha Cyanoacrylate	4180186
19474281	Isobutyl 2 cyanoacrylate	4180186
19474281	2-Propenoic acid, 2-cyano-, 2-methylpropyl ester	4180186
19474281	Cyanoacrylate, Isobutyl	4180186
19474281	Isobutyl alpha-Cyanoacrylate	4180186
19474281	Bucrilate	4180186
19474281	alpha-Cyanoacrylate, Isobutyl	4180186
19474281	Isobutylcyanoacrylate	4180186
19474281	Isobutyl-2-cyanoacrylate	4180186
19474281	Isobutyl Cyanoacrylate	4180186
19474282	Ethic, Buddhist	4180186
19474282	Buddhist Ethics	4180186
19474282	Ethics, Buddhist	4180186
19474282	Buddhist Ethic	4180186
19474283	Buffer	4180186
19474284	1 Butylbiguanide	4180186
19474284	1-Butylbiguanide	4180186
19474284	Butylbiguanide	4180186
19474284	Imidodicarbonimidic diamide, N-butyl-	4180186
19474284	Gliporal	4180186
19474284	Silubin	4180186
19474284	Retard, Silubin	4180186
19474284	Silubin Retard	4180186
19474284	Adebit	4180186
19474286	Burn Unit	4180186
19474286	Burn Center	4180186
19474286	Centers, Burn	4180186
19474286	Unit, Burn	4180186
19474286	Center, Burn	4180186
19474286	Burn Centers	4180186
19474286	Units, Burn	4180186
19474287	AY 23,028	4180186
19474287	Hydrochloride, Butaclamol	4180186
19474287	Butaclamol Hydrochloride	4180186
19474287	AY-23,028	4180186
19474287	AY23,028	4180186
19474288	Isobutane	4180186
19474288	Isobutanes	4180186
19474289	Butirosin A	4180186
19474289	Butirosins	4180186
19474289	Butirosin Sulfate, Anhydrous	4180186
19474289	Sulfate, Butirosin	4180186
19474289	Sulphate, Butirosin	4180186
19474289	Butirosin	4180186
19474289	Butirosin Sulphate	4180186
19474289	Butirosin B	4180186
19474289	Sulfate, Anhydrous Butirosin	4180186
19474289	Anhydrous Butirosin Sulfate	4180186
19474290	Butaxamine	4180186
19474290	Benzenemethanol, alpha-(1-((1,1-dimethylethyl)amino)ethyl)-2,5-dimethoxy-	4180186
19474290	Butoxamine Hydrochloride	4180186
19474290	Hydrochloride, Butoxamine	4180186
19474294	High Sensitivity C-Reactive Protein	4180186
19474294	hsCRP	4180186
19474294	Proteins, specific or class, C-reactive	4180186
19474294	hs-CRP	4180186
19474294	High Sensitivity C Reactive Protein	4180186
19474294	C Reactive Protein	4180186
19474296	Pentamethylenediamine	4180186
19474296	1,5-Pentanediamine	4180186
19474296	1,5 Pentanediamine	4180186
19474296	BioDex 1	4180186
19474298	Calcium Dobesilate Monoammonium Salt	4180186
19474298	Calcium Dobesilate (1:1)	4180186
19474298	2,5 Dihydroxybenzenesulfonic Acid	4180186
19474298	2,5-Dihydroxybenzenesulfonic Acid	4180186
19474298	Doxium	4180186
19474298	Calcium, Dobesilate	4180186
19474298	Benzenesulfonic acid, 2,5-dihydroxy-, calcium salt (2:1)	4180186
19474298	Dobesilate, Calcium	4180186
19474298	Dobica	4180186
19474298	2,5-Dihydroxybenzenesulfonate	4180186
19474298	Calcium Dobesilate Monopotassium Salt	4180186
19474298	Dexium	4180186
19474298	Dobesilate Calcium	4180186
19474298	2,5 Dihydroxybenzenesulfonate	4180186
19474300	1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-	4180186
19474300	Camptothecine	4180186
19474305	Hexahydro-2H-Azepin-2-One	4180186
19474305	2H-Azepin-2-one, hexahydro-	4180186
19474305	Hexahydro 2H Azepin 2 One	4180186
19474305	Aminocaproic Lactam	4180186
19474305	Lactam, Aminocaproic	4180186
19474306	Carboquinone	4180186
19474306	Esquinon	4180186
19474306	Carboquone	4180186
19474306	2,5-Cyclohexadiene-1,4-dione, 2-(2-((aminocarbonyl)oxy)-1-methoxyethyl)-3,6-bis(1-aziridinyl)-5-methyl-	4180186
19474318	Catechol Estrogens	4180186
19474318	Catecholestrogens	4180186
19474319	Catecholamine	4180186
19474319	Sympathins	4180186
19474319	Sympathin	4180186
19474320	Cation Exchangers (Resins)	4180186
19474320	Resins, Cation Exchange	4180186
19474320	Exchange Resins, Cation	4180186
19474320	Exchange Resin, Cation	4180186
19474320	Cation Exchange Resin	4180186
19474320	Resin, Cation Exchange	4180186
19474321	Pyrrolidine, 1-(2-(4-(3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl)phenoxy)ethyl)-, trans-	4180186
19474321	Compound 6720	4180186
19474321	Compound 67-20	4180186
19474321	Compound 67 20	4180186
19474324	Cephamycin	4180186
19474324	Cephamycin Antibiotics	4180186
19474324	Antibiotics, Cephamycin	4180186
19474326	Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, (2R-(2alpha,3alpha(4E,7E)))-	4180186
19474326	2,3-Epoxy-4-oxo-7,10-dodecadienoylamide	4180186
19474327	Fern Tests	4180186
19474327	Reactions, Palm-Leaf	4180186
19474327	Tests, Fern	4180186
19474327	Mucus, Cervical	4180186
19474327	Test, Fern	4180186
19474327	Mucus, Cervix	4180186
19474327	Reaction, Palm-Leaf	4180186
19474327	Palm-Leaf Reaction	4180186
19474327	Palm Leaf Reaction	4180186
19474327	Cervical Mucus	4180186
19474327	Fern Test	4180186
19474327	Palm-Leaf Reactions	4180186
19474328	Chelating Agent	4180186
19474328	Antagonists, Metal	4180186
19474328	Metal Antagonists	4180186
19474328	Chelator	4180186
19474328	Complexons	4180186
19474328	Agents, Metal Chelating	4180186
19474328	Agent, Chelating	4180186
19474328	Chelators	4180186
19474328	Chelating Agents, Metal	4180186
19474328	Agents, Chelating	4180186
19474328	Metal Chelating Agents	4180186
19474329	Chemistry Technique, Analytical	4180186
19474329	Analytical Chemistry Method	4180186
19474329	Analytical Chemistry Technique	4180186
19474329	Methods, Analytical Chemistry	4180186
19474329	Chemistry Method, Analytical	4180186
19474329	Techniques, Analytical Chemistry	4180186
19474329	Chemistry Methods, Analytical	4180186
19474329	Analytical Chemistry Methods	4180186
19474329	Technique, Analytical Chemistry	4180186
19474329	Method, Analytical Chemistry	4180186
19474329	Analytical Chemistry Techniques	4180186
19474331	Child Daycare Center	4180186
19474331	Daycare Centers for Children	4180186
19474331	Day Care Centers for Children	4180186
19474331	Child Daycare Centers	4180186
19474332	Guidance Clinic, Child	4180186
19474332	Guidance Clinics, Child	4180186
19474332	Clinics, Child Guidance	4180186
19474332	Child Guidance Clinic	4180186
19474332	Clinic, Child Guidance	4180186
19474333	Hydrate, Chloral	4180186
19474333	1,1-Ethanediol, 2,2,2-trichloro-	4180186
19474333	Noctec	4180186
19474334	alpha Chloralose	4180186
19474334	Anhydroglucochloral	4180186
19474334	alpha-D-Glucofuranose, 1,2-O-(2,2,2-trichloroethylidene)-, (R)-	4180186
19474334	alpha-Chloralose	4180186
19474334	Glucochloralose	4180186
19474334	beta-Chloralose	4180186
19474334	Glucochloral	4180186
19474334	beta Chloralose	4180186
19474335	Chlorate	4180186
19474342	Toxin B, Cholera	4180186
19474342	Choleragenoid	4180186
19474342	Cholera Enterotoxin CT	4180186
19474342	Cholera Toxin Protomer B	4180186
19474342	Cholera Exotoxin	4180186
19474342	Toxin, Cholera	4180186
19474342	Cholera Toxin B Subunit	4180186
19474342	Enterotoxin CT, Cholera	4180186
19474342	Cholera Toxin B	4180186
19474342	Cholera Toxin Protomer A	4180186
19474342	Toxin A, Cholera	4180186
19474342	Cholera Toxin A Subunit	4180186
19474342	Cholera Toxin A	4180186
19474342	Exotoxin, Cholera	4180186
19474342	Cholera Toxin Subunit A	4180186
19474342	Cholera Toxin Subunit B	4180186
19474342	Procholeragenoid	4180186
19474342	Choleragen	4180186
19474343	Cholalic Acids	4180186
19474343	Acids, Cholic	4180186
19474343	Acids, Cholalic	4180186
19474346	Chromomycin	4180186
19474347	Mercurate(1-), (2,3-dihydro-2-thioxo-5-benzoxazolecarboxylato(2-)-S)ethyl-, sodium	4180186
19474348	Cinanserin Hydrochloride	4180186
19474348	SQ-10,643	4180186
19474348	SQ 10,643	4180186
19474348	SQ16,167	4180186
19474348	Cinanserin Monohydrochloride	4180186
19474348	Monohydrochloride, Cinanserin	4180186
19474348	Hydrochloride, Cinanserin	4180186
19474348	SQ10,643	4180186
19474348	SQ-16,167	4180186
19474348	SQ 16,167	4180186
19474348	2-Propenamide, N-(2-((3-(dimethylamino)propyl)thio)phenyl)-3-phenyl-	4180186
19474354	Clofenapate, Methyl	4180186
19474354	ICI55695	4180186
19474354	ICI 55695	4180186
19474354	Propanoic acid, 2-((4'-chloro(1,1'-biphenyl)-4-yl)oxy)-2-methyl-, methyl ester	4180186
19474354	ICI-55695	4180186
19474354	Methyl Clofenapate	4180186
19474354	Methylclofenapate	4180186
19474355	2-(4-Chlorophenoxy)-2-methylpropionic Acid	4180186
19474355	Propanoic acid, 2-(4-chlorophenoxy)-2-methyl-	4180186
19474355	NSC-1149	4180186
19474355	Clofibrinic Acid	4180186
19474355	p-Chlorophenoxyisobutyrate	4180186
19474355	NSC 1149	4180186
19474355	p-Chlorophenoxyisobutyric Acid	4180186
19474355	NSC1149	4180186
19474356	Chlorgyline	4180186
19474356	2-Propyn-1-amine, N-(3-(2,4-dichlorophenoxy)propyl)-N-methyl-	4180186
19474356	Clorgiline	4180186
19474356	Clorgilin	4180186
19474358	Imidazo(4,5-d)(1,3)diazepin-8-ol, 3,4,7,8-tetrahydro-3-beta-D-ribofuranosyl-, (R)-	4180186
19474359	Climates, Cold	4180186
19474359	Regions, Polar	4180186
19474359	Climate, Cold	4180186
19474359	Region, Polar	4180186
19474359	Polar Region	4180186
19474359	Cold Climates	4180186
19474359	Polar Regions	4180186
19474360	Precolicin E1	4180186
19474360	Colicin HSC10	4180186
19474360	Colicin Ib	4180186
19474360	Colicins E	4180186
19474360	Colicin N	4180186
19474360	Colicin V	4180186
19474360	Colicin K	4180186
19474360	Colicin A	4180186
19474360	E9, Colicin	4180186
19474360	Colicin	4180186
19474360	Colicin E3	4180186
19474360	Colicin E	4180186
19474360	Colicin E1	4180186
19474360	Colicins E9	4180186
19474360	Colicin K K235	4180186
19474360	Colicin K-K235	4180186
19474360	Colicin E9	4180186
19474360	Colicin Ia	4180186
19474360	Colicin B	4180186
19474360	Colicin E2	4180186
19474360	Colicine	4180186
19474360	Colicin M	4180186
19474360	Colicin E8	4180186
19474360	Colicines	4180186
19474361	Mentally Ill Commitments	4180186
19474361	Commitment, Outpatient	4180186
19474361	Outpatient Commitment	4180186
19474363	Centers, Community Health	4180186
19474363	Health Centers, Community	4180186
19474363	Neighborhood Health Centers	4180186
19474363	Center, Community Health	4180186
19474363	Satellite Center	4180186
19474363	Center, Neighborhood Health	4180186
19474363	Centers, Satellite	4180186
19474363	Satellite Centers	4180186
19474363	Health Center, Community	4180186
19474363	Center, Satellite	4180186
19474363	Health Center, Neighborhood	4180186
19474363	Community Health Center	4180186
19474363	Neighborhood Health Center	4180186
19474363	Health Centers, Neighborhood	4180186
19474363	Centers, Neighborhood Health	4180186
19474364	CMHC	4180186
19474368	Complement 1	4180186
19474368	Complement Component 1	4180186
19474368	C1 Complement	4180186
19474368	Component 1, Complement	4180186
19474368	Complement, C1	4180186
19474368	C1, Complement	4180186
19474370	Complement C1r Protease Inhibitor Proteins	4180186
19474370	Complement 1 Esterase Inhibitors	4180186
19474370	Complement C1 Inhibiting Proteins	4180186
19474370	Complement Component 1 Inactivator Proteins	4180186
19474370	Complement C1s Esterase Inhibitor Proteins	4180186
19474370	Complement C1 Inhibitor Proteins	4180186
19474370	Complement C1 Inactivating Proteins	4180186
19474372	IgG Autoantibody, C3NeF	4180186
19474372	C3NeF IgG Autoantibody	4180186
19474372	Complement 3 Nephritic Factor	4180186
19474372	C3 NeF IgG Autoantibody	4180186
19474372	C3 NeF IgG Autoantibodies	4180186
19474372	C3 Nephritic Factor	4180186
19474372	C3NeF IgG Autoantibodies	4180186
19474372	C 3 Nephritic Factor	4180186
19474372	Autoantibody, C3NeF IgG	4180186
19474372	C3 NeF	4180186
19474375	C5, Complement	4180186
19474375	Component 5, Complement	4180186
19474375	C5 Complement	4180186
19474375	Precursor Complement C5	4180186
19474375	Complement Component 5	4180186
19474375	C5, Precursor Complement	4180186
19474375	Pro-complement 5	4180186
19474375	Complement C5, Precursor	4180186
19474375	Pro-C5	4180186
19474375	C5, Precursor	4180186
19474375	Complement 5	4180186
19474375	Pro C5	4180186
19474375	Precursor C5	4180186
19474375	Complement, C5	4180186
19474375	Pro complement 5	4180186
19474376	Component 6, Complement	4180186
19474376	Complement, C6	4180186
19474376	Complement 6	4180186
19474376	C6 Complement	4180186
19474376	Complement Component 6	4180186
19474376	C6, Complement	4180186
19474381	Extranet	4180186
19474381	Distributed System	4180186
19474381	Networks, Telecommunication	4180186
19474381	Network Communication Protocols	4180186
19474381	Network, Computer Communication	4180186
19474381	Telecommunication Networks	4180186
19474381	Distributed Database	4180186
19474381	Distributed Systems	4180186
19474381	Databases, Distributed	4180186
19474381	Distributed Databases	4180186
19474381	Communication Network, Computer	4180186
19474381	Intranets	4180186
19474381	Protocols, Network Communication	4180186
19474381	Network, Telecommunication	4180186
19474381	Network Management, Computer	4180186
19474381	Extranets	4180186
19474381	Database, Distributed	4180186
19474381	Communication Networks, Computer	4180186
19474381	Networks, Computer Communication	4180186
19474381	Systems, Distributed	4180186
19474381	Communication Protocol, Network	4180186
19474381	Computer Communication Network	4180186
19474381	Protocol, Network Communication	4180186
19474381	Computer Network Management	4180186
19474381	Management, Computer Network	4180186
19474381	Network Communication Protocol	4180186
19474381	System, Distributed	4180186
19474381	Intranet	4180186
19474381	Communication Protocols, Network	4180186
19474381	Telecommunication Network	4180186
19474382	System, Computer	4180186
19474382	Computer System	4180186
19474382	Computer Architecture	4180186
19474382	Architectures, Computer	4180186
19474382	Organization, Computer Systems	4180186
19474382	Systems, Real-Time	4180186
19474382	Computer Systems Evaluation	4180186
19474382	Real-Time System	4180186
19474382	Computer Architectures	4180186
19474382	Computer Systems Development	4180186
19474382	Real Time System	4180186
19474382	System, Real-Time	4180186
19474382	Computer Systems Organization	4180186
19474382	Systems, Computer	4180186
19474382	Evaluation, Computer Systems	4180186
19474382	System, Real Time	4180186
19474382	Architecture, Computer	4180186
19474382	Time Systems, Real	4180186
19474382	Time System, Real	4180186
19474382	Real Time Systems	4180186
19474382	Real-Time Systems	4180186
19474382	Computer Systems Evaluations	4180186
19474382	Development, Computer Systems	4180186
19474382	Systems, Real Time	4180186
19474382	Evaluations, Computer Systems	4180186
19474384	Congresses as Topics	4180186
19474384	Conference Proceedings as Topic	4180186
19474384	Conferences and Congresses	4180186
19474384	Topics, Congresses as	4180186
19474384	Conferences	4180186
19474384	Congresses and Conferences	4180186
19474384	Proceedings and Conferences	4180186
19474384	Professional Meetings and Conferences	4180186
19474384	Conferences and Proceedings	4180186
19474385	Contraceptive Effects	4180186
19474385	Agents, Contraceptive	4180186
19474385	Contraceptive	4180186
19474385	Contraceptive Effect	4180186
19474385	Effects, Contraceptive	4180186
19474385	Effect, Contraceptive	4180186
19474385	Contraceptives	4180186
19474390	Product, Personal Care	4180186
19474390	Care Products, Personal	4180186
19474390	Products, Personal Care	4180186
19474390	Personal Care Product	4180186
19474390	Care Product, Personal	4180186
19474390	Personal Care Products	4180186
19474391	Scotine	4180186
19474391	2-Pyrrolidinone, 1-methyl-5-(3-pyridinyl)-, (S)-	4180186
19474392	Phosphorothioic acid, O-(3-chloro-4-methyl-2-oxo-2H-1-benzopyran-7-yl) O,O-diethyl ester	4180186
19474392	Coumafos	4180186
19474392	Asuntol	4180186
19474393	1,2-Benzopyrone Derivatives	4180186
19474393	Coumarin Derivatives	4180186
19474393	Derivatives, 1,2-Benzopyrone	4180186
19474393	Derivatives, Coumarin	4180186
19474393	1,2 Benzo Pyrones	4180186
19474393	Coumarine	4180186
19474393	Benzopyran-2-ones	4180186
19474393	Coumarin Derivative	4180186
19474393	Benzopyran 2 ones	4180186
19474393	Coumarines	4180186
19474393	1,2 Benzopyrones	4180186
19474393	1,2 Benzopyrone Derivatives	4180186
19474393	1,2-Benzopyrones	4180186
19474393	Derivative, Coumarin	4180186
19474393	1,2-Benzo-Pyrones	4180186
19474394	6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-	4180186
19474395	Fluorogestone Acetate	4180186
19474395	Acetate, Flurogestone	4180186
19474395	Acetate, Fluorogestone	4180186
19474395	17 beta-Acetoxy-9-fluoro-11 beta-hydroxyprogesterone	4180186
19474395	beta-hydroxyprogesterone, 17 beta-Acetoxy-9-fluoro-11	4180186
19474395	Cronolone	4180186
19474395	Acetate, Flugestone	4180186
19474395	Pregn-4-ene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-, (11beta)-	4180186
19474395	17 beta Acetoxy 9 fluoro 11 beta hydroxyprogesterone	4180186
19474395	Flugestone Acetate	4180186
19474395	Flurogestone	4180186
19474395	beta-Acetoxy-9-fluoro-11 beta-hydroxyprogesterone, 17	4180186
19474395	Flugestone	4180186
19474398	Biscyclohexanone Oxaldihydrazone	4180186
19474398	Ethanedioic acid, bis(cyclohexylidenehydrazide)	4180186
19474398	Oxaldihydrazone, Biscyclohexanone	4180186
19474404	NSC 1026	4180186
19474404	Acid, Aminocyclopentanecarboxylic	4180186
19474404	Acid, 1-Aminocyclopentanecarboxylic	4180186
19474404	1 Aminocyclopentanecarboxylic Acid	4180186
19474404	Cyclopentanecarboxylic acid, 1-amino-	4180186
19474404	Aminocyclopentanecarboxylic Acid	4180186
19474404	1-Aminocyclopentanecarboxylic Acid	4180186
19474405	Card-20(22)-enolide, 3-((2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3beta,5beta)-	4180186
19474405	k-Strophanthin-alpha	4180186
19474405	Zimarin	4180186
19474405	Cymarin	4180186
19474405	k Strophanthin alpha	4180186
19474405	h Strophanthin	4180186
19474405	Strophantisel	4180186
19474405	Tsimarin	4180186
19474405	h-Strophanthin	4180186
19474406	Acid, Cytidylic	4180186
19474406	Cytidylic Acids	4180186
19474406	3' CMP	4180186
19474406	Cytidylic Acid	4180186
19474406	CMP	4180186
19474406	5'-Cytidylic acid	4180186
19474406	Acids, Cytidylic	4180186
19474406	2'-CMP	4180186
19474406	Monophosphate, Cytidine	4180186
19474406	2' CMP	4180186
19474406	3'-CMP	4180186
19474409	Dimethylaminonaphthalenesulfonyl Compounds	4180186
19474409	Compounds, Dimethylaminonaphthalenesulfonyl	4180186
19474409	Compounds, Dansyl	4180186
19474413	Death, Cardiac	4180186
19474413	Near-Death Experience	4180186
19474413	Determination of Death	4180186
19474413	Cardiac Death	4180186
19474413	End Of Life	4180186
19474413	End-Of-Life	4180186
19474419	Clinic, Dental	4180186
19474419	Clinics, Dental	4180186
19474419	Dental Clinic	4180186
19474422	Retention, Denture	4180186
19474422	Denture Stability	4180186
19474422	Stability, Denture	4180186
19474423	Prints, Plantar	4180186
19474423	Fingerprints	4180186
19474423	Print, Plantar	4180186
19474423	Fingerprint	4180186
19474423	Plantar Print	4180186
19474423	Plantar Prints	4180186
19474424	Laundry Detergent Pod	4180186
19474424	Pod, Laundry Detergent	4180186
19474424	Detergent	4180186
19474424	Detergents, Synthetic	4180186
19474424	Cleansing Agents	4180186
19474424	Syndet	4180186
19474424	Pods, Laundry	4180186
19474424	Detergent Pod, Laundry	4180186
19474424	Detergent Pod	4180186
19474424	Pod, Laundry	4180186
19474424	Agents, Cleansing	4180186
19474424	Agent, Cleansing	4180186
19474424	Laundry Pod	4180186
19474424	Pods, Laundry Detergent	4180186
19474424	Detergent Pods, Laundry	4180186
19474424	Synthetic Detergent	4180186
19474424	Cleansing Agent	4180186
19474424	Laundry Detergent Pods	4180186
19474424	Detergent Pods	4180186
19474424	Detergent, Synthetic	4180186
19474424	Synthetic Detergents	4180186
19474424	Pods, Detergent	4180186
19474424	Pod, Detergent	4180186
19474424	Laundry Pods	4180186
19474426	Diagnoses, Antemortem	4180186
19474426	Examination and Diagnoses	4180186
19474426	Diagnoses	4180186
19474426	Diagnoses and Examination	4180186
19474426	Diagnoses, Postmortem	4180186
19474426	Postmortem Diagnoses	4180186
19474426	Diagnosis, Antemortem	4180186
19474426	Diagnosis, Postmortem	4180186
19474426	Diagnoses and Examinations	4180186
19474426	Examinations and Diagnoses	4180186
19474426	Antemortem Diagnoses	4180186
19474426	Diagnose	4180186
19474426	Antemortem Diagnosis	4180186
19474426	Postmortem Diagnosis	4180186
19474431	Methane, diazo-	4180186
19474431	Diazirine	4180186
19474434	2,5-Dibromo-3-methyl-6-isopropyl-p-benzoquinone	4180186
19474434	2,5-Cyclohexadiene-1,4-dione, 2,5-dibromo-3-methyl-6-(1-methylethyl)-	4180186
19474434	2,5 Dibromo 3 methyl 6 isopropyl p benzoquinone	4180186
19474444	Dihydro beta Erythroidine	4180186
19474444	16(15H)-Oxaerythrinan-15-one, 1,6-didehydro-14,17-dihydro-3-methoxy-, (3beta)-	4180186
19474444	Erythroidine, Dihydro beta	4180186
19474444	beta Erythroidine, Dihydro	4180186
19474445	Morphinan-3,6-diol, 4,5-epoxy-17-methyl-, (5alpha,6alpha)-	4180186
19474445	Paramorphan	4180186
19474445	Paramorfan	4180186
19474449	5,5-Dimethyloxazolidine-2,4-dione	4180186
19474449	2,4-Oxazolidinedione, 5,5-dimethyl-	4180186
19474449	Dimethyloxazolidinedione	4180186
19474449	5,5-Dimethyl-2,4-oxazolidinedione	4180186
19474451	Adipimidate, Dimethyl	4180186
19474451	Hexanediimidic acid, dimethyl ester	4180186
19474451	Adipimate, Dimethyl	4180186
19474451	Dimethyl Adipinamidate	4180186
19474451	Dimethyl Adipimate	4180186
19474451	Adipinamidate, Dimethyl	4180186
19474452	Suberimidate, Bismethyl	4180186
19474452	Suberimidate, Dimethyl	4180186
19474452	Octanediimidic acid, dimethyl ester	4180186
19474452	Dimethylsuberimidate	4180186
19474452	Bismethyl Suberimidate	4180186
19474454	N,N Dimethylformamide	4180186
19474454	N,N-Dimethylformamide	4180186
19474454	Formamide, N,N-dimethyl-	4180186
19474456	Benzene, 1-fluoro-2,4-dinitro-	4180186
19474456	1 Fluoro 2,4 dinitrobenzene	4180186
19474456	Fluorodinitrobenzene	4180186
19474456	1-Fluoro-2,4-dinitrobenzene	4180186
19474456	DNFB	4180186
19474460	Diploidies	4180186
19474460	Diploid Cells	4180186
19474460	Diploid Cell	4180186
19474460	Cell, Diploid	4180186
19474460	Diploid	4180186
19474460	Cells, Diploid	4180186
19474460	Diploids	4180186
19474465	2,3-Butanediol, 1,4-dimercapto-, (R*,S*)-	4180186
19474465	2,3-Dihydroxy-1,4-dithiolbutane	4180186
19474465	Dithioerythreitol	4180186
19474467	Reagent, Cleland's	4180186
19474467	Reagent, Cleland	4180186
19474467	Cleland's Reagent	4180186
19474467	Cleland Reagent	4180186
19474467	2,3-Butanediol, 1,4-dimercapto-, (R*,R*)-	4180186
19474467	Clelands Reagent	4180186
19474467	Sputolysin	4180186
19474468	Diphenylthiocarbazone	4180186
19474468	Dithizon	4180186
19474468	Diazenecarbothioic acid, phenyl-, 2-phenylhydrazide	4180186
19474469	Effect, Diuretic	4180186
19474469	Diuretic Effect	4180186
19474469	Diuretic	4180186
19474469	Diuretic Effects	4180186
19474469	Effects, Diuretic	4180186
19474475	1-(2,5-Dimethoxy-4-Methylphenyl)-2-Aminopropane	4180186
19474475	DOM	4180186
19474475	2,5-Dimethoxy-4-Methylamphetamine Hydrochloride, (R)-Isomer	4180186
19474475	2,5-Dimethoxy-4-Methylamphetamine, Hydrochloride	4180186
19474475	2,5 Dimethoxy 4 Methylamphetamine	4180186
19474475	Benzeneethanamine, 2,5-dimethoxy-alpha,4-dimethyl-	4180186
19474475	2 5 DOM	4180186
19474475	2,5-Dimethoxy-4-Methylamphetamine, (+,-)-Isomer	4180186
19474475	2,5-Dimethoxy-4-Methylamphetamine, (S)-Isomer	4180186
19474475	2,5-Dimethoxy-4-Methylamphetamine Hydrochloride, (+,-)-Isomer	4180186
19474475	2,5-Dimethoxy-4-Methylamphetamine Hydrochloride, (S)-Isomer	4180186
19474475	2,5-Dimethoxy-4-Methylamphetamine, (R)-Isomer	4180186
19474477	Pharmaceuticals	4180186
19474477	Products, Pharmaceutical	4180186
19474477	Preparations, Pharmaceutical	4180186
19474477	Pharmaceutical Preparation	4180186
19474477	Drug	4180186
19474477	Preparation, Pharmaceutical	4180186
19474477	Product, Pharmaceutical	4180186
19474477	Preparations, Pharmaceutic	4180186
19474477	Pharmaceutical	4180186
19474477	Drugs	4180186
19474477	Pharmaceutic Preparations	4180186
19474477	Pharmaceutical Product	4180186
19474477	Pharmaceutical Products	4180186
19474484	Electrolyte	4180186
19474486	Communication System, EMS	4180186
19474486	Communication Systems, EMS	4180186
19474486	Systems, EMS Communication	4180186
19474486	EMS Communication System	4180186
19474486	EMS Communication Systems	4180186
19474486	System, EMS Communication	4180186
19474486	Communication Systems, Emergency Medical Service	4180186
19474487	Emergency, Hospital Service	4180186
19474487	Emergencies, Hospital Service	4180186
19474487	Emergency Room	4180186
19474487	Hospital Emergency Services	4180186
19474487	Service Emergencies, Hospital	4180186
19474487	Emergency Unit	4180186
19474487	Emergency Outpatient Units	4180186
19474487	Wards, Emergency	4180186
19474487	Emergency Outpatient Unit	4180186
19474487	Accident and Emergency Department	4180186
19474487	Hospital Services, Emergency	4180186
19474487	Outpatient Units, Emergency	4180186
19474487	Services, Emergency Hospital	4180186
19474487	Service Emergency, Hospital	4180186
19474487	Services, Hospital Emergency	4180186
19474487	Emergency Hospital Service	4180186
19474487	Service, Hospital Emergency	4180186
19474487	Unit, Emergency	4180186
19474487	Ward, Emergency	4180186
19474487	Emergency Hospital Services	4180186
19474487	Emergency Units	4180186
19474487	Hospital Service Emergency	4180186
19474487	Rooms, Emergency	4180186
19474487	Service, Emergency Hospital	4180186
19474487	Hospital Service, Emergency	4180186
19474487	Department, Emergency	4180186
19474487	Outpatient Unit, Emergency	4180186
19474487	Emergency Services, Hospital	4180186
19474487	Emergency Wards	4180186
19474487	Hospital Service Emergencies	4180186
19474487	Departments, Emergency	4180186
19474487	Emergency Ward	4180186
19474487	Hospital Emergency Service	4180186
19474487	Room, Emergency	4180186
19474487	Emergency Departments	4180186
19474487	Units, Emergency	4180186
19474487	Units, Emergency Outpatient	4180186
19474487	Unit, Emergency Outpatient	4180186
19474487	Emergency Rooms	4180186
19474487	Emergency Department	4180186
19474488	Emetic Drugs	4180186
19474488	Agent, Emetic	4180186
19474488	Emetic Effect	4180186
19474488	Agents, Emetic	4180186
19474488	Emetic Agents	4180186
19474488	Emetic Effects	4180186
19474488	Drugs, Emetic	4180186
19474488	Drug, Emetic	4180186
19474488	Effects, Emetic	4180186
19474488	Emetic Drug	4180186
19474488	Emetic	4180186
19474488	Emetic Agent	4180186
19474488	Effect, Emetic	4180186
19474490	Cyanoacrylates, Polyisobutyl	4180186
19474490	2-Cyanobutylacrylate	4180186
19474490	Histacryl	4180186
19474490	Butyl 2 Cyanacrylate	4180186
19474490	NBCA compound	4180186
19474490	Polyisobutylcyanoacrylate	4180186
19474490	N Butyl Cyanoacrylate	4180186
19474490	Poly(Isobutyl Cyanoacrylate)	4180186
19474490	Cyanoacrylates, Polybutyl	4180186
19474490	Histoacryl	4180186
19474490	Enbucrylate	4180186
19474490	Butylcyanoacrylate	4180186
19474490	Butyl 2-Cyanacrylate	4180186
19474490	Polybutyl Cyanoacrylates	4180186
19474490	Polyisobutyl Cyanoacrylates	4180186
19474490	N-Butyl-2-Cyanoacrylates	4180186
19474490	Histoacryl N blau	4180186
19474490	Histoacryls	4180186
19474490	Enbucrylates	4180186
19474490	N-Butyl-Cyanoacrylate	4180186
19474490	NBCA compounds	4180186
19474490	Chirurcoll	4180186
19474490	Histoacryl Blue	4180186
19474490	2-Propenoic acid, 2-cyano-, butyl ester	4180186
19474490	Polybutyl Cyanoacrylate	4180186
19474490	2 Cyanobutylacrylate	4180186
19474490	Kanokonlit	4180186
19474490	Ligament-Fimomed	4180186
19474490	Histoacryl N-blau	4180186
19474490	Cyanoacrylate, Polyisobutyl	4180186
19474490	N Butyl 2 Cyanoacrylate	4180186
19474490	N-Butyl-2-Cyanoacrylate	4180186
19474490	Polyisobutyl Cyanoacrylate	4180186
19474490	Enbucrilate, Homopolymer	4180186
19474490	Cyanoacrylate, Polybutyl	4180186
19474490	Enbucrilates	4180186
19474490	N-Butyl-Cyanoacrylates	4180186
19474490	Butylcyanoacrylates	4180186
19474490	Fimomed	4180186
19474490	Butyl 2-Cyanacrylates	4180186
19474490	Histacryls	4180186
19474490	2-Cyanobutylacrylates	4180186
19474490	Polyisobutylcyanoacrylates	4180186
19474490	Enbucrilates, Homopolymer	4180186
19474491	Glucagon Like Peptide	4180186
19474491	Glucagon-Like Peptide	4180186
19474491	Glucagon Like Polypeptides	4180186
19474491	Glucagon, Gut	4180186
19474491	Glucagon-Like Polypeptides	4180186
19474491	Polypeptide, Glucagon-Like	4180186
19474491	Enteroglucagons	4180186
19474491	Glucagon-Like Polypeptide	4180186
19474491	Gut Glucagon	4180186
19474491	Enteroglucagon	4180186
19474491	Glucagon Like Peptides	4180186
19474491	Glucagon Like Polypeptide	4180186
19474491	Peptide, Glucagon-Like	4180186
19474496	Stimuvol	4180186
19474496	Estra-1,3,5(10)-triene-16,17-diol, 3-methoxy-, (16alpha,17alpha)-	4180186
19474502	Acids, Docosenoic	4180186
19474502	Docosenoic Acids	4180186
19474502	Acids, Brassidic	4180186
19474502	Acids, Erucic	4180186
19474502	Brassidic Acids	4180186
19474504	Etazolate Hydrochloride	4180186
19474504	Hydrochloride, Etazolate	4180186
19474504	SQ 20009	4180186
19474504	1H-Pyrazolo(3,4-b)pyridine-5-carboxylic acid, 1-ethyl-4-((1-methylethylidene)hydrazino)-, ethyl ester	4180186
19474504	SQ-20009	4180186
19474504	SQ20009	4180186
19474505	Ethacrynate Sodium	4180186
19474505	Acid, Ethacrynic	4180186
19474505	Hydromedin	4180186
19474505	Ethacrinic Acid	4180186
19474505	Acid, Ethacrinic	4180186
19474505	Acetic acid, (2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy)-	4180186
19474505	Edecrin	4180186
19474505	Acid, Etacrynic	4180186
19474505	Ethacrynic Acid, Sodium Salt	4180186
19474505	Etacrynic Acid	4180186
19474505	Sodium, Ethacrynate	4180186
19474507	Bromide, Homidium	4180186
19474507	Bromide, Ethidium	4180186
19474507	Phenanthridinium, 3,8-diamino-5-ethyl-6-phenyl-	4180186
19474507	Homidium Bromide	4180186
19474507	Novidium	4180186
19474507	Ethidium Bromide	4180186
19474509	Ethyldicoumarol	4180186
19474509	Tromexan	4180186
19474509	Carbethoxydicoumarol	4180186
19474509	Biscoumacetate, Ethyl	4180186
19474509	Pelentan	4180186
19474509	2H-1-Benzopyran-3-acetic acid, 4-hydroxy-alpha-(4-hydroxy-2-oxo-2H-1-benzopyran-3-yl)-2-oxo-, ethyl ester	4180186
19474510	Ethylmesylate	4180186
19474510	Sulfonate, Ethylmethane	4180186
19474510	Methanesulfonic acid, ethyl ester	4180186
19474510	Ethyl Mesylate	4180186
19474510	Ethylmethane Sulfonate	4180186
19474510	Ethylmesilate	4180186
19474510	Methanesulfonate, Ethyl	4180186
19474510	Mesilate, Ethyl	4180186
19474510	Ethyl Mesilate	4180186
19474510	Mesylate, Ethyl	4180186
19474514	Femulen	4180186
19474514	Ethynodiol Diacetate, (17 alpha)-Isomer	4180186
19474514	Ethyndiol Diacetate	4180186
19474514	(3 beta, 17 alpha)-19-Norpregn-4-en-20-yne-3,17 diol Diacetate	4180186
19474514	19-Norpregn-4-en-20-yne-3,17-diol, diacetate, (3beta,17alpha)-	4180186
19474514	Continuin	4180186
19474516	5 beta Androsterone	4180186
19474516	5-beta-Androsterone	4180186
19474516	Androstan-17-one, 3-hydroxy-, (3alpha,5beta)-	4180186
19474516	3 alpha Hydroxy 5 beta Androstan 17 One	4180186
19474516	3-alpha-Hydroxy-5-beta-Androstan-17-One	4180186
19474518	Glucan 1,4 alpha Glucosidase	4180186
19474518	gamma Amylase	4180186
19474518	1,4-alpha-D-Glucan glucohydrolase	4180186
19474518	gamma-Amylase	4180186
19474518	Glucoamylase	4180186
19474518	1,4-alpha-Glucosidase, Exo	4180186
19474518	1,4-alpha-Glucosidase, Glucan	4180186
19474518	Glucoamylase G1	4180186
19474518	Exo-1,4-alpha-Glucosidase	4180186
19474518	Exo 1,4 alpha Glucosidase	4180186
19474518	Amyloglucosidase	4180186
19474518	Glucoamylase G2	4180186
19474519	Systems, Expert	4180186
19474519	System, Expert	4180186
19474519	Expert System	4180186
19474520	Extravasation of Contrast Media	4180186
19474520	Contrast Media Extravasation	4180186
19474520	Extravasation of Diagnostic, Therapeutic Materials	4180186
19474525	Ferrozine, Monosodium Salt, Monohydrate	4180186
19474525	Monosodium Salt Ferrozine	4180186
19474525	Ferrozine, Monosodium Salt	4180186
19474525	Benzenesulfonic acid, 4,4'-(3-(2-pyridinyl)-1,2,4-triazine-5,6-diyl)bis-, disodium salt	4180186
19474529	Cirrhosis	4180186
19474529	Fibroses	4180186
19474531	NSC-3364	4180186
19474531	Filipin IV	4180186
19474531	NSC 3364	4180186
19474531	Filipin II	4180186
19474531	Filipin I	4180186
19474531	Desoxylagosin	4180186
19474531	U5956	4180186
19474531	NSC3364	4180186
19474531	U 5956	4180186
19474531	Filimarisin	4180186
19474531	U-5956	4180186
19474531	Filipin III	4180186
19474535	Rice Flour	4180186
19474535	Grain Flours	4180186
19474535	Soybean Meal	4180186
19474535	Meals, Wheat	4180186
19474535	Meal, Wheat	4180186
19474535	Rice Meals	4180186
19474535	Flour, Nut	4180186
19474535	Flours, Wheat	4180186
19474535	Almond Meals	4180186
19474535	Meal, Almond	4180186
19474535	Almond Flour	4180186
19474535	Soybean Flours	4180186
19474535	Flour, Almond	4180186
19474535	Flours, Semolina	4180186
19474535	Flour, Rice	4180186
19474535	Flours, Almond	4180186
19474535	Almond Meal	4180186
19474535	Meals, Grain	4180186
19474535	Meals, Soybean	4180186
19474535	Wheat Meal	4180186
19474535	Flour, Soybean	4180186
19474535	Flours	4180186
19474535	Flours, Grain	4180186
19474535	Flour, Wheat	4180186
19474535	Corn Flours	4180186
19474535	Corn Flour	4180186
19474535	Flour, Potato	4180186
19474535	Nut Flours	4180186
19474535	Potato Flour	4180186
19474535	Meals, Almond	4180186
19474535	Flours, Rice	4180186
19474535	Meal, Grain	4180186
19474535	Soybean Flour	4180186
19474535	Flours, Nut	4180186
19474535	Meal, Rice	4180186
19474535	Rice Meal	4180186
19474535	Semolina Flours	4180186
19474535	Corn Meal	4180186
19474535	Almond Flours	4180186
19474535	Flour, Grain	4180186
19474535	Potato Flours	4180186
19474535	Rice Flours	4180186
19474535	Flour, Corn	4180186
19474535	Wheat Flour	4180186
19474535	Nut Flour	4180186
19474535	Meals, Rice	4180186
19474535	Semolina Flour	4180186
19474535	Meal, Corn	4180186
19474535	Flour, Semolina	4180186
19474535	Grain Meal	4180186
19474535	Wheat Meals	4180186
19474535	Grain Meals	4180186
19474535	Corn Meals	4180186
19474535	Flours, Soybean	4180186
19474535	Flours, Corn	4180186
19474535	Grain Flour	4180186
19474535	Wheat Flours	4180186
19474535	Meal, Soybean	4180186
19474535	Soybean Meals	4180186
19474535	Meals, Corn	4180186
19474535	Flours, Potato	4180186
19474536	Flucinar	4180186
19474536	Acetonide, Fluortriamcinolone	4180186
19474536	Derma-Smooth FS	4180186
19474536	Jellin	4180186
19474536	Fluotrex	4180186
19474536	Derma Smooth FS	4180186
19474536	Flusolgen	4180186
19474536	Co-Fluocin	4180186
19474536	Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)-	4180186
19474536	Cortiespec	4180186
19474536	Synalar-HP	4180186
19474536	Fluodermo	4180186
19474536	Fluocid	4180186
19474536	Alvadermo	4180186
19474536	Flurosyn	4180186
19474536	Synamol	4180186
19474536	Gelidina	4180186
19474536	Jellisoft	4180186
19474536	Synemol	4180186
19474536	Synalar	4180186
19474536	Fluortriamcinolone Acetonide	4180186
19474536	Co Fluocin	4180186
19474536	Acetonide, Fluocinolone	4180186
19474536	Capex	4180186
19474536	Synalar HP	4180186
19474536	Fluonid	4180186
19474537	Fluram	4180186
19474537	Spiro(furan-2(3H),1'(3'H)-isobenzofuran)-3,3'-dione, 4-phenyl-	4180186
19474538	Tetraiodofluorescein	4180186
19474539	Polarization, Fluorescence	4180186
19474539	Anisotropies, Fluorescence	4180186
19474539	Anisotropy, Fluorescence	4180186
19474539	Fluorescence Anisotropies	4180186
19474539	Polarizations, Fluorescence	4180186
19474539	Fluorescence Anisotropy	4180186
19474539	Fluorescence Polarizations	4180186
19474541	Fluorothyl	4180186
19474541	Flurotyl	4180186
19474541	Indoklon	4180186
19474541	Ethane, 1,1'-oxybis(2,2,2-trifluoro)-	4180186
19474542	Preservatives, Food	4180186
19474543	Formazan	4180186
19474547	2,4-Imidazolidinedione, 1-((3-(5-nitro-2-furanyl)-2-propenylidene)amino)-	4180186
19474547	Furazidin	4180186
19474547	Solafur	4180186
19474549	29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, (3alpha,4alpha,8alpha,9beta,11alpha,13alpha,14beta,16beta,17Z)-	4180186
19474549	Sodium Fusidate	4180186
19474549	Acid, Fusidic	4180186
19474549	Silver Fusidate	4180186
19474549	Fusidate, Silver	4180186
19474549	Fusidic Acid, Sodium Salt	4180186
19474549	Fusidate Sodium	4180186
19474549	Sodium, Fusidate	4180186
19474549	Fusidin	4180186
19474549	Fucithalmic	4180186
19474549	Stanicide	4180186
19474549	Fusidate, Sodium	4180186
19474550	Tetraglycosyl Ceramide, Monosialosyl	4180186
19474550	Monosialosyl Tetraglycosyl Ceramide	4180186
19474550	Ganglioside GM1	4180186
19474550	Ceramide, Monosialosyl Tetraglycosyl	4180186
19474550	GM1a Monosialoganglioside	4180186
19474550	Monosialoganglioside, GM1a	4180186
19474550	GM1 Ganglioside	4180186
19474550	Ganglioside, GM1	4180186
19474551	gamma-Aminobutyric Acid, Monolithium Salt	4180186
19474551	Gammalon	4180186
19474551	gamma-Aminobutyric Acid, Calcium Salt (2:1)	4180186
19474551	gamma-Aminobutyric Acid, Zinc Salt (2:1)	4180186
19474551	Aminalone	4180186
19474551	gamma-Aminobutyric Acid, Monosodium Salt	4180186
19474551	4 Aminobutyric Acid	4180186
19474551	Butanoic acid, 4-amino-	4180186
19474551	Aminalon	4180186
19474551	gamma Aminobutyric Acid, Monolithium Salt	4180186
19474551	GABA	4180186
19474551	GABA, Lithium	4180186
19474551	Lithium GABA	4180186
19474551	4 Aminobutanoic Acid	4180186
19474551	gamma-Aminobutyric Acid, Hydrochloride	4180186
19474551	gamma Aminobutyric Acid, Hydrochloride	4180186
19474551	Hydrochloride gamma-Aminobutyric Acid	4180186
19474551	gamma Aminobutyric Acid, Monosodium Salt	4180186
19474551	gamma Aminobutyric Acid	4180186
19474551	4-Aminobutanoic Acid	4180186
19474551	4-Aminobutyric Acid	4180186
19474551	Acid, Hydrochloride gamma-Aminobutyric	4180186
19474553	Ganglioside	4180186
19474553	Sialoglycosphingolipids	4180186
19474558	Dominant Gene	4180186
19474558	Genetic Conditions, Dominant	4180186
19474558	Dominant Genes	4180186
19474558	Condition, Dominant Genetic	4180186
19474558	Genetic Condition, Dominant	4180186
19474558	Dominant Genetic Conditions	4180186
19474558	Gene, Dominant	4180186
19474558	Dominant Genetic Condition	4180186
19474558	Conditions, Dominant Genetic	4180186
19474559	Condition, Recessive Genetic	4180186
19474559	Recessive Gene	4180186
19474559	Conditions, Recessive Genetic	4180186
19474559	Gene, Recessive	4180186
19474559	Genetic Conditions, Recessive	4180186
19474559	Recessive Genes	4180186
19474559	Genetic Condition, Recessive	4180186
19474559	Recessive Genetic Conditions	4180186
19474559	Recessive Genetic Condition	4180186
19474561	Glafenin	4180186
19474561	Glaphenine	4180186
19474561	Exidol	4180186
19474561	Glycerylaminophenaquine	4180186
19474561	Benzoic acid, 2-((7-chloro-4-quinolinyl)amino)-, 2,3-dihydroxypropyl ester	4180186
19474566	Glucose Hypertonic Solutions	4180186
19474566	Solution, Hypertonic Glucose	4180186
19474566	Glucose Solutions, Hypertonic	4180186
19474566	Glucose Hypertonic Solution	4180186
19474566	Hypertonic Glucose Solution	4180186
19474566	Hypertonic Solutions, Glucose	4180186
19474566	Hypertonic Glucose Solutions	4180186
19474566	Hypertonic Solution, Glucose	4180186
19474566	Solutions, Hypertonic Glucose	4180186
19474566	Solutions, Glucose Hypertonic	4180186
19474566	Solution, Glucose Hypertonic	4180186
19474567	Isomerase, Glucosephosphate	4180186
19474567	Tumor-Cell Autocrine Motility Factor	4180186
19474567	Isomerase, Glucose 6 Phosphate	4180186
19474567	Isomerase, Phosphohexose	4180186
19474567	D-Glucose-6-phosphate ketol-isomerase	4180186
19474567	Phosphohexose Isomerase	4180186
19474567	Tumor Autocrine Motility Factor	4180186
19474567	Neuroleukin	4180186
19474567	Isomerase, Phosphoglucose	4180186
19474567	Factor, Autocrine Motility	4180186
19474567	Isomerase, Glucose-6-Phosphate	4180186
19474567	Glucose 6 Phosphate Isomerase	4180186
19474567	Autocrine Motility Factor	4180186
19474567	Glucosephosphate Isomerase	4180186
19474567	Phosphoglucose Isomerase	4180186
19474567	Tumor Cell Autocrine Motility Factor	4180186
19474567	Motility Factor, Autocrine	4180186
19474569	Acylglycerols	4180186
19474569	Acylglycerol	4180186
19474570	Glycophorin D	4180186
19474570	Glycophorin E	4180186
19474570	Glycophorin HA	4180186
19474570	beta-Sialoglycoprotein	4180186
19474570	Glycoconnectins	4180186
19474570	Sialoglycoprotein, MN	4180186
19474570	Glycophorin A	4180186
19474570	Glycophorin B	4180186
19474570	beta Sialoglycoprotein	4180186
19474570	Glycophorin	4180186
19474570	Glycoconnectin	4180186
19474570	Ss Sialoglycoprotein	4180186
19474570	Glycophorin C	4180186
19474570	Sialoglycoprotein, Ss	4180186
19474570	Ss Erythrocyte Membrane Sialoglycoproteins	4180186
19474570	Sialoglycoproteins, Erythrocyte	4180186
19474570	Erythrocyte Sialoglycoproteins	4180186
19474570	Red Blood Cell Membrane Sialoglycoprotein	4180186
19474570	Glycophorin A(M)	4180186
19474570	MN Sialoglycoprotein	4180186
19474571	Exoglycosidases	4180186
19474571	Glycohydrolase	4180186
19474571	Endoglycosidases	4180186
19474571	Glycosidases	4180186
19474571	Endoglycosidase	4180186
19474571	Exoglycosidase	4180186
19474571	Glycohydrolases	4180186
19474571	Hydrolases, Glycoside	4180186
19474571	Glycoside Hydrolase	4180186
19474571	Glycosidase	4180186
19474571	Hydrolase, Glycoside	4180186
19474573	Gonadotropin	4180186
19474575	Gossypol, (+-)-Isomer	4180186
19474575	Sodium Salt, Gossypol	4180186
19474575	Gossypol Dipotassium Salt	4180186
19474575	Gossypol, (-)-Isomer	4180186
19474575	Gossypol Sodium Salt	4180186
19474575	(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-	4180186
19474575	Gossypol, (+)-Isomer	4180186
19474575	Dipotassium Salt, Gossypol	4180186
19474576	Inhibitors, Growth	4180186
19474576	Cell Growth Inhibitors	4180186
19474576	Inhibitors, Cell Growth	4180186
19474576	Inhibitor, Growth	4180186
19474576	Growth Inhibitor, Cell	4180186
19474576	Growth Inhibitor	4180186
19474576	Growth Inhibitors, Cell	4180186
19474576	Inhibitor, Cell Growth	4180186
19474576	Cell Growth Inhibitor	4180186
19474577	Mitogens, Endogenous	4180186
19474577	Endogenous Mitogens	4180186
19474579	Acacia, Gum	4180186
19474579	Gum, Acacia	4180186
19474579	Acacia Gum	4180186
19474579	Arabic, Gum	4180186
19474579	Gum Acacia	4180186
19474582	Haploid	4180186
19474582	Haploid Cells	4180186
19474582	Cells, Haploid	4180186
19474582	Haploid Cell	4180186
19474582	Haploidies	4180186
19474582	Haploids	4180186
19474582	Cell, Haploid	4180186
19474584	9H-Pyrido(3,4-b)indole, 7-methoxy-1-methyl-	4180186
19474584	Yageine	4180186
19474584	Telepathine	4180186
19474584	Leucoharmine	4180186
19474584	Banisterine	4180186
19474585	Alkaloids, Cephalotaxine	4180186
19474585	Cephalotaxus Alkaloids	4180186
19474585	Cephalotaxine Alkaloids	4180186
19474585	Alkaloids, Cephalotaxus	4180186
19474586	Facilities, Health	4180186
19474586	Facility, Health	4180186
19474586	Health Facility	4180186
19474587	Health Facility, Proprietary	4180186
19474587	Facility, Proprietary Health	4180186
19474587	Proprietary Health Facilities	4180186
19474587	Programs, Privately Sponsored	4180186
19474587	Facilities, Proprietary Health	4180186
19474587	Proprietary Health Facility	4180186
19474587	Program, Privately Sponsored	4180186
19474587	Privately Sponsored Program	4180186
19474587	Privately Sponsored Programs	4180186
19474589	Isohemagglutinins	4180186
19474589	Exohemagglutinins	4180186
19474589	Hemagglutinin	4180186
19474591	Haematoxylon	4180186
19474591	Hydroxybrasilin	4180186
19474591	Hemotoxylin	4180186
19474591	Benz(b)indeno(1,2-d)pyran-3,4,6a,9,10(6H)-pentol, 7,11b-dihydro-, cis-(+)-	4180186
19474591	Hematoxiline	4180186
19474591	Hydroxybrazilin	4180186
19474592	Morpholinium, 2,2'-(1,1'-biphenyl)-4,4'-diylbis(2-hydroxy-4,4-dimethyl)-, dibromide	4180186
19474592	Hemicholinium	4180186
19474593	Hospital Hemodialysis Units	4180186
19474593	Hemodialysis Unit, Hospital	4180186
19474593	Unit, Hospital Hemodialysis	4180186
19474593	Units, Hospital Hemodialysis	4180186
19474593	Hospital Hemodialysis Unit	4180186
19474593	Renal Dialysis Units, Hospital	4180186
19474597	Hexadimethrine	4180186
19474597	Bromide, Hexadimethrine	4180186
19474597	1,5-Dimethyl-1,5-Diazaundecamethylene Polymethobromide	4180186
19474597	1,6-Hexanediamine, N,N,N',N'-tetramethyl-, polymer with 1,3-dibromopropane	4180186
19474597	Polybrene	4180186
19474598	Hexestrol, (R-(R*,R*))-Isomer	4180186
19474598	Hexestrol, (R*,R*)-(+-)-Isomer	4180186
19474598	Hexestrol, (R*,S*)-Isomer	4180186
19474598	Hexestrol, (S-(R*,R*))-Isomer	4180186
19474598	Dihydrodiethylstilbestrol	4180186
19474598	Phenol, 4,4'-(1,2-diethyl-1,2-ethanediyl)bis-	4180186
19474600	Hirudin	4180186
19474603	1H-Imidazole-4-propanol, beta-amino-	4180186
19474603	Histidol	4180186
19474604	Transplantation Antigens	4180186
19474604	Antigens, SD	4180186
19474604	Histocompatibility Antigen	4180186
19474604	Antigens, Transplantation	4180186
19474604	LD Antigens	4180186
19474604	Antigens, LD	4180186
19474604	SD Antigens	4180186
19474604	Antigens, Histocompatibility	4180186
19474604	Antigen, Histocompatibility	4180186
19474606	Histone Deacetylase	4180186
19474606	Deacetylases, Histone	4180186
19474606	Class I Histone Deacetylases	4180186
19474606	Class II Histone Deacetylases	4180186
19474606	Deacetylase Complexes, Histone	4180186
19474606	Complexes, Histone Deacetylase	4180186
19474606	HDAC Proteins	4180186
19474606	Histone Deacetylase Complexes	4180186
19474606	Deacetylase, Histone	4180186
19474609	HLA-DP	4180186
19474609	HLA-PL	4180186
19474609	Antigens, HLA-PL	4180186
19474609	HLA-SB	4180186
19474609	HLA DP Antigens	4180186
19474609	Antigens, HLA-SB	4180186
19474609	HLA PL Antigens	4180186
19474609	HLA SB Antigens	4180186
19474609	HLA-PL Antigens	4180186
19474609	Antigens, HLA-DP	4180186
19474609	HLA-SB Antigens	4180186
19474611	HLA DR Antigens	4180186
19474611	HLA-DR	4180186
19474611	Antigens, HLA-DR	4180186
19474612	NSC322921	4180186
19474612	Bisbenzimide	4180186
19474612	Hoe 33258	4180186
19474612	NSC-322921	4180186
19474612	4-(5-(5-(4-Methylpiperazin-1-yl)benzimidazol-2- yl)benzimidazol-2-yl)phenol	4180186
19474612	Hoe33258	4180186
19474612	4-(5-(4-Methyl-1-piperazinyl)(2,5'-bi-1H-benzimidazol)-2'-yl)phenol, trihydrochloride	4180186
19474612	NSC 322921	4180186
19474612	Pibenzimol	4180186
19474612	Bisbenzimidazole Trihydrochloride	4180186
19474612	Hoe-33258	4180186
19474612	Hoechst 33258	4180186
19474616	Information System, Multihospital	4180186
19474616	Information System, Multi-Hospital	4180186
19474616	Multihospital Information Systems	4180186
19474616	Multihospital Information System	4180186
19474616	Information Systems, Multihospital	4180186
19474616	Information System, Hospital	4180186
19474616	Multi Hospital Information Systems	4180186
19474616	Information Systems, Hospital	4180186
19474616	Multi-Hospital Information Systems	4180186
19474616	Hospital Information System	4180186
19474616	Multi-Hospital Information System	4180186
19474616	Information Systems, Multi-Hospital	4180186
19474618	Unit, Hospital	4180186
19474618	Hospital Unit	4180186
19474618	Units, Hospital	4180186
19474619	Hospital	4180186
19474620	Veterinary Clinic	4180186
19474620	Hospital, Veterinary	4180186
19474620	Veterinary Hospital	4180186
19474620	Animal Hospital	4180186
19474620	Hospitals, Veterinary	4180186
19474620	Veterinary Hospitals	4180186
19474620	Clinic, Veterinary	4180186
19474620	Hospital, Animal	4180186
19474620	Veterinary Clinics	4180186
19474620	Clinics, Veterinary	4180186
19474620	Animal Hospitals	4180186
19474624	District Hospitals	4180186
19474624	Hospital, District	4180186
19474624	District Hospital	4180186
19474627	Hospital, Group Practice	4180186
19474627	Group Practice Hospital	4180186
19474627	Practice Hospital, Group	4180186
19474627	Practice Hospitals, Group	4180186
19474627	Group Practice Hospitals	4180186
19474630	Packaged Hospitals	4180186
19474630	Hospital, Packaged	4180186
19474630	Packaged Hospital	4180186
19474631	Pediatric Hospital	4180186
19474631	Hospital, Pediatric	4180186
19474631	Pediatric Hospitals	4180186
19474633	Mental Institutions	4180186
19474633	Hospital, Mental	4180186
19474633	Hospital, Psychiatric	4180186
19474633	Mental Hospitals	4180186
19474633	Mental Hospital	4180186
19474633	Institutions, Mental	4180186
19474633	Psychiatric Hospitals	4180186
19474633	Psychiatric Hospital	4180186
19474633	Institution, Mental	4180186
19474633	Mental Institution	4180186
19474633	Hospitals, Mental	4180186
19474634	Public Hospital	4180186
19474634	Public Hospitals	4180186
19474634	Hospital, Public	4180186
19474638	University Hospitals	4180186
19474642	Hydrogen Sulfide (H2S3)	4180186
19474642	Sulfide, Hydrogen	4180186
19474642	Hydrogen Sulfide (H2(Sx))	4180186
19474642	Hydrogen Sulfide (H2S2)	4180186
19474642	Hydrogen sulfide (H2S)	4180186
19474643	p Dihydroxybenzenes	4180186
19474643	para Dihydroxybenzenes	4180186
19474643	Quinols	4180186
19474643	p-Dihydroxybenzenes	4180186
19474643	Quinol	4180186
19474643	para-Dihydroxybenzenes	4180186
19474648	Sedative Effects	4180186
19474648	Hypnotic Effect	4180186
19474648	Sedative	4180186
19474648	Hypnotic and Sedative	4180186
19474648	Effect, Hypnotic	4180186
19474648	Hypnotics	4180186
19474648	Sedative Effect	4180186
19474648	Effects, Hypnotic	4180186
19474648	Sedative and Hypnotic	4180186
19474648	Hypnotic	4180186
19474648	Sedatives and Hypnotics	4180186
19474648	Sedatives	4180186
19474648	Effect, Sedative	4180186
19474648	Effects, Sedative	4180186
19474648	Hypnotic Effects	4180186
19474649	Antidiabetic Agent	4180186
19474649	Agent, Antidiabetic	4180186
19474649	Antidiabetics	4180186
19474649	Hypoglycemic Effect	4180186
19474649	Drugs, Antidiabetic	4180186
19474649	Agent, Antihyperglycemic	4180186
19474649	Drug, Antidiabetic	4180186
19474649	Agents, Antidiabetic	4180186
19474649	Antihyperglycemic	4180186
19474649	Agent, Hypoglycemic	4180186
19474649	Drugs, Hypoglycemic	4180186
19474649	Hypoglycemic	4180186
19474649	Effects, Hypoglycemic	4180186
19474649	Hypoglycemic Agent	4180186
19474649	Hypoglycemic Effects	4180186
19474649	Antihyperglycemic Agent	4180186
19474649	Drug, Hypoglycemic	4180186
19474649	Antidiabetic Drugs	4180186
19474649	Hypoglycemic Drugs	4180186
19474649	Antihyperglycemics	4180186
19474649	Antihyperglycemic Agents	4180186
19474649	Hypoglycemics	4180186
19474649	Antidiabetic Drug	4180186
19474649	Agents, Hypoglycemic	4180186
19474649	Effect, Hypoglycemic	4180186
19474649	Antidiabetic	4180186
19474649	Agents, Antihyperglycemic	4180186
19474649	Antidiabetic Agents	4180186
19474649	Hypoglycemic Drug	4180186
19474650	Hypothalamic Pituitary-Regulating Peptides	4180186
19474650	Peptides, Hypothalamic Pituitary-Regulating	4180186
19474650	Hypothalamic Pituitary Regulating Hormones	4180186
19474650	Hypothalamic Pituitary-Regulating Hormones	4180186
19474650	Hypothalamic Pituitary Regulating Peptides	4180186
19474650	Hormones, Hypothalamic Pituitary-Regulating	4180186
19474650	Pituitary-Regulating Peptides, Hypothalamic	4180186
19474650	Hormones, Hypothalamic	4180186
19474650	Pituitary-Regulating Hormones, Hypothalamic	4180186
19474651	12-Methoxyibogamine	4180186
19474651	Ibogamine, 12-methoxy-	4180186
19474651	12 Methoxyibogamine	4180186
19474651	Endabuse	4180186
19474651	NIH-10567	4180186
19474651	NIH 10567	4180186
19474651	NIH10567	4180186
19474653	Iduronatesulfate Sulfohydrolase	4180186
19474653	Sulfate Sulfatase, Iduronate	4180186
19474653	Sulfoiduronate Sulfatase	4180186
19474653	Hunter Corrective Factor	4180186
19474653	Sulfatase, Iduronate Sulfate	4180186
19474653	Sulfohydrolase, Iduronatesulfate	4180186
19474653	Sulfatase, Sulfoiduronate	4180186
19474653	Corrective Factor, Hunter	4180186
19474653	Factor, Hunter Corrective	4180186
19474653	Iduronate Sulfate Sulfatase	4180186
19474653	L-Iduronate-2-sulfate 2-sulfohydrolase	4180186
19474653	Sulfatase, Iduronate	4180186
19474656	Imidates	4180186
19474657	Sera, Immune	4180186
19474657	Immune Serums	4180186
19474657	Serums, Immune	4180186
19474657	Antisera	4180186
19474665	Fc Fragments	4180186
19474665	Fragment Immunoglobulins, Fc	4180186
19474665	Fc Immunoglobulins	4180186
19474665	Fc Fragment Immunoglobulins	4180186
19474665	Fc Fragment, Immunoglobulin	4180186
19474665	Fragments, Ig Fc	4180186
19474665	Immunoglobulins, Fc	4180186
19474665	Immunoglobulin Fc Fragment	4180186
19474665	Fc Fragments, Ig	4180186
19474665	Fc Fragments, Immunoglobulin	4180186
19474665	Fc Immunoglobulin	4180186
19474665	Immunoglobulins, Fc Fragment	4180186
19474665	Ig Fc Fragments	4180186
19474665	Fc Fragment	4180186
19474665	Fragment, Fc	4180186
19474665	Immunoglobulin, Fc	4180186
19474667	J Polypeptide, Immunoglobulin	4180186
19474667	Chains, Ig J	4180186
19474667	J-Peptide, Ig	4180186
19474667	Ig J-Peptide	4180186
19474667	Polypeptide, Immunoglobulin J	4180186
19474667	Immunoglobulin J-Peptide	4180186
19474667	Immunoglobulin J Chains	4180186
19474667	Ig J Chains	4180186
19474667	J Chains, Ig	4180186
19474667	J Chains, Immunoglobulin	4180186
19474667	J-Chains, Immunoglobulin	4180186
19474667	Ig J Peptide	4180186
19474667	Immunoglobulin J Polypeptide	4180186
19474667	J-Peptide, Immunoglobulin	4180186
19474667	Immunoglobulin J Peptide	4180186
19474671	mu-Chain, Immunoglobulin	4180186
19474671	mu Immunoglobulin Heavy Chain	4180186
19474671	mu-Chains, Immunoglobulin	4180186
19474671	mu-Chain Immunoglobulins	4180186
19474671	Immunoglobulins, mu Chain	4180186
19474671	Immunoglobulin mu-Chain	4180186
19474671	mu Immunoglobulin Heavy Chains	4180186
19474671	mu Chains, Ig	4180186
19474671	Immunoglobulin mu Chain	4180186
19474671	Immunoglobulin mu Chains	4180186
19474671	Chains, Ig mu	4180186
19474671	Immunoglobulins, mu-Chain	4180186
19474671	Ig mu Chains	4180186
19474671	mu Chain Immunoglobulins	4180186
19474677	Family Planning Information Centers	4180186
19474677	Center, Information	4180186
19474677	Information Center	4180186
19474677	Centers, Information	4180186
19474679	Systems, Information Retrieval	4180186
19474679	Emergency Care Information Systems	4180186
19474679	Perinatal Information System	4180186
19474679	Information System, Perinatal	4180186
19474679	Ancillary Information System	4180186
19474679	Ancillary Information Systems	4180186
19474679	Perinatal Information Systems	4180186
19474679	Information System	4180186
19474679	Information Retrieval System	4180186
19474679	Information Retrieval Systems	4180186
19474679	Information System, Ancillary	4180186
19474680	Inhibin F	4180186
19474680	Inhibin-F	4180186
19474680	Inhibins, Female	4180186
19474680	Inhibin, Female	4180186
19474680	Inhibin, Ovarian	4180186
19474680	Female Inhibins	4180186
19474680	Inhibin	4180186
19474680	Testicular Inhibin	4180186
19474680	Ovarian Inhibin	4180186
19474680	Inhibins, Testicular	4180186
19474680	Inhibin, Testicular	4180186
19474680	Female Inhibin	4180186
19474680	Testicular Inhibins	4180186
19474681	Diphosphate, Inosine	4180186
19474681	Inosine Pyrophosphate	4180186
19474681	IDP	4180186
19474681	Riboxine	4180186
19474681	Pyrophosphate, Inosine	4180186
19474681	Riboxin	4180186
19474681	Inosine 5'-(trihydrogen diphosphate)	4180186
19474682	Hormones, Insect	4180186
19474682	Insect Hormone	4180186
19474682	Hormone, Insect	4180186
19474683	ICU Intensive Care Units	4180186
19474683	Intensive Care Unit	4180186
19474683	Unit, Intensive Care	4180186
19474686	Interferon	4180186
19474689	Ro 236019	4180186
19474689	RU49637	4180186
19474689	Ro 23 6019	4180186
19474689	T-Cell Growth Factor	4180186
19474689	T Cell Stimulating Factor	4180186
19474689	T Cell Growth Factor	4180186
19474689	Lymphocyte Mitogenic Factor	4180186
19474689	Thymocyte Stimulating Factor	4180186
19474689	Interleukin 2	4180186
19474689	T-Cell Stimulating Factor	4180186
19474689	RU-49637	4180186
19474689	Mitogenic Factor, Lymphocyte	4180186
19474689	IL-2	4180186
19474689	RU 49637	4180186
19474689	Interleukin II	4180186
19474689	Ro236019	4180186
19474689	Ro-236019	4180186
19474689	Interleukine 2	4180186
19474689	TCGF	4180186
19474689	Ro-23-6019	4180186
19474689	IL2	4180186
19474690	Interleukin	4180186
19474692	Iodolipol	4180186
19474692	Iodized Oils	4180186
19474692	Oil, Iodized	4180186
19474692	Oils, Iodized	4180186
19474692	Fats and Glyceridic oils, vegetable, iodinated	4180186
19474693	Acetamide, 2-iodo-	4180186
19474694	Iodoacetic Acids	4180186
19474694	Acids, Iodoacetic	4180186
19474695	Orthoiodohippurate	4180186
19474695	Glycine, N-(2-iodobenzoyl)-	4180186
19474695	RadioHippuran	4180186
19474695	Radio-Hippuran	4180186
19474695	ortho-Iodohippurate	4180186
19474695	Sodium Iodohippurate	4180186
19474695	Sodium o Iodohippurate	4180186
19474695	I Hippuran	4180186
19474695	Iodobenzoylglycine	4180186
19474695	I-Hippuran	4180186
19474695	Sodium o-Iodohippurate	4180186
19474695	ortho Iodohippurate	4180186
19474695	Acid, Iodohippuric	4180186
19474695	Iodohippurate, Sodium	4180186
19474695	I-OIH	4180186
19474695	Radio Hippuran	4180186
19474695	o-Iodohippurate, Sodium	4180186
19474695	I OIH	4180186
19474696	1(4H)-Pyridineacetic acid, 3,5-diiodo-4-oxo-, compd. with 2,2'-iminobis(ethanol) (1:1)	4180186
19474696	Cardiotrast	4180186
19474696	Diodone	4180186
19474696	Diodrast	4180186
19474696	Kardiotrast	4180186
19474698	Acid, Ioglycamic	4180186
19474698	Benzoic acid, 3,3'-(oxybis((1-oxo-2,1-ethanediyl)imino))bis(2,4,6-triiodo)-	4180186
19474698	Ioglycamide	4180186
19474698	Bilivistan	4180186
19474699	1H-Imidazole, 1-methyl-2-(1-methylethyl)-5-nitro-	4180186
19474700	Agents, Iron Chelating	4180186
19474700	Chelates, Iron	4180186
19474700	Iron Chelates	4180186
19474700	Chelating Agents, Iron	4180186
19474701	Counterirritants	4180186
19474701	Irritant	4180186
19474701	Pustulants	4180186
19474701	Pustulant	4180186
19474701	Rubefacients	4180186
19474701	Rubefacient	4180186
19474701	Vesicant	4180186
19474701	Counterirritant	4180186
19474701	Vesicants	4180186
19474703	Alloantibodies	4180186
19474704	Jaw Relation Records	4180186
19474704	Records, Jaw Relation	4180186
19474704	Axiography	4180186
19474704	Bite Registration	4180186
19474704	Bite Registrations	4180186
19474704	Sirognathography	4180186
19474704	Registration, Bite	4180186
19474704	Record, Jaw Relation	4180186
19474704	Registrations, Bite	4180186
19474706	Lysine Bradykinin	4180186
19474706	N2-L-Lysylbradykinin	4180186
19474706	Tetraacetate, Kallidin	4180186
19474706	Bradykinin, N2-L-lysyl-	4180186
19474706	Lysyl Bradykinin	4180186
19474706	Bradykinin, Lysine	4180186
19474706	Lys-Bradykinin	4180186
19474706	Lys Bradykinin	4180186
19474706	Bradykinin, Lysyl	4180186
19474706	Kallidin, (D)-Isomer	4180186
19474706	Kallidin Tetraacetate	4180186
19474706	N2 L Lysylbradykinin	4180186
19474708	ACE1 Angiotensin Converting Enzyme 1	4180186
19474708	Angiotensin Converting Enzyme 1	4180186
19474708	Dipeptidyl Carboxypeptidase I	4180186
19474708	ACE1 Angiotensin-Converting Enzyme 1	4180186
19474708	CD143 Antigens	4180186
19474708	Dipeptidyl Peptidase A	4180186
19474708	Angiotensin I Converting Enzyme	4180186
19474708	Peptidyl Dipeptidase A	4180186
19474708	Carboxypeptidase I, Dipeptidyl	4180186
19474708	Angiotensin Converting Enzyme	4180186
19474708	Kininase A	4180186
19474708	Kininase II	4180186
19474708	Antigens, CD143	4180186
19474708	Carboxycathepsin	4180186
19474708	Angiotensin I-Converting Enzyme	4180186
19474708	Peptidase P	4180186
19474708	ACE1 Protein	4180186
19474711	Laboratory	4180186
19474714	Lactim	4180186
19474714	Lactam	4180186
19474714	Lactims	4180186
19474715	beta Lactoglobulin A	4180186
19474715	beta-Lactoglobulin B	4180186
19474715	beta-Lactoglobulin F	4180186
19474715	beta Lactoglobulin F	4180186
19474715	beta-Lactoglobulin A	4180186
19474715	Lactoglobulin	4180186
19474715	beta Lactoglobulin I	4180186
19474715	beta Lactoglobulin E	4180186
19474715	beta-Lactoglobulin E	4180186
19474715	beta-Lactoglobulin C	4180186
19474715	beta Lactoglobulin C	4180186
19474715	beta-Lactoglobulin G	4180186
19474715	beta Lactoglobulin B	4180186
19474715	beta Lactoglobulin	4180186
19474715	beta Lactoglobulin G	4180186
19474715	beta-Lactoglobulin I	4180186
19474715	beta-Lactoglobulin	4180186
19474716	Saccharinas	4180186
19474716	Kjellmaniella	4180186
19474716	Laminarias	4180186
19474716	Kombu	4180186
19474716	Laminaria Tents	4180186
19474716	Kjellmaniellas	4180186
19474716	Saccharina japonica	4180186
19474716	Laminaria Tent	4180186
19474716	Saccharina	4180186
19474716	Laminaria japonica	4180186
19474716	Kombus	4180186
19474717	Digilanides	4180186
19474722	Sialyl Lewis Antigens	4180186
19474722	Lewis Antigens	4180186
19474722	Lewis Related Antigens	4180186
19474722	Lewis System	4180186
19474722	Lewis Blood Group Related Tumor-Associated Antigens	4180186
19474722	Antigens, Sialyl Lewis	4180186
19474722	Lewis Blood Group Related Tumor Associated Antigens	4180186
19474722	Le Antigens	4180186
19474722	Lewis Blood Group System	4180186
19474722	Antigens, Lewis Related	4180186
19474722	Blood Group Lewis Related Antigens	4180186
19474722	Blood-Group System, Lewis	4180186
19474722	Antigens, Lewis	4180186
19474722	Lewis Antigen Related Tumor-Associated Antigens	4180186
19474722	Lewis Blood Group Related Antigens	4180186
19474722	Lewis Blood-Group System	4180186
19474722	Lewis Antigen Related Tumor Associated Antigens	4180186
19474722	Le(a) Blood Group System	4180186
19474723	Library	4180186
19474724	Dental Library	4180186
19474724	Library, Dental	4180186
19474724	Dental Libraries	4180186
19474725	Biomedical Library	4180186
19474725	Libraries, Biomedical	4180186
19474725	Health Science Library	4180186
19474725	Health Science Libraries	4180186
19474725	Libraries, Health Science	4180186
19474725	Medical Libraries	4180186
19474725	Medical Library	4180186
19474725	Biomedical Libraries	4180186
19474725	Library, Medical	4180186
19474725	Library, Biomedical	4180186
19474727	Analysis, Genetic Linkage	4180186
19474727	Linkage Analyses, Genetic	4180186
19474727	Genetic Linkage Analyses	4180186
19474727	Genetic Linkage Analysis	4180186
19474727	Analyses, Genetic Linkage	4180186
19474727	Linkage, Genetic	4180186
19474727	Linkage Analysis, Genetic	4180186
19474729	Liponsaure-ratiopharm	4180186
19474729	alpha Liponsaure von ct	4180186
19474729	espa-lipon	4180186
19474729	PleomixAlpha	4180186
19474729	Verla-Lipon	4180186
19474729	Injekt, Thiogamma	4180186
19474729	alpha-Vibolex	4180186
19474729	MTWAlphaliponsaure	4180186
19474729	Thiogamma oral	4180186
19474729	biomo-lipon	4180186
19474729	VerlaLipon	4180186
19474729	Liponsaure ratiopharm	4180186
19474729	alpha-Lipoic Acid	4180186
19474729	alpha Vibolex	4180186
19474729	alphaLiponaure Heumann	4180186
19474729	Acid, alpha-Lipoic	4180186
19474729	alpha-Liponsaure von ct	4180186
19474729	Alpha-Lipogamma	4180186
19474729	espalipon	4180186
19474729	AlphaLiponsaure Sofotec	4180186
19474729	AlphaLipon Stada	4180186
19474729	Lipoic Acid	4180186
19474729	Azulipont	4180186
19474729	PleomixAlpha N	4180186
19474729	Pleomix-Alpha N	4180186
19474729	biomolipon	4180186
19474729	Alphaflam	4180186
19474729	espa lipon	4180186
19474729	Alpha-Liponsaure Sofotec	4180186
19474729	Verla Lipon	4180186
19474729	Neurium	4180186
19474729	Alpha-Lipon Stada	4180186
19474729	alphaVibolex	4180186
19474729	1,2-Dithiolane-3-pentanoic acid	4180186
19474729	AlphaLippon AL	4180186
19474729	Alpha Lipogamma	4180186
19474729	Thioctacide T	4180186
19474729	MTW Alphaliponsaure	4180186
19474729	alpha-Liponaure Heumann	4180186
19474729	alpha Liponaure Heumann	4180186
19474729	Thiogamma Injekt	4180186
19474729	Pleomix Alpha	4180186
19474729	Alpha-Lippon AL	4180186
19474729	alpha Lipoic Acid	4180186
19474729	AlphaLipogamma	4180186
19474729	duralipon	4180186
19474729	alphaLiponsaure von ct	4180186
19474729	MTW-Alphaliponsaure	4180186
19474729	Tromlipon	4180186
19474729	biomo lipon	4180186
19474729	Liponsaureratiopharm	4180186
19474729	Alpha Liponsaure Sofotec	4180186
19474729	Alpha Lipon Stada	4180186
19474729	Alpha Lippon AL	4180186
19474729	Juthiac	4180186
19474729	Pleomix-Alpha	4180186
19474729	Fenint	4180186
19474729	Pleomix Alpha N	4180186
19474729	Thioctacid	4180186
19474730	Adipozin	4180186
19474730	beta-Lipotrophin	4180186
19474730	beta-LPH	4180186
19474730	beta LPH	4180186
19474730	beta Lipotropin	4180186
19474730	Lipotropin	4180186
19474730	beta Lipotrophin	4180186
19474731	Green Dyes, Lissamine	4180186
19474731	Dyes, Lissamine Green	4180186
19474732	Acid, Isolithocholic	4180186
19474732	Isolithocholic Acid	4180186
19474732	Acid, Lithocholic	4180186
19474732	Lithocholate	4180186
19474732	Cholan-24-oic acid, 3-hydroxy-, (3alpha,5beta)-	4180186
19474734	Tixantone	4180186
19474734	Lucanthone Hydrochloride	4180186
19474734	9H-Thioxanthen-9-one, 1-((2-(diethylamino)ethyl)amino)-4-methyl-	4180186
19474734	Miracil D	4180186
19474735	Lucimycin	4180186
19474735	Etruscomycin	4180186
19474736	Luciferase	4180186
19474744	Anhydride, Maleic	4180186
19474744	Maleic Anhydride	4180186
19474744	2,5 Furandiones	4180186
19474744	Anhydrides, Maleic	4180186
19474744	2,5-Furandiones	4180186
19474746	Information Systems, Management	4180186
19474746	System, Management Information	4180186
19474746	Systems, Management Information	4180186
19474746	Information System, Management	4180186
19474746	Management Information System	4180186
19474760	Megacin A	4180186
19474760	Megacin	4180186
19474761	Arsobal	4180186
19474761	Melarsenoxid-BAL	4180186
19474761	Melarsenoxid BAL	4180186
19474761	Mel B	4180186
19474761	MelarsenoxidBAL	4180186
19474761	1,3,2-Dithiarsolane-4-methanol, 2-(4-((4,6-diamino-1,3,5-triazin-2-yl)amino)phenyl)-	4180186
19474762	Melengestrol	4180186
19474762	Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-16-methylene-, acetate	4180186
19474762	Acetate, Melengestrol	4180186
19474763	Methylpartricin	4180186
19474763	Methyl Partricin	4180186
19474763	SPAS 160	4180186
19474763	Mepartricin B	4180186
19474763	SPA S 160	4180186
19474763	Tricandil	4180186
19474763	SPA-S 160	4180186
19474763	Partricin, methyl ester	4180186
19474763	Mepartricin A	4180186
19474764	Metalloporphyrin	4180186
19474765	Piperazine, 1-(10,11-dihydro-8-(methylthio)dibenzo(b,f)thiepin-10-yl)-4-methyl-	4180186
19474765	Methiothepine	4180186
19474765	Methiothepin Maleate	4180186
19474765	Maleate, Methiothepin	4180186
19474765	Metitepine	4180186
19474772	Metrizoate Sodium	4180186
19474772	Triosil	4180186
19474772	Benzoic acid, 3-(acetylamino)-5-(acetylmethylamino)-2,4,6-triiodo-	4180186
19474772	Metrizoate	4180186
19474772	Isopaque	4180186
19474775	Effects, Mineralocorticoid	4180186
19474775	Mineralocorticoid	4180186
19474775	Mineralocorticoid Effects	4180186
19474775	Effect, Mineralocorticoid	4180186
19474775	Mineralocorticoid Effect	4180186
19474780	NSC32946	4180186
19474780	NSC-32946	4180186
19474780	MGBG	4180186
19474780	Methylglyoxal Bis(guanylhydrazone)	4180186
19474780	Methylgag	4180186
19474780	Methyl gag	4180186
19474780	Methyl-gag	4180186
19474780	NSC 32946	4180186
19474780	Hydrazinecarboximidamide, 2,2'-(1-methyl-1,2-ethanediylidene)bis-	4180186
19474781	NSC104800	4180186
19474781	NSC-104800	4180186
19474781	Dibromodulcitol	4180186
19474781	Galactitol, 1,6-dibromo-1,6-dideoxy-	4180186
19474781	NSC 104800	4180186
19474783	Mobile Clinics	4180186
19474783	Units, Mobile Health	4180186
19474783	Hospital, Field	4180186
19474783	Unit, Mobile Health	4180186
19474783	Clinic, Mobile	4180186
19474783	Hospital, Mobile	4180186
19474783	Mobile Health Van	4180186
19474783	Health Unit, Mobile	4180186
19474783	Field Hospitals	4180186
19474783	Clinics, Mobile	4180186
19474783	Mobile Hospitals	4180186
19474783	Hospitals, Mobile	4180186
19474783	Health Units, Mobile	4180186
19474783	Field Hospital	4180186
19474783	Van, Mobile Health	4180186
19474783	Hospitals, Field	4180186
19474783	Vans, Mobile Health	4180186
19474783	Mobile Health Unit	4180186
19474783	Mobile Clinic	4180186
19474783	Mobile Hospital	4180186
19474783	Health Van, Mobile	4180186
19474783	Mobile Health Vans	4180186
19474783	Health Vans, Mobile	4180186
19474785	Monoamine Oxidase Inhibitor	4180186
19474785	MAO Inhibitor	4180186
19474785	Inhibitors, MAO	4180186
19474785	Reversible Inhibitors of Monoamine Oxidase	4180186
19474785	Inhibitor, MAO	4180186
19474785	Inhibitor, Monoamine Oxidase	4180186
19474785	MAO Inhibitors	4180186
19474785	Inhibitors, Monoamine Oxidase	4180186
19474785	RIMA (Reversible Inhibitor of Monoamine Oxidase A)	4180186
19474785	Reversible Inhibitor of Monoamine Oxidase	4180186
19474790	Funeral Undertakings	4180186
19474790	Undertaking, Funeral	4180186
19474790	Practice, Mortuary	4180186
19474790	Mortuary Practices	4180186
19474790	Funeral Undertaking	4180186
19474792	Film	4180186
19474792	Motion Picture	4180186
19474792	Cinema	4180186
19474792	Movies	4180186
19474792	Films as Topics	4180186
19474792	Picture, Motion	4180186
19474792	Movie	4180186
19474792	Movies as Topic	4180186
19474792	Movies as Topics	4180186
19474792	Films as Topic	4180186
19474792	Pictures, Motion	4180186
19474792	Cinemas	4180186
19474792	Films	4180186
19474794	Melanocyte-Stimulating Hormone Release-Inhibiting Factor	4180186
19474794	Melanostatin	4180186
19474794	Melanocyte-Stimulating Hormone Release-Inhibiting Hormone	4180186
19474794	Pro-Leu-Glyamide	4180186
19474794	Oxytocin (7-9)	4180186
19474794	Prolyl Leucyl Glycinamide	4180186
19474794	Prolyl-Leucyl-Glycinamide	4180186
19474794	MSH Release-Inhibiting Factor	4180186
19474794	MIF-I	4180186
19474794	Prol Leu Gly NH2	4180186
19474794	Prol-Leu-Gly-NH2	4180186
19474794	Prolylleucylglycinamide	4180186
19474794	H-Pro-Leu-Gly-NH2	4180186
19474794	Pro-Leu-Gly-NH2	4180186
19474794	MIF-1	4180186
19474795	Purpurate, Acid Ammonium	4180186
19474795	2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-((hexahydro-2,4,6-trioxo-5-pyrimidinyl)imino)-, monoammonium salt	4180186
19474795	Acid Ammonium Purpurate	4180186
19474795	Ammonium Purpurate, Acid	4180186
19474795	Ammonium Purpurate	4180186
19474795	Purpurate, Ammonium	4180186
19474796	3(2H)-Isoxazolone, 5-(aminomethyl)-	4180186
19474796	Agarin	4180186
19474796	Pantherine	4180186
19474802	U 11,100A	4180186
19474802	Nafoxidine Hydrochloride	4180186
19474802	Pyrrolidine, 1-(2-(4-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthalenyl)phenoxy)ethyl)-	4180186
19474802	Hydrochloride, Nafoxidine	4180186
19474802	U11,100A	4180186
19474802	U11000A	4180186
19474802	U-11,100A	4180186
19474802	U 11000A	4180186
19474802	U-11000A	4180186
19474803	Sodium Nalidixic Acid, Monohydrate	4180186
19474803	Sodium Anhydrous, Nalidixate	4180186
19474803	Sodium Nalidixic Acid, Anhydrous	4180186
19474803	Nalidixate Sodium Anhydrous	4180186
19474803	Nalidixin	4180186
19474803	Nevigramon	4180186
19474803	Nalidixate Sodium	4180186
19474803	Anhydrous, Nalidixate Sodium	4180186
19474803	Sodium, Nalidixate	4180186
19474803	1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-	4180186
19474803	Acid, Nalidixic	4180186
19474805	Pyridine, 4-(2-(1-naphthalenyl)ethenyl)-	4180186
19474809	Experimental Neoplasm	4180186
19474809	Experimental Neoplasms	4180186
19474809	Neoplasm, Experimental	4180186
19474817	Pandavir	4180186
19474817	Epinigericin	4180186
19474818	Indantrione Monohydrate	4180186
19474818	Monohydrate, Indantrione	4180186
19474818	1H-Indene-1,3(2H)-dione, 2,2-dihydroxy-	4180186
19474823	Glycine, N,N-bis(carboxymethyl)-	4180186
19474823	Nitrilotriacetate, Aluminum	4180186
19474823	Acid, Nitrilotriacetic	4180186
19474823	Aluminum Nitrilotriacetate	4180186
19474823	Nitrilotriacetate, Trisodium	4180186
19474823	Trisodium Nitrilotriacetate	4180186
19474823	Nitrilotriacetate, Dysprosium	4180186
19474823	Dysprosium Nitrilotriacetate	4180186
19474825	Nitro-BT	4180186
19474825	Tetrazolium, Nitroblue	4180186
19474825	Nitroblue, Tetrazolium	4180186
19474825	Blue, Nitrotetrazolium	4180186
19474825	2H-Tetrazolium, 3,3'-(3,3'-dimethoxy(1,1'-biphenyl))-4,4'-diyl bis(2-(4-nitrophenyl))-5-phenyl-, dichloride	4180186
19474825	Tetrazolium Nitroblue	4180186
19474825	Nitrotetrazolium Blue	4180186
19474834	NSILA	4180186
19474834	Insulinlike Activity, Nonsuppressible	4180186
19474834	Activity, Nonsuppressible Insulin-Like	4180186
19474834	NSILA-P	4180186
19474834	Insulin-Like Activity, Nonsuppressible	4180186
19474834	Nonsuppressible Insulin Like Activity	4180186
19474834	Nonsuppressible Insulinlike Activity	4180186
19474834	NSILA-S	4180186
19474834	Activity, Nonsuppressible Insulinlike	4180186
19474835	Norleucine, L-Isomer	4180186
19474835	L-Isomer Norleucine	4180186
19474835	Norleucine, L Isomer	4180186
19474838	Coins	4180186
19474838	Medals	4180186
19474838	Medal	4180186
19474838	Coin	4180186
19474839	Infant Nursery	4180186
19474839	Nursery, Infant	4180186
19474839	Nurseries	4180186
19474839	Infant Nurseries	4180186
19474840	Hospital Nurseries	4180186
19474840	Nursery, Hospital	4180186
19474840	Hospital Nursery	4180186
19474841	Nursing Home	4180186
19474841	Homes, Nursing	4180186
19474842	Nursing Record	4180186
19474842	Records, Nursing	4180186
19474842	Record, Nursing	4180186
19474845	Olivomycin	4180186
19474848	Rooms, Operating	4180186
19474848	Operating Room	4180186
19474848	Room, Operating	4180186
19474849	Opsonins	4180186
19474849	Opsonin	4180186
19474849	Protein, Opsonin	4180186
19474849	Opsonin Protein	4180186
19474853	4-Ethoxymethylene-2-phenyloxazolone	4180186
19474853	2-Phenyl-4-(ethoxymethylene)oxazol-5-one	4180186
19474853	5(4H)-Oxazolone, 4-(ethoxymethylene)-2-phenyl-	4180186
19474853	4 Ethoxymethylene 2 phenyloxazolone	4180186
19474854	1,3,5-Triazine-2-carboxylic acid, 1,4,5,6-tetrahydro-4,6-dioxo-	4180186
19474854	Oteracil	4180186
19474855	Oxytremorine	4180186
19474855	2-Pyrrolidinone, 1-(4-(1-pyrrolidinyl)-2-butynyl)-	4180186
19474856	Benzamide, 2,3,5-trichloro-N-(3,5-dichloro-2-hydroxyphenyl)-6-hydroxy-	4180186
19474856	Oxiclozanidum	4180186
19474856	Zanil	4180186
19474858	Thiazolium, 3-((1,4-dihydro-2-methyl-4-oxo-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-	4180186
19474858	Hydroxythiamine	4180186
19474863	Benzoic acid, 2-hydroxy-6-methyl-, (5-((3-acetylphenyl)amino)-4-amino-3-(((dimethylamino)carbonyl)amino)-1,2-dihydroxy-3-(1-hydroxyethyl)-2-methylcyclopentyl)methyl ester, (1S-(1alpha,2beta,3alpha,3(R*),4alpha,5beta))-	4180186
19474864	Painting	4180186
19474865	Brochures	4180186
19474865	Brochure	4180186
19474865	Booklet	4180186
19474865	Pamphlet	4180186
19474865	Booklets	4180186
19474871	Agent, Parasympathetic-Blocking	4180186
19474871	Antispasmodic Agent	4180186
19474871	Effect, Parasympatholytic	4180186
19474871	Agents, Parasympathetic-Blocking	4180186
19474871	Parasympatholytic	4180186
19474871	Agents, Parasympatholytic	4180186
19474871	Parasympathetic Blocking Agents	4180186
19474871	Agents, Antispasmodic	4180186
19474871	Parasympathetic-Blocking Agents	4180186
19474871	Antispasmodic Agents	4180186
19474871	Agent, Antispasmodic	4180186
19474871	Parasympathetic-Blocking Agent	4180186
19474871	Effects, Parasympatholytic	4180186
19474871	Parasympatholytic Agent	4180186
19474871	Spasmolytic	4180186
19474871	Parasympatholytic Drugs	4180186
19474871	Parasympatholytic Effects	4180186
19474871	Drug, Antispasmodic	4180186
19474871	Parasympatholytic Drug	4180186
19474871	Parasympatholytic Effect	4180186
19474871	Agent, Parasympatholytic	4180186
19474871	Drugs, Antispasmodic	4180186
19474871	Effects, Antispasmodic	4180186
19474871	Antispasmodics	4180186
19474871	Parasympatholytic Agents	4180186
19474871	Spasmolytics	4180186
19474871	Antispasmodic	4180186
19474871	Drug, Parasympatholytic	4180186
19474871	Antispasmodic Effect	4180186
19474871	Antispasmodic Drugs	4180186
19474871	Effect, Antispasmodic	4180186
19474871	Antispasmodic Drug	4180186
19474871	Parasympathetic Blocking Agent	4180186
19474871	Antispasmodic Effects	4180186
19474871	Drugs, Parasympatholytic	4180186
19474874	Pectinate, Zinc	4180186
19474874	Pectin, Methoxy	4180186
19474874	Methoxylpectin	4180186
19474874	Pectinate, Calcium	4180186
19474874	Methoxypectin	4180186
19474874	Calcium Pectinate	4180186
19474874	Zinc Pectinate	4180186
19474874	Pectin	4180186
19474874	Methoxy Pectin	4180186
19474874	Pectinic Acid	4180186
19474876	4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-, (2S-cis)-	4180186
19474876	Acid, Penicillanic	4180186
19474878	1,3-Propanediol, 2,2-bis((nitrooxy)methyl)-, dinitrate (ester)	4180186
19474878	Pentalog	4180186
19474878	Peritrate	4180186
19474878	Nirason	4180186
19474878	Nitrodex	4180186
19474878	Tetrate	4180186
19474878	Erinit	4180186
19474878	Dilcoran	4180186
19474878	Tetranitrate, Pentaerythritol	4180186
19474879	Pentolonium Tartrate	4180186
19474879	Tartrate, Pentolinium	4180186
19474879	Pentolinium	4180186
19474879	Tartrate, Pentolonium	4180186
19474879	Pyrrolidinium, 1,1'-(1,5-pentanediyl)bis(1-methyl)-, salt with (R-(R*,R*))-2,3-dihydroxybutanedioic acid (1:2)	4180186
19474880	Polypeptides	4180186
19474880	Polypeptide	4180186
19474880	Peptide	4180186
19474884	Factor Hemagglutinin, Leukocytosis-Promoting	4180186
19474884	Agglutinogen 2, Bordetella Pertussis	4180186
19474884	Agglutinins, Pertussis	4180186
19474884	Pertussis Agglutinins	4180186
19474884	Bordetella Virulence Factors	4180186
19474884	Factors, Bordetella Virulence	4180186
19474884	Virulence Determinant, Bordetella	4180186
19474884	Hemagglutinin, Leukocytosis-Promoting Factor	4180186
19474884	Determinant, Bordetella Virulence	4180186
19474884	Leukocytosis-Promoting Factor Hemagglutinin	4180186
19474884	Lymphocytosis-Promoting Factor-Hemagglutinin	4180186
19474884	LFP-Hemagglutinin	4180186
19474884	LFP Hemagglutinin	4180186
19474884	Lymphocytosis Promoting Factor Hemagglutinin	4180186
19474884	Factor-Hemagglutinin, Lymphocytosis-Promoting	4180186
19474884	LP HA	4180186
19474884	LP-HA	4180186
19474884	Bordetella Virulence Determinant	4180186
19474884	Leukocytosis Promoting Factor Hemagglutinin	4180186
19474886	Crude Oil	4180186
19474886	Oil, Crude	4180186
19474886	Petroleums	4180186
19474886	Oils, Crude	4180186
19474886	Crude Oils	4180186
19474887	Community Pharmacy	4180186
19474887	Distribution, Pharmacy	4180186
19474887	Pharmacy, Community	4180186
19474887	Pharmacies, Community	4180186
19474887	Distributions, Pharmacy	4180186
19474887	Community Pharmacies	4180186
19474887	Pharmacy Distributions	4180186
19474887	Pharmacy Distribution	4180186
19474890	Phenylethylamines	4180186
19474894	Ammonia-Lyase, Phenylalanine	4180186
19474894	L-Phenylalanine ammonia-lyase	4180186
19474894	Phenylalanine-Tyrosine Ammonia-lyase	4180186
19474894	Ammonia-lyase, Phenylalanine-Tyrosine	4180186
19474894	Phenylalanine Ammonia Lyase	4180186
19474894	Phenylalanine Tyrosine Ammonia lyase	4180186
19474896	Ethylphenylmalonamide	4180186
19474896	2-Ethyl-2-Phenylmalonamide	4180186
19474896	Phenylethylmalondiamide	4180186
19474896	2 Ethyl 2 Phenylmalonamide	4180186
19474896	Propanediamide, 2-ethyl-2-phenyl-	4180186
19474898	Stamps, Postage	4180186
19474898	Philatelies	4180186
19474898	Postage Stamps	4180186
19474898	Stamp, Postage	4180186
19474898	Postage Stamp	4180186
19474900	Phosphorodithioic acid, S-((1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl) O,O-dimethyl ester	4180186
19474900	N-(Mercaptomethyl)phthalimide S-(O,O-dimethyl phosphorothionate)	4180186
19474900	Prolate	4180186
19474900	Imidan	4180186
19474900	Phthalophos	4180186
19474902	Phosphatidylserine Synthetase	4180186
19474902	CDPdiacylglycerol Serine O Phosphatidyltransferase	4180186
19474902	CDP-DG Synthase	4180186
19474902	CDP Diacylglycerol Serine O Phosphatidyltransferase	4180186
19474902	Synthase, CDP-DG	4180186
19474902	CDPdiacylglycerol:L-serine 3-O-phosphatidyltransferase	4180186
19474902	Synthase, Phosphatidylserine	4180186
19474902	Diacylglycerol-Serine O-Phosphatidyltransferase, CDP	4180186
19474902	CDP DG Synthase	4180186
19474902	CDP Diacylglycerol-Serine O-Phosphatidyltransferase	4180186
19474902	CDP Diglyceride Serine O Phosphatidyltransferase	4180186
19474902	O-Phosphatidyltransferase, CDP Diacylglycerol-Serine	4180186
19474902	O-Phosphatidyltransferase, CDPdiacylglycerol-Serine	4180186
19474902	Synthetase, Phosphatidylserine	4180186
19474902	Phosphatidylserine Synthase	4180186
19474902	CDP Diglyceride Serine O-Phosphatidyltransferase	4180186
19474903	Acetic acid, phosphono-	4180186
19474903	Phosphonoacetate	4180186
19474903	Phosphonoacetate, Disodium	4180186
19474903	Fosfonet Sodium	4180186
19474903	Disodium Phosphonoacetate	4180186
19474903	Phosphonacetic Acid	4180186
19474907	Fitness, Physical	4180186
19474909	Phaseolus vulgaris Lectin	4180186
19474909	Phaseolus vulgaris Lectins	4180186
19474909	Phytohemagglutinin	4180186
19474909	Lectin, Kidney Bean	4180186
19474909	Kidney Bean Lectins	4180186
19474909	Kidney Bean Lectin	4180186
19474909	Hemagglutinins, Plant	4180186
19474909	Lectins, Kidney Bean	4180186
19474909	Lectins, Phaseolus vulgaris	4180186
19474909	Lectin, Phaseolus vulgaris	4180186
19474909	Plant Hemagglutinins	4180186
19474913	Acid, Piromidic	4180186
19474913	Pyrido(2,3-d)pyrimidine-6-carboxylic acid, 8-ethyl-5,8-dihydro-5-oxo-2-(1-pyrrolidinyl)-	4180186
19474924	Platelet Glycoproteins	4180186
19474924	Membrane Glycoproteins, Platelet	4180186
19474924	Platelet Glycoprotein	4180186
19474924	Glycoprotein, Platelet Membrane	4180186
19474924	PM GP	4180186
19474924	Platelet Membrane Glycoprotein	4180186
19474924	Membrane Glycoprotein, Platelet	4180186
19474924	Glycoprotein, Platelet	4180186
19474924	Glycoproteins, Platelet Membrane	4180186
19474924	PM-GPs	4180186
19474924	PM-GP	4180186
19474924	Glycoproteins, Platelet	4180186
19474925	Plaything	4180186
19474925	Plays	4180186
19474925	Playthings	4180186
19474925	Playthings and Play	4180186
19474925	Toys	4180186
19474925	Toy	4180186
19474925	Puppet	4180186
19474925	Puppets	4180186
19474925	Play	4180186
19474928	Polyriboinosinic Polyribocytidylic Acid	4180186
19474928	Polyinosinic-Polycytidylic Acid	4180186
19474928	Polyriboinosinic-Polyribocytidylic Acid	4180186
19474928	Poly I C	4180186
19474928	Polyribose Inosin-Cytidil	4180186
19474928	5'-Inosinic acid, homopolymer, complex with 5'-cytidylic acid homopolymer (1:1)	4180186
19474928	Polyinosinic-Polycytidylic Acid (High MW)	4180186
19474928	Poly(I-C)	4180186
19474928	Polyribose Inosin Cytidil	4180186
19474928	Poly(rI).Poly(rC)	4180186
19474928	Inosin-Cytidil, Polyribose	4180186
19474928	Polyinosinic Polycytidylic Acid	4180186
19474930	Zinc Polycarboxylate Cement	4180186
19474930	Polycarboxylate Cement, Zinc	4180186
19474930	Cement, Polycarboxylate	4180186
19474930	Cement, Zinc Polycarboxylate	4180186
19474931	Polyester	4180186
19474935	Polymer	4180186
19474937	Polymyxin M	4180186
19474937	Polymyxin	4180186
19474938	Prolene	4180186
19474938	Polymers, Propylene	4180186
19474938	Polypro	4180186
19474938	Marlex Polypropylene	4180186
19474938	Propylene Polymers	4180186
19474938	Polymers, Propene	4180186
19474938	Marlex	4180186
19474938	Propene Polymers	4180186
19474938	Polypropylene, Marlex	4180186
19474938	Hostalen	4180186
19474938	Polypropylene	4180186
19474940	Polymer, Chloroethylene	4180186
19474940	Ultron	4180186
19474940	Geon	4180186
19474940	Viaflex	4180186
19474940	Polychloroethylene	4180186
19474940	Ethene, chloro-, homopolymer	4180186
19474940	PVC	4180186
19474940	Chloride, Polyvinyl	4180186
19474940	Vinyl Chloride Polymer	4180186
19474940	Homopolymer, Chloroethylene	4180186
19474940	Chloroethylene Polymer	4180186
19474940	Vinylite	4180186
19474940	Chloroethylene Homopolymer	4180186
19474940	Polymer, Vinyl Chloride	4180186
19474948	Sepranolone	4180186
19474948	Pregnanolone, (3beta, 5beta, 17alpha)-isomer	4180186
19474948	Pregnan 3alpha ol 20 one	4180186
19474948	Pregnanolone, (3beta, 5alpha, 8alpha, 17beta)-isomer	4180186
19474948	Pregnanolone, (3beta)-isomer	4180186
19474948	3 alpha Hydroxy 5 beta pregnan 20 one	4180186
19474948	3 Hydroxypregnan 20 one	4180186
19474948	Epipregnanolone	4180186
19474948	Pregnanolone, (3beta, 5alpha, 17alpha)-isomer	4180186
19474948	Pregnan-20-one, 3-hydroxy-, (3alpha,5beta)-	4180186
19474948	Eltanolone	4180186
19474948	Allopregnanolone	4180186
19474948	beta-ol-20-one, Allopregnan-3	4180186
19474948	alpha-Hydroxy-5 beta-pregnan-20-one, 3	4180186
19474948	3 alpha-Hydroxy-5 beta-pregnan-20-one	4180186
19474948	Pregnan-3alpha-ol-20-one	4180186
19474948	Allopregnan-3 beta-ol-20-one	4180186
19474948	Pregnanolone, (3alpha,5beta)-isomer	4180186
19474948	Pregnanolone, (3alpha)-isomer	4180186
19474948	alpha-Hydroxy-5 alpha-pregnan-20-one, 3	4180186
19474948	3 alpha, 5 beta-Tetrahydroprogesterone	4180186
19474948	3 alpha Hydroxy 5 alpha pregnan 20 one	4180186
19474948	3 alpha-Hydroxy-5 alpha-pregnan-20-one	4180186
19474948	alpha-pregnan-20-one, 3 alpha-Hydroxy-5	4180186
19474948	Pregnanolone, (3beta, 5beta,14beta)-isomer	4180186
19474948	Allopregnan 3 beta ol 20 one	4180186
19474948	beta-pregnan-20-one, 3 alpha-Hydroxy-5	4180186
19474948	3-Hydroxypregnan-20-one	4180186
19474948	Pregnanolone, (3alpha,5alpha)-isomer	4180186
19474948	3beta Hydroxy 5alpha pregnan 20 one	4180186
19474948	3beta-Hydroxy-5alpha-pregnan-20-one	4180186
19474948	3 alpha, 5 beta Tetrahydroprogesterone	4180186
19474948	Pregnanolone, (5alpha)-isomer	4180186
19474948	Pregnanolone, (3beta, 5beta)-isomer	4180186
19474948	Pregnanolone, (3alpha, 5beta, 17-alpha)-isomer	4180186
19474948	Pregnanolone, (3beta, 5alpha)-isomer	4180186
19474950	Pro-Opio-Melanocortin	4180186
19474950	ACTH-Endorphin Precursor	4180186
19474950	ACTH-beta-Lipotropin Precursor	4180186
19474950	Preproopiomelanocortin	4180186
19474950	Pre pro opiocortin	4180186
19474950	Endorphin ACTH Precursor	4180186
19474950	Pro-Opiocortin	4180186
19474950	Pro ACTH Endorphin	4180186
19474950	Opiomelanocortin, pro-	4180186
19474950	ACTH Endorphin Precursor	4180186
19474950	ACTH beta Lipotropin Precursor	4180186
19474950	Pro Opiomelanocortin	4180186
19474950	Pre POMC	4180186
19474950	Pro-ACTH-Endorphin	4180186
19474950	Pre-pro-opiocortin	4180186
19474950	Corticotropin beta Lipotropin Precursor	4180186
19474950	Endorphin-ACTH Precursor	4180186
19474950	Opiocortin	4180186
19474950	Pre-POMC	4180186
19474950	Proopiomelanocortin	4180186
19474950	Pro Opio Melanocortin	4180186
19474950	Corticotropin-beta-Lipotropin Precursor	4180186
19474950	Proopiocortin	4180186
19474950	Pro Opiocortin	4180186
19474950	POMC	4180186
19474951	SKF-525A	4180186
19474951	Benzeneacetic acid, alpha-phenyl-alpha-propyl-, 2-(diethylamino)ethyl ester	4180186
19474951	SK&F 525 A	4180186
19474951	Diethylaminoethyldiphenylpropyl Acetate	4180186
19474951	SK-525A	4180186
19474951	Propyladiphenin	4180186
19474951	SKF-525-A	4180186
19474951	SKF525A	4180186
19474951	SK&F-525-A	4180186
19474951	SK 525A	4180186
19474951	SK&F525A	4180186
19474951	Proadifen Hydrochloride	4180186
19474951	Hydrochloride, Proadifen	4180186
19474951	SKF 525 A	4180186
19474951	Acetate, Diethylaminoethyldiphenylpropyl	4180186
19474951	SK525A	4180186
19474954	Package Insert	4180186
19474954	Insert, Package	4180186
19474954	Inserts, Package	4180186
19474954	Product Labelling	4180186
19474954	Labelling, Product	4180186
19474954	Labeling, Product	4180186
19474954	Package Inserts	4180186
19474955	Progestagen	4180186
19474955	Effect, Gestagenic	4180186
19474955	Effect, Gestagen	4180186
19474955	Progestogens	4180186
19474955	Compound, Progestational	4180186
19474955	Gestagens	4180186
19474955	Progestational Agents	4180186
19474955	Gestagenic Effect	4180186
19474955	Progestin Effect	4180186
19474955	Gestagen Effect	4180186
19474955	Agent, Progestagenic	4180186
19474955	Gestagen	4180186
19474955	Agent, Gestagenic	4180186
19474955	Progestational Compounds	4180186
19474955	Effects, Progestogen	4180186
19474955	Gestagenic Agents	4180186
19474955	Progestin Effects	4180186
19474955	Progestogen	4180186
19474955	Effect, Progestin	4180186
19474955	Progestagenic Agents	4180186
19474955	Effects, Gestagenic	4180186
19474955	Effect, Progestogen	4180186
19474955	Gestagenic Effects	4180186
19474955	Agent, Progestational	4180186
19474955	Progestational Hormones	4180186
19474955	Progestagens	4180186
19474955	Progestagenic Agent	4180186
19474955	Gestagenic Agent	4180186
19474955	Progestational Agent	4180186
19474955	Effects, Gestagen	4180186
19474955	Progestin	4180186
19474955	Gestagen Effects	4180186
19474955	Progestational Compound	4180186
19474955	Progestogen Effects	4180186
19474955	Progestogen Effect	4180186
19474955	Hormone, Progestational	4180186
19474955	Progestational Hormone	4180186
19474955	Effects, Progestin	4180186
19474957	Aminopropanols	4180186
19474958	Complement Factor P	4180186
19474958	Complement factor P	4180186
19474958	Factor P, Complement	4180186
19474959	Factor B, Properdin	4180186
19474959	Factor B	4180186
19474959	Factor B, Complement	4180186
19474959	Complement Protein Factor B	4180186
19474959	Complement Factor Ba	4180186
19474959	Complement Protein B	4180186
19474959	Factor Ba, Properdin	4180186
19474959	Factor Ba, Complement	4180186
19474959	Properdin Factor Bf F1	4180186
19474959	Proactivator, C3	4180186
19474959	Protein B, Complement	4180186
19474959	Bb, Complement Factor	4180186
19474959	Complement Factor B, Alternative Pathway	4180186
19474959	Factor Bf, Properdin	4180186
19474959	C3 Proactivator	4180186
19474959	Proactivator, Complement 3	4180186
19474959	Complement Factor B Derived Fragment Bb	4180186
19474959	C3PA	4180186
19474959	Properdin Factor Bb	4180186
19474959	Properdin Factor Ba	4180186
19474959	Bb Fragment of Factor B	4180186
19474959	Complement Factor Bb	4180186
19474959	Factor Bb, Complement	4180186
19474959	Complement 3 Proactivator	4180186
19474959	Properdin Factor B	4180186
19474959	Complement Factor B Fragment, Bb	4180186
19474959	Factor Bb, Properdin	4180186
19474959	Properdin Factor Bf	4180186
19474959	Complement Factor B-Derived Fragment Bb	4180186
19474961	Propidium Iodide	4180186
19474961	Propidium Diiodide	4180186
19474961	Phenanthridinium, 3,8-diamino-5-(3-(diethylmethylammonio)propyl)-6-phenyl-	4180186
19474961	Iodide, Propidium	4180186
19474961	Diiodide, Propidium	4180186
19474962	Propionate	4180186
19474962	Propanoic Acid	4180186
19474962	Propionic Acids	4180186
19474962	Propanoic Acids	4180186
19474962	Propanoates	4180186
19474962	Propionic Acid Derivatives	4180186
19474962	Derivatives, Propionic Acid	4180186
19474962	Propanoate	4180186
19474962	Propanoic Acid Derivatives	4180186
19474962	Acids, Propanoic	4180186
19474962	Derivatives, Propanoic Acid	4180186
19474962	Acids, Propionic	4180186
19474962	Acid, Propanoic	4180186
19474963	Prospidium Chloride	4180186
19474963	Prospidine	4180186
19474963	3,12-Bis(3-chloro-2-hydroxypropyl)-3,12-diaza-6,9- diazoniadispiro(5.2.5.2)hexadecane	4180186
19474963	Chloride, Prospidium	4180186
19474963	Prospidin	4180186
19474964	Prostanoids	4180186
19474964	Prostaglandin	4180186
19474964	Prostanoid	4180186
19474966	Prostaglandin Analog	4180186
19474966	Prostaglandin Analogues	4180186
19474966	PG Analogs	4180186
19474966	Synthetic Prostaglandin	4180186
19474966	Prostaglandin Analogue	4180186
19474966	Synthetic Prostaglandins	4180186
19474966	Analogs, PG	4180186
19474966	Prostaglandin Analogs	4180186
19474966	Prostaglandin, Synthetic	4180186
19474966	Analog, Prostaglandin	4180186
19474966	PG Analog	4180186
19474966	Analogue, Prostaglandin	4180186
19474966	Analogs, Prostaglandin	4180186
19474966	Analogues, Prostaglandin	4180186
19474966	Analog, PG	4180186
19474969	Pteridine	4180186
19474969	Pteridinone	4180186
19474969	Pyrazinopyrimidines	4180186
19474969	Pyrazinopyrimidine	4180186
19474969	Pteridinones	4180186
19474970	Publication	4180186
19474973	Pyocin	4180186
19474973	Pyocin F 1	4180186
19474973	Pyocin S 2	4180186
19474973	Pyocin R	4180186
19474973	Pyocin 103	4180186
19474973	Pyocin 1 4	4180186
19474973	Pyocin P 3	4180186
19474973	Pyocin F 2	4180186
19474973	Pyocin R 1	4180186
19474973	Pyocin 1-4	4180186
19474973	Pyocin R1	4180186
19474973	Pyocin F 3	4180186
19474973	Pyocin R 2	4180186
19474980	Pyrophosphates	4180186
19474980	Pyrophosphate Analog	4180186
19474980	Diphosphate	4180186
19474980	Pyrophosphate Analogs	4180186
19474980	Analog, Pyrophosphate	4180186
19474981	1-aza-2,4-cyclopentadiene	4180186
19474981	Pyrrole	4180186
19474982	1H-Pyrrole, 3-chloro-4-(3-chloro-2-nitrophenyl)-	4180186
19474984	Benzilate, Quinuclidinyl	4180186
19474984	Benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 1-azabicyclo(2.2.2)oct-3-yl ester	4180186
19474985	Quipazine Hydrochloride	4180186
19474985	MA-1291	4180186
19474985	2-(1-Piperazinyl)quinoline	4180186
19474985	MA 1291	4180186
19474985	Quipazine Maleate	4180186
19474985	Quinoline, 2-(1-piperazinyl)-	4180186
19474985	Quipazine Maleate (1:1)	4180186
19474985	MA1291	4180186
19474986	Radiation-Protective Drug	4180186
19474986	Radioprotective Drugs	4180186
19474986	Radiation-Protective Effect	4180186
19474986	Radiation-Protective Drugs	4180186
19474986	Radiation Protective Agent	4180186
19474986	Protective Agent, Radiation	4180186
19474986	Agent, Radiation-Protective	4180186
19474986	Effect, Radiation-Protective	4180186
19474986	Drugs, Radiation-Protective	4180186
19474986	Radioprotective Agents	4180186
19474986	Protective Agents, Radiation	4180186
19474986	Radiation-Protective Agent	4180186
19474986	Radiation Protective Drug	4180186
19474986	Agents, Radioprotective	4180186
19474986	Radiation Protectants	4180186
19474986	Agent, Radiation Protective	4180186
19474986	Radiation Protectant	4180186
19474986	Protectants, Radiation	4180186
19474986	Radioprotective Agent	4180186
19474986	Effects, Radiation-Protective	4180186
19474986	Agent, Radioprotective	4180186
19474986	Radiation-Protective Effects	4180186
19474986	Radiation Protective Effect	4180186
19474986	Drug, Radioprotective	4180186
19474986	Protectant, Radiation	4180186
19474986	Agents, Radiation-Protective	4180186
19474986	Radiation Protective Agents	4180186
19474986	Drug, Radiation-Protective	4180186
19474986	Radiation Protective Drugs	4180186
19474986	Agents, Radiation Protective	4180186
19474986	Radiation Protective Effects	4180186
19474986	Drugs, Radioprotective	4180186
19474986	Radioprotective Drug	4180186
19474988	Tracer, Radionuclide	4180186
19474988	Tracers, Radionuclide	4180186
19474988	Tracer, Radioactive	4180186
19474988	Radionuclide Tracers	4180186
19474988	Tracers, Radioactive	4180186
19474988	Radioactive Tracer	4180186
19474988	Radionuclide Tracer	4180186
19474989	Geiger-Mueller Probes	4180186
19474989	Detection, Nuclear Track	4180186
19474989	Radiation Dosimetries	4180186
19474989	Geiger Mueller Probe	4180186
19474989	Tubes, Geiger-Mueller	4180186
19474989	Radiation Counter	4180186
19474989	Counter Tubes, Geiger-Mueller	4180186
19474989	Tubes, Geiger-Mueller Counter	4180186
19474989	Geiger-Mueller Tubes	4180186
19474989	Counters, Radiation	4180186
19474989	Tube, Geiger-Mueller	4180186
19474989	Geiger Mueller Tube	4180186
19474989	Counter Tube, Geiger-Mueller	4180186
19474989	Geiger Mueller Counters	4180186
19474989	Dosimetries, Radiation	4180186
19474989	Geiger Mueller Counter Tube	4180186
19474989	Probe, Geiger-Mueller	4180186
19474989	Geiger-Mueller Probe	4180186
19474989	Radiation Dosimetry	4180186
19474989	Geiger-Mueller Counter Tube	4180186
19474989	Counters, Geiger-Mueller	4180186
19474989	Geiger Counter	4180186
19474989	Geiger-Mueller Tube	4180186
19474989	Counter, Radiation	4180186
19474989	Nuclear Track Detection	4180186
19474989	Counter, Geiger	4180186
19474989	Probes, Geiger-Mueller	4180186
19474989	Geiger-Mueller Counter Tubes	4180186
19474989	Geiger-Mueller Counters	4180186
19474989	Counters, Geiger	4180186
19474989	Tube, Geiger-Mueller Counter	4180186
19474989	Geiger Counters	4180186
19474989	Dosimetry, Radiation	4180186
19474989	Radiation Counters	4180186
19474990	MK 990	4180186
19474990	Benzamide, N-(3-chloro-4-(4-chlorophenoxy)phenyl)-2-hydroxy-3,5-diiodo-	4180186
19474990	Ranide	4180186
19474990	Flukanide	4180186
19474990	Disalan	4180186
19474990	Rafoxanid	4180186
19474992	Homocytotropic Antibodies	4180186
19474992	Reagin	4180186
19474994	Bound Immunoglobulin, Membrane	4180186
19474994	Antigen Receptors, B Cell	4180186
19474994	Membrane Bound Immunoglobulins	4180186
19474994	Immunoglobulins, Membrane-Bound	4180186
19474994	B Cell Antigen Receptor	4180186
19474994	Antigen Receptors, B-Cell	4180186
19474994	Membrane-Bound Immunoglobulins	4180186
19474994	B-Cell Antigen Receptor	4180186
19474994	Receptors, B-Cell Antigen	4180186
19474994	Receptors, Antigen, B Cell	4180186
19474994	Immunoglobulin, Surface	4180186
19474994	Surface Immunoglobulins	4180186
19474994	B Cell Antigen Receptors	4180186
19474994	Membrane Bound Immunoglobulin	4180186
19474994	Immunoglobulins, Membrane Bound	4180186
19474994	B-Cell Antigen Receptors	4180186
19474994	Immunoglobulins, Surface	4180186
19474994	Receptor, B-Cell Antigen	4180186
19474994	Surface Immunoglobulin	4180186
19474994	Immunoglobulin, Membrane Bound	4180186
19474994	Antigen Receptor, B-Cell	4180186
19474996	Receptor, Complement	4180186
19474996	Complement Receptor	4180186
19474996	Complement Receptor Type 1	4180186
19474996	Complement Receptors	4180186
19474997	Fc Receptors	4180186
19474997	Fc Receptor	4180186
19474997	Receptor, Fc	4180186
19474999	Lectin Receptors	4180186
19474999	Mitogen Receptor	4180186
19474999	Receptors, Lectin	4180186
19474999	Receptor, Mitogen	4180186
19474999	Mitogen Receptors	4180186
19475000	Identification Systems, Personal	4180186
19475000	Personal Identification Systems	4180186
19475000	Records as Topic	4180186
19475000	Personal Identification System	4180186
19475000	Travel Documents	4180186
19475000	Record	4180186
19475000	Documents, Travel	4180186
19475000	Records as Topics	4180186
19475002	Medical Reference Books	4180186
19475002	Books, Medical Reference	4180186
19475003	Standard Preparation	4180186
19475003	Standard Preparations	4180186
19475003	Standards, Reference	4180186
19475003	Preparations, Standard	4180186
19475003	Standardization	4180186
19475003	Reference Standard	4180186
19475003	Standards	4180186
19475003	Standard, Reference	4180186
19475003	Preparation, Standard	4180186
19475004	Index, Refractive	4180186
19475004	Refractive Index	4180186
19475004	Refractive Indices	4180186
19475004	Indices, Refractive	4180186
19475005	Center, Rehabilitation	4180186
19475005	Rehabilitation Center	4180186
19475005	Centers, Rehabilitation	4180186
19475008	Selection, Residential	4180186
19475008	Residential Selection	4180186
19475008	Characteristic, Residence	4180186
19475008	Domicile	4180186
19475008	Arrangements, Living	4180186
19475008	Neighborhoods	4180186
19475008	Residential Selections	4180186
19475008	Living Arrangements	4180186
19475008	Domiciles	4180186
19475008	Place of Birth	4180186
19475008	Residence Characteristic	4180186
19475008	Arrangement, Living	4180186
19475008	Neighborhood	4180186
19475008	Characteristics, Residence	4180186
19475008	Selections, Residential	4180186
19475008	Birth Place	4180186
19475008	Living Arrangement	4180186
19475008	Community	4180186
19475008	Communities	4180186
19475009	Facility, Residential	4180186
19475009	Facilities, Residential	4180186
19475009	Residential Facility	4180186
19475011	Unit, Respiratory Care	4180186
19475011	Units, Respiratory Care	4180186
19475011	Respiratory Care Unit	4180186
19475011	Care Unit, Respiratory	4180186
19475011	Care Units, Respiratory	4180186
19475012	Retinoid	4180186
19475014	Velocimetry	4180186
19475014	Flowmetry	4180186
19475014	Velocimetries	4180186
19475015	Rhodamine	4180186
19475021	Rubbers, Natural	4180186
19475021	Rubber, Natural	4180186
19475021	Vulcanite	4180186
19475021	Rubber, natural	4180186
19475021	India Rubber	4180186
19475021	Rubbers, Plant	4180186
19475021	Plant Rubber	4180186
19475021	Natural Rubbers	4180186
19475021	Elastica	4180186
19475021	Natural Rubber	4180186
19475021	Plant Rubbers	4180186
19475021	Latex Rubber	4180186
19475021	Rubber, Plant	4180186
19475023	A272	4180186
19475023	Oligomycin A, 26-demethyl-	4180186
19475023	RR 32705	4180186
19475023	RR-32705	4180186
19475023	RR32705	4180186
19475023	A 272	4180186
19475023	Oligomycin D	4180186
19475023	A-272	4180186
19475027	Alkaloids, Salsoline	4180186
19475029	Sizofilan	4180186
19475029	beta-D-Glucopyranosyl-(1->3)-(beta-D-glucopyranosyl-(1->6))-beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranose	4180186
19475029	Schizophyllan	4180186
19475029	Sonifilan	4180186
19475035	Training Schools, Nurse	4180186
19475035	Nurse Training School	4180186
19475035	Schools, Nurse Training	4180186
19475035	School, Nurse Training	4180186
19475035	Nursing Schools	4180186
19475035	Nursing School	4180186
19475035	Training School, Nurse	4180186
19475035	Nurse Training Schools	4180186
19475036	Pharmacy School	4180186
19475036	Pharmacy Schools	4180186
19475036	School, Pharmacy	4180186
19475038	School, Veterinary	4180186
19475038	Veterinary Schools	4180186
19475038	Veterinary School	4180186
19475040	Sculptures	4180186
19475042	4B, Sepharose C1	4180186
19475042	C1 4B, Sepharose	4180186
19475042	Sepharose C1 4B	4180186
19475042	Agarose	4180186
19475042	Sepharose 4B	4180186
19475047	SITS Disodium Salt	4180186
19475047	4 Acetamido 4' isothiocyanatostilbene 2,2' disulfonic Acid	4180186
19475047	4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid, Disodium Salt	4180186
19475047	Disodium Salt, SITS	4180186
19475047	Benzenesulfonic acid, 5-(acetylamino)-2-(2-(4-isothiocyanato-2-sulfophenyl)ethenyl)-	4180186
19475047	SITS	4180186
19475048	Care Facility, Extended	4180186
19475048	Facilities, Extended Care	4180186
19475048	Care Facilities, Extended	4180186
19475048	Facilities, Skilled Nursing	4180186
19475048	Facility, Extended Care	4180186
19475048	Nursing Facilities, Skilled	4180186
19475048	Skilled Nursing Facility	4180186
19475048	Facility, Skilled Nursing	4180186
19475048	Nursing Facility, Skilled	4180186
19475048	Extended Care Facility	4180186
19475048	Extended Care Facilities	4180186
19475049	Vestin	4180186
19475049	MSG	4180186
19475049	Accent	4180186
19475049	Monosodium Glutamate	4180186
19475049	Glutamate, Sodium	4180186
19475049	L-Glutamic acid, monosodium salt	4180186
19475051	Somatomedin	4180186
19475051	Factors, Insulin-Like Growth	4180186
19475051	Sulfation Factor	4180186
19475051	Growth Factors, Insulin-Like	4180186
19475051	Insulin-Like Growth Factors	4180186
19475051	Factor, Sulfation	4180186
19475051	Insulin Like Growth Factor	4180186
19475051	Insulin Like Growth Factors	4180186
19475051	Insulin-Like Growth Factor	4180186
19475051	Factor, Insulin-Like Growth	4180186
19475051	Growth Factor, Insulin-Like	4180186
19475052	Recombinant Growth Hormone	4180186
19475052	Recombinant Somatotropin	4180186
19475052	Pituitary Growth Hormones, Recombinant	4180186
19475052	Recombinant Growth Hormones	4180186
19475052	Pituitary Growth Hormone	4180186
19475052	Somatotropin	4180186
19475052	Somatotropin, Recombinant	4180186
19475052	Growth Hormone, Pituitary	4180186
19475052	Growth Hormones Pituitary, Recombinant	4180186
19475052	Growth Hormones, Recombinant	4180186
19475052	Growth Hormone, Recombinant	4180186
19475052	Recombinant Somatotropins	4180186
19475052	Recombinant Pituitary Growth Hormones	4180186
19475052	Somatotropins, Recombinant	4180186
19475053	Somatocrinin	4180186
19475053	Somatotropin Releasing Hormone	4180186
19475053	Growth Hormone-Releasing Factor	4180186
19475053	Somatotropin Releasing Factor 44	4180186
19475053	Growth Hormone Releasing Factor	4180186
19475053	Somatotropin-Releasing Hormone	4180186
19475053	GRF 1-44	4180186
19475053	hpGRF 44	4180186
19475053	Growth Hormone Releasing Factor 44	4180186
19475053	Growth Hormone-Releasing Factor 44	4180186
19475053	GHRH 1-44	4180186
19475053	Growth Hormone Releasing Hormone	4180186
19475053	Somatotropin-Releasing Factor 44	4180186
19475053	Somatoliberin	4180186
19475053	Human Pancreatic Growth Hormone-Releasing Factor	4180186
19475054	L Sorbose	4180186
19475054	L-Sorbose	4180186
19475054	D Sorbose	4180186
19475054	D-Sorbose	4180186
19475056	2-Propenamide, N-(1-(hydroxymethyl)-2-(((methylthio)methyl)sulfinyl)ethyl)-3-(1,2,3,4-tetrahydro-6-methyl-2,4-dioxo-5-pyrimidinyl)-, (R-(R*,S*-(E)))-	4180186
19475059	Effects, Sperm-Immobilizing	4180186
19475059	Sperm-Immobilizing Effect	4180186
19475059	Sperm Immobilizing Effect	4180186
19475059	Agents, Sperm Immobilizing	4180186
19475059	Sperm-Immobilizing Effects	4180186
19475059	Effect, Sperm-Immobilizing	4180186
19475059	Sperm Immobilizing Effects	4180186
19475059	Agents, Sperm-Immobilizing	4180186
19475059	Sperm-Immobilizing Agents	4180186
19475061	S 18506	4180186
19475061	S-18506	4180186
19475061	SQ 18 506	4180186
19475061	1,2,4-Oxadiazol-5-amine, 3-(2-(5-nitro-2-furanyl)ethenyl)-, (E)-	4180186
19475061	SQ18506	4180186
19475061	SQ-18506	4180186
19475061	SQ 18506	4180186
19475061	S18506	4180186
19475063	Protein A	4180186
19475063	Protein A, Staphylococcal	4180186
19475064	Toxoid, Staphylococcal	4180186
19475065	Colony Forming Units	4180186
19475065	Stem Cell	4180186
19475065	Progenitor Cell	4180186
19475065	Cells, Stem	4180186
19475065	Cell, Stem	4180186
19475065	Progenitor Cells	4180186
19475065	Colony-Forming Unit	4180186
19475065	Colony Forming Unit	4180186
19475065	Mother Cells	4180186
19475065	Cell, Progenitor	4180186
19475065	Cells, Progenitor	4180186
19475065	Cell, Mother	4180186
19475065	Cells, Mother	4180186
19475065	Colony-Forming Units	4180186
19475065	Mother Cell	4180186
19475066	Stereoisomer	4180186
19475066	Stereochemistry, Molecular	4180186
19475066	Stereoisomers	4180186
19475066	Molecular Stereochemistry	4180186
19475069	Bruneomycin	4180186
19475069	Nigrin	4180186
19475069	NSC-45383	4180186
19475069	NSC45383	4180186
19475069	2-Pyridinecarboxylic acid, 5-amino-6-(7-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolinyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl-	4180186
19475069	NSC 45383	4180186
19475069	Rufocromomycin	4180186
19475069	Brunemycin	4180186
19475071	Metabolic Stress Response	4180186
19475071	Biotic Stresses	4180186
19475071	Biotic Stress	4180186
19475071	Metabolic Stresses	4180186
19475071	Biological Stresses	4180186
19475071	Abiotic Stress Reaction	4180186
19475071	Physiological Stress Responses	4180186
19475071	Physiological Stress Reactions	4180186
19475071	Abiotic Stress Responses	4180186
19475071	Physiological Stresses	4180186
19475071	Stress Response, Metabolic	4180186
19475071	Stress, Biological	4180186
19475071	Reaction, Abiotic Stress	4180186
19475071	Abiotic Stress Reactions	4180186
19475071	Stress, Abiotic	4180186
19475071	Physiological Stress Response	4180186
19475071	Abiotic Stresses	4180186
19475071	Stress Response, Physiological	4180186
19475071	Physiological Stress Reactivity	4180186
19475071	Physiological Stress	4180186
19475071	Response, Metabolic Stress	4180186
19475071	Physiological Stress Reaction	4180186
19475071	Metabolic Stress Responses	4180186
19475071	Biological Stress	4180186
19475071	Reactions, Abiotic Stress	4180186
19475071	Response, Abiotic Stress	4180186
19475071	Abiotic Stress	4180186
19475071	Stress Reaction, Physiological	4180186
19475071	Metabolic Stress	4180186
19475071	Stress, Biotic	4180186
19475071	Stress, Metabolic	4180186
19475071	Abiotic Stress Response	4180186
19475072	Convallatoxigenin	4180186
19475072	Card-20(22)-enolide, 3,5,14-trihydroxy-19-oxo-, (3beta,5beta)-	4180186
19475072	K-Strophanthidin	4180186
19475072	K Strophanthidin	4180186
19475072	Cymarigenin	4180186
19475072	KStrophanthidin	4180186
19475072	Corchsularin	4180186
19475075	Butanimides	4180186
19475075	Pyrrolidinediones	4180186
19475076	Sulfamethoxydiazine	4180186
19475076	Sulfamethoxydine	4180186
19475076	Sulfametoxydiazine	4180186
19475076	Sulfametoxidine	4180186
19475076	Sulfametin	4180186
19475076	Benzenesulfonamide, 4-amino-N-(5-methoxy-2-pyrimidinyl)-	4180186
19475076	Sulfametorinum	4180186
19475076	Sulphamethoxydiazine	4180186
19475078	Sulphanilamides	4180186
19475084	Sulfone	4180186
19475085	Suloctidil Hydrochloride	4180186
19475085	CP-556S	4180186
19475085	Benzenemethanol, 4-((1-methylethyl)thio)-alpha-(1-(octylamino)ethyl)-, (R*,S*)-	4180186
19475086	Superoxide Anion	4180186
19475086	Superoxide	4180186
19475086	Superoxide Radical	4180186
19475088	Tensides	4180186
19475088	Surfactants	4180186
19475088	Agents, Surface Active	4180186
19475088	Active Agents, Surface	4180186
19475088	Agents, Surface-Active	4180186
19475088	Surface-Active Agent	4180186
19475088	Agents, Amphiphilic	4180186
19475088	Surface Active Agent	4180186
19475088	Active Agent, Surface	4180186
19475088	Agent, Surface-Active	4180186
19475088	Agent, Surface Active	4180186
19475088	Surface Active Agents	4180186
19475088	Tenside	4180186
19475088	Amphiphilic Agents	4180186
19475088	Surfactant	4180186
19475092	Incident Technique, Critical	4180186
19475092	Task Performances	4180186
19475092	Performances, Analysis Task	4180186
19475092	Technics, Critical Incident	4180186
19475092	Incident Technics, Critical	4180186
19475092	Technic, Critical Incident	4180186
19475092	Techniques, Critical Incident	4180186
19475092	Critical Incident Technic	4180186
19475092	Performances, Task	4180186
19475092	Critical Incident Techniques	4180186
19475092	Technique, Critical Incident	4180186
19475092	Incident Technic, Critical	4180186
19475092	Performance, Task	4180186
19475092	Critical Incident Technique	4180186
19475092	Performance, Analysis Task	4180186
19475092	Task Performance	4180186
19475092	Incident Techniques, Critical	4180186
19475092	Critical Incident Technics	4180186
19475092	Task Performance, Analysis	4180186
19475092	Task Performances, Analysis	4180186
19475096	Bradykinin potentiator B, 2-L-tryptophan-3-de-L-leucine-4-de-L-proline-8-L-glutamine-	4180186
19475096	Peptide 9a, Bradykinin-Potentiating	4180186
19475096	Enzyme Inhibitor, Nonapeptide-Converting	4180186
19475096	Nonapeptide-Converting Enzyme Inhibitor	4180186
19475096	Nonapeptide Converting Enzyme Inhibitor	4180186
19475096	Bradykinin-Potentiating Peptide 9a	4180186
19475096	Bradykinin Potentiating Peptide 9a	4180186
19475096	SQ-20881	4180186
19475096	BPP-9a	4180186
19475098	12-O-Tetradecanoyl Phorbol 13-Acetate	4180186
19475098	Tetradecanoylphorbol Acetate, 4a alpha Isomer	4180186
19475098	12-Myristoyl-13-acetylphorbol	4180186
19475098	Acetate, Tetradecanoylphorbol	4180186
19475098	Tetradecanoylphorbol Acetate, 4a alpha-Isomer	4180186
19475098	Myristate Acetate, Phorbol	4180186
19475098	Phorbol 13-Acetate, 12-O-Tetradecanoyl	4180186
19475098	Acetate, Phorbol Myristate	4180186
19475098	13-Acetate, 12-O-Tetradecanoyl Phorbol	4180186
19475098	Phorbol Myristate Acetate	4180186
19475098	Tetradecanoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester, (1aR-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha))-	4180186
19475098	12 O Tetradecanoyl Phorbol 13 Acetate	4180186
19475098	12 Myristoyl 13 acetylphorbol	4180186
19475103	Benzenediamine, N,N,N',N'-tetramethyl-	4180186
19475103	Reagent, Wurster's	4180186
19475103	Wurster Reagent	4180186
19475103	Wurster Blue	4180186
19475103	Wursters Reagent	4180186
19475103	Wursters Blue	4180186
19475103	Blue, Wurster's	4180186
19475103	Wurster's Blue	4180186
19475103	Blue, Wurster	4180186
19475103	Wurster's Reagent	4180186
19475104	Nilverm	4180186
19475104	Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (+-)-	4180186
19475105	Tetraphenylborate, Sodium	4180186
19475105	Tetraphenylboron Sodium	4180186
19475105	Tetraphenylborate, Barium Salt (2:1)	4180186
19475105	Ammonium Salt Tetraphenylborate	4180186
19475105	Kalignost	4180186
19475105	Borate(1-), tetraphenyl-	4180186
19475105	Tetraphenylborate, Ammonium Salt	4180186
19475105	Potassium Salt Tetraphenylborate	4180186
19475105	Tetraphenylboron	4180186
19475105	Tetraphenylborate Sodium Salt	4180186
19475105	Sodium, Tetraphenylboron	4180186
19475105	Tetraphenylborate, Potassium Salt	4180186
19475105	Sodium Tetraphenylborate	4180186
19475105	Sodium Salt, Tetraphenylborate	4180186
19475109	Morphinan, 6,7,8,14-tetradehydro-4,5-epoxy-3,6-dimethoxy-17-methyl-, (5alpha)-	4180186
19475115	Blood Coagulation Factor III	4180186
19475115	Tissue Thromboplastin	4180186
19475115	Procoagulant Activity, Glomerular	4180186
19475115	Tissue Factor	4180186
19475115	Thromboplastin, Tissue	4180186
19475115	Tissue Factor Procoagulant	4180186
19475115	Prothrombinase	4180186
19475115	Factor III	4180186
19475115	CD142 Antigens	4180186
19475115	Urothromboplastin	4180186
19475115	Glomerular Procoagulant Activity	4180186
19475115	Procoagulant, Tissue Factor	4180186
19475115	Factor III, Coagulation	4180186
19475115	Blood-coagulation factor III	4180186
19475115	Coagulin	4180186
19475115	Coagulation Factor III	4180186
19475115	Antigens, CD142	4180186
19475115	Activity, Glomerular Procoagulant	4180186
19475117	Thymopoietin	4180186
19475117	Thymopoietin I	4180186
19475117	TP-49	4180186
19475117	Thymopoietin II	4180186
19475117	Thymin	4180186
19475117	TP 49	4180186
19475117	Thymins	4180186
19475124	Banking, Tissue	4180186
19475124	Bank, Tissue	4180186
19475124	Tissue Bank	4180186
19475124	Banks, Tissue	4180186
19475124	Tissue Banking	4180186
19475125	Tobaccos, Dipping	4180186
19475125	Gutka Tobaccos	4180186
19475125	Dipping Tobacco	4180186
19475125	Mint Snuff	4180186
19475125	Snus	4180186
19475125	Gutkas	4180186
19475125	Snuff	4180186
19475125	Tobacco, Gutka	4180186
19475125	Smokeless Tobacco	4180186
19475125	Tobaccos, Chewing	4180186
19475125	Tobacco, Chewing	4180186
19475125	Chewing Tobacco	4180186
19475125	Dipping Tobaccos	4180186
19475125	Tobaccos, Gutka	4180186
19475125	Gutka Tobacco	4180186
19475125	Oral Tobacco	4180186
19475125	Snuff, Mint	4180186
19475125	Tobacco, Oral	4180186
19475125	Tobacco, Dipping	4180186
19475125	Gutka	4180186
19475125	Tobaccos, Smokeless	4180186
19475125	Chewing Tobaccos	4180186
19475126	Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, monohydrochloride	4180186
19475126	Todrazoline	4180186
19475126	Binazine	4180186
19475126	Apirachol	4180186
19475126	Binazin	4180186
19475126	Ecarazine	4180186
19475135	Major Tranquilizers	4180186
19475135	Tranquilizing Agents, Major	4180186
19475135	Tranquillizing Agents, Major	4180186
19475135	Major Tranquilizing Agents	4180186
19475135	Neuroleptic Drugs	4180186
19475135	Antipsychotic Medication	4180186
19475135	Major Tranquillizing Agents	4180186
19475135	Effect, Antipsychotic	4180186
19475135	Antipsychotics	4180186
19475135	Neuroleptic Agents	4180186
19475135	Major Tranquilizer	4180186
19475135	Antipsychotic Effect	4180186
19475135	Antipsychotic Effects	4180186
19475135	Agent, Antipsychotic	4180186
19475135	Neuroleptics	4180186
19475135	Antipsychotic Drugs	4180186
19475135	Medication, Antipsychotic	4180186
19475135	Neuroleptic Agent	4180186
19475135	Neuroleptic Drug	4180186
19475135	Drug, Antipsychotic	4180186
19475135	Agent, Neuroleptic	4180186
19475135	Neuroleptic	4180186
19475135	Tranquilizer, Major	4180186
19475135	Antipsychotic	4180186
19475135	Antipsychotic Drug	4180186
19475135	Antipsychotic Agent	4180186
19475135	Drug, Neuroleptic	4180186
19475136	Agents, Minor Tranquilizing	4180186
19475136	Antianxiety Effect	4180186
19475136	Anti Anxiety Agents	4180186
19475136	Agents, Anti-Anxiety	4180186
19475136	Anti Anxiety Agent	4180186
19475136	Minor Tranquilizing Agents	4180186
19475136	Tranquillizing Agents, Minor	4180186
19475136	Effect, Anti-Anxiety	4180186
19475136	Anti-Anxiety Drugs	4180186
19475136	Anxiolytic Agent	4180186
19475136	Antianxiety Effects	4180186
19475136	Anti Anxiety Effects	4180186
19475136	Anxiolytic Agents	4180186
19475136	Anxiolytic Effect	4180186
19475136	Anti-Anxiety Effect	4180186
19475136	Effects, Anti-Anxiety	4180186
19475136	Anxiolytic Effects	4180186
19475136	Effects, Anxiolytic	4180186
19475136	Agent, Anxiolytic	4180186
19475136	Minor Tranquillizing Agents	4180186
19475136	Anti Anxiety Drug	4180186
19475136	Agents, Anxiolytic	4180186
19475136	Anxiolytic	4180186
19475136	Anti-Anxiety Effects	4180186
19475136	Effect, Antianxiety	4180186
19475136	Agents, Minor Tranquillizing	4180186
19475136	Anti Anxiety Drugs	4180186
19475136	Tranquilizing Agents, Minor	4180186
19475136	Anti-Anxiety Drug	4180186
19475136	Drug, Anti-Anxiety	4180186
19475136	Anxiolytics	4180186
19475136	Drugs, Anti-Anxiety	4180186
19475136	Anti Anxiety Effect	4180186
19475136	Agent, Anti-Anxiety	4180186
19475136	Anti-Anxiety Agent	4180186
19475136	Effects, Antianxiety	4180186
19475136	Effect, Anxiolytic	4180186
19475137	Centers, Trauma	4180186
19475137	Units, Trauma	4180186
19475137	Trauma Units	4180186
19475137	Center, Trauma	4180186
19475137	Trauma Unit	4180186
19475137	Trauma Center	4180186
19475137	Unit, Trauma	4180186
19475138	Pyrrolidine, 1,1'-(2-butyne-1,4-diyl)bis-	4180186
19475141	Compounds, Diazoamino	4180186
19475141	Diazoamino Compounds	4180186
19475145	Oxirane, (trichloromethyl)-	4180186
19475145	Trichloropropane Oxide	4180186
19475145	Oxide, Trichloropropane	4180186
19475145	Oxide, Trichloropropene	4180186
19475145	Trichloropropene Oxide	4180186
19475145	Trichloropropylene Oxide	4180186
19475145	1,1,1-Trichloropropene-2,3-oxide	4180186
19475145	1,2-Epoxy-3,3,3-Trichloropropane	4180186
19475145	Oxide, Trichloropropylene	4180186
19475146	Trichothec-9-en-4-ol, 12,13-epoxy-, acetate, (4beta)-	4180186
19475146	Trichodermol	4180186
19475147	Triethylene Melamine	4180186
19475147	1,3,5-Triazine, 2,4,6-tris(1-aziridinyl)-	4180186
19475147	2,4,6-Triethylimino-1,3,5-Triazine	4180186
19475147	Melamine, Triethylene	4180186
19475147	Tretamine	4180186
19475148	Compounds, Triethyltin	4180186
19475150	Dipyroxime	4180186
19475150	Bromide, Trimedoxime	4180186
19475150	Pyridinium, 1,1'-(1,3-propanediyl)bis(4-(hydroxyimino)methyl)-, dibromide	4180186
19475150	Trimedoxime Bromide	4180186
19475150	TMB-4	4180186
19475151	Compounds, Trimethyltin	4180186
19475158	Deazaadenosine	4180186
19475158	4-Amino-7 beta-D-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine	4180186
19475158	7H-Pyrrolo(2,3-d)pyrimidin-4-amine, 7-beta-D-ribofuranosyl-	4180186
19475158	7 Deazaadenosine	4180186
19475158	7-Deazaadenosine	4180186
19475159	Tumor Necrosis Factor alpha	4180186
19475159	TNF Superfamily, Member 2	4180186
19475159	TNF-alpha	4180186
19475159	Cachectin Tumor Necrosis Factor	4180186
19475159	Cachectin-Tumor Necrosis Factor	4180186
19475159	TNFalpha	4180186
19475159	Tumor Necrosis Factor	4180186
19475159	Tumor Necrosis Factor Ligand Superfamily Member 2	4180186
19475159	Cachectin	4180186
19475164	Distributions, Urban Spatial	4180186
19475164	Residence, Urban	4180186
19475164	Urban Residence	4180186
19475164	Urban Populations	4180186
19475164	Distribution, Urban Spatial	4180186
19475164	Urban Spatial Distributions	4180186
19475164	Urban Residences	4180186
19475164	Urban Spatial Distribution	4180186
19475164	Population, Urban	4180186
19475164	Populations, Urban	4180186
19475169	Vaccine	4180186
19475172	Vanadate, Sodium	4180186
19475172	Vanadate	4180186
19475172	Monovanadate	4180186
19475172	Metavanadate	4180186
19475172	Decavanadate	4180186
19475172	Sodium Vanadate	4180186
19475172	Oxyvanadium	4180186
19475172	Vanadyl	4180186
19475172	Orthovanadate	4180186
19475174	Cevane-3,4,12,14,16,17,20-heptol, 4,9-epoxy-, 3-(3,4-dimethoxybenzoate), (3beta,4alpha,16beta)-	4180186
19475177	Alkaloids, Vinca	4180186
19475178	Viologen	4180186
19475179	Tuberactinomycin B	4180186
19475179	Florimycin	4180186
19475179	Viomicin	4180186
19475179	Viomycins	4180186
19475179	Vinactane	4180186
19475179	Viocin	4180186
19475179	Celiomycin	4180186
19475180	Vitamin	4180186
19475181	Microbiology, Water	4180186
19475182	Measures	4180186
19475182	Weights	4180186
19475182	Scales	4180186
19475182	Measures and Weights	4180186
19475182	Measure	4180186
19475186	2-Benzoxazolamine, 5-chloro-	4180186
19475187	Zymosans	4180186
19475187	Zymosan A	4180186
19475188	alpha-Naphthylisothiocyanate	4180186
19475188	alpha Naphthylisothiocyanate	4180186
19475188	Naphthalene, 1-isothiocyanato-	4180186
19475188	1 Naphthylisothiocyanate	4180186
19475189	11 Hydroxycorticosteroids	4180186
19475190	E2, 16,16-Dimethylprostaglandin	4180186
19475190	Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-16,16-dimethyl-9-oxo-, (5Z,11alpha,13E,15R)-	4180186
19475190	16,16 Dimethyl PGE2	4180186
19475190	16,16 Dimethylprostaglandin E2	4180186
19475190	16,16-Dimethyl-PGE2	4180186
19475192	17 Oxosteroids	4180186
19475192	17-Oxosteroids	4180186
19475192	17 Ketosteroids	4180186
19475193	Hydroxycorticosterone, 18	4180186
19475193	18 Hydrocorticosterone	4180186
19475193	Pregn-4-ene-3,20-dione, 11,18,21-trihydroxy-, (11beta)-	4180186
19475193	18-Hydrocorticosterone	4180186
19475193	18 Hydroxycorticosterone	4180186
19475194	2-AAF	4180186
19475194	2-Acetamidofluorene	4180186
19475194	2 Fluorenylacetamide	4180186
19475194	Aminofluorene AAF	4180186
19475194	2 Acetylaminofluorene	4180186
19475194	N Acetyl 2 Aminofluorene	4180186
19475194	N-2-Fluorenylacetamide	4180186
19475194	N-Acetyl-2-Aminofluorene	4180186
19475194	N 2 Fluorenylacetamide	4180186
19475194	Fluoren-2-ylacetamide	4180186
19475194	Acetamide, N-9H-fluoren-2-yl-	4180186
19475194	Acetylaminofluorene	4180186
19475194	AAF, Aminofluorene	4180186
19475194	2-Fluorenylacetamide	4180186
19475194	2 Acetamidofluorene	4180186
19475194	Fluoren 2 ylacetamide	4180186
19475196	Bipyridyl	4180186
19475196	2,2' Dipyridyl	4180186
19475196	2,2 Bipyridine	4180186
19475196	2,2'-Bipyridine	4180186
19475196	2,2' Bipyridine	4180186
19475196	alpha,alpha-Dipyridyl	4180186
19475196	alpha,alpha Dipyridyl	4180186
19475196	2,2 Dipyridyl	4180186
19475196	2,2-Dipyridyl	4180186
19475196	Dipyridyl, 2,2	4180186
19475196	Dipyridyl, 2,2'	4180186
19475196	2,2-Bipyridyl	4180186
19475196	2,2-Bipyridine	4180186
19475196	2,2 Bipyridyl	4180186
19475197	2,6-Dichloroindophenol, Sodium	4180186
19475197	Dichloroindophenol, 2,6	4180186
19475197	Tillmans' Reagent	4180186
19475197	Reagent, Tillmans'	4180186
19475197	2,5-Cyclohexadien-1-one, 2,6-dichloro-4-((4-hydroxyphenyl)imino)-	4180186
19475197	Tillman's Reagent	4180186
19475197	Reagent, Tillmans	4180186
19475197	2,6 Dichlorophenolindophenol	4180186
19475197	Indophenol, Dichlorophenol	4180186
19475197	Tillman Reagent	4180186
19475197	Sodium 2,6 Dichloroindophenol	4180186
19475197	Tillmans Reagent	4180186
19475197	2,6-Dichlorobenzenoneindophenol Dye	4180186
19475197	2,6 Dichloroindophenol	4180186
19475197	Dichlorophenolindophenol	4180186
19475197	2,6 Dichlorobenzenoneindophenol Dye	4180186
19475197	Dye, 2,6-Dichlorobenzenoneindophenol	4180186
19475197	2,6-Dichlorophenolindophenol	4180186
19475197	Sodium 2,6-Dichloroindophenol	4180186
19475197	Dichlorophenol Indophenol	4180186
19475198	Acid, 3-Hydroxy-3-methylglutaric	4180186
19475198	beta Hydroxy beta Methylglutarate	4180186
19475198	beta-Hydroxy-beta-Methylglutarate	4180186
19475198	3 Hydroxy 3 methylpentanedioic Acid	4180186
19475198	Acid, 3-Hydroxy-3-methylpentanedioic	4180186
19475198	3-Hydroxy-3-methylglutaric Acid	4180186
19475198	3-Hydroxy-3-methylpentanedioic Acid	4180186
19475198	Pentanedioic acid, 3-hydroxy-3-methyl-	4180186
19475198	3 Hydroxy 3 methylglutaric Acid	4180186
19475199	Acid, 3-Mercaptopropanoic	4180186
19475199	beta-Mercaptopropionate	4180186
19475199	3-Mercaptopropanoic Acid	4180186
19475199	3 Mercaptopropanoic Acid	4180186
19475199	Acid, 3-Mercaptopropionic	4180186
19475199	beta Mercaptopropionate	4180186
19475199	Propanoic acid, 3-mercapto-	4180186
19475199	3 Mercaptopropionic Acid	4180186
19475200	3,3 Diaminobenzidine	4180186
19475200	Diaminobenzidine, 3,3'	4180186
19475200	3,3' Diaminobenzidine	4180186
19475200	3,3-Diaminobenzidine	4180186
19475200	(1,1'-Biphenyl)-3,3',4,4'-tetramine	4180186
19475200	Diaminobenzidine, 3,3	4180186
19475201	Dihydro-2(3H)-furanone	4180186
19475201	gamma Butyrolactone	4180186
19475201	Lactone, 4-Hydroxybutyric Acid	4180186
19475201	1,4 Butanolide	4180186
19475201	2(3H)-Furanone, dihydro-	4180186
19475201	Furanone, tetrahydro 2	4180186
19475201	gamma-Butyrolactone	4180186
19475201	4-Hydroxybutyric Acid Lactone	4180186
19475201	4 Butyrolactone	4180186
19475201	1,4-Butanolide	4180186
19475201	Furanone, tetrahydro-2-	4180186
19475201	4 Hydroxybutyric Acid Lactone	4180186
19475207	ETYA	4180186
19475207	Ro 3 1428	4180186
19475207	5,8,11,14 Eicosatetraynoic Acid	4180186
19475207	Ro 31428	4180186
19475207	Ro 3-1428	4180186
19475211	HLA-C	4180186
19475211	Antigens, HLA-C	4180186
19475211	Antigens, HLA C	4180186
19475211	HLA C Antigens	4180186
19475213	Pediatric Intensive Care Units	4180186
19475213	Pediatric ICUs	4180186
19475213	ICUs, Pediatric	4180186
19475213	ICU, Pediatric	4180186
19475213	Pediatric ICU	4180186
19475213	Pediatric Intensive Care Unit	4180186
19475215	Solutions, Hemodialysis	4180186
19475215	Hemodialysis Dialysis Solutions	4180186
19475215	Dialysis Solutions, Hemodialysis	4180186
19475215	Hemodialyzates	4180186
19475215	Hemodialysates	4180186
19475215	Solutions, Hemodialysis Dialysis	4180186
19475216	Tachykinin	4180186
19475218	Hybridization Probes, DNA	4180186
19475218	Conserved Gene Probes	4180186
19475218	Chromosomal Probes	4180186
19475218	DNA Hybridization Probes	4180186
19475218	Probes, DNA Gene	4180186
19475218	Probes, DNA	4180186
19475218	Whole Genomic DNA Probes	4180186
19475218	DNA Hybridization Probe	4180186
19475218	Probes, Whole Chromosomal	4180186
19475218	Probe, DNA Hybridization	4180186
19475218	Probes, Chromosomal	4180186
19475218	Gene Probes, Conserved	4180186
19475218	DNA Probe	4180186
19475218	Hybridization Probe, DNA	4180186
19475218	Gene Probes, DNA	4180186
19475218	Probes, Conserved Gene	4180186
19475218	Chromosomal Probes, Whole	4180186
19475218	DNA Gene Probes	4180186
19475218	Probes, DNA Hybridization	4180186
19475218	Probe, DNA	4180186
19475218	Whole Chromosomal Probes	4180186
19475219	Human Leukocyte Antigen DNA Probes	4180186
19475219	HLA-D DNA Probes	4180186
19475219	HLA C DNA Probes	4180186
19475219	Probes, HLA-DR DNA	4180186
19475219	Probes, HLA-D DNA	4180186
19475219	Probes, HLA DNA	4180186
19475219	HLA-DR DNA Probes	4180186
19475219	Probes, HLA-B DNA	4180186
19475219	DNA Probes, HLA-DR	4180186
19475219	DNA Probes, HLA-Dw	4180186
19475219	DNA Probes, HLA-D	4180186
19475219	HLA-Dw DNA Probes	4180186
19475219	HLA DR DNA Probes	4180186
19475219	DNA Probes, HLA-B	4180186
19475219	HLA-A DNA Probes	4180186
19475219	Histocompatibility Antigen DNA Probes	4180186
19475219	HLA Dw DNA Probes	4180186
19475219	HLA D DNA Probes	4180186
19475219	Probes, HLA-C DNA	4180186
19475219	Probes, HLA-Dw DNA	4180186
19475219	HLA-B DNA Probes	4180186
19475219	HLA B DNA Probes	4180186
19475219	DNA Probes, Histocompatibility Antigen	4180186
19475219	HLA-C DNA Probes	4180186
19475219	HLA A DNA Probes	4180186
19475219	Probes, HLA-A DNA	4180186
19475219	DNA Probes, HLA-A	4180186
19475219	DNA Probes, HLA-C	4180186
19475219	HLA DNA Probes	4180186
19475221	Oligodeoxyribonucleotide Probes	4180186
19475221	Probe, Oligonucleotide	4180186
19475221	Probes, Oligoribonucleotide	4180186
19475221	Probes, Oligodeoxyribonucleotide	4180186
19475221	Oligoribonucleotide Probes	4180186
19475221	Probes, Oligonucleotide	4180186
19475221	Oligonucleotide Probe	4180186
19475222	Probes, RNA Gene	4180186
19475222	RNA Gene Probes	4180186
19475222	Gene Probes, RNA	4180186
19475222	RNA Probe	4180186
19475222	Probe, RNA	4180186
19475222	Probes, RNA	4180186
19475224	IL2 Receptors	4180186
19475224	TCGF Receptors	4180186
19475224	Receptor, IL-2	4180186
19475224	Receptors, T Cell Growth Factor	4180186
19475224	IL 2 Receptor	4180186
19475224	Receptor, IL2	4180186
19475224	Interleukin-2 Receptor	4180186
19475224	T Cell Growth Factor Receptor	4180186
19475224	Receptor, Interleukin-2	4180186
19475224	Interleukin 2 Receptors	4180186
19475224	Receptor, TCGF	4180186
19475224	Receptors, IL-2	4180186
19475224	Receptors, IL 2	4180186
19475224	Receptor, Interleukin 2	4180186
19475224	T-Cell Growth Factor Receptors	4180186
19475224	T Cell Growth Factor Receptors	4180186
19475224	Interleukin-2 Receptors	4180186
19475224	IL 2 Receptors	4180186
19475224	Receptors, Interleukin 2	4180186
19475224	IL-2 Receptor	4180186
19475224	Receptors, TCGF	4180186
19475224	Interleukin 2 Receptor	4180186
19475224	TCGF Receptor	4180186
19475224	IL2 Receptor	4180186
19475224	Receptors, IL2	4180186
19475224	Receptors, T-Cell Growth Factor	4180186
19475224	T-Cell Growth Factor Receptor	4180186
19475224	IL-2 Receptors	4180186
19475226	Leukemia Lymphoma Virus Antibodies, Human T Cell	4180186
19475226	BLV Antibodies	4180186
19475226	HTLV Antibodies	4180186
19475226	Human T Cell Leukemia Virus Antibodies	4180186
19475226	T Cell Leukemia Lymphoma Virus Antibodies, Human	4180186
19475226	HTLV BLV Antibodies	4180186
19475226	Leukemia Virus Antibodies, Human T-Cell	4180186
19475226	Antibodies, HTLV	4180186
19475226	T-Cell Leukemia-Lymphoma Virus Antibodies, Human	4180186
19475226	Antibodies, HTLV-BLV	4180186
19475226	Human T-Cell Leukemia Virus Antibodies	4180186
19475226	Antibodies, BLV	4180186
19475226	Antibodies, Deltaretrovirus	4180186
19475226	Leukemia Virus Antibodies, Human T Cell	4180186
19475226	Leukemia-Lymphoma Virus Antibodies, Human T-Cell	4180186
19475226	HTLV-BLV Antibodies	4180186
19475227	Human T-Cell Leukemia Virus I Antibodies	4180186
19475227	Leukemia Lymphoma Virus I Antibodies, Human T Cell	4180186
19475227	Antibodies, HTLV I	4180186
19475227	HTLV I Antibodies	4180186
19475227	I Antibodies, HTLV	4180186
19475227	Antibodies, HTLV-I	4180186
19475227	T-Cell Leukemia Virus I Antibodies, Adult	4180186
19475227	T-Cell Leukemia Virus I Antibodies, Human	4180186
19475227	Antibodies, ATLV	4180186
19475227	Leukemia-Lymphoma Virus I Antibodies, Human T-Cell	4180186
19475227	Human T Cell Leukemia Virus I Antibodies	4180186
19475227	ATLV Antibodies	4180186
19475227	T Cell Leukemia Virus I Antibodies, Adult	4180186
19475227	T Cell Leukemia Virus I Antibodies, Human	4180186
19475228	Leukemia-Lymphoma Virus II Antibodies, Human T-Cell	4180186
19475228	Antibodies, HTLV II	4180186
19475228	Human T Cell Leukemia Virus II Antibodies	4180186
19475228	T Cell Leukemia Virus II Antibodies, Human	4180186
19475228	Human T-Cell Leukemia Virus II Antibodies	4180186
19475228	HTLV II Antibodies	4180186
19475228	T-Cell Leukemia Virus II Antibodies, Human	4180186
19475228	Human T-Lymphotropic Virus II Antibodies	4180186
19475228	Antibodies, HTLV-II	4180186
19475228	Leukemia Lymphoma Virus II Antibodies, Human T Cell	4180186
19475228	Human T Lymphotropic Virus II Antibodies	4180186
19475228	II Antibodies, HTLV	4180186
19475230	SKF-38393	4180186
19475230	SK&F-38393	4180186
19475230	RSK&F 38393	4180186
19475230	1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-	4180186
19475230	SKF 38393	4180186
19475230	SK&F38393	4180186
19475230	SKF 38393 A	4180186
19475230	SK&F 38393	4180186
19475230	SKF38393	4180186
19475230	SKF 38393A	4180186
19475230	SKF 38393-A	4180186
19475230	R-SK&F 38393	4180186
19475231	Receptors, Surface CD4	4180186
19475231	T4 Antigens, T-Cell	4180186
19475231	CD4 Receptor	4180186
19475231	CD4 Molecule	4180186
19475231	Receptors, CD4	4180186
19475231	T4 Antigens, T Cell	4180186
19475231	CD4 Receptors, Surface	4180186
19475231	Antigens, T-Cell T4	4180186
19475231	Antigens, CD4	4180186
19475231	T-Cell T4 Antigens	4180186
19475231	Surface CD4 Receptor	4180186
19475231	Receptor, CD4	4180186
19475231	Antigen, CD4	4180186
19475231	Surface CD4 Receptors	4180186
19475231	CD4 Receptor, Surface	4180186
19475231	CD4 Receptors	4180186
19475231	CD4 Antigen	4180186
19475232	L-Threonine, N-(N-(N2-(N-(N-(N-(N-D-alanyl-L-seryl)-L-threonyl)-L-threonyl)-L-threonyl)-L-asparaginyl)-L-tyrosyl)-	4180186
19475232	HIV Peptide T	4180186
19475232	Peptide T, HIV	4180186
19475234	IMP Nucleotidase	4180186
19475234	5' Nucleotidase Phosphoribolase	4180186
19475234	5'-Nucleotidase Phosphoribolase	4180186
19475234	CD73 Antigen	4180186
19475234	Antigens, CD73	4180186
19475234	Cytidylate Phosphatase	4180186
19475234	IMPase	4180186
19475234	5'-Ribonucleotide phosphohydrolase	4180186
19475234	Ecto 5' Nucleotidase	4180186
19475234	Adenylate Phosphatase	4180186
19475234	5' AMP Nucleotidase	4180186
19475234	Uridylate 5'-Nucleotidase	4180186
19475234	5'-AMP Nucleotidase	4180186
19475234	Antigen, CD73	4180186
19475234	Uridylate 5' Nucleotidase	4180186
19475234	Ecto-5'-Nucleotidase	4180186
19475234	Thymidine Phosphatase	4180186
19475234	Pyrimidine 5' Nucleotidase	4180186
19475234	IMP Phosphatase	4180186
19475234	CD73 Antigens	4180186
19475234	AMP Phosphatase	4180186
19475234	Pyrimidine 5'-Nucleotidase	4180186
19475234	5' Nucleotidase	4180186
19475234	Inosinate Phosphatase	4180186
19475235	AIDS Virus Receptors	4180186
19475235	Virus Receptors, AIDS	4180186
19475235	HIV Receptors	4180186
19475235	Receptors, AIDS Virus	4180186
19475235	Receptors, HTLV-III	4180186
19475235	HTLV III Receptors	4180186
19475235	Receptors, HTLV III	4180186
19475235	HTLV-III Receptors	4180186
19475239	SQ 23377	4180186
19475239	SQ-23377	4180186
19475239	SQ23377	4180186
19475240	BW755C	4180186
19475240	BW-755C	4180186
19475240	BW 755C	4180186
19475240	1H-Pyrazol-3-amine, 4,5-dihydro-1-(3-(trifluoromethyl)phenyl)-	4180186
19475245	Antigen, HLA-B7	4180186
19475245	HLA B7 Antigen	4180186
19475245	HLA Class I Histocompatibility Antigen, B-7 alpha Chain	4180186
19475245	HLA Class I Histocompatibility Antigen, B 7 alpha Chain	4180186
19475245	HLA-B7	4180186
19475246	HLA B8 Antigen	4180186
19475246	HLA-B8	4180186
19475246	HLA Class I Histocompatibility Antigen, B 8 alpha Chain	4180186
19475246	Antigen, HLA-B8	4180186
19475246	HLA Class I Histocompatibility Antigen, B-8 alpha Chain	4180186
19475247	HLA B27 Antigen	4180186
19475247	HLA-B27	4180186
19475247	HLA Class I Histocompatibility Antigen, B 27 alpha Chain	4180186
19475247	Antigen, HLA-B27	4180186
19475247	HLA Class I Histocompatibility Antigen, B-27 alpha Chain	4180186
19475250	Antigen, HLA-DR5	4180186
19475250	HLA-DR5	4180186
19475250	HLA DR5 Antigen	4180186
19475251	HLA DR6 Antigen	4180186
19475251	Antigen, HLA-DR6	4180186
19475251	HLA-DR6	4180186
19475252	HLA-DR7	4180186
19475252	HLA DR7 Antigen	4180186
19475252	Antigen, HLA-DR7	4180186
19475253	Serine Protease Inhibitors, Exogenous	4180186
19475253	Protease Inhibitor, Serine	4180186
19475253	Serine Protease Inhibitor	4180186
19475253	Serine Proteinase Antagonist	4180186
19475253	Inhibitor, Serine Proteinase	4180186
19475253	Endopeptidase Inhibitor, Serine	4180186
19475253	Proteinase Inhibitor, Serine	4180186
19475253	Serine Proteinase Inhibitors, Endogenous	4180186
19475253	Antagonist, Serine Proteinase	4180186
19475253	Serine Proteinase Inhibitor	4180186
19475253	Serine Endopeptidase Inhibitors	4180186
19475253	Serine Endopeptidase Inhibitor	4180186
19475253	Inhibitor, Serine Endopeptidase	4180186
19475253	Inhibitor, Serine Protease	4180186
19475253	Proteinase Antagonist, Serine	4180186
19475253	Serine Protease Inhibitors	4180186
19475253	Serine Proteinase Inhibitors, Exogenous	4180186
19475253	Serine Proteinase Antagonists	4180186
19475253	Serine Protease Inhibitors, Endogenous	4180186
19475254	Inhibitors, Serpin Protease	4180186
19475254	Protease Inhibitors, Serpin	4180186
19475254	Serpin Superfamily	4180186
19475254	Superfamily, Serpin	4180186
19475254	Serpin	4180186
19475254	Serpin Peptidase Inhibitors	4180186
19475254	Serpin Protease Inhibitors	4180186
19475254	Peptidase Inhibitors, Serpin	4180186
19475254	Inhibitors, Serpin Peptidase	4180186
19475256	Protease Inhibitor, Cysteine	4180186
19475256	Protease Inhibitors, Cysteine	4180186
19475256	alpha Cysteine Protease Inhibitors	4180186
19475256	Inhibitors, Cysteine Proteinase	4180186
19475256	Proteinase Inhibitor, Cysteine	4180186
19475256	Cysteine Protease Inhibitors	4180186
19475256	Cysteine Proteinase Antagonists	4180186
19475256	alpha Cysteine Protease Inhibitor	4180186
19475256	Cysteine Proteinase Inhibitors, Exogenous	4180186
19475256	Proteinase Antagonist, Cysteine	4180186
19475256	alpha-Cysteine Protease Inhibitor	4180186
19475256	Cysteine Proteinase Inhibitor	4180186
19475256	Cysteine Protease Inhibitor	4180186
19475256	Antagonists, Cysteine Proteinase	4180186
19475256	Inhibitor, Cysteine Protease	4180186
19475256	Protease Inhibitor, alpha-Cysteine	4180186
19475256	alpha-Cysteine Protease Inhibitors	4180186
19475256	Inhibitor, Cysteine Proteinase	4180186
19475256	Acid Cysteine Proteinase Inhibitor	4180186
19475256	Inhibitors, alpha-Cysteine Protease	4180186
19475256	Cysteine Proteinase Inhibitors, Endogenous	4180186
19475256	Protease Inhibitors, alpha-Cysteine	4180186
19475256	Proteinase Inhibitors, Cysteine	4180186
19475256	Cysteine Proteinase Antagonist	4180186
19475256	Antagonist, Cysteine Proteinase	4180186
19475256	Acid Cysteine Proteinase Inhibitors	4180186
19475256	Proteinase Antagonists, Cysteine	4180186
19475256	Inhibitor, alpha-Cysteine Protease	4180186
19475256	Inhibitors, Cysteine Protease	4180186
19475259	Component 1r, Complement	4180186
19475259	C1r, Complement	4180186
19475259	Complement 1r	4180186
19475259	Complement Component 1r	4180186
19475259	Complement, C1r	4180186
19475259	C1r Complement	4180186
19475263	C4a, Complement	4180186
19475263	C4a Complement	4180186
19475263	Complement 4a	4180186
19475263	Component 4a, Complement	4180186
19475263	Complement Component 4a	4180186
19475263	Complement, C4a	4180186
19475275	Satellites, Natural	4180186
19475275	Satellite, Natural	4180186
19475275	System, Solar	4180186
19475275	Natural Satellite	4180186
19475275	Sun	4180186
19475275	Natural Satellites	4180186
19475276	Agents, Bronchial-Constricting	4180186
19475276	Bronchoconstrictors	4180186
19475276	Bronchoconstrictor Effect	4180186
19475276	Effects, Bronchoconstrictor	4180186
19475276	Bronchial-Constricting Agents	4180186
19475276	Effect, Bronchoconstrictor	4180186
19475276	Bronchial Constricting Agents	4180186
19475276	Bronchoconstrictor Effects	4180186
19475276	Agents, Bronchoconstrictor	4180186
19475277	alphaXbeta2 Integrin	4180186
19475277	Receptor, CR4	4180186
19475277	Neutrophil GP150	4180186
19475277	alphaXbeta2, Integrin	4180186
19475277	p150,95 Glycoprotein	4180186
19475277	Glycoprotein Gp150, Neutrophil	4180186
19475277	Neutrophil Glycoprotein Gp150	4180186
19475277	Antigen p150,95	4180186
19475277	Integrin, alphaXbeta2	4180186
19475277	Antigen, p150,95	4180186
19475277	Glycoprotein, p150,95	4180186
19475277	Leukocyte Adhesion Protein p150,95	4180186
19475277	CR4 Receptor	4180186
19475277	GP150, Neutrophil	4180186
19475277	Complement Receptor 4	4180186
19475277	Gp150, Neutrophil Glycoprotein	4180186
19475277	Complement Receptor Type 4	4180186
19475277	p150,95 Antigen	4180186
19475278	alphaLbeta2, Integrin	4180186
19475278	Antigen-1, Lymphocyte Function-Associated	4180186
19475278	LFA-1	4180186
19475278	Lymphocyte Function Associated Antigen 1	4180186
19475278	Integrin alphaLbeta2	4180186
19475278	Leukocyte Function Associated Antigen-1	4180186
19475280	B-1 Lymphocyte	4180186
19475280	Cell, Be2	4180186
19475280	B-1 Cells	4180186
19475280	B-1 Cell	4180186
19475280	Be2 Cell	4180186
19475280	B Effector 1 Cells	4180186
19475280	Be1 Cell	4180186
19475280	Be2 Cells	4180186
19475280	Lymphocyte, B1	4180186
19475280	B-1 Lymphocytes	4180186
19475280	Tumor-Infiltrating B Cells	4180186
19475280	B-Lymphocytes, Effector	4180186
19475280	Tumor Infiltrating B Cells	4180186
19475280	Tumor Infiltrating B Lymphocytes	4180186
19475280	B-2 Lymphocyte	4180186
19475280	B Effector 2 Cells	4180186
19475280	B Lymphocyte, Tumor-Infiltrating	4180186
19475280	Cell, Be1	4180186
19475280	Cell, B-1	4180186
19475280	Lymphocyte, B2	4180186
19475280	B2 Lymphocytes	4180186
19475280	Effector B Cells	4180186
19475280	B-Lymphocyte, Effector	4180186
19475280	B Cell Subsets	4180186
19475280	B-Cell Subsets	4180186
19475280	B 1 Lymphocytes	4180186
19475280	B Lymphocyte Subsets	4180186
19475280	B1 Lymphocyte	4180186
19475280	Lymphocyte, B-1	4180186
19475280	B-2 Lymphocytes	4180186
19475280	B-Cell Subset	4180186
19475280	Tumor-Infiltrating B Lymphocytes	4180186
19475280	B 1 Cells	4180186
19475280	B 2 Lymphocytes	4180186
19475280	Effector B-Lymphocyte	4180186
19475280	B1 Lymphocytes	4180186
19475280	B-Lymphocyte Subset	4180186
19475280	Be1 Cells	4180186
19475280	B2 Lymphocyte	4180186
19475280	Tumor-Infiltrating B Cell	4180186
19475280	B Cell, Tumor-Infiltrating	4180186
19475280	Lymphocyte, B-2	4180186
19475280	Effector B Cell	4180186
19475280	Tumor-Infiltrating B Lymphocyte	4180186
19475280	Effector B-Lymphocytes	4180186
19475282	TC-GM-CSF	4180186
19475282	GM-CSF	4180186
19475282	CSF-GM	4180186
19475282	Granulocyte Macrophage Colony Stimulating Factor	4180186
19475282	Tumor Cell Human GM Colony Stimulating Factor	4180186
19475282	Histamine Producing Cell Stimulating Factor	4180186
19475282	Colony-Stimulating Factor, Granulocyte-Macrophage	4180186
19475282	CSF-2	4180186
19475282	Colony-stimulating factor 2	4180186
19475282	Colony Stimulating Factor, Granulocyte Macrophage	4180186
19475282	Tumor-Cell Human GM Colony-Stimulating Factor	4180186
19475282	Cell-Stimulating Factor, Histamine-Producing	4180186
19475282	Histamine-Producing Cell-Stimulating Factor	4180186
19475283	G-CSF	4180186
19475283	Colony-stimulating factor, granulocyte	4180186
19475285	Receptors, IL 3	4180186
19475285	Receptor, IL3	4180186
19475285	Interleukin-3 Receptors	4180186
19475285	Interleukin-3 Receptor	4180186
19475285	Receptor, IL-3	4180186
19475285	Receptor, Interleukin-3	4180186
19475285	Receptors, IL-3	4180186
19475285	IL-3 Receptors	4180186
19475285	Receptors, IL3	4180186
19475285	Interleukin 3 Receptor	4180186
19475285	IL-3 Receptor	4180186
19475285	Receptors, Interleukin 3	4180186
19475285	IL 3 Receptors	4180186
19475285	Interleukin 3 Receptors	4180186
19475285	IL3 Receptor	4180186
19475285	IL 3 Receptor	4180186
19475285	IL3 Receptors	4180186
19475286	M-CSF Receptor	4180186
19475286	Receptors, M CSF	4180186
19475286	Receptors, Macrophage Colony Stimulating Factor	4180186
19475286	Antigen, CD115	4180186
19475286	Receptor, CSF 1	4180186
19475286	Receptors, CSF-1	4180186
19475286	CD115 Antigen	4180186
19475286	Receptors, CSF 1	4180186
19475286	Receptors, M-CSF	4180186
19475286	Proto-Oncogene Protein fms	4180186
19475286	c-fms Protein	4180186
19475286	Receptor, CSF-1	4180186
19475286	Receptor, M-CSF	4180186
19475286	CSF-1 Receptor	4180186
19475286	CSF-1 Receptors	4180186
19475286	CD115 Antigens	4180186
19475286	Macrophage Colony Stimulating Factor Receptors	4180186
19475286	Proto-Oncogene Protein, fms	4180186
19475286	c fms Protein	4180186
19475286	fms Proto Oncogene Protein	4180186
19475286	M CSF Receptor	4180186
19475286	M-CSF Receptors	4180186
19475286	Antigens, CD115	4180186
19475286	Macrophage Colony Stimulating Factor Receptor	4180186
19475286	Receptors, Macrophage Colony-Stimulating Factor	4180186
19475286	Receptor, Macrophage Colony Stimulating Factor	4180186
19475286	Macrophage Colony-Stimulating Factor Receptors	4180186
19475286	Macrophage Colony-Stimulating Factor Receptor	4180186
19475286	fms Proto-Oncogene Protein	4180186
19475287	CD116 Antigen	4180186
19475287	Receptors, GM CSF	4180186
19475287	GM CSF Receptor	4180186
19475287	Receptors, Granulocyte Macrophage Colony Stimulating Factor	4180186
19475287	Antigens, CD116	4180186
19475287	GM CSF Receptors	4180186
19475287	Receptor, Granulocyte Macrophage Colony Stimulating Factor	4180186
19475287	Receptor, Granulocyte-Macrophage Colony-Stimulating Factor	4180186
19475287	Receptor, GM-CSF	4180186
19475287	GM-CSF Receptors	4180186
19475287	GM-CSF Receptor	4180186
19475287	Antigen, CD116	4180186
19475287	CD116 Antigens	4180186
19475287	Receptors, GM-CSF	4180186
19475289	Cytokine	4180186
19475293	GTPgammaS	4180186
19475293	gamma S, GTP	4180186
19475293	Guanosine 5'-(3-O-Thio)Triphosphate	4180186
19475293	Guanosine 5'-(trihydrogen diphosphate), P'-anhydride with phosphorothioic acid	4180186
19475293	GTP gamma S	4180186
19475293	Guanosine 5'-(gamma-S)Triphosphate	4180186
19475293	gamma Thio GTP	4180186
19475293	gamma-Thio-GTP	4180186
19475294	Compact Disk Read-Only Memory	4180186
19475294	Compact Disk Read Only Memory	4180186
19475294	CDROM	4180186
19475295	Lewis X Hapten	4180186
19475295	Antigens, CD15	4180186
19475295	X Hapten, Lewis	4180186
19475295	Embryonic Antigen-1, Stage-Specific	4180186
19475295	CD15 Antigen	4180186
19475295	Leu M1 Antigens	4180186
19475295	SSEA-1	4180186
19475295	CD15 Antigens	4180186
19475295	SSEA 1	4180186
19475295	3 alpha Fucosyl N Acetyl Lactosamine	4180186
19475295	X Antigen, Lewis	4180186
19475295	3 alpha-Fucosyl-N-Acetyl Lactosamine	4180186
19475295	Leu-M1 Antigens	4180186
19475295	SSEA-1 Determinant	4180186
19475295	Antigen, Lewis X	4180186
19475295	Stage-Specific Embryonic Antigen-1	4180186
19475295	Lewis X Related Antigens	4180186
19475295	Stage Specific Embryonic Antigen 1	4180186
19475295	Le(X) Antigen	4180186
19475295	SSEA 1 Determinant	4180186
19475295	Galbeta(1-4)Fucalpha(1-3)GlcNAc	4180186
19475295	Hapten X	4180186
19475296	5-Oxazolecarboxylic acid, 2-(6-(bis(carboxymethyl)amino)-5-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)-2-benzofuranyl)-	4180186
19475296	Fura 2	4180186
19475298	Technetium diethylenetriamine pentaacetic acid	4180186
19475298	Technetium-DTPA	4180186
19475298	Technetium DTPA	4180186
19475298	Tc-DTPA	4180186
19475298	99m-DTPA, Tc	4180186
19475298	Pentetic Acid, Technetium	4180186
19475298	Technetate(1-)-99Tc, (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, sodium	4180186
19475298	Tc 99m DTPA	4180186
19475298	Tc 99m-DTPA	4180186
19475298	Technetium Pentetic Acid	4180186
19475298	Technetium (99m) Pentetate	4180186
19475300	Private Hospital	4180186
19475300	Private Hospitals	4180186
19475300	Hospital, Private	4180186
19475301	Enkephalin-Leu,Ala(2)	4180186
19475301	D-Leucine, N-(N-(N-(N-L-tyrosyl-D-alanyl)glycyl)-L-phenylalanyl)-	4180186
19475301	BW 180C	4180186
19475301	5 Leucine 2 Alanine Enkephalin	4180186
19475301	Leu Enkephalin 2 Ala	4180186
19475301	Enkephalin, 2-Alanyl-Leucine	4180186
19475301	Leucine Enkephalin 2 Alanine	4180186
19475301	D-Ala(2)-D-Leu(5)-Enkephalin	4180186
19475301	Enkephalin, 5-Leucine-2-Alanine	4180186
19475301	2-Alanyl-Leucine Enkephalin	4180186
19475301	BW-180C	4180186
19475301	Leucine Enkephalin-2-Alanine	4180186
19475301	2 Alanyl Leucine Enkephalin	4180186
19475301	Enkephalin, Leucine 2 Alanine	4180186
19475301	Leu-Enkephalin-2-Ala	4180186
19475301	BW180C	4180186
19475301	5-Leucine-2-Alanine Enkephalin	4180186
19475301	Leucine-2-Alanine Enkephalin	4180186
19475301	Enkephalin-2-Alanine, Leucine	4180186
19475301	DADLE	4180186
19475302	Win-35197-2	4180186
19475302	Ethylketocyclazocine Methanesulfonate	4180186
19475302	Ethylketazocine	4180186
19475302	Win 35197 2	4180186
19475302	2,6-Methano-3-benzazocin-1(2H)-one, 3-(cyclopropylmethyl)-6-ethyl-3,4,5,6-tetrahydro-8-hydroxy-11-methyl-, (2alpha,6alpha,11S*)-(+-)-	4180186
19475302	Win351972	4180186
19475303	1,2,4-Oxadiazolidine-2-propanoic acid, alpha-amino-3,5-dioxo-, (S)-	4180186
19475303	Quisqualate	4180186
19475305	kappa B Enhancer Binding Protein	4180186
19475305	Nuclear Factor Kappab	4180186
19475305	Immunoglobulin Enhancer Binding Protein	4180186
19475305	NF kB	4180186
19475305	NF-kappa B Complex	4180186
19475305	Enhancer-Binding Protein, Immunoglobulin	4180186
19475305	Ig EBP 1	4180186
19475305	NF kappaB	4180186
19475305	Factor NF-kB, Transcription	4180186
19475305	Transcription Factor NF-kB	4180186
19475305	Immunoglobulin Enhancer-Binding Protein	4180186
19475305	Nuclear Factor kappa B	4180186
19475305	NF-kB, Transcription Factor	4180186
19475305	Ig-EBP-1	4180186
19475305	NF-kappaB	4180186
19475305	Complex, NF-kappa B	4180186
19475305	NF kappa B Complex	4180186
19475305	Nuclear Factor-Kappab	4180186
19475305	Factor-Kappab, Nuclear	4180186
19475305	NF-kB	4180186
19475305	Transcription Factor NF kB	4180186
19475308	Region, Protein Coding	4180186
19475308	Coding Regions, Protein	4180186
19475308	Unidentified Reading Frames	4180186
19475308	ORFs	4180186
19475308	Frames, Unidentified Reading	4180186
19475308	Reading Frames, Unidentified	4180186
19475308	Reading Frame, Open	4180186
19475308	Protein Coding Regions	4180186
19475308	Open Reading Frame	4180186
19475308	Regions, Protein Coding	4180186
19475308	Frames, Open Reading	4180186
19475308	Reading Frame, Unidentified	4180186
19475308	Frame, Open Reading	4180186
19475308	Frame, Unassigned Reading	4180186
19475308	Unassigned Reading Frame	4180186
19475308	Protein Coding Region	4180186
19475308	Unidentified Reading Frame	4180186
19475308	Reading Frame, Unassigned	4180186
19475308	Reading Frames, Open	4180186
19475308	Frame, Unidentified Reading	4180186
19475308	Unassigned Reading Frames	4180186
19475308	Frames, Unassigned Reading	4180186
19475308	Coding Region, Protein	4180186
19475308	Reading Frames, Unassigned	4180186
19475311	Anti Sense Oligonucleotide	4180186
19475311	Oligonucleotide, Antisense	4180186
19475311	Anti-Sense Oligonucleotides	4180186
19475311	Oligonucleotide, Anti-Sense	4180186
19475311	Anti-Sense Oligonucleotide	4180186
19475311	Anti Sense Oligonucleotides	4180186
19475311	Antisense Oligonucleotide	4180186
19475311	Oligonucleotides, Anti-Sense	4180186
19475311	Antisense Oligonucleotides	4180186
19475313	Free-Standing Birth Centers	4180186
19475313	Center, Birthing	4180186
19475313	Birthing Centers, Free-Standing	4180186
19475313	Birth Center	4180186
19475313	Free-Standing Birth Center	4180186
19475313	Birthing Center, Free-Standing	4180186
19475313	Free Standing Birthing Center	4180186
19475313	Birth Center, Free Standing	4180186
19475313	Birthing Center	4180186
19475313	Centers, Birth	4180186
19475313	Birth Center, Free-Standing	4180186
19475313	Birth Centers	4180186
19475313	Centers, Birthing	4180186
19475313	Birth Centers, Free-Standing	4180186
19475313	Center, Birth	4180186
19475313	Free-Standing Birthing Center	4180186
19475313	Free Standing Birth Centers	4180186
19475313	Free-Standing Birthing Centers	4180186
19475313	Birthing Centers, Free Standing	4180186
19475314	Effect, Anticarcinogenic	4180186
19475314	Agents, Anticarcinogenic	4180186
19475314	Effects, Anticarcinogenic	4180186
19475314	Anti-Carcinogenic Drugs	4180186
19475314	Effect, Anti-Carcinogenic	4180186
19475314	Effects, Anti-Carcinogenic	4180186
19475314	Anti-Carcinogenic Agents	4180186
19475314	Anti Carcinogenic Drugs	4180186
19475314	Anticarcinogenic Drugs	4180186
19475314	Drugs, Anticarcinogenic	4180186
19475314	Anti-Carcinogenic Effect	4180186
19475314	Anticarcinogens	4180186
19475314	Anti Carcinogenic Effects	4180186
19475314	Anti Carcinogenic Effect	4180186
19475314	Anti Carcinogenic Agents	4180186
19475314	Agents, Anti-Carcinogenic	4180186
19475314	Anti-Carcinogenic Effects	4180186
19475314	Drugs, Anti-Carcinogenic	4180186
19475314	Anticarcinogenic Effects	4180186
19475314	Anticarcinogenic Effect	4180186
19475318	Telefacsimiles	4180186
19475318	Facsimile Transceiver	4180186
19475318	Facsimile Transmission	4180186
19475318	Telefax	4180186
19475318	Transmissions, Facsimile	4180186
19475318	Facsimile Transceivers	4180186
19475318	Facsimile Transmissions	4180186
19475318	Transceivers, Facsimile	4180186
19475318	Transceiver, Facsimile	4180186
19475318	Fax	4180186
19475318	Transmission, Facsimile	4180186
19475320	gag Protein p24, HIV	4180186
19475320	p24 Antigen, HIV	4180186
19475320	p24, HTLV-III	4180186
19475320	p24, HIV Protein	4180186
19475320	HTLV III p24	4180186
19475320	p24 protein, Human Immunodeficiency Virus	4180186
19475320	HIV gag Gene Product p24	4180186
19475320	HIV Major Core Protein p24	4180186
19475320	HTLV-III p24	4180186
19475320	HIV p24 Antigen	4180186
19475320	HIV Protein p24	4180186
19475320	p24(HIV)	4180186
19475322	Methanesulfonate, Gabexate	4180186
19475322	Foy	4180186
19475322	Mesylate, Gabexate	4180186
19475322	Gabexate Monomethanesulfonate	4180186
19475322	Gabexate Methanesulfonate	4180186
19475322	Benzoic acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, ethyl ester	4180186
19475322	Gabexate Monomethanesulfonate, 14C Labeled Cpd	4180186
19475322	Gabexate Mesylate	4180186
19475322	Gabexate Monomethanesulfonate, 14C-Labeled Cpd	4180186
19475322	Gabexate Mesilate	4180186
19475322	Monomethanesulfonate, Gabexate	4180186
19475322	Mesilate, Gabexate	4180186
19475324	Absolok	4180186
19475324	Poly(oxy(1-oxo-1,2-ethanediyl)oxy-1,2-ethanediyl)	4180186
19475324	PDS II (Ethicon)	4180186
19475324	Polydioxanones	4180186
19475324	Absoloks	4180186
19475325	T Cell Receptors, gamma delta	4180186
19475325	T-Cell Receptor gamma-Chain	4180186
19475325	T Cell Receptors delta Chain	4180186
19475325	Receptors, Antigen, T Cell, gamma delta	4180186
19475325	T Cell Receptors gamma Chain	4180186
19475325	gamma-Chain, T-Cell Receptors	4180186
19475325	TcR gamma delta	4180186
19475325	T Cell Receptor, gamma delta	4180186
19475325	Antigen T Cell Receptor, delta Chain	4180186
19475325	T-Cell Receptor, gamma-delta	4180186
19475325	gamma-delta, TcR	4180186
19475325	T Cell Receptor gamma Chain	4180186
19475325	Antigen T Cell Receptor, gamma Chain	4180186
19475325	T-Cell Receptors gamma-Chain	4180186
19475325	gamma-Chain, T-Cell Receptor	4180186
19475325	gamma-delta T-Cell Receptors	4180186
19475325	delta-Chain, T-Cell Receptors	4180186
19475325	TcR gamma-delta	4180186
19475325	T-Cell Receptor delta-Chain	4180186
19475325	T Cell Receptor delta Chain	4180186
19475325	gamma-delta T-Cell Receptor	4180186
19475325	delta-Chain, T-Cell Receptor	4180186
19475325	Antigen Receptors, T-Cell, gamma-delta	4180186
19475325	T-Cell Receptors delta-Chain	4180186
19475325	T-Cell Receptors, gamma-delta	4180186
19475327	6-(2-(4-(Bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-5H-thiazolo(3,2-a)pyrimidin-5-one	4180186
19475327	R 55667	4180186
19475327	Ritanserin Tartrate	4180186
19475327	R55667	4180186
19475327	R-55667	4180186
19475327	Ritanserin Hydrochloride	4180186
19475327	5H-Thiazolo(3,2-a)pyrimidin-5-one, 6-(2-(4-(bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-	4180186
19475329	Proto-Oncogenes, jun	4180186
19475329	c-jun Proto-Oncogene	4180186
19475329	Oncogene, jun	4180186
19475329	c-jun Proto-Oncogenes	4180186
19475329	jun Proto Oncogene	4180186
19475329	c jun Genes	4180186
19475329	jun Proto-Oncogene	4180186
19475329	c-jun Gene	4180186
19475329	jun Gene	4180186
19475329	v-jun Gene	4180186
19475329	Proto-Oncogene, jun	4180186
19475329	jun Oncogenes	4180186
19475329	jun Oncogene	4180186
19475329	c jun Proto Oncogenes	4180186
19475329	c-jun Genes	4180186
19475329	jun Proto-Oncogenes	4180186
19475329	v jun Genes	4180186
19475329	v jun Oncogenes	4180186
19475329	v-jun Oncogene	4180186
19475329	Oncogenes, jun	4180186
19475329	v-jun Genes	4180186
19475329	jun Genes	4180186
19475329	v-jun Oncogenes	4180186
19475330	Alloantigen, Platelet	4180186
19475330	Antigens, Platelet Specific	4180186
19475330	Antigens, Platelet-Specific	4180186
19475330	Platelet Specific Antigens	4180186
19475330	Alloantigens, Platelet	4180186
19475330	Human Platelet Antigen	4180186
19475330	Platelet Specific Antigen	4180186
19475330	Antigen, Platelet-Specific	4180186
19475330	Platelet-Specific Antigen	4180186
19475330	Platelet Alloantigen	4180186
19475330	Human Platelet Antigens	4180186
19475330	Platelet Antigens, Human	4180186
19475330	Platelet-Specific Antigens	4180186
19475330	Platelet Antigen, Human	4180186
19475330	Antigen, Human Platelet	4180186
19475330	Platelet Alloantigens	4180186
19475331	CD4-IgG	4180186
19475331	Immunoadhesins, CD4	4180186
19475331	CD4 IgG	4180186
19475334	Antibody, Anticardiolipin	4180186
19475334	Anticardiolipin Antibody	4180186
19475334	Autoantibody, Cardiolipin	4180186
19475334	Cardiolipin Autoantibody	4180186
19475334	Cardiolipin Autoantibodies	4180186
19475334	Anticardiolipin Antibodies	4180186
19475334	Autoantibody, Anticardiolipin	4180186
19475334	Anticardiolipin Autoantibodies	4180186
19475334	Anticardiolipin Autoantibody	4180186
19475336	C3b Inactivator	4180186
19475336	Complement 3b-Complement 4b Inactivator	4180186
19475336	C3b C4b Inactivator	4180186
19475336	Complement C4b-C3b Inactivator	4180186
19475336	C3b-C4b Inactivator	4180186
19475336	Complement C4b C3b Inactivator	4180186
19475336	Inactivator, C3b	4180186
19475336	C4bC3bINA	4180186
19475336	Inactivator, Complement C4b-C3b	4180186
19475336	Inactivator, C3b-C4b	4180186
19475336	C4b C3b INA	4180186
19475336	C4b-C3b Inactivator, Complement	4180186
19475336	C4b-C3b-INA	4180186
19475336	Complement 3b Complement 4b Inactivator	4180186
19475338	TCR CD3 Complex	4180186
19475338	Complex, TCR-CD3	4180186
19475338	TCR-CD3 Complex	4180186
19475338	T-Cell Antigen Receptor-CD3 Complex	4180186
19475338	T Cell Antigen Receptor CD3 Complex	4180186
19475339	99m Mertiatide, Tc	4180186
19475339	99mTc Mercaptoacetyltriglycine	4180186
19475339	Technetium 99m Mercaptoacetylglycyl-glycyl-glycine	4180186
19475339	Technetium-99m-Mercaptoacetyltriglycine	4180186
19475339	99mTc-MAG3	4180186
19475339	Technetium 99m MAG3	4180186
19475339	Technetium 99m Mercaptoacetyltriglycine	4180186
19475339	99m Mercaptoacetylglycyl-glycyl-glycine, Technetium	4180186
19475339	MAG3, TechneScan	4180186
19475339	Mercaptoacetylglycyl-glycyl-glycine, Technetium 99m	4180186
19475339	Technetium 99m Mercaptoacetylglycylglycylglycine	4180186
19475339	Tc 99m Mertiatide	4180186
19475339	Technetium-99m-MAG3	4180186
19475339	Technetium-99m-Mercaptoacetylglycylglycylglycine	4180186
19475339	Mertiatide, Tc 99m	4180186
19475339	TechneScan MAG3	4180186
19475339	99mTc-Mercaptoacetyltriglycine	4180186
19475339	Technetium 99m Mercaptoacetylglycyl glycyl glycine	4180186
19475339	99mTc MAG3	4180186
19475339	Technetate(2-)-99Tc, (N-(N-(N-(mercaptoacetyl)glycyl)glycyl)glycinato(5-)-N,N',N'',S)oxo-, disodium, (SP-5-25)-	4180186
19475340	Condom Manufacture	4180186
19475340	Condom	4180186
19475340	Manufacture, Condom	4180186
19475342	Fenretinide, 13 cis Isomer	4180186
19475342	13-cis-Isomer Fenretinide	4180186
19475342	4-Hydroxyphenylretinamide	4180186
19475342	MCNR1967	4180186
19475342	N-(4-Hydroxyphenyl)-trans-Retinamide	4180186
19475342	Fenretinide, 13-cis-Isomer	4180186
19475342	MCN R 1967	4180186
19475342	MCN-R-1967	4180186
19475342	4 Hydroxyphenylretinamide	4180186
19475342	N-(4-Hydroxyphenyl)retinamide	4180186
19475342	Retinamide, N-(4-hydroxyphenyl)-	4180186
19475342	Fenretinimide	4180186
19475342	4-HPR	4180186
19475345	Hematoporphyrin YHPD	4180186
19475345	YHPD, Hematoporphyrin	4180186
19475345	Photofrin I	4180186
19475345	Hematoporphyrin D	4180186
19475345	WR-246310	4180186
19475346	Hepatitis B Vaccine	4180186
19475346	Vaccines, Hepatitis B	4180186
19475346	Vaccine, Hepatitis B	4180186
19475347	SR-2508	4180186
19475347	SR 2508	4180186
19475347	1H-Imidazole-1-acetamide, N-(2-hydroxyethyl)-2-nitro-	4180186
19475347	NSC301467	4180186
19475347	NSC 301467	4180186
19475347	NSC-301467	4180186
19475347	SR2508	4180186
19475349	alpha-TIF HSV-1	4180186
19475349	alpha Trans Inducing Factor	4180186
19475349	HSV 1 Protein VP16	4180186
19475349	Herpes Simplex Virus Type 2 Protein VP16	4180186
19475349	Factor, alpha-Trans Inducing	4180186
19475349	Protein, VP16	4180186
19475349	Protein, Vmw65	4180186
19475349	Protein VP-16, HSV-1	4180186
19475349	Herpes Simplex Virus Transcriptional Activator Vmw65	4180186
19475349	Vmw65 Protein	4180186
19475349	VP-16, HSV-1 Protein	4180186
19475349	HSV-1 Protein VP-16	4180186
19475349	Inducing Factor, alpha-Trans	4180186
19475349	VP16, HSV-1 Protein	4180186
19475349	Herpes Simplex Virus Trans Activator Vmw65	4180186
19475349	alpha-Trans Inducing Factor	4180186
19475349	Protein VP16, HSV-1	4180186
19475349	Herpes Simplex Virus Trans-Activator Vmw65	4180186
19475349	alpha Trans Inducing Factor, Herpes Simplex Virus 1	4180186
19475349	VP16 Protein	4180186
19475349	Herpes Simplex Virus Protein VP16	4180186
19475349	alpha TIF HSV 1	4180186
19475349	HSV-1 Protein VP16	4180186
19475349	alpha-Trans-Inducing Factor, Herpes Simplex Virus 1	4180186
19475349	Herpes Simplex Virus Protein VP 16	4180186
19475349	HSV-1, alpha-TIF	4180186
19475349	HSV 1 Protein VP 16	4180186
19475350	RNA Sequence Analyses	4180186
19475350	Analyses, RNA Sequence	4180186
19475350	Determination, RNA Sequence	4180186
19475350	Determinations, RNA Sequence	4180186
19475350	Sequence Analyses, RNA	4180186
19475350	RNA Sequence Analysis	4180186
19475350	Sequence Determination, RNA	4180186
19475350	RNA Sequence Determination	4180186
19475350	Sequence Determinations, RNA	4180186
19475350	Analysis, RNA Sequence	4180186
19475350	RNA Sequence Determinations	4180186
19475350	RNA Sequencing	4180186
19475350	Sequencing, RNA	4180186
19475353	CD64 Antigen	4180186
19475353	CD 64 Antigens	4180186
19475353	Antigens, CDw32	4180186
19475353	Antigens, CD32	4180186
19475353	IgG Receptors	4180186
19475353	gamma RI, Fc	4180186
19475353	Antigens, CD 64	4180186
19475353	Antigens, CD16	4180186
19475353	Receptor, Fc Gamma	4180186
19475353	Leu 11 Antigen	4180186
19475353	gamma Fc Receptors	4180186
19475353	Fc gamma RIII	4180186
19475353	Receptor, gamma Fc	4180186
19475353	Leu-11 Antigens	4180186
19475353	IgG Receptor	4180186
19475353	Gamma Receptor, Fc	4180186
19475353	Fc Receptor, gamma	4180186
19475353	CD32 Antigens	4180186
19475353	CD 16 Antigens	4180186
19475353	Leu 11 Antigens	4180186
19475353	Antigens, CD64	4180186
19475353	CD64 Antigens	4180186
19475353	CDw32 Antigens	4180186
19475353	Fc gamma RI	4180186
19475353	gamma RII, Fc	4180186
19475353	Fc Gamma Receptor	4180186
19475353	Immunoglobulin G Receptor	4180186
19475353	Leu-11 Antigen	4180186
19475353	Receptor, IgG	4180186
19475353	Antigens, CD 32	4180186
19475353	CD 32 Antigens	4180186
19475353	Fc Receptors, gamma	4180186
19475353	Antigens, CD 16	4180186
19475353	Receptors, Fc gamma	4180186
19475353	Fc gamma RII	4180186
19475353	Receptors, gamma Fc	4180186
19475353	Antigen, CD64	4180186
19475353	Receptor, Immunoglobulin G	4180186
19475353	Antigen, Leu-11	4180186
19475353	gamma Receptors, Fc	4180186
19475353	Antigens, Leu-11	4180186
19475353	Fc gamma Receptors	4180186
19475353	gamma RIII, Fc	4180186
19475353	CD16 Antigens	4180186
19475353	gamma Fc Receptor	4180186
19475355	E29 Proteins, Adenovirus	4180186
19475355	Protein, Adenovirus E29	4180186
19475355	Adenovirus Early Region Transforming Proteins	4180186
19475355	E19 Protein, Adenovirus	4180186
19475355	Proteins, Adenovirus E29	4180186
19475355	Adenovirus E29 Proteins	4180186
19475355	Early Proteins, Adenovirus	4180186
19475355	Adenovirus E29 Protein	4180186
19475355	Adenovirus E19 Proteins	4180186
19475355	Adenovirus E19 Protein	4180186
19475355	E19 Proteins, Adenovirus	4180186
19475355	Protein, Adenovirus E19	4180186
19475355	Proteins, Adenovirus E19	4180186
19475355	E29 Protein, Adenovirus	4180186
19475356	Complement 3b Receptors	4180186
19475356	Antigen, CD35	4180186
19475356	CD35 Antigen	4180186
19475356	CR1 Receptors	4180186
19475356	Complement 3b Receptor	4180186
19475356	Antigens, CD 35	4180186
19475356	C3b Receptors	4180186
19475356	Receptors, C3b	4180186
19475356	Receptor, Complement 3b	4180186
19475356	Receptors, CR1	4180186
19475356	CD 35 Antigens	4180186
19475356	Antigens, CD35	4180186
19475356	CD35 Antigens	4180186
19475358	Fibronectin Receptors	4180186
19475361	Laminin Receptors	4180186
19475361	Receptor, Laminin	4180186
19475361	Laminin Receptor	4180186
19475367	E2 Protein, Adenovirus	4180186
19475367	Adenovirus E2 Protein	4180186
19475367	Adenovirus E2F Protein	4180186
19475367	E2A Proteins, Adenovirus	4180186
19475367	E2 Proteins, Adenovirus	4180186
19475367	E2A 72K Protein, Adenovirus	4180186
19475367	E2F Protein, Adenovirus	4180186
19475367	Adenovirus E2A 72K Protein	4180186
19475367	E2A Protein, Adenovirus	4180186
19475367	Adenovirus E2A Proteins	4180186
19475367	Adenovirus E2F Proteins	4180186
19475367	E2F Proteins, Adenovirus	4180186
19475367	Adenovirus E2A Protein	4180186
19475369	Adenovirus E4F Protein	4180186
19475369	E4 Protein, Adenovirus	4180186
19475369	E4F Protein, Adenovirus	4180186
19475369	E4 Proteins, Adenovirus	4180186
19475369	Adenovirus E4 Protein	4180186
19475372	4,4'-Diisothiocyano-2,2'-Stilbene Disulfonic Acid	4180186
19475372	Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis(5-isothiocyanato)-	4180186
19475372	DIDS	4180186
19475375	Superantigen	4180186
19475377	Receptor, Cytokine	4180186
19475377	Cytokine Receptor	4180186
19475377	Receptors, Cytokines	4180186
19475377	Cytokines Receptors	4180186
19475377	Cytokine Receptors	4180186
19475379	Receptors, Interleukins	4180186
19475379	Interleukins Receptors	4180186
19475379	Interleukin Receptors	4180186
19475379	Receptor, Interleukin	4180186
19475379	Interleukin Receptor	4180186
19475381	Antigen, CD27	4180186
19475381	TNFRSF7 Receptor	4180186
19475381	Antigens, CD27	4180186
19475381	CD27 Antigen	4180186
19475381	Activation Antigen, T-Cell	4180186
19475381	Receptor, TNFRSF7	4180186
19475381	CD27 Antigens	4180186
19475381	T Cell Activation Antigen	4180186
19475381	T-Cell Activation Antigen	4180186
19475381	Antigen, T-Cell Activation	4180186
19475382	Pore Proteins	4180186
19475382	Proteins, Pore	4180186
19475382	Porin	4180186
19475382	Protein, Pore	4180186
19475382	Pore Protein	4180186
19475383	AMPA	4180186
19475383	AMPA, (S)-Isomer	4180186
19475383	AMPA, (+-)-Isomer	4180186
19475383	AMPA, (S)-Isomer, Monohydrobromide	4180186
19475383	AMPA, (R)-Isomer, Monohydrobromide	4180186
19475383	AMPA, (R)-Isomer	4180186
19475383	4-Isoxazolepropanoic acid, alpha-amino-2,3-dihydro-5-methyl-3-oxo-	4180186
19475383	alpha Amino 3 hydroxy 5 methyl 4 isoxazolepropionic Acid	4180186
19475384	Peripheral Nervous System Drugs	4180186
19475384	Peripheral Nervous System Effect	4180186
19475384	Peripheral Nervous System Effects	4180186
19475385	Transmitter Substances, Nerve	4180186
19475385	Nerve Transmitter Substance	4180186
19475385	Neuroregulators	4180186
19475385	Neurohumor	4180186
19475385	Nerve Transmitter Substances	4180186
19475385	Transmitter Substance, Nerve	4180186
19475385	Neuroregulator	4180186
19475385	Neurohormone	4180186
19475385	Substances, Nerve Transmitter	4180186
19475385	Neurotransmitters	4180186
19475385	Neurotransmitter	4180186
19475385	Neuromodulator	4180186
19475385	Neurohumors	4180186
19475385	Neurohormones	4180186
19475385	Substance, Nerve Transmitter	4180186
19475385	Neuromodulators	4180186
19475385	Neurotransmitter Agent	4180186
19475388	Effect, Serotonin	4180186
19475388	Serotoninergic Effects	4180186
19475388	Serotonin Effect	4180186
19475388	Serotonin Drugs	4180186
19475388	Serotonin Effects	4180186
19475388	Effect, Serotoninergic	4180186
19475388	Serotonergic Drugs	4180186
19475388	Serotoninergic Effect	4180186
19475388	Serotonergic Agents	4180186
19475388	Agents, Serotonin	4180186
19475388	Drugs, Serotonergic	4180186
19475388	Drugs, Serotonin	4180186
19475388	Effects, Serotoninergic	4180186
19475388	Effects, Serotonin	4180186
19475388	Agents, Serotonergic	4180186
19475390	Io	4180186
19475390	Europa	4180186
19475390	Ganymede	4180186
19475390	Callisto	4180186
19475392	Human Figures	4180186
19475392	Human Bodies	4180186
19475392	Body, Human	4180186
19475392	Figures, Human	4180186
19475392	Body Parts	4180186
19475392	Figure, Human	4180186
19475392	Parts, Body	4180186
19475392	Bodies, Human	4180186
19475392	Human Figure	4180186
19475392	Body Parts and Fluids	4180186
19475394	Inhibitors, Adrenergic Synthesis	4180186
19475394	Depleters, Adrenergic Neurohumor	4180186
19475394	Drugs, Adrenergic	4180186
19475394	Agents, Adrenergic Neuron	4180186
19475394	Adrenergic Effects	4180186
19475394	Adrenergic Neuron Agents	4180186
19475394	Synthesis Inhibitors, Adrenergic	4180186
19475394	Agent, Adrenergic	4180186
19475394	Neuron Drugs, Adrenergic	4180186
19475394	Adrenergic Release Inhibitors	4180186
19475394	Adrenergic	4180186
19475394	Drug, Adrenergic	4180186
19475394	Adrenergic Agent	4180186
19475394	Agents, Adrenergic	4180186
19475394	Releasers, Sympathetic Transmitter	4180186
19475394	Effects, Adrenergic	4180186
19475394	Adrenergic Neuron Drugs	4180186
19475394	Sympathetic Transmitter Releasers	4180186
19475394	Adrenergics	4180186
19475394	Inhibitors, Adrenergic Release	4180186
19475394	Adrenergic Drugs	4180186
19475394	Neurohumor Depleters, Adrenergic	4180186
19475394	Adrenergic Synthesis Inhibitors	4180186
19475394	Adrenergic Effect	4180186
19475394	Neuron Agents, Adrenergic	4180186
19475394	Transmitter Releasers, Sympathetic	4180186
19475394	Drugs, Adrenergic Neuron	4180186
19475394	Adrenergic Drug	4180186
19475394	Adrenergic Neurohumor Depleters	4180186
19475394	Effect, Adrenergic	4180186
19475394	Release Inhibitors, Adrenergic	4180186
19475396	Agents, Nicotinic	4180186
19475396	Agent, Muscarinic	4180186
19475396	Effects, Muscarinic	4180186
19475396	Muscarinic	4180186
19475396	Muscarinic Agent	4180186
19475396	Agents, Acetylcholine	4180186
19475396	Agents, Cholinergic	4180186
19475396	Effects, Cholinergic	4180186
19475396	Cholinomimetic	4180186
19475396	Nicotinic Agent	4180186
19475396	Acetylcholine Agents	4180186
19475396	Cholinergic	4180186
19475396	Cholinergic Drug	4180186
19475396	Effect, Cholinergic	4180186
19475396	Nicotinic Agents	4180186
19475396	Muscarinic Effects	4180186
19475396	Nicotinic Effect	4180186
19475396	Cholinergics	4180186
19475396	Agent, Nicotinic	4180186
19475396	Agents, Muscarinic	4180186
19475396	Cholinomimetics	4180186
19475396	Agent, Cholinergic	4180186
19475396	Muscarinics	4180186
19475396	Drug, Cholinergic	4180186
19475396	Effect, Muscarinic	4180186
19475396	Muscarinic Agents	4180186
19475396	Effects, Nicotinic	4180186
19475396	Effect, Nicotinic	4180186
19475396	Drugs, Cholinergic	4180186
19475396	Cholinergic Agent	4180186
19475396	Acetylcholine Agent	4180186
19475396	Muscarinic Effect	4180186
19475396	Nicotinic Effects	4180186
19475396	Agent, Acetylcholine	4180186
19475396	Cholinergic Drugs	4180186
19475396	Cholinergic Effects	4180186
19475396	Cholinergic Effect	4180186
19475397	Acid Agents, gamma-Aminobutyric	4180186
19475397	GABAergic Effect	4180186
19475397	gamma Aminobutyric Acid Agents	4180186
19475397	Agent, GABAergic	4180186
19475397	GABAergic Effects	4180186
19475397	GABAergic Agents	4180186
19475397	gamma-Aminobutyric Acid Agents	4180186
19475397	Agents, GABAergic	4180186
19475397	Effect, GABA	4180186
19475397	GABA Effect	4180186
19475397	Agents, GABA	4180186
19475397	Effects, GABAergic	4180186
19475397	Effects, GABA	4180186
19475397	Agents, gamma-Aminobutyric Acid	4180186
19475397	Effect, GABAergic	4180186
19475397	GABA Effects	4180186
19475397	GABAergic Agent	4180186
19475399	Glycine Effects	4180186
19475399	Glycinergic Agent	4180186
19475399	Agents, Glycine	4180186
19475399	Effects, Glycine	4180186
19475399	Agents, Glycinergic	4180186
19475399	Glycine Effect	4180186
19475399	Effect, Glycine	4180186
19475399	Glycinergic Agents	4180186
19475399	Agent, Glycinergic	4180186
19475402	Neuroprotective Drug	4180186
19475402	Agent, Neuroprotective	4180186
19475402	Agents, Neuroprotective	4180186
19475402	Drugs, Neuroprotective	4180186
19475402	Effects, Neuroprotective	4180186
19475402	Neuroprotective Drugs	4180186
19475402	Neuroprotective Agent	4180186
19475402	Neuroprotective Effects	4180186
19475402	Neuroprotective Effect	4180186
19475402	Neuroprotectant	4180186
19475402	Effect, Neuroprotective	4180186
19475402	Neuroprotectants	4180186
19475402	Drug, Neuroprotective	4180186
19475403	Multidisciplinary Pain Center	4180186
19475403	Pain Relief Unit	4180186
19475403	Center, Multidisciplinary Pain	4180186
19475403	Pain Service, Acute	4180186
19475403	Multidisciplinary Pain Centers	4180186
19475403	Center, Pain	4180186
19475403	Multidisciplinary Pain Clinics	4180186
19475403	Centers, Multidisciplinary Pain	4180186
19475403	Pain Clinic	4180186
19475403	Pain Center, Multidisciplinary	4180186
19475403	Service, Acute Pain	4180186
19475403	Centers, Pain	4180186
19475403	Pain Clinic, Multidisciplinary	4180186
19475403	Clinics, Multidisciplinary Pain	4180186
19475403	Acute Pain Services	4180186
19475403	Pain Center	4180186
19475403	Pain Relief Units	4180186
19475403	Pain Centers, Multidisciplinary	4180186
19475403	Units, Pain Relief	4180186
19475403	Services, Acute Pain	4180186
19475403	Pain Centers	4180186
19475403	Pain Clinics, Multidisciplinary	4180186
19475403	Clinic, Pain	4180186
19475403	Unit, Pain Relief	4180186
19475403	Pain Services, Acute	4180186
19475403	Clinic, Multidisciplinary Pain	4180186
19475403	Multidisciplinary Pain Clinic	4180186
19475403	Acute Pain Service	4180186
19475403	Clinics, Pain	4180186
19475404	Human Identifications	4180186
19475404	Human Identification	4180186
19475404	Anthropology, Forensic	4180186
19475404	Identification, Human	4180186
19475404	Identifications, Human	4180186
19475405	Hexamethonium Dichloride Dihydrate	4180186
19475405	Iodide, Hexamethonium	4180186
19475405	Hexonium	4180186
19475405	Hexamethonium Iodide	4180186
19475405	Dimethylsulfate, Hexamethonium	4180186
19475405	Bitartrate, Hexamethonium	4180186
19475405	1,6-hexanediaminium, N,N,N,N',N',N'-hexamethyl-	4180186
19475405	Hexamethonium Monotartrate	4180186
19475405	Hexamethonium Dihydroxide	4180186
19475405	Bromide, Hexamethonium	4180186
19475405	Dibromide, Hexamethonium	4180186
19475405	Diiodide, Hexamethonium	4180186
19475405	Dihydrate, Hexamethonium Dibromide	4180186
19475405	Hexamethonium Dimethylsulfate	4180186
19475405	Hexamethonium Bromide	4180186
19475405	Chloride, Hexamethonium	4180186
19475405	Hexamethonium Bitartrate	4180186
19475405	Diperchlorate, Hexamethonium	4180186
19475405	Monotartrate, Hexamethonium	4180186
19475405	Hexamethonium Dibromide	4180186
19475405	Dihydrate, Hexamethonium Dichloride	4180186
19475405	Hexamethonium Diperchlorate	4180186
19475405	Hexamethonium Chloride	4180186
19475405	Depressin	4180186
19475405	Hexamethonium Diiodide	4180186
19475405	Dibromide Dihydrate, Hexamethonium	4180186
19475405	Dihydroxide, Hexamethonium	4180186
19475405	Hexamethonium Dibromide Dihydrate	4180186
19475405	Dichloride Dihydrate, Hexamethonium	4180186
19475406	CNQX	4180186
19475406	6 Cyano 7 nitroquinoxaline 2,3 dione	4180186
19475406	FG 9065	4180186
19475406	1,4-dihydro-2,3-dihydroxy-7-nitro-6-quinoxalinecarbonitrile	4180186
19475406	6 Cyano 2,3 dihydroxy 7 nitroquinoxaline	4180186
19475406	FG-9065	4180186
19475406	FG9065	4180186
19475406	6-Quinoxalinecarbonitrile, 1,2,3,4-tetrahydro-7-nitro-2,3-dioxo-	4180186
19475406	6-Cyano-2,3-dihydroxy-7-nitroquinoxaline	4180186
19475408	Intercellular Adhesion Molecule 1	4180186
19475408	Antigens, CD54	4180186
19475408	ICAM-1	4180186
19475408	Antigen, CD54	4180186
19475408	Glycoprotein ICAM 1 (human clone pHRVr1 deblocked protein moiety reduced)	4180186
19475408	CD54 Antigens	4180186
19475408	CD54 Antigen	4180186
19475409	Antigen, Thy-1.2	4180186
19475409	Antigens, CD90	4180186
19475409	Antigens, Thy 1	4180186
19475409	Antigen, Thy-1	4180186
19475409	Antigens, Thy-1	4180186
19475409	Thy 1 Antigen	4180186
19475409	Thy-1.2 Antigen	4180186
19475409	Thy-1.1 Antigen	4180186
19475409	Thy 1 Antigens	4180186
19475409	CD90 Antigen	4180186
19475409	Thy 1.2 Antigen	4180186
19475409	CD90 Antigens	4180186
19475409	Antigen, Thy-1.1	4180186
19475409	Thy 1.1 Antigen	4180186
19475409	Antigen, CD90	4180186
19475409	Thy-1 Antigen	4180186
19475413	Antigens, CD18	4180186
19475413	CD18 Antigen	4180186
19475413	Integrin beta2	4180186
19475413	beta-Subunit, p150,95	4180186
19475413	beta2, Integrin	4180186
19475413	p150,95 beta Subunit	4180186
19475413	beta2 Integrin	4180186
19475413	p150,95 beta-Subunit	4180186
19475413	Integrin, beta2	4180186
19475414	Antigens, CD13	4180186
19475414	CD13 Antigen	4180186
19475414	Aminooligopeptidase	4180186
19475414	Protein, ANPEP	4180186
19475414	Aminopeptidase N	4180186
19475414	Membrane Alanyl Aminopeptidase	4180186
19475414	Alanine Aminopeptidase	4180186
19475414	Aminopeptidase M	4180186
19475414	Amino-oligopeptidase	4180186
19475414	ANPEP Protein	4180186
19475414	Alanyl Aminopeptidase	4180186
19475414	Antigen, CD13	4180186
19475416	Adhesins, Fimbrial	4180186
19475416	Adhesin, Bacterial	4180186
19475416	Fimbrial Adhesins	4180186
19475416	Bacterial Adhesins	4180186
19475416	Bacterial Adhesin	4180186
19475417	Adhesin, E coli	4180186
19475417	Escherichia coli Adhesins	4180186
19475417	Adhesin, Escherichia coli	4180186
19475417	Escherichia coli Adhesin	4180186
19475417	E coli Adhesin	4180186
19475418	Antigens, CD11	4180186
19475418	CD11 Antigen	4180186
19475419	Cytokines, Chemotactic	4180186
19475419	Chemokine	4180186
19475419	Chemotactic Cytokines	4180186
19475419	Chemotactic Cytokine	4180186
19475419	Intercrine	4180186
19475419	Intercrines	4180186
19475419	Cytokine, Chemotactic	4180186
19475420	Chemokine (C-C Motif) Ligand 2	4180186
19475420	Monocyte Chemoattractant Protein 1	4180186
19475420	Monocyte Chemoattractant Protein-1	4180186
19475420	Chemokines CCL2	4180186
19475420	Monocyte Chemotactic Protein-1	4180186
19475420	Chemotactic Protein-1, Monocyte	4180186
19475420	Chemoattractant Protein-1, Monocyte	4180186
19475420	Monocyte Chemotactic Protein 1	4180186
19475420	CCL2, Chemokines	4180186
19475420	CCL2, Chemokine	4180186
19475420	Monocyte Chemotactic and Activating Factor	4180186
19475420	Chemokine, CCL2	4180186
19475420	CCL2 Chemokine	4180186
19475421	Hepatitis C Antigen	4180186
19475421	Hepatitis Non-A, Non-B Antigen	4180186
19475421	Hepatitis Non A, Non B Antigen	4180186
19475422	HCV Antibodies	4180186
19475422	Anti-Hepatitis C Virus Antibodies	4180186
19475422	Hepatitis C Virus Antibodies	4180186
19475422	Anti HCV Antibodies	4180186
19475422	Anti Hepatitis C Virus Antibodies	4180186
19475422	Anti-HCV Antibodies	4180186
19475423	Antigen, CD19	4180186
19475423	CD19 Antigens	4180186
19475423	CD19 Antigen	4180186
19475423	B Cell Antigen CD19	4180186
19475426	CCL5 Chemokine	4180186
19475426	RANTES	4180186
19475426	T-Cell RANTES Protein	4180186
19475426	Chemokine, CCL5	4180186
19475426	RANTES Protein, T-Cell	4180186
19475426	RANTES Protein, T Cell	4180186
19475426	CCL5, Chemokine	4180186
19475427	Antigen, CD1	4180186
19475427	CD1 Antigen	4180186
19475427	CD1 Antigens	4180186
19475428	CD14 Antigens	4180186
19475428	Receptor, Lipoglycan	4180186
19475428	CD14 Antigen	4180186
19475428	CD14 Antigen, Soluble	4180186
19475428	Receptors, Lipopolysaccharide	4180186
19475428	CD14 Monocyte Differentiation Antigen	4180186
19475428	CD14, Soluble	4180186
19475428	CD14 Protein, Soluble	4180186
19475428	Receptor, LPS	4180186
19475428	Soluble CD14	4180186
19475428	Soluble CD14 Protein	4180186
19475428	Antigens, CD14	4180186
19475428	Soluble CD14 Antigen	4180186
19475428	Lipoglycan Receptor	4180186
19475428	LPS Receptor	4180186
19475428	sCD14	4180186
19475429	CD20 Antigens	4180186
19475429	Antigen, CD20	4180186
19475429	CD20 Antigen	4180186
19475430	Antigen, CD34	4180186
19475430	CD34 Antigens	4180186
19475430	CD34 Antigen	4180186
19475435	Antigens, CD57	4180186
19475435	Antigen, CD57	4180186
19475435	Leu 7 Antigen	4180186
19475435	Antigen, HNK-1	4180186
19475435	HNK-1 Antigen	4180186
19475435	HNK 1 Antigen	4180186
19475435	Leu-7 Antigen	4180186
19475435	CD57 Antigen	4180186
19475435	Antigen, Leu-7	4180186
19475439	WGA-HRP	4180186
19475439	Wheat Germ Agglutinin Horseradish Peroxidase Conjugate	4180186
19475441	Antigens, CD62P	4180186
19475441	CD62P Antigens	4180186
19475441	LECAM-3	4180186
19475441	Platelet alpha Granule Membrane Protein	4180186
19475441	Selectin, P	4180186
19475441	CD62P Antigen	4180186
19475441	Antigen, CD62P	4180186
19475441	P Selectin	4180186
19475441	GMP-140	4180186
19475441	Platelet alpha-Granule Membrane Protein	4180186
19475441	PADGEM	4180186
19475442	p145c kit	4180186
19475442	SCF Receptor	4180186
19475442	p145 c-kit	4180186
19475442	Proto Oncogene Protein c kit	4180186
19475442	c-kit Receptor	4180186
19475442	Proto-Oncogene Protein kit	4180186
19475442	c kit Receptor	4180186
19475442	Proto-Oncogene Protein c-kit	4180186
19475442	p145(c-kit)	4180186
19475442	c-kit, Proto-Oncogene Protein	4180186
19475442	Proto Oncogene Proteins c kit	4180186
19475442	c-kit, Proto-Oncogene Proteins	4180186
19475442	p145c-kit	4180186
19475442	Receptor, Stem Cell Factor	4180186
19475442	p145 c kit	4180186
19475442	Antigens, CD117	4180186
19475442	Stem Cell Factor Receptor	4180186
19475442	CD117 Antigen	4180186
19475442	kit Proto-Oncogene Protein	4180186
19475442	CD117 Antigens	4180186
19475442	Proto-Oncogene Protein, kit	4180186
19475442	c-kit Protein	4180186
19475442	c-kit, p145	4180186
19475442	kit Proto Oncogene Protein	4180186
19475442	Proto Oncogene Protein kit	4180186
19475442	c kit Protein	4180186
19475444	Antigen, CD7	4180186
19475444	CD7 Antigens	4180186
19475444	CD7 Antigen	4180186
19475445	Antigen, CDw29	4180186
19475445	Antigens, CD29	4180186
19475445	Antigen, CD29	4180186
19475445	Integrin, beta1	4180186
19475445	CD29 Antigen	4180186
19475445	beta1 Integrin	4180186
19475445	Antigen, 4B4	4180186
19475445	4B4 Antigen	4180186
19475445	CD29 Antigens	4180186
19475445	CDw29 Antigen	4180186
19475446	Antigens, CD40	4180186
19475446	Tumor Necrosis Factor Receptor Superfamily, Member 5	4180186
19475446	CDw40 Antigen	4180186
19475446	CD40 Antigen	4180186
19475446	Receptor, TNFRSF5	4180186
19475446	TNFRSF5 Receptor	4180186
19475446	Antigen, CDw40	4180186
19475446	Antigen, CD40	4180186
19475447	Antigens, CD95	4180186
19475447	CD95 Antigen	4180186
19475447	Receptor, TNFRSF6	4180186
19475447	fas Antigen	4180186
19475447	Receptor, fas	4180186
19475447	Fas Cell Surface Death Receptor	4180186
19475447	fas Antigens	4180186
19475447	Tumor Necrosis Factor Receptor Superfamily, Member 6	4180186
19475447	fas Receptors	4180186
19475447	APO-1 Antigen	4180186
19475447	TNFRSF6 Receptor	4180186
19475447	Receptors, fas	4180186
19475447	APO 1 Antigen	4180186
19475447	CD95 Antigens	4180186
19475448	Vitronectin Receptors	4180186
19475450	Platelet Membrane Glycoprotein Ib	4180186
19475450	CD42c Antigens	4180186
19475450	Glycoprotein Ib-IX Complex	4180186
19475450	Platelet Glycoprotein GPIb IX Complex	4180186
19475450	CD42b Antigen	4180186
19475450	Glycoprotein Ib beta	4180186
19475450	CD42d Antigen	4180186
19475450	Platelet Membrane Glycoprotein V	4180186
19475450	Glycoprotein Ib IX Complex	4180186
19475450	CD42a Antigen	4180186
19475450	Platelet Membrane Glycoprotein IX	4180186
19475450	Antigen, CD42d	4180186
19475450	Antigen, CD42c	4180186
19475450	Glycoprotein Ib	4180186
19475450	Antigens, CD42d	4180186
19475450	Antigens, CD42a	4180186
19475450	Platelet Glycoprotein IX	4180186
19475450	Antigen, CD42b	4180186
19475450	CD42b Antigens	4180186
19475450	Antigens, CD42c	4180186
19475450	CD42a Antigens	4180186
19475450	Antigen, CD42a	4180186
19475450	CD42c Antigen	4180186
19475450	Antigens, CD42b	4180186
19475450	CD42d Antigens	4180186
19475450	Glycoprotein Ib alpha	4180186
19475451	Receptors, GPIIb-IIIa	4180186
19475451	alphaIIbbeta3, Integrin	4180186
19475451	Integrin alpha IIb beta 3	4180186
19475451	GPIIb IIIa Receptors	4180186
19475451	Glycoproteins IIb-IIIa	4180186
19475451	Integrin alphaIIbbeta3	4180186
19475451	GPIIb-IIIa Receptors	4180186
19475451	Platelet Glycoprotein GPIIb IIIa Complex	4180186
19475451	Integrin alpha-IIb beta-3	4180186
19475451	Glycoproteins IIb IIIa	4180186
19475451	beta-3, Integrin alpha-IIb	4180186
19475453	Antigen, TQ1	4180186
19475453	Antigen, Leu-8	4180186
19475453	Antigens, CD62L	4180186
19475453	LAM-1	4180186
19475453	Antigen, Mel-14	4180186
19475453	TQ1 Antigen	4180186
19475453	CD62L Antigens	4180186
19475453	Antigen, CD62L	4180186
19475453	Leukocyte Adhesion Molecule, LAM-1	4180186
19475453	Mel 14 Antigen	4180186
19475453	Selectin, L	4180186
19475453	Leu 8 Antigen	4180186
19475453	Leukocyte Adhesion Molecule, LAM 1	4180186
19475453	Mel-14 Antigen	4180186
19475453	L Selectin	4180186
19475453	LECAM-1	4180186
19475453	CD62L Antigen	4180186
19475453	Leu-8 Antigen	4180186
19475454	Tolerable Daily Intake	4180186
19475454	Intakes, Tolerable Daily	4180186
19475454	No-Observed-Effect Level	4180186
19475454	Acceptable Daily Intake	4180186
19475454	Intake, Tolerable Daily	4180186
19475454	Daily Intake, Acceptable	4180186
19475454	NOAEL	4180186
19475454	No-Observed-Effect Levels	4180186
19475454	Intake, Acceptable Daily	4180186
19475454	Levels, No-Observed-Effect	4180186
19475454	Tolerable Daily Intakes	4180186
19475454	Acceptable Daily Intakes	4180186
19475454	No-Observed-Adverse-Effect Levels	4180186
19475454	Daily Intakes, Tolerable	4180186
19475454	No Observed Adverse Effect Level	4180186
19475454	Daily Intakes, Acceptable	4180186
19475454	Levels, No-Observed-Adverse-Effect	4180186
19475454	Daily Intake, Tolerable	4180186
19475454	Level, No-Observed-Effect	4180186
19475454	Intakes, Acceptable Daily	4180186
19475454	No Observed Effect Level	4180186
19475454	Level, No-Observed-Adverse-Effect	4180186
19475456	Product Packagings	4180186
19475456	Packaging, Product	4180186
19475456	Packagings, Product	4180186
19475456	Product Container	4180186
19475456	Packaging	4180186
19475456	Container, Product	4180186
19475456	Packagings	4180186
19475456	Product Containers	4180186
19475456	Containers, Product	4180186
19475457	Antigen, Bacterial O	4180186
19475457	O-Specific Polysaccharide	4180186
19475457	O-Antigens	4180186
19475457	O Specific Polysaccharides	4180186
19475457	O-Antigen	4180186
19475457	Bacterial O Antigen	4180186
19475457	Polysaccharides, O-Specific	4180186
19475457	O Specific Polysaccharide	4180186
19475457	Antigen, O	4180186
19475457	O Antigen	4180186
19475457	O-Specific Polysaccharides	4180186
19475457	Antigens, O	4180186
19475457	O Antigen, Bacterial	4180186
19475457	Polysaccharide, O-Specific	4180186
19475458	Teleconsultation	4180186
19475458	Consultation, Remote	4180186
19475458	Teleconsultations	4180186
19475460	HMG-CoA Statins	4180186
19475460	Inhibitors, HMG-CoA Reductase	4180186
19475460	Statins, HMG-CoA	4180186
19475460	Inhibitors, Hydroxymethylglutaryl-Coenzyme A	4180186
19475460	HMG CoA Reductase Inhibitor	4180186
19475460	Reductase Inhibitors, HMG-CoA	4180186
19475460	Inhibitors, HMG CoA Reductase	4180186
19475460	HMG-CoA Reductase Inhibitor	4180186
19475460	Reductase Inhibitor, Hydroxymethylglutaryl-CoA	4180186
19475460	Hydroxymethylglutaryl-CoA Reductase Inhibitor	4180186
19475460	HMG-CoA Reductase Inhibitors	4180186
19475460	Inhibitors, Hydroxymethylglutaryl Coenzyme A	4180186
19475460	Inhibitors, Hydroxymethylglutaryl CoA	4180186
19475460	Inhibitors, Hydroxymethylglutaryl-CoA	4180186
19475460	Hydroxymethylglutaryl CoA Reductase Inhibitors	4180186
19475460	Statins, HMG CoA	4180186
19475460	HMG CoA Reductase Inhibitors	4180186
19475460	Statins	4180186
19475460	Hydroxymethylglutaryl-CoA Inhibitors	4180186
19475460	Hydroxymethylglutaryl-Coenzyme A Inhibitors	4180186
19475460	Hydroxymethylglutaryl CoA Reductase Inhibitor	4180186
19475460	Statin	4180186
19475460	Inhibitors, Hydroxymethylglutaryl-CoA Reductase	4180186
19475460	Reductase Inhibitors, Hydroxymethylglutaryl-CoA	4180186
19475462	Anti-Neutrophil Cytoplasmic Antibody	4180186
19475462	Antibody, Antineutrophil Cytoplasmic	4180186
19475462	Anti-Neutrophil Cytoplasmic Autoantibodies	4180186
19475462	Antibody, Anti-Neutrophil Cytoplasmic	4180186
19475462	Antineutrophil Cytoplasmic Antibodies	4180186
19475462	Autoantibody, Anti-Neutrophil Cytoplasmic	4180186
19475462	Cytoplasmic Antibody, Anti-Neutrophil	4180186
19475462	Cytoplasmic Autoantibody, Neutrophil	4180186
19475462	p ANCA	4180186
19475462	ANCA	4180186
19475462	Anti Neutrophil Cytoplasmic Antibodies	4180186
19475462	Neutrophil Cytoplasmic Autoantibodies	4180186
19475462	Anti Neutrophil Cytoplasmic Antibody	4180186
19475462	p-ANCA	4180186
19475462	Cytoplasmic Antibody, Antineutrophil	4180186
19475462	Antineutrophil Cytoplasmic Antibody	4180186
19475462	Anti Neutrophil Cytoplasmic Autoantibody	4180186
19475462	c-ANCA	4180186
19475462	Anti Neutrophil Cytoplasmic Autoantibodies	4180186
19475462	Neutrophil Cytoplasmic Autoantibody	4180186
19475462	Autoantibody, Neutrophil Cytoplasmic	4180186
19475462	Cytoplasmic Autoantibody, Anti-Neutrophil	4180186
19475462	Anti-Neutrophil Cytoplasmic Autoantibody	4180186
19475462	Anti-Neutrophil Cytoplasmic Antibodies	4180186
19475462	c ANCA	4180186
19475465	Piperazine, 1-(5-isoquinolinylsulfonyl)-2-methyl-, (2S-(1(R*(R*)), 2alpha, 3abeta, 7abeta))-	4180186
19475465	H 7	4180186
19475465	1-(5-Isoquinolinylsulfonyl)-2-Methylpiperazine	4180186
19475465	H-7	4180186
19475468	8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-	4180186
19475470	3-O-Methyl-D-Glucose	4180186
19475470	D-glucose, 3-O-methyl-	4180186
19475470	3 O Methylglucose	4180186
19475470	3 O Methyl D Glucose	4180186
19475471	RX-781094	4180186
19475471	Idazoxan Hydrochloride	4180186
19475471	RX 781094	4180186
19475471	Hydrochloride, Idazoxan	4180186
19475471	RX781094	4180186
19475474	Synthesis Inhibitors, RNA	4180186
19475474	Synthesis Inhibitor, RNA	4180186
19475474	DNA Synthesis Inhibitor	4180186
19475474	DNA Polymerase Inhibitors	4180186
19475474	Inhibitor, DNA Synthesis	4180186
19475474	Polymerase Inhibitor, DNA	4180186
19475474	RNA Synthesis Inhibitors	4180186
19475474	Inhibitors, RNA Synthesis	4180186
19475474	Inhibitor, DNA Polymerase	4180186
19475474	Inhibitors, DNA Synthesis	4180186
19475474	Inhibitor, RNA Synthesis	4180186
19475474	Synthesis Inhibitors, DNA	4180186
19475474	DNA Polymerase Inhibitor	4180186
19475474	Inhibitors, DNA Polymerase	4180186
19475474	RNA Synthesis Inhibitor	4180186
19475474	Inhibitors, Nucleic Acid Synthesis	4180186
19475474	Polymerase Inhibitors, DNA	4180186
19475474	DNA Synthesis Inhibitors	4180186
19475474	Synthesis Inhibitor, DNA	4180186
19475474	Nucleic Acid Synthesis Inhibitor	4180186
19475475	Retinal S-Antigen	4180186
19475475	S Antigen, Retinal	4180186
19475475	Retinal S Antigen	4180186
19475475	S-Antigen, Retinal	4180186
19475476	Antigen, MIB-1	4180186
19475476	Antigen Ki67	4180186
19475476	Ki 67 Antigen	4180186
19475476	MIB 1 Antigen	4180186
19475476	Antigen Ki 67	4180186
19475476	Ki-67, Antigen	4180186
19475476	Antigen Ki-67	4180186
19475476	MIB-1 Antigen	4180186
19475476	Antigen, Ki-67	4180186
19475476	Ki67, Antigen	4180186
19475479	PECAM-1	4180186
19475479	Platelet Endothelial Cell Adhesion Molecule 1	4180186
19475479	CD31 Antigens	4180186
19475479	CD31 Antigen	4180186
19475479	Antigen, CD31	4180186
19475479	Antigens, CD31	4180186
19475480	IL15	4180186
19475480	IL-15	4180186
19475480	Interleukin 15	4180186
19475484	DNA Vaccines, Recombinant	4180186
19475484	Vaccine, DNA	4180186
19475484	Naked DNA Vaccine	4180186
19475484	Vaccine, Naked DNA	4180186
19475484	Vaccines, Recombinant DNA	4180186
19475484	DNA Vaccine, Recombinant	4180186
19475484	DNA Vaccines, Naked	4180186
19475484	Recombinant DNA Vaccine	4180186
19475484	DNA Vaccine, Naked	4180186
19475484	Vaccine, Recombinant DNA	4180186
19475484	DNA Vaccine	4180186
19475484	Naked DNA Vaccines	4180186
19475484	Recombinant DNA Vaccines	4180186
19475484	Vaccines, Naked DNA	4180186
19475484	DNA Vaccines	4180186
19475487	Broadsides	4180186
19475489	Vaccine, Tumor	4180186
19475489	Vaccine, Cancer	4180186
19475489	Tumor Vaccine	4180186
19475489	Vaccines, Neoplasm	4180186
19475489	Neoplasm Vaccines	4180186
19475489	Tumor Vaccines	4180186
19475489	Vaccines, Tumor	4180186
19475489	Vaccines, Cancer	4180186
19475489	Cancer Vaccine	4180186
19475491	Procedures, Unnecessary	4180186
19475491	Unnecessary Surgery	4180186
19475491	Procedure, Unnecessary	4180186
19475491	Unnecessary Procedure	4180186
19475491	Surgery, Unnecessary	4180186
19475497	TIMP 3 Protein	4180186
19475497	TIMP-3 Protein	4180186
19475497	TIMP3 Protein	4180186
19475497	Tissue Inhibitor of Metalloproteinase 3	4180186
19475497	Metalloproteinase-3 Tissue Inhibitor	4180186
19475497	TIMP-3	4180186
19475501	gamma Chemokines	4180186
19475501	C Chemokines	4180186
19475501	gamma-Chemokines	4180186
19475502	Lidofenin, Tc-99m	4180186
19475502	99m-Tc-Lidofenin	4180186
19475502	99mTc Lidofenin	4180186
19475502	Technetium 99m Lidofenin	4180186
19475502	Tc 99m Lidofenin	4180186
19475502	Technetium-99m-Lidofenin	4180186
19475502	Technetium Tc 99m 2,6 Dimethyl Iminodiacetic Acid	4180186
19475502	99mTc-Lidofenin	4180186
19475502	99m Tc Lidofenin	4180186
19475502	Technetium Tc 99m 2,6-Dimethyl Iminodiacetic Acid	4180186
19475502	Tc-99m Lidofenin	4180186
19475502	99mTc-HIDA	4180186
19475502	99mTc HIDA	4180186
19475504	Iodide, Tetraethylammonium	4180186
19475504	Bromide, Tetraethylammonium	4180186
19475504	Chloride, Tetraethylammonium	4180186
19475504	Tetraethylammonium Bromide	4180186
19475504	Tetraethylammonium Hydroxide	4180186
19475504	Tetraethylammonium Chloride	4180186
19475504	Tetraethylammonium Ion	4180186
19475504	Ion, Tetraethylammonium	4180186
19475504	Tetraethylammonium Iodide	4180186
19475504	Hydroxide, Tetraethylammonium	4180186
19475508	Strepavidin	4180186
19475509	NaN3	4180186
19475509	Azide, Sodium	4180186
19475512	gamma Melanocyte-Stimulating Hormone	4180186
19475512	Pro-gamma-MSH	4180186
19475512	Pro gamma MSH	4180186
19475512	gamma-Melanotropin	4180186
19475512	Melanocyte-Stimulating Hormone, gamma	4180186
19475512	gamma-Melanocyte-Stimulating Hormone	4180186
19475512	gamma1-MSH	4180186
19475512	N-Terminal Peptide of POMC (NPP)	4180186
19475512	gamma Melanotropin	4180186
19475512	gamma Melanocyte Stimulating Hormone	4180186
19475512	gamma3 MSH	4180186
19475512	Pro gamma Melanotropin	4180186
19475512	gamma MSH	4180186
19475512	gamma-Melanotropin Precursor	4180186
19475512	gamma3-MSH	4180186
19475512	gamma2 MSH	4180186
19475512	gamma Melanotropin Precursor	4180186
19475512	N-POMC	4180186
19475512	gamma2-MSH	4180186
19475512	Pro-gamma-Melanotropin	4180186
19475512	gamma1 MSH	4180186
19475512	Melanocyte Stimulating Hormone, gamma	4180186
19475512	MSH, gamma	4180186
19475513	Screening, Preimplantation	4180186
19475513	Diagnosis, Preimplantation	4180186
19475513	Diagnoses, Preimplantation Genetic	4180186
19475513	Preimplantation Genetic Diagnoses	4180186
19475513	Screenings, Preimplantation	4180186
19475513	Diagnosis, Preimplantation Genetic	4180186
19475513	Preimplantation Screening	4180186
19475513	Genetic Diagnoses, Preimplantation	4180186
19475513	Preimplantation Screenings	4180186
19475513	Diagnoses, Preimplantation	4180186
19475513	Genetic Diagnosis, Preimplantation	4180186
19475513	Preimplantation Genetic Diagnosis	4180186
19475513	Preimplantation Diagnoses	4180186
19475515	PYY Peptide	4180186
19475515	Peptide, PYY	4180186
19475518	IL-6 Receptor	4180186
19475518	Receptor, IL6	4180186
19475518	Receptor, Interleukin-6	4180186
19475518	Receptors, IL-6	4180186
19475518	IL-6 Receptors	4180186
19475518	Interleukin-6 Receptors	4180186
19475518	IL 6 Receptor	4180186
19475518	Receptors, Interleukin 6	4180186
19475518	Receptor, IL-6	4180186
19475518	Receptor, Interleukin 6	4180186
19475518	Interleukin 6 Receptors	4180186
19475518	Receptors, IL 6	4180186
19475518	IL 6 Receptors	4180186
19475518	IL6 Receptor	4180186
19475518	Receptors, IL6	4180186
19475518	IL6 Receptors	4180186
19475518	Interleukin-6 Receptor	4180186
19475518	Interleukin 6 Receptor	4180186
19475520	Antagonist, Leukotriene Receptor	4180186
19475520	Leukotriene Receptor Antagonists	4180186
19475520	Antagonists, Leukotriene	4180186
19475520	Antagonist, Leukotriene	4180186
19475520	Leukotriene Antagonist	4180186
19475520	Receptor Antagonist, Leukotriene	4180186
19475520	Antagonists, Leukotriene Receptor	4180186
19475520	Leukotriene Receptor Antagonist	4180186
19475520	Receptor Antagonists, Leukotriene	4180186
19475521	P. vivax MSP1	4180186
19475521	MSA1 Protein	4180186
19475521	PMMSA	4180186
19475521	Surface Protein-1, Merozoite	4180186
19475521	Protein, MSA1	4180186
19475521	MSA 1 Protein	4180186
19475521	MSA-1	4180186
19475521	PFM-PSCP	4180186
19475521	Merozoite Surface Antigen 1	4180186
19475521	Major Merozoite Surface Protein Precursor	4180186
19475521	MSP1	4180186
19475521	MSP-1	4180186
19475521	MSA-1 Protein	4180186
19475521	MSA1	4180186
19475521	Protein, MSA-1	4180186
19475521	MSP1, P. vivax	4180186
19475521	Plasmodium falciparum Merozoite Precursor Surface Coat Protein	4180186
19475521	Merozoite Surface Protein-1	4180186
19475523	Xanthylium, 3,6-diamino-9-(2-(methoxycarbonyl)phenyl)-, chloride	4180186
19475524	Hydroperoxide, t-Butyl	4180186
19475524	tert Butylhydroperoxide	4180186
19475524	t-Butyl Hydroperoxide	4180186
19475524	t-Butylhydroperoxide	4180186
19475524	tertiary Butylhydroperoxide	4180186
19475524	tert Butyl Hydroperoxide	4180186
19475524	Hydroperoxide, tert-Butyl	4180186
19475524	Hydroperoxide, 1,1-dimethylethyl	4180186
19475524	t Butylhydroperoxide	4180186
19475524	tert-Butyl Hydroperoxide	4180186
19475524	tertiary-Butylhydroperoxide	4180186
19475524	t Butyl Hydroperoxide	4180186
19475525	Ascotoxin	4180186
19475525	Cyanein	4180186
19475525	NSC 89671	4180186
19475525	Synergisidin	4180186
19475525	4H-Cyclopent(f)oxacyclotridecin-4-one,1,6,7,8,9,11a-beta,12,13,14,14a-alpha-decahydro-1-beta-13-alpha-dihydroxy-6-beta-methyl-	4180186
19475525	NSC-89671	4180186
19475525	NSC89671	4180186
19475525	Decumbin	4180186
19475526	Sodium Butyrate	4180186
19475526	Dibutyrate, Magnesium	4180186
19475526	Butyrate, Sodium	4180186
19475526	Magnesium Butyrate	4180186
19475526	Butyrate, Magnesium	4180186
19475526	Butyric Acid Magnesium Salt	4180186
19475526	Butanoic Acid	4180186
19475526	Butyric Acid, Sodium Salt	4180186
19475526	Acid, Butyric	4180186
19475526	Acid, Butanoic	4180186
19475526	Magnesium Dibutyrate	4180186
19475527	Benzoic acid, sodium salt	4180186
19475527	Benzoate, Sodium	4180186
19475528	Tag, Expressed Sequence	4180186
19475528	Tags, Expressed Sequence	4180186
19475528	Sequence Tag, Expressed	4180186
19475528	Expressed Sequence Tag	4180186
19475528	Sequence Tags, Expressed	4180186
19475528	ESTs	4180186
19475532	IL 17E	4180186
19475532	Cytotoxic T lymphocyte-Associated Antigen 8	4180186
19475532	IL-17A	4180186
19475532	Cytotoxic T lymphocyte Associated Antigen 8	4180186
19475532	Interleukin 17C	4180186
19475532	IL-17E	4180186
19475532	Interleukin 17F	4180186
19475532	Interleukin 17A	4180186
19475532	Interleukin 25	4180186
19475532	Interleukin-25	4180186
19475532	CTLA-8	4180186
19475532	Interleukin-17F	4180186
19475532	IL-17C	4180186
19475532	Cytokine CX2	4180186
19475532	Cytokine ML 1	4180186
19475532	Interleukin-17C	4180186
19475532	CX2, Cytokine	4180186
19475532	Interleukin-17B	4180186
19475532	Interleukin 17B	4180186
19475532	Interleukin-17A	4180186
19475532	Interleukin 17	4180186
19475532	IL-17F	4180186
19475532	IL-17	4180186
19475532	IL-17B	4180186
19475532	Cytokine ML-1	4180186
19475532	CTLA8	4180186
19475532	Interleukin-17E	4180186
19475532	Interleukin 17E	4180186
19475533	IFN-gamma-Inducing Factor	4180186
19475533	IFN-gamma Inducing Factor	4180186
19475533	Inducing Factor, IFN-gamma	4180186
19475533	Interleukin 18	4180186
19475533	IFN gamma Inducing Factor	4180186
19475533	Inducing Factor, Interferon-gamma	4180186
19475533	Interferon-gamma Inducing Factor	4180186
19475533	IL18	4180186
19475533	IL-18	4180186
19475533	Interferon-gamma-Inducing Factor	4180186
19475533	Interferon gamma Inducing Factor	4180186
19475537	Health Clubs	4180186
19475537	Spas, Health	4180186
19475537	Health Spa	4180186
19475537	Centers, Fitness	4180186
19475537	Spa, Health	4180186
19475537	Gymnasium	4180186
19475537	Center, Fitness	4180186
19475537	Wellness Centers	4180186
19475537	Center, Wellness	4180186
19475537	Wellness Center	4180186
19475537	Health Spas	4180186
19475537	Gym	4180186
19475537	Clubs, Health	4180186
19475537	Fitness Center	4180186
19475537	Gymnasiums	4180186
19475537	Gyms	4180186
19475537	Centers, Wellness	4180186
19475537	Health Club	4180186
19475537	Club, Health	4180186
19475538	Manuscripts	4180186
19475539	CX3C Chemokines	4180186
19475540	Antagonists, Angiogenetic	4180186
19475540	Inhibitors, Neovascularization	4180186
19475540	Angiogenic Antagonist	4180186
19475540	Agents, Anti-Angiogenetic	4180186
19475540	Angiostatic Agent	4180186
19475540	Effects, Antiangiogenesis	4180186
19475540	Effects, Anti-Angiogenesis	4180186
19475540	Angiogenetic Inhibitors	4180186
19475540	Factor Inhibitor, Angiogenesis	4180186
19475540	Anti Angiogenetic Agents	4180186
19475540	Agents, Antiangiogenic	4180186
19475540	Antagonist, Angiogenetic	4180186
19475540	Angiogenetic Antagonists	4180186
19475540	Antagonist, Angiogenic	4180186
19475540	Effect, Antiangiogenesis	4180186
19475540	Inhibitor, Angiogenetic	4180186
19475540	Angiogenesis Factor Inhibitor	4180186
19475540	Anti-Angiogenetic Agent	4180186
19475540	Anti Angiogenetic Agent	4180186
19475540	Anti Angiogenic Drugs	4180186
19475540	Neovascularization Inhibitor	4180186
19475540	Effect, Anti-Angiogenesis	4180186
19475540	Inhibitors, Angiogenic	4180186
19475540	Neovascularization Inhibitors	4180186
19475540	Anti-Angiogenic Drug	4180186
19475540	Inhibitor, Neovascularization	4180186
19475540	Angiogenic Inhibitors	4180186
19475540	Agents, Angiostatic	4180186
19475540	Angiogenetic Antagonist	4180186
19475540	Inhibitor, Angiogenesis Factor	4180186
19475540	Angiostatic Agents	4180186
19475540	Anti Angiogenesis Effects	4180186
19475540	Drugs, Anti-Angiogenic	4180186
19475540	Antiangiogenic Agent	4180186
19475540	Inhibitors, Angiogenesis Factor	4180186
19475540	Angiogenetic Inhibitor	4180186
19475540	Antiangiogenic Agents	4180186
19475540	Anti-Angiogenesis Effect	4180186
19475540	Angiogenic Antagonists	4180186
19475540	Anti Angiogenic Drug	4180186
19475540	Antiangiogenesis Effects	4180186
19475540	Anti-Angiogenesis Effects	4180186
19475540	Agent, Antiangiogenic	4180186
19475540	Inhibitor, Angiogenic	4180186
19475540	Inhibitors, Angiogenesis	4180186
19475540	Anti-Angiogenetic Agents	4180186
19475540	Angiogenic Inhibitor	4180186
19475540	Agent, Angiostatic	4180186
19475540	Inhibitors, Angiogenetic	4180186
19475540	Angiogenesis Factor Inhibitors	4180186
19475540	Anti-Angiogenic Drugs	4180186
19475540	Factor Inhibitors, Angiogenesis	4180186
19475540	Antiangiogenesis Effect	4180186
19475540	Angiogenesis Inhibitor	4180186
19475540	Drug, Anti-Angiogenic	4180186
19475540	Agent, Anti-Angiogenetic	4180186
19475540	Anti Angiogenesis Effect	4180186
19475540	Antagonists, Angiogenic	4180186
19475540	Inhibitor, Angiogenesis	4180186
19475542	Activators, Small GTPase	4180186
19475542	Small GTPase Activators	4180186
19475542	Activators, GTPase	4180186
19475542	GTPase Activators	4180186
19475542	Activators, GTP Phosphohydrolase	4180186
19475543	v-rel Protein	4180186
19475543	Proteins, v-rel	4180186
19475543	Oncogene Proteins, rel	4180186
19475543	rel, Oncogene Protein	4180186
19475543	rel, Oncogene Proteins	4180186
19475543	Oncogene Protein rel	4180186
19475543	Oncogene Proteins v rel	4180186
19475543	v-rel Proteins	4180186
19475543	Oncogene Products v rel	4180186
19475543	Protein, v-rel	4180186
19475543	rel Oncogene Proteins	4180186
19475543	v-rel, Oncogene Products	4180186
19475543	v rel Proteins	4180186
19475543	v rel Protein	4180186
19475543	Oncogene Protein pp59(v-rel)	4180186
19475543	Oncogene Products v-rel	4180186
19475543	pp59(v-rel)	4180186
19475543	v-rel, Oncogene Proteins	4180186
19475543	Oncogene Proteins rel	4180186
19475544	I kappa B	4180186
19475544	I-kappa B	4180186
19475544	IkB DNA Binding Proteins	4180186
19475544	I kappa B Proteins	4180186
19475544	IkB DNA-Binding Proteins	4180186
19475545	Synthetic Rubbers	4180186
19475545	Rubber, Synthetic	4180186
19475545	Synthetic Rubber	4180186
19475545	Rubbers, Synthetic	4180186
19475545	Elastomer	4180186
19475548	2 Ala 4 MePhe 5 Gly Enkephalin	4180186
19475548	L-Phenylalaninamide, L-tyrosyl-D-alanylglycyl-N-(2-hydroxyethyl)-nalpha-methyl-	4180186
19475548	DAGOL	4180186
19475548	RX 783006	4180186
19475548	Ala(2)-MePhe(4)-Gly-ol(5) Enkephalin	4180186
19475548	Enkephalin, alanyl(2)-methylphenylalanyl(4)-glycine(5)-	4180186
19475548	RX-783006	4180186
19475548	D-Ala2-NMe-Phe4-Gly-ol Enkephalin	4180186
19475548	DAMGE	4180186
19475548	D Ala2 NMe Phe4 Gly ol Enkephalin	4180186
19475548	D-Ala(2)-MePhe(4)-Gly-ol(5) Enkephalin	4180186
19475548	Tyr-Ala-Gly-(NMe)Phe-Gly-ol	4180186
19475548	Enkephalin, D-Ala2-NMe-Phe4-Gly-ol	4180186
19475548	DAMGO	4180186
19475548	DAGO	4180186
19475548	2-Ala-4-MePhe-5-Gly-Enkephalin	4180186
19475555	Bivalent Meningococcal Vaccine	4180186
19475555	Tetravalent Meningococcal Vaccine	4180186
19475555	Meningococcal Vaccine	4180186
19475555	Polysaccharide Vaccine, Meningococcal	4180186
19475555	Vaccine, Meningococcal	4180186
19475555	Menomune	4180186
19475555	Vaccines, Meningococcal	4180186
19475555	Vaccine, Meningococcal Polysaccharide	4180186
19475555	Menactra	4180186
19475555	Meningococcal Polysaccharide Vaccine	4180186
19475555	Menveo	4180186
19475555	Meningococcal Vaccine, Tetravalent	4180186
19475555	Meningococcal Vaccine, Bivalent	4180186
19475560	CXCR2 Receptor	4180186
19475560	Interleukin 8 Receptors Type B	4180186
19475560	CXCR2 Protein	4180186
19475560	Interleukin 8B Receptors	4180186
19475560	CDw128b Antigens	4180186
19475560	Interleukin 8B Receptor	4180186
19475560	Receptor, CXCR2	4180186
19475560	Interleukin-8 Receptor Type B	4180186
19475560	Receptors, CXCR2	4180186
19475560	Antigens, CDw128b	4180186
19475560	Interleukin-8 Receptors B	4180186
19475560	Interleukin 8 Receptor Type B	4180186
19475560	Receptor, Interleukin-8B	4180186
19475560	Interleukin-8B Receptor	4180186
19475560	Interleukin 8 Receptors B	4180186
19475560	Receptors, Interleukin 8B	4180186
19475560	CDw128b Antigen	4180186
19475560	Interleukin-8 Receptors Type B	4180186
19475560	Interleukin-8B Receptors	4180186
19475560	Antigen, CDw128b	4180186
19475560	CXC Chemokine Receptor 2	4180186
19475560	CXCR2 Receptors	4180186
19475562	Neutrophil Antimicrobial Peptides	4180186
19475562	Antimicrobial Peptides, Neutrophil	4180186
19475562	Defensin, alpha	4180186
19475562	alpha-Defensin	4180186
19475562	alpha Defensin	4180186
19475562	alpha Defensins	4180186
19475562	Peptides, Neutrophil Antimicrobial	4180186
19475564	TNF Superfamily, Member 5	4180186
19475564	T-Cell gp39 Antigen	4180186
19475564	gp39 Antigen, T Cell	4180186
19475564	Tumor Necrosis Factor Ligand Superfamily Member 5	4180186
19475564	Antigen, CD154	4180186
19475564	CD154 Antigens	4180186
19475564	CD154 Antigen	4180186
19475564	gp39 Antigen, T-Cell	4180186
19475564	CD40L	4180186
19475564	T-B Cell Activating Molecule	4180186
19475564	Antigens, CD154	4180186
19475565	1,3 Oxazolidin 2 one	4180186
19475565	1,3-Oxazolidine-2-one	4180186
19475565	2-oxazolidinone	4180186
19475565	Oxazolidinone	4180186
19475565	Oxazolidin 2 one	4180186
19475565	2 Oxazolidone	4180186
19475565	Oxazolidin-2-one	4180186
19475565	2-Oxazolidone	4180186
19475565	2 oxazolidinone	4180186
19475565	1,3-Oxazolidin-2-one	4180186
19475565	1,3 Oxazolidine 2 one	4180186
19475567	Streptogramin	4180186
19475569	4-(4-(Dimethylamino)-N-methyl-L-phenylalanine)virginiamycin S1	4180186
19475569	Osteogrycin B	4180186
19475569	Pristinamycin IA	4180186
19475569	Mikamycin B	4180186
19475569	Synergistin B	4180186
19475569	Vernamycin Balpha	4180186
19475574	S-Nitrosothiol	4180186
19475576	FRP-1 protein	4180186
19475576	4F2 Antigen	4180186
19475576	Antigens, CD98	4180186
19475576	Antigen, CD98	4180186
19475576	CD98 Transport Proteins	4180186
19475576	H4F2 Antigen	4180186
19475576	Human Lymphocyte Activation Antigen 4F2	4180186
19475576	Fusion Regulatory Protein 1	4180186
19475576	CD98 Antigens	4180186
19475576	CD98 Antigen	4180186
19475576	Human 4F2 Antigen	4180186
19475576	Human 4F2 Cell-Surface Antigen	4180186
19475576	4F2-antigen	4180186
19475576	Human 4F2 Cell Surface Antigen	4180186
19475576	4F2 Antigen, Human	4180186
19475576	Antigen 4F2	4180186
19475576	Transport Proteins, CD98	4180186
19475576	Regulatory Protein-1, Fusion	4180186
19475576	FRP 1 protein	4180186
19475577	4F2 Light Chains	4180186
19475577	CD98 Antigen Light Chain	4180186
19475577	4F2 Antigen, Light Chains	4180186
19475577	Antigens, CD98 Light Chains	4180186
19475577	CD98 Antigens Light Chain	4180186
19475578	Raisins	4180186
19475578	Vitis vinifera	4180186
19475578	Grape	4180186
19475578	Raisin	4180186
19475578	Grapes	4180186
19475581	Calamus Roots	4180186
19475581	Flagroot	4180186
19475581	Root, Calamus	4180186
19475581	Sweet Sedge	4180186
19475581	Calamus Root	4180186
19475581	Sweet Flag	4180186
19475581	Sweet Sedges	4180186
19475581	Sedges, Sweet	4180186
19475581	Acorus gramineus	4180186
19475581	Acorus calamus	4180186
19475581	Roots, Calamus	4180186
19475581	Sweetflag	4180186
19475581	Sedge, Sweet	4180186
19475582	Passionflower, Purple	4180186
19475582	Passiflora edulis	4180186
19475582	Purple Passionflower	4180186
19475582	Passionflower	4180186
19475582	Passionflowers, Purple	4180186
19475582	Passion Flowers	4180186
19475582	Granadilla	4180186
19475582	Granadillas	4180186
19475582	Passionflowers	4180186
19475582	Passiflora incarnata	4180186
19475582	Passionfruits	4180186
19475582	Flowers, Passion	4180186
19475582	Passionfruit	4180186
19475582	Passion Flower	4180186
19475582	Purple Passionflowers	4180186
19475582	Passiflora alata	4180186
19475582	Flower, Passion	4180186
19475584	Levisticums	4180186
19475584	Levisticum officinale	4180186
19475584	Lovage	4180186
19475584	officinales, Levisticum	4180186
19475584	Lovages	4180186
19475584	Levisticum officinales	4180186
19475585	Kola Nuts	4180186
19475585	Cola acuminata	4180186
19475585	Kola Nut	4180186
19475585	Nut, Kola	4180186
19475585	Cola nitida	4180186
19475585	Nuts, Kola	4180186
19475586	Soy Protein	4180186
19475586	Soybean Proteins, Dietary	4180186
19475586	Dietary Soybean Protein	4180186
19475586	Proteins, Soy	4180186
19475586	Protein, Soy	4180186
19475586	Soy Proteins	4180186
19475586	Protein, Dietary Soybean	4180186
19475586	Bean Protein, Soy	4180186
19475586	Soybean Protein, Dietary	4180186
19475586	Protein, Soy Bean	4180186
19475586	Dietary Soybean Proteins	4180186
19475586	Soybean Protein	4180186
19475586	Proteins, Dietary Soybean	4180186
19475586	Soy Bean Proteins	4180186
19475586	Protein, Soybean	4180186
19475586	Soy Bean Protein	4180186
19475588	Sorrels, French	4180186
19475588	Garden Sorrel	4180186
19475588	Garden Sorrels	4180186
19475588	Docks, Yellow	4180186
19475588	Sorrel, French	4180186
19475588	Rumex acetosa	4180186
19475588	Sorrels, Garden	4180186
19475588	French Sorrels	4180186
19475588	Rumex scutatus	4180186
19475588	Yellow Dock	4180186
19475588	French Sorrel	4180186
19475588	Canaigre	4180186
19475588	Rumex thyrsiflorus	4180186
19475588	Dock, Yellow	4180186
19475588	Rumex crispus	4180186
19475588	Yellow Docks	4180186
19475588	Sorrel, Garden	4180186
19475591	Willows, Goat	4180186
19475591	Salix alba	4180186
19475591	White Willows	4180186
19475591	Willows, White	4180186
19475591	Salix viminalis	4180186
19475591	Salix caprea	4180186
19475591	Salix matsudana	4180186
19475591	White Willow	4180186
19475591	Willow, White	4180186
19475591	Willow, Goat	4180186
19475591	Goat Willows	4180186
19475591	Willows	4180186
19475591	Goat Willow	4180186
19475591	Willow	4180186
19475592	Epothilon	4180186
19475592	Epothilone	4180186
19475593	System, Integumentary	4180186
19475593	Systems, Integumentary	4180186
19475593	Integumentary Systems	4180186
19475594	Kutajas	4180186
19475594	Kutaja	4180186
19475594	Holarrhenas	4180186
19475595	Antibodies, Hepatitis A	4180186
19475595	Anti-HAV	4180186
19475595	Anti HAV	4180186
19475595	Hepatitis A Virus Antibodies	4180186
19475598	Curcuminoid	4180186
19475598	Diarylheptanoid Derivative	4180186
19475598	Diarylheptanones	4180186
19475598	Curcuminoids	4180186
19475598	Diarylheptanoid	4180186
19475598	Linear Diarylheptanoids	4180186
19475598	Acyclic Diarylheptanoids	4180186
19475598	Diarylheptanoid, Cyclic	4180186
19475598	Heptanoids, Diaryl	4180186
19475598	Diarylheptanoid Derivatives	4180186
19475598	Cyclic Diarylheptanoid	4180186
19475598	Diaryl Heptanoids	4180186
19475598	Cyclic Diarylheptanoids	4180186
19475598	Diarylheptanoids, Acyclic	4180186
19475598	Diarylheptanoids, Linear	4180186
19475598	Derivative, Diarylheptanoid	4180186
19475598	Diarylheptanoids, Cyclic	4180186
19475600	Galectin-3	4180186
19475600	Macrophage 2 Antigen	4180186
19475600	L-29 Lectin	4180186
19475600	CBP35	4180186
19475600	Carbohydrate Binding Protein 35	4180186
19475600	Epsilon-Binding Protein	4180186
19475600	L-34	4180186
19475600	Epsilon Binding Protein	4180186
19475600	L-31	4180186
19475600	L 29 Lectin	4180186
19475600	CBP-30	4180186
19475600	Antigen, Mac-2	4180186
19475600	Carbohydrate-Binding Protein 35	4180186
19475600	Mac 2 Antigen	4180186
19475600	IgEBP	4180186
19475600	LGALS3	4180186
19475600	Binding Protein, IgE	4180186
19475600	CBP-35	4180186
19475600	Antigen, Macrophage-2	4180186
19475600	Mac-2 Antigen	4180186
19475600	Macrophage-2 Antigen	4180186
19475600	L30 Lectin	4180186
19475600	Protein, IgE Binding	4180186
19475600	HL-29	4180186
19475600	IgE Binding Protein	4180186
19475602	Mannan-Binding Protein	4180186
19475602	Mannan Binding Protein	4180186
19475602	Mannan Binding Lectin	4180186
19475602	Mannose-Binding Protein	4180186
19475602	Mannan-Binding Lectin	4180186
19475602	Lectin, Mannose-Binding	4180186
19475602	Mannose Binding Protein	4180186
19475602	Mannose Binding Lectin	4180186
19475602	Lectin, Mannan-Binding	4180186
19475604	Tumor Specific Protein-180 Complex	4180186
19475604	Laminin-5 Receptor (alpha6beta4 Integrin)	4180186
19475604	alpha(6)beta(4) Epithelial Integrin	4180186
19475604	A9 Antigen	4180186
19475604	Integrin alpha(6),beta(4)	4180186
19475604	alpha(6)beta(4) Integrin	4180186
19475604	beta4 Integrin, alpha6	4180186
19475604	Integrin, alpha6 beta4	4180186
19475604	alpha6beta4, Integrin	4180186
19475604	Tumor Specific Protein 180 Complex	4180186
19475604	alpha6 beta4 Integrin	4180186
19475604	TSP-180	4180186
19475604	Antigen, A9	4180186
19475605	DNA Computers	4180186
19475605	Computer, DNA	4180186
19475605	Computations, DNA	4180186
19475605	RNA Computations	4180186
19475605	RNA Computers	4180186
19475605	Molecular Computations	4180186
19475605	Computers, RNA	4180186
19475605	Molecular Computer	4180186
19475605	DNA Computations	4180186
19475605	Computation, DNA	4180186
19475605	DNA Computer	4180186
19475605	Computers, DNA	4180186
19475605	Molecular Computers	4180186
19475605	DNA Computation	4180186
19475605	RNA Computer	4180186
19475605	Computer, Molecular	4180186
19475605	Computation, Molecular	4180186
19475605	Computations, Molecular	4180186
19475605	RNA Computation	4180186
19475605	Computations, RNA	4180186
19475605	Computer, RNA	4180186
19475605	Molecular Computation	4180186
19475605	Computation, RNA	4180186
19475608	alphaM Integrin	4180186
19475608	Complement Component Receptor 3, alpha	4180186
19475608	Integrin alpha M	4180186
19475608	Integrin alphaM	4180186
19475608	alphaM, Integrin	4180186
19475608	alpha M, Integrin	4180186
19475608	CD11b Antigens	4180186
19475608	Mo1 Antigen	4180186
19475608	ITGAM Protein	4180186
19475608	Antigen, CD11b	4180186
19475608	Antigen, Mo1	4180186
19475608	Integrin, alphaM	4180186
19475608	Antigens, CD11b	4180186
19475608	Mo1 Glycoprotein	4180186
19475609	Antigens, CD49e	4180186
19475609	Integrin, alpha5	4180186
19475609	Ic, Platelet Glycoprotein	4180186
19475609	VLA 5 alpha Chain	4180186
19475609	Platelet Glycoprotein Ic	4180186
19475609	alpha(5) Integrin	4180186
19475609	Glycoprotein Ic, Platelet	4180186
19475609	alpha5 Integrin	4180186
19475609	CD49e Antigens	4180186
19475609	alphaF, Integrin	4180186
19475609	Antigen, CD49e	4180186
19475609	alpha Chain, VLA-5	4180186
19475609	CD49e Antigen	4180186
19475609	VLA-5 alpha Chain	4180186
19475609	Integrin alphaF	4180186
19475609	alpha5, Integrin	4180186
19475610	Leu-M5 Antigens	4180186
19475610	Antigens, Leu-M5	4180186
19475610	Leu M5 Antigens	4180186
19475610	alphaX, Integrin	4180186
19475610	Antigen, CD11c	4180186
19475610	Antigens, CD11c	4180186
19475610	Integrin alphaX	4180186
19475610	CD11c Antigens	4180186
19475611	Third Generation H1 Antagonists	4180186
19475611	Second Generation Antihistamines	4180186
19475611	Second Generation H1 Antagonists	4180186
19475611	Third Generation H1 Antagonist	4180186
19475611	H1 Antihistamines, Non-Sedating	4180186
19475611	Generation Antihistamine, Second	4180186
19475611	Histamine H1 Antagonists, Non Sedating	4180186
19475611	Non-Sedating H1 Antihistamines	4180186
19475611	Antihistamine, Second Generation	4180186
19475611	Second Generation H1 Antagonist	4180186
19475611	Second Generation Antihistamine	4180186
19475611	H1 Antihistamines, Non Sedating	4180186
19475611	Antihistamines, Second Generation	4180186
19475612	Antigen, CD104	4180186
19475612	Integrin, beta4	4180186
19475612	CD104 Antigen	4180186
19475612	beta4, Integrin	4180186
19475612	Antigens, CD104	4180186
19475612	Integrin beta(4)	4180186
19475612	CD104 Antigens	4180186
19475612	beta4 Integrin	4180186
19475613	Calanolides	4180186
19475614	House Dust Mite Antigens	4180186
19475614	Dermatophagoides pteronyssinus Allergens	4180186
19475614	Dermatophagoides pteronyssinus Antigens	4180186
19475614	Antigens, Dermatophagoides pteronyssinus	4180186
19475614	Antigens, House Dust Mites	4180186
19475614	Dermatophagoides farinae Allergens	4180186
19475614	Dermatophagoides Allergens	4180186
19475614	Antigens, Dermatophagoides farinae	4180186
19475614	Dermatophagoides Antigens	4180186
19475614	Pharmalgen	4180186
19475614	Dermatophagoides farinae Antigens	4180186
19475614	Allergens, House Dust Mites	4180186
19475614	Norisen	4180186
19475617	Membrane Glycoprotein IIb	4180186
19475617	CD41 Antigens	4180186
19475617	Glycoprotein IIb, Membrane	4180186
19475617	Antigens, CD41	4180186
19475617	GP IIb	4180186
19475617	Integrin alpha IIb	4180186
19475617	Antigen, CD41	4180186
19475617	CD41 Antigen	4180186
19475617	Plasma Membrane Glycoprotein IIb	4180186
19475617	Surface Antigen, HUPL-ml	4180186
19475617	GPalpha IIb	4180186
19475617	Antigen, HUPL-ml Surface	4180186
19475617	alphaIIb, Integrin	4180186
19475617	HUPL-ml Surface Antigen	4180186
19475617	HUPL ml Surface Antigen	4180186
19475617	CD41 Cell Surface Antigen	4180186
19475617	Integrin alphaIIb	4180186
19475619	Leukocyte L1 Protein Light Chain	4180186
19475619	Myeloid Calcium-Binding Protein P8	4180186
19475619	A8 Protein, S100	4180186
19475619	Macrophage-Related Protein-8	4180186
19475619	Antigen, Cystic Fibrosis	4180186
19475619	Antigen, 60B8-B	4180186
19475619	MRP8 Protein	4180186
19475619	MRP-8 Protein	4180186
19475619	S100 A8 Protein	4180186
19475619	Cystic Fibrosis Antigen	4180186
19475619	60B8-B Antigen	4180186
19475619	Myeloid Calcium Binding Protein P8	4180186
19475619	Macrophage Related Protein 8	4180186
19475619	CABP-P8	4180186
19475619	MRP 8 Protein	4180186
19475619	60B8 B Antigen	4180186
19475619	S100A8 Protein	4180186
19475621	Facilities, Assisted Living	4180186
19475621	Assisted Living Facility	4180186
19475621	Facility, Assisted Living	4180186
19475623	4-Quinolinones	4180186
19475623	4-Quinolone	4180186
19475623	4 Quinolinones	4180186
19475623	4 Oxoquinoline	4180186
19475623	4-Quinolinone	4180186
19475623	4 Quinolones	4180186
19475623	4-Oxoquinolines	4180186
19475623	4 Oxoquinolines	4180186
19475623	4 Quinolinone	4180186
19475623	4-Oxoquinoline	4180186
19475623	4 Quinolone	4180186
19475624	Angiopoietin 2	4180186
19475627	Angiostatin	4180186
19475628	Polyrotaxanes	4180186
19475628	Pseudorotaxanes	4180186
19475628	Pseudorotaxane	4180186
19475628	Rotaxane	4180186
19475629	Angiogenic Factor	4180186
19475629	Factor, Angiogenic	4180186
19475629	Agents, Angiogenesis Inducing	4180186
19475629	Angiogenesis Inducers	4180186
19475629	Stimulating Agents, Angiogenesis	4180186
19475629	Factor, Angiogenesis	4180186
19475629	Inducing Agents, Angiogenesis	4180186
19475629	Effect, Angiogenesis	4180186
19475629	Inducers, Angiogenesis	4180186
19475629	Angiogenic Factor, Tumor	4180186
19475629	Angiogenesis Factor	4180186
19475629	Factor, Tumor Angiogenic	4180186
19475629	Angiogenesis Effect	4180186
19475629	Effects, Angiogenesis	4180186
19475629	Tumor Angiogenic Factor	4180186
19475629	Stimulators, Angiogenesis	4180186
19475629	Angiogenesis Stimulating Agents	4180186
19475629	Angiogenesis Stimulators	4180186
19475629	Agents, Angiogenesis Stimulating	4180186
19475629	Angiogenesis Effects	4180186
19475633	GALP Peptide	4180186
19475633	Galanin Like Peptide	4180186
19475633	Galanin Like Protein	4180186
19475633	Galanin-Like Protein	4180186
19475634	Parathyroid Hormone-Like Protein	4180186
19475634	PTH-Related Peptide	4180186
19475634	Parathyroid Hormone Like Tumor Factor	4180186
19475634	PTH Like Protein	4180186
19475634	Parathyroid Hormone Related Protein	4180186
19475634	PTH-Like Protein	4180186
19475634	Parathyroid Hormone Related Peptide	4180186
19475634	PTH Like Tumor Factor	4180186
19475634	Tumor Hypercalcemic Factor	4180186
19475634	Parathyroid Hormone-Related Peptide	4180186
19475634	Hypercalcemic Hormone of Malignancy	4180186
19475634	PTHrP	4180186
19475634	Hypercalcemic Factor, Tumor	4180186
19475634	PTH Related Peptide	4180186
19475634	Parathyroid Hormone Like Protein	4180186
19475634	Hormone-Related Protein, Parathyroid	4180186
19475635	Biflavonoid	4180186
19475638	2-Phenyl-Benzopyran-4-Ones	4180186
19475638	2 Phenyl Benzopyran 4 Ones	4180186
19475639	Glitazones	4180186
19475640	Phosphorylation State-Specific Antibodies	4180186
19475640	Antibodies, Phosphopeptide Specific	4180186
19475640	Antibodies, Phosphorylation State-Specific	4180186
19475640	Antiphosphopeptide-Specific Antibodies	4180186
19475640	State-Specific Antibodies, Phosphorylation	4180186
19475640	Phospho Specific Antibodies	4180186
19475640	Phosphospecific Antibody	4180186
19475640	Antibodies, Antiphosphopeptide-Specific	4180186
19475640	Antibody, Phosphospecific	4180186
19475640	Phospho-Specific Antibodies	4180186
19475640	Phosphopeptide-Specific Antibodies	4180186
19475640	Antibodies, Phospho Specific	4180186
19475640	Phosphopeptide Specific Antibodies	4180186
19475640	Antibodies, Antiphosphopeptide Specific	4180186
19475640	Phosphorylation State Specific Antibodies	4180186
19475640	Antibodies, Phosphopeptide-Specific	4180186
19475643	Synthetic Progestin	4180186
19475643	Progestin Analogues	4180186
19475643	Synthetic Progestogens	4180186
19475643	Progestin, Synthetic	4180186
19475643	Progestagens, Synthetic	4180186
19475643	Progestational Hormone Analogues	4180186
19475643	Progestogens, Synthetic	4180186
19475643	Progestational Hormone Analogs	4180186
19475643	Progestational Hormones, Synthetic	4180186
19475643	Synthetic Progestins	4180186
19475643	Progestins, Synthetic	4180186
19475643	Synthetic Progestagens	4180186
19475643	Progestin Analogs	4180186
19475643	Synthetic Progestational Hormones	4180186
19475644	Peptide, Natriuretic	4180186
19475644	Natriuretic Peptide	4180186
19475644	Peptides, Natriuretic	4180186
19475644	Natriuretic Peptide Hormones	4180186
19475644	Peptide Hormones, Natriuretic	4180186
19475647	Chloroplast Reaction Center Protein D1	4180186
19475647	Photosystem II Reaction Center	4180186
19475647	RCII-D1 Protein	4180186
19475647	Light-Induced D1 Protein, Photosystem II	4180186
19475647	Water Oxidase	4180186
19475647	Water Splitting Enzyme of Photosynthesis	4180186
19475647	D1 Photosystem II Protein, Plant	4180186
19475647	Oxygen Evolving Enzyme	4180186
19475647	Photosystem II	4180186
19475647	Oxidase, Water	4180186
19475647	Photosystem II Reaction Center Complex D2 Protein	4180186
19475647	Evolving Enzyme, Oxygen	4180186
19475647	Photosynthesis Water-Splitting Enzyme	4180186
19475647	Enzyme, Oxygen Evolving	4180186
19475647	Photosystem II Reaction Center Complex D1 Protein	4180186
19475647	Light Induced D1 Protein, Photosystem II	4180186
19475647	Water-Splitting Enzyme of Photosynthesis	4180186
19475647	PRCP II D2 Protein	4180186
19475649	Vaccine, Ebolavirus	4180186
19475649	Ebola Virus Vaccine	4180186
19475649	Virus Vaccine, Ebola	4180186
19475649	Ebolavirus Vaccine	4180186
19475649	Virus Vaccines, Ebola	4180186
19475649	Ebola Vaccine	4180186
19475649	Vaccines, Ebola	4180186
19475649	Vaccine, Ebola	4180186
19475649	Vaccines, Ebola Virus	4180186
19475649	Vaccines, Ebolavirus	4180186
19475649	Ebola Virus Vaccines	4180186
19475649	Ebolavirus Vaccines	4180186
19475649	Vaccine, Ebola Virus	4180186
19475650	Nanoarray Analytical Devices	4180186
19475650	Device, Microarray Analytical	4180186
19475650	Microarray Analytical Devices	4180186
19475650	Microarray Microchips	4180186
19475650	Microarray Analytical Device	4180186
19475650	Devices, Microarray Analytical	4180186
19475650	Microchips, Microarray	4180186
19475650	Devices, Nanoarray Analytical	4180186
19475650	Analytical Devices, Microarray	4180186
19475650	Analytical Device, Nanoarray	4180186
19475650	Nanoarray Analytical Device	4180186
19475650	Analytical Device, Microarray	4180186
19475650	Analysis, Microarray	4180186
19475650	Microchip, Microarray	4180186
19475650	Analytical Devices, Nanoarray	4180186
19475650	Device, Nanoarray Analytical	4180186
19475650	Microarray Microchip	4180186
19475651	Virtual Libraries	4180186
19475651	Digital Libraries	4180186
19475651	Library, Digital	4180186
19475651	Library, Virtual	4180186
19475651	Libraries, Virtual	4180186
19475651	Virtual Library	4180186
19475651	Digital Library	4180186
19475654	Sericin	4180186
19475654	Proteins, Silk Gum	4180186
19475654	Sericin 1	4180186
19475654	Sericin-1	4180186
19475654	Silk Gum Proteins	4180186
19475655	beta Glucan	4180186
19475655	beta Glucans	4180186
19475655	beta-Glucan	4180186
19475656	beta Lactams	4180186
19475656	4-Thia-1-Azabicyclo(3.2.0)Heptanes	4180186
19475656	beta-Lactam	4180186
19475656	beta Lactam	4180186
19475656	4-Thia-1-Azabicyclo(4.2.0)Octanes	4180186
19475657	EG2 Antigen	4180186
19475657	Antigen, EG2	4180186
19475657	Granule Proteins, Eosinophil	4180186
19475658	MBP Protein, Eosinophil	4180186
19475658	Basic Protein, Eosinophil	4180186
19475658	Eosinophil MBP Protein	4180186
19475658	Major Basic Protein, Eosinophil	4180186
19475658	Eosinophil Basic Protein	4180186
19475660	Calixarene	4180186
19475660	Calix(n)Arenes	4180186
19475663	Tumor Necrosis Factor Receptor Type 1	4180186
19475663	120a Antigen, CD	4180186
19475663	TNFR-I	4180186
19475663	CD 120a Antigen	4180186
19475663	TNFR p60	4180186
19475663	Antigen, CD120a	4180186
19475663	Receptor, TNFRSF1A	4180186
19475663	Tumor Necrosis Factor Receptor Type I	4180186
19475663	Antigens, CD120a	4180186
19475663	Tumor Necrosis Factor Receptor 1A	4180186
19475663	Antigen, CD 120a	4180186
19475663	CD120a Antigen	4180186
19475663	CD120a Antigens	4180186
19475663	TNFR1	4180186
19475663	TNFRSF1A (Tumor Necrosis Factor Receptor Superfamily, Member 1A)	4180186
19475663	Receptors, Tumor Necrosis Factor, Member 1A	4180186
19475663	TNFRSF1A Receptor	4180186
19475663	Tumor Necrosis Factor Receptor Superfamily, Member 1A	4180186
19475667	G(M1) Ganglioside Activating Factor	4180186
19475667	Hexosaminidase A Activating Protein	4180186
19475667	GM1 Activator Protein	4180186
19475667	G(M1) Activator Protein	4180186
19475667	Hexosaminidase Activating Factor	4180186
19475667	Cerebroside Sulfate Activator Protein	4180186
19475667	Ganglioside Hydrolysis Activator Proteins	4180186
19475667	Ganglioside Degradation Activator Protein	4180186
19475669	Recognition Software, Speech	4180186
19475669	Software, Speech Recognition	4180186
19475669	Software, Voice Recognition	4180186
19475669	Voice Recognition Software	4180186
19475669	Recognition Software, Voice	4180186
19475671	Proteins, Green Fluorescent	4180186
19475671	Green Fluorescent Protein	4180186
19475671	Fluorescent Protein, Green	4180186
19475671	Fluorescent Proteins, Green	4180186
19475671	Protein, Green-Fluorescent	4180186
19475671	Green-Fluorescent Proteins	4180186
19475671	Proteins, Green-Fluorescent	4180186
19475671	Protein, Green Fluorescent	4180186
19475671	Green-Fluorescent Protein	4180186
19475673	(S)-4,5-Dihydro-2-(6-hydroxybenzothiazol-2-yl)thiazole-4-carboxylic acid	4180186
19475675	Salacia reticulata	4180186
19475675	Salacia chinensis	4180186
19475675	Salacia oblonga	4180186
19475677	Anti Diuretic Agents	4180186
19475677	Effect, Antidiuretic	4180186
19475677	Antidiuretic Effect	4180186
19475677	Agents, Antidiuretic	4180186
19475677	Anti-Diuretic Agents	4180186
19475677	Antidiuretic Effects	4180186
19475677	Effects, Antidiuretic	4180186
19475677	Agents, Anti-Diuretic	4180186
19475679	Y Linked Traits	4180186
19475679	Y-Linked Trait	4180186
19475679	Y-Linked Inheritances	4180186
19475679	Inheritance, Y-Linked	4180186
19475679	Y-Linked Alleles	4180186
19475679	Y-Linked Allele	4180186
19475679	Y Linked Genes	4180186
19475679	Y-Linked Traits	4180186
19475679	Trait, Y-Linked	4180186
19475679	Y-Linked Inheritance	4180186
19475679	Inheritance, Y Linked	4180186
19475679	Genes, Y-Chromosome	4180186
19475679	Y-Chromosome Genes	4180186
19475679	Y-Linked Gene	4180186
19475679	Allele, Y-Linked	4180186
19475679	Y Linked Inheritance	4180186
19475679	Gene, Y-Linked	4180186
19475679	Gene, Y-Chromosome	4180186
19475679	Y-Linked Genes	4180186
19475679	Holandric Inheritance	4180186
19475679	Traits, Y-Linked	4180186
19475679	Y-Chromosome Gene	4180186
19475679	Traits, Y Linked	4180186
19475679	Alleles, Y Linked	4180186
19475679	Inheritances, Y-Linked	4180186
19475679	Genes, Y Linked	4180186
19475679	Inheritance, Holandric	4180186
19475679	Genes, Y Chromosome	4180186
19475679	Alleles, Y-Linked	4180186
19475680	Monoacylglycerol	4180186
19475680	Monoglyceride	4180186
19475680	Monoacylglycerols	4180186
19475682	Viability, Bacterial	4180186
19475682	Viability, Microbial	4180186
19475682	Inactivation, Microbial	4180186
19475682	Bacteria Viability	4180186
19475682	Viability, Virus	4180186
19475682	Bacterial Viability	4180186
19475682	Microbial Inactivation	4180186
19475682	Virus Viability	4180186
19475682	Viability, Bacteria	4180186
19475684	Ig Subunits	4180186
19475684	Ig Polypeptide Chains	4180186
19475684	Subunit, Ig	4180186
19475684	Immunoglobulin Polypeptide Chains	4180186
19475684	Subunits, Ig	4180186
19475684	Ig Subunit	4180186
19475684	Immunoglobulin Chains	4180186
19475686	Alternative Pathway C3 C5 Convertases	4180186
19475686	Alternative Pathway C3-C5 Convertases	4180186
19475686	Complement C3 C5 Convertases, Alternative Pathway	4180186
19475689	Signal-Transducing Receptor gp130	4180186
19475689	gp130, Signal Transducer	4180186
19475689	IL-6 Receptor Signal Transducer gp130	4180186
19475689	Interleukin-6 Receptor Subunit Beta	4180186
19475689	gp130 Transducing Protein	4180186
19475689	Signal Transducer, gp130	4180186
19475689	CD130 Antigens	4180186
19475689	gp130, Cytokine Receptor	4180186
19475689	Receptor gp130, Signal-Transducing	4180186
19475689	gp130, Signal-Transducing Receptor	4180186
19475689	sgp130	4180186
19475689	Signal Transducer gp130	4180186
19475689	Antigens, CD130	4180186
19475689	Interleukin 6 Receptor Subunit Beta	4180186
19475689	Soluble gp130	4180186
19475689	Signal Transducing Receptor gp130	4180186
19475689	gp130 IL 6 Family Receptor	4180186
19475689	gp130, Soluble	4180186
19475689	IL6ST gp130	4180186
19475689	IL-6 Family Receptor gp130	4180186
19475689	Soluble Glycoprotein 130	4180186
19475689	gp130 IL-6 Family Receptor	4180186
19475689	Glycoprotein 130, Soluble	4180186
19475689	gp130 Signal Transducer	4180186
19475690	Liquid Crystal	4180186
19475690	Material, Mesomorphous Phase	4180186
19475690	Mesomorphous Phase Materials	4180186
19475690	Liquid Crystalline Materials	4180186
19475690	Crystals, Liquid	4180186
19475690	Mesomorphous Phase Material	4180186
19475690	Materials, Mesomorphous Phase	4180186
19475690	Crystal, Liquid	4180186
19475691	Complement Inhibiting Agents	4180186
19475691	Agents, Complement Inhibiting	4180186
19475691	Inhibiting Agents, Complement	4180186
19475691	Complement Inhibitor	4180186
19475691	Complement Inhibitors	4180186
19475691	Complement Cytolysis Inhibiting Agents	4180186
19475691	Inhibitors, Complement	4180186
19475691	Agents, Complement Inactivating	4180186
19475691	Inactivating Agents, Complement	4180186
19475691	Inhibitor, Complement	4180186
19475694	Pattern Recognition Receptors	4180186
19475694	Pattern Recognition Receptor	4180186
19475694	Receptor, Pattern Recognition	4180186
19475694	Recognition Receptor, Pattern	4180186
19475696	Toll Like Receptor 6	4180186
19475696	TLR6 Receptor	4180186
19475696	Receptor, TLR6	4180186
19475697	CD289 Antigen	4180186
19475697	Toll Like Receptor 9	4180186
19475697	TLR9 Protein	4180186
19475697	Receptor, TLR9	4180186
19475697	Antigen, CD289	4180186
19475697	TLR9 Receptor	4180186
19475700	Alternative Pathway C3 Convertase	4180186
19475700	Complement 3b-Associated Factor B-fragment Bb	4180186
19475700	Complement 3b Associated Factor B fragment Bb	4180186
19475700	Complement 3 Convertase, Alternative Pathway	4180186
19475700	C3 Convertase (C3bBb)	4180186
19475700	Complement C3 Convertase, CVFBb	4180186
19475700	C3 Convertase, Alternative Pathway	4180186
19475700	CVFBb	4180186
19475701	C5 Convertase (C3bBb3b)	4180186
19475701	Alternative Pathway C5 Convertase	4180186
19475701	C5 Convertase, Alternative Pathway	4180186
19475707	CD46 Antigen	4180186
19475707	Trophoblast-Leukocyte Common Antigen	4180186
19475707	Trophoblast Leukocyte Common Antigen	4180186
19475707	Common Antigen, Trophoblast-Leukocyte	4180186
19475707	CD46 Antigens	4180186
19475707	Antigen, CD46	4180186
19475707	Antigens, CD46	4180186
19475710	NK Cell Lectin Like Receptor Subfamily D	4180186
19475710	CD94, Antigen	4180186
19475710	Killer Cell Lectin Like Receptor Subfamily D, Member 1	4180186
19475710	NK Cell Lectin Like Receptor Subfamily D, Member 1	4180186
19475710	Antigen CD94	4180186
19475710	NK Cell Lectin-Like Receptor Subfamily D, Member 1	4180186
19475710	CD94 Antigen	4180186
19475710	Antigens, CD94	4180186
19475710	Antigen, CD94	4180186
19475710	Killer Cell Lectin-Like Receptor Subfamily D, Member 1	4180186
19475710	CD94 Antigens	4180186
19475713	Antigen, CD24	4180186
19475713	Nectadrin	4180186
19475713	Heat Stable Antigen CD24	4180186
19475713	CD24, Heat-Stable Antigen	4180186
19475713	Antigens, CD24	4180186
19475713	CD24 Antigens	4180186
19475713	Heat-Stable Antigen CD24	4180186
19475717	Hu Paraneoplastic Encephalomyelitis Antigens	4180186
19475717	ELAV Protein	4180186
19475717	Proteins, ELAV	4180186
19475717	Protein, ELAV	4180186
19475717	Embryonic Lethal, Abnormal Vision Like Proteins	4180186
19475717	Antigens, Hu	4180186
19475717	Embryonic Lethal, Abnormal Vision-Like Proteins	4180186
19475717	Hu Antigens	4180186
19475718	Antigen, T10	4180186
19475718	Cyclase T10, ADPR	4180186
19475718	Cyclase 1, ADP-ribosyl	4180186
19475718	NIM R5 Antigen	4180186
19475718	Acute Lymphoblastic Leukemia Cells Antigen CD38	4180186
19475718	CD38 Antigens	4180186
19475718	ADPR Cyclase CD38	4180186
19475718	Cyclase CD38, ADPR	4180186
19475718	Antigens, CD38	4180186
19475718	1, ADP-ribosyl Cyclase	4180186
19475718	NIM-R5 Antigen	4180186
19475718	CD38 Antigen	4180186
19475718	ADP ribosyl Cyclase 1	4180186
19475718	Lymphocyte Differentiation Antigen CD38	4180186
19475718	T10 Antigen	4180186
19475718	CD38, ADPR Cyclase	4180186
19475718	ADPR Cyclase T10	4180186
19475719	CD107a Antigens	4180186
19475719	CD107a Antigen	4180186
19475719	Antigens, CD107a	4180186
19475719	Lysosomal Associated Membrane Protein 1	4180186
19475719	LAMP1 Protein	4180186
19475719	LGP120 Protein	4180186
19475719	LAMPA Protein	4180186
19475720	Lysosomal Associated Membrane Protein 2	4180186
19475720	LGP110 Protein	4180186
19475720	CD107b Antigens	4180186
19475720	LAMP2 Protein	4180186
19475720	CD107b Antigen	4180186
19475720	LGP B Protein	4180186
19475720	LGP-B Protein	4180186
19475720	Antigens, CD107b	4180186
19475721	Adipocyte Cysteine Rich Secreted Protein FIZZ3	4180186
19475721	Adipocyte Cysteine-Rich Secreted Protein FIZZ3	4180186
19475722	COX 2 Inhibitor	4180186
19475722	Inhibitors, Cyclooxygenase 2	4180186
19475722	COX2 Inhibitor	4180186
19475722	Coxib	4180186
19475722	Cyclooxygenase-2 Inhibitors	4180186
19475722	COX 2 Inhibitors	4180186
19475722	Inhibitor, COX2	4180186
19475722	Inhibitor, Cyclooxygenase 2	4180186
19475722	Cyclooxygenase 2 Inhibitor	4180186
19475722	Coxibs	4180186
19475722	Cyclooxygenase-2 Inhibitor	4180186
19475722	Inhibitors, COX-2	4180186
19475722	Inhibitors, Cyclooxygenase-2	4180186
19475722	Inhibitor, COX-2	4180186
19475722	Inhibitors, COX2	4180186
19475722	Inhibitor, Cyclooxygenase-2	4180186
19475722	COX-2 Inhibitors	4180186
19475722	COX-2 Inhibitor	4180186
19475722	2 Inhibitor, Cyclooxygenase	4180186
19475722	COX2 Inhibitors	4180186
19475723	Pre-Proglucagons	4180186
19475723	Glucagon Precursor	4180186
19475723	Pro-Glucagon	4180186
19475723	Preproglucagons	4180186
19475723	Pro Glucagon	4180186
19475723	Preproglucagon	4180186
19475723	Glucagon Precursors	4180186
19475725	Neutrophil Proteinase 3, Human	4180186
19475725	C-ANCA Antigen	4180186
19475725	Azurophil Granule Protein 7	4180186
19475725	Proteinase 3, Neutrophil	4180186
19475725	Proteinase 3, Leukocyte	4180186
19475725	Myeloblastin, Human	4180186
19475725	PRTN3 Gene Protein	4180186
19475725	Neutrophil Proteinase 4	4180186
19475725	Leukocyte Proteinase 3	4180186
19475725	Human Myeloblastin	4180186
19475725	C ANCA Antigen	4180186
19475725	Protein, PRTN3 Gene	4180186
19475725	Autoantigen, Wegener	4180186
19475725	Proteinase 4, Neutrophil	4180186
19475725	N Proteinase 4	4180186
19475725	Wegener Autoantigen	4180186
19475725	Proteinase 3	4180186
19475725	Antigen, C-ANCA	4180186
19475725	N-Proteinase 4	4180186
19475725	Neutrophil Proteinase 3	4180186
19475726	TRAIL Protein	4180186
19475726	Apo 2 Ligand	4180186
19475726	CD253 Antigen	4180186
19475726	Apo 2L Protein	4180186
19475726	Apo-2 Ligand	4180186
19475726	Antigen, CD253	4180186
19475726	TNF Superfamily, Member 10	4180186
19475726	TNF Related Apoptosis Inducing Ligand	4180186
19475726	Apoptosis-Inducing Ligand, TNF-Related	4180186
19475726	Tumor Necrosis Factor Ligand Superfamily Member 10	4180186
19475726	Apo-2L Protein	4180186
19475732	Secretory Protein, Parathyroid	4180186
19475732	Secretory Protein I, Parathyroid Gland	4180186
19475732	CHGA Protein	4180186
19475732	Parathyroid Secretory Protein	4180186
19475733	Endothelial Cell Viability Maintaining Factor	4180186
19475733	EC VMFa	4180186
19475733	Apolipoprotein H	4180186
19475733	EC-VMFa	4180186
19475733	beta 2 Glycoprotein I	4180186
19475733	Apo H	4180186
19475733	Endothelial Cell-Viability Maintaining Factor	4180186
19475733	beta2 Glycoprotein I	4180186
19475733	beta2-Glycoprotein I	4180186
19475733	Anticardiolipin Cofactor	4180186
19475733	beta(2)GPI	4180186
19475733	Cofactor, Anticardiolipin	4180186
19475734	Melanocortin	4180186
19475735	gamma Lipotropin	4180186
19475735	gamma Lipotrophin	4180186
19475735	gamma LPH	4180186
19475735	gamma-LPH	4180186
19475735	gamma-Lipotrophin	4180186
19475736	Interleukin-1 Receptors Type I	4180186
19475736	CDw121a Antigens	4180186
19475736	Interleukin 1 Receptors Type I	4180186
19475736	Interleukin 1 Receptor Type I	4180186
19475736	CD121a Antigens	4180186
19475736	Receptor Type I, Interleukin 1	4180186
19475736	Receptors, Interleukin 1 Type I	4180186
19475736	Interleukin-1 Receptor Type I	4180186
19475736	Receptor Type I, Interleukin-1	4180186
19475736	Antigens, CDw121a	4180186
19475739	D Factor (Leukemia Inhibitory Factor)	4180186
19475739	AM424	4180186
19475739	Differentiation-Stimulating Factor, Myeloid	4180186
19475739	Differentiation Stimulating Factor	4180186
19475739	Inhibitory Factor, Leukemia	4180186
19475739	Cholinergic Differentiation Factor	4180186
19475739	Myeloid Differentiation Stimulating Factor	4180186
19475739	Myeloid Differentiation-Stimulating Factor	4180186
19475739	Differentiation-Stimulating Factor	4180186
19475739	Emfilermin	4180186
19475739	Differentiation Factor, Cholinergic	4180186
19475741	Adrenomedullin (1-52)	4180186
19475741	Proadrenomedullin N Terminal 20 Peptide	4180186
19475741	ADM (1-52)	4180186
19475741	Proadrenomedullin (1-20)	4180186
19475741	Proadrenomedullin N-Terminal 20 Peptide	4180186
19475741	ADM(1-52)	4180186
19475741	PAMP(1-20)NH2	4180186
19475743	Interleukin 2 Receptor alpha Subunit	4180186
19475743	Receptors alpha, Interleukin-2	4180186
19475743	Interleukin 2 Receptor alpha	4180186
19475743	Interleukin 2 Receptors alpha	4180186
19475743	Interleukin-2Ralpha	4180186
19475743	Interleukin-2 Receptor alpha	4180186
19475743	Interleukin-2 Receptors alpha	4180186
19475743	alpha-subunit, Receptor, Interleukin-2	4180186
19475743	IL 2Ralpha	4180186
19475743	Antigen, CD25	4180186
19475743	Tac P55 Peptide	4180186
19475743	CD25 Antigen	4180186
19475743	Interleukin 2Ralpha	4180186
19475743	CD25 Antigens	4180186
19475743	Antigens, CD25	4180186
19475743	Interleukin-2 Receptor alpha Chain	4180186
19475743	IL-2Ralpha	4180186
19475743	Interleukin 2 Receptor alpha Chain	4180186
19475743	Receptor alpha, Interleukin-2	4180186
19475744	Interleukin 2 Receptor beta Subunit	4180186
19475744	Interleukin 2 Receptor beta	4180186
19475744	Interleukin 2 Receptor beta Chain	4180186
19475744	IL-2-15 Receptor-beta	4180186
19475744	IL 2Rbeta2	4180186
19475744	Interleukin-2-15 Receptor-beta	4180186
19475744	IL-2R BETA	4180186
19475744	Interleukin 15 Receptor beta Subunit	4180186
19475744	IL 2R BETA	4180186
19475744	Interleukin-Binding Peptide p75	4180186
19475744	Interleukin Binding Peptide p75	4180186
19475744	Interleukin 2 15 Receptor beta	4180186
19475744	Interleukin-2 Receptor beta Chain	4180186
19475744	Antigens, CD122	4180186
19475744	CD122 Antigen	4180186
19475744	Interleukin 2 15 Receptors beta	4180186
19475744	Interleukin-2 Receptor beta	4180186
19475744	Interleukin-2, 15 Receptor beta Subunit	4180186
19475744	Interleukin 2, 15 Receptor beta Subunit	4180186
19475744	Interleukin 2-15 Receptors-beta	4180186
19475744	CD122 Antigens	4180186
19475744	Interleukin-15 Receptor beta Subunit	4180186
19475744	IL-2Rbeta2	4180186
19475744	IL 2 15 Receptor beta	4180186
19475744	Receptor-beta, IL-2-15	4180186
19475748	Receptors, Il-16	4180186
19475748	Interleukin 16 Receptors	4180186
19475748	Interleukin-16 Receptors	4180186
19475748	Il-16 Receptors	4180186
19475748	Receptors, Interleukin 16	4180186
19475748	Il 16 Receptors	4180186
19475750	Glucagon-Like Peptide-2 (1-33)	4180186
19475750	Glucagon Like Peptide 2	4180186
19475750	Proglucagon (126-158)	4180186
19475751	Proglucagon (33-69)	4180186
19475751	Glicentin (33-69)	4180186
19475752	Timoprazoles	4180186
19475752	2 Pyridinylmethylsulfinyl 2 Benzimidazoles	4180186
19475752	Sulfoxides, Benzimidazole Methylpyridine	4180186
19475752	Methylpyridine Sulfoxides, Benzimidazole	4180186
19475752	2-Pyridinylmethylsulfinyl-2-Benzimidazoles	4180186
19475752	2 Methylpyridine 2 Benzimidazole Sulfoxides	4180186
19475752	2-Methylpyridine 2-Benzimidazole Sulfoxides	4180186
19475752	Benzimidazole Methylpyridine Sulfoxides	4180186
19475752	Sulfoxides, 2-Methylpyridine 2-Benzimidazole	4180186
19475752	2 Pyridinylmethylsulfinylbenzimidazoles	4180186
19475752	2-Benzimidazole Sulfoxides, 2-Methylpyridine	4180186
19475752	Timoprazole Derivatives	4180186
19475754	HPV Vaccine	4180186
19475754	Vaccines, Human Papillomavirus	4180186
19475754	Vaccine, HPV	4180186
19475754	Human Papillomavirus Vaccine	4180186
19475754	Papillomavirus Vaccine	4180186
19475754	Human Papilloma Virus Vaccine	4180186
19475754	Human Papilloma Virus Vaccines	4180186
19475754	Human Papillomavirus Vaccines	4180186
19475754	HPV Vaccines	4180186
19475754	Papillomavirus Vaccine, Human	4180186
19475754	Vaccine, Papillomavirus	4180186
19475754	Vaccines, Papillomavirus	4180186
19475754	Papillomavirus Vaccines, Human	4180186
19475754	Vaccine, Human Papillomavirus	4180186
19475755	Atomic Bomb	4180186
19475755	Dirty Bombs	4180186
19475755	Bomb, Hydrogen	4180186
19475755	Bomb, Atomic	4180186
19475755	Bomb, Dirty	4180186
19475755	Weapon, Nuclear	4180186
19475755	Testing, Nuclear Weapons	4180186
19475755	Nuclear Weapons Testing	4180186
19475755	Weapons, Nuclear	4180186
19475755	Weapons Testing, Nuclear	4180186
19475755	Nuclear Weapons Testings	4180186
19475755	Bombs, Dirty	4180186
19475755	Dirty Bomb	4180186
19475755	Bombs, Atomic	4180186
19475755	Testings, Nuclear Weapons	4180186
19475755	Nuclear Weapon	4180186
19475755	Bombs, Hydrogen	4180186
19475755	Hydrogen Bombs	4180186
19475755	Weapons Testings, Nuclear	4180186
19475755	Atomic Bombs	4180186
19475755	Hydrogen Bomb	4180186
19475756	Agents, Biological Select	4180186
19475756	Agent, Biowarfare	4180186
19475756	Biological Select Agent	4180186
19475756	Warfare Agents, Biological	4180186
19475756	Agent, Bioterrorism	4180186
19475756	Agent, Biological Select	4180186
19475756	Biowarfare Agent	4180186
19475756	Biological Warfare Agent	4180186
19475756	Biological Select Agents	4180186
19475756	Agents, Biowarfare	4180186
19475756	Bioterrorism Agent	4180186
19475756	Agents, Bioterrorism	4180186
19475756	Weapons, Biological	4180186
19475756	Biological Weapon	4180186
19475756	Agent, Biological Warfare	4180186
19475756	Agents, Biological Warfare	4180186
19475756	Biowarfare Agents	4180186
19475756	Select Agent, Biological	4180186
19475756	Select Agents, Biological	4180186
19475756	Warfare Agent, Biological	4180186
19475756	Weapon, Biological	4180186
19475756	Biological Weapons	4180186
19475756	Bioterrorism Agents	4180186
19475757	Muellerian Inhibiting Hormone	4180186
19475757	Anti Mullerian Factor	4180186
19475757	Anti Mullerian Hormone	4180186
19475757	Mullerian-Inhibiting Factor	4180186
19475757	Mullerian-Inhibiting Hormone	4180186
19475757	Hormone, Anti-Muellerian	4180186
19475757	Mullerian Inhibitory Substance	4180186
19475757	Mullerian Inhibiting Substance	4180186
19475757	Anti Muellerian Hormone	4180186
19475757	Mullerian Inhibiting Factor	4180186
19475757	Mullerian Inhibiting Hormone	4180186
19475757	Antimullerian Hormone	4180186
19475757	Anti-Mullerian Factor	4180186
19475757	Mullerian-Inhibitory Substance	4180186
19475757	Mullerian Regression Factor	4180186
19475757	Anti-Muellerian Hormone	4180186
19475758	Drug Dosing Biomarkers	4180186
19475758	Drug Response Biomarkers	4180186
19475758	Biomarkers, Drug Response	4180186
19475758	Pharmacological Biological Markers	4180186
19475758	Drug Dosing Biomarker	4180186
19475758	Pharmacological Biomarkers	4180186
19475758	Biological Markers, Pharmacological	4180186
19475758	Response Biomarkers, Drug	4180186
19475758	Biomarkers, Drug Dosing	4180186
19475758	Dosing Biomarkers, Drug	4180186
19475758	Biomarker, Drug Dosing	4180186
19475758	Drug Safety Biomarkers	4180186
19475758	Markers, Pharmacological Biological	4180186
19475758	Safety Biomarkers, Drug	4180186
19475758	Dosing Biomarker, Drug	4180186
19475758	Biomarkers, Drug Safety	4180186
19475760	Chemokine, Mig	4180186
19475760	Mig Chemokine	4180186
19475760	Monokine Induced by gamma Interferon Chemokine	4180186
19475760	Chemokine (C-X-C Motif) Ligand 9 Protein	4180186
19475760	CXCL9 Chemokine	4180186
19475760	Small Inducible Cytokine B9	4180186
19475760	SCYB9 Chemokine	4180186
19475760	Chemokine, SCYB9	4180186
19475760	CXCL9, Chemokine	4180186
19475760	Chemokine, CXCL9	4180186
19475763	Acetogenins, Annonaceous	4180186
19475763	Acetogenin Compounds	4180186
19475763	Annonaceous Acetogenins	4180186
19475764	CCR Receptors	4180186
19475764	Chemokine (C-C Motif) Receptors	4180186
19475764	Chemokine Receptor, CC	4180186
19475764	Chemokine Receptors, CC	4180186
19475764	CC Chemokine Receptors	4180186
19475764	CC Chemokine Receptor	4180186
19475771	Myeloid Progenitor Inhibitory Factor 2	4180186
19475771	Eotaxin 2	4180186
19475771	Chemokine, CCL24	4180186
19475771	CCL24 Chemokine	4180186
19475771	Eotaxin-2	4180186
19475771	CCL24, Chemokine	4180186
19475772	Macrophage Inflammatory Protein-2alpha	4180186
19475772	MIP 2alpha	4180186
19475772	MIP-2alpha	4180186
19475772	Chemokine, CXCL2	4180186
19475772	Chemokine, MIP-2	4180186
19475772	Inflammatory Protein-2alpha, Macrophage	4180186
19475772	MIP-2 Chemokine	4180186
19475772	MIP2alpha	4180186
19475772	LDNCF-2	4180186
19475772	MIP 2 Chemokine	4180186
19475772	Macrophage Inflammatory Protein 2	4180186
19475772	Macrophage Inflammatory Protein 2alpha	4180186
19475772	Chemokine (C-X-C Motif) Ligand 2	4180186
19475772	CXCL2 Chemokine	4180186
19475772	CXCL2, Chemokine	4180186
19475773	Chemotactic Protein-2, Granulocyte	4180186
19475773	CXCL6, Chemokine	4180186
19475773	Chemokine, CXCL6	4180186
19475773	Granulocyte Chemotactic Protein 2	4180186
19475773	Small Inducible Cytokine B6	4180186
19475773	Chemokine alpha 3	4180186
19475773	Granulocyte Chemotactic Protein-2	4180186
19475773	CXCL6 Chemokine	4180186
19475773	Chemokine (C-X-C Motif) Ligand 6	4180186
19475774	Ppghrelin	4180186
19475774	Appetite-Regulating Hormone	4180186
19475774	Motilin Related Peptide	4180186
19475774	Appetite Regulating Hormone	4180186
19475774	PpMTLRP	4180186
19475774	GHRL Protein	4180186
19475774	Precursor, Motilin-Related Peptide	4180186
19475774	Ghrelin Precursor	4180186
19475774	Obestatin	4180186
19475774	Peptide Precursor, Motilin-Related	4180186
19475774	Gastric MLTRP	4180186
19475774	Ghrelin Obestatin Preprohormone	4180186
19475774	Precursor, Ghrelin	4180186
19475774	Motilin-Related Peptide Precursor	4180186
19475774	Ghrelin-Obestatin Preprohormone	4180186
19475774	Motilin-Related Peptide	4180186
19475774	Motilin Related Peptide Precursor	4180186
19475778	Diketopiperazine	4180186
19475778	Diketopiperazine Ion (1-)	4180186
19475778	Pyrrolopiperazinediones	4180186
19475778	Diketopiperazine Compounds	4180186
19475778	Piperazinediones	4180186
19475778	Pyrrolodiketopiperazines	4180186
19475781	Incretin Effect	4180186
19475781	Effect, Incretin	4180186
19475781	Incretin	4180186
19475781	Glucose-Dependent Insulin-Releasing Hormone	4180186
19475781	Incretin Effects	4180186
19475781	Effects, Incretin	4180186
19475781	Glucose Dependent Insulin Releasing Hormone	4180186
19475781	Insulin-Releasing Hormone, Glucose-Dependent	4180186
19475781	Hormone, Glucose-Dependent Insulin-Releasing	4180186
19475785	Histatin	4180186
19475791	Epidermal SH-Protease Inhibitor	4180186
19475791	Epidermal SH Protease Inhibitor	4180186
19475791	Stefin A	4180186
19475792	Liver Thiol Proteinase Inhibitor	4180186
19475792	Stefin B	4180186
19475793	Post gamma Globulin	4180186
19475793	Cystatin 3	4180186
19475793	Basic Polypeptide, Neuroendocrine	4180186
19475793	gamma-Trace	4180186
19475793	Post-gamma-Globulin	4180186
19475793	gamma Trace	4180186
19475793	Neuroendocrine Basic Polypeptide	4180186
19475795	Anti-Static Material	4180186
19475795	Anti Static Material	4180186
19475795	Material, Anti-Static	4180186
19475795	Materials, Antistatic	4180186
19475795	Antistatic Materials	4180186
19475795	Agents, Antistatic	4180186
19475795	Anti Static Agents	4180186
19475795	Anti-Static Agents	4180186
19475795	Agents, Anti-Static	4180186
19475796	GDF-15	4180186
19475796	Prostate Differentiation Factor	4180186
19475796	Differentiation Factor, Prostate	4180186
19475796	Macrophage Inhibitory Cytokine 1	4180186
19475797	Small Nuclear Ribonucleoprotein-Associated Protein B1	4180186
19475797	Small Nuclear Ribonucleoprotein-Associated Protein D1	4180186
19475797	Sm Core Proteins	4180186
19475797	Small Nuclear Ribonucleoprotein Associated Protein D3	4180186
19475797	snRNP Core Protein D1	4180186
19475797	Small Nuclear Ribonucleoprotein Core Proteins	4180186
19475797	Small Nuclear Ribonucleoprotein Sm D1	4180186
19475797	Small Nuclear Ribonucleoprotein-Associated Protein B	4180186
19475797	Small Nuclear Ribonucleoprotein B	4180186
19475797	SNRPN Protein	4180186
19475797	Small Nuclear Ribonucleoprotein-Associated Protein D2	4180186
19475797	Small Nuclear Ribonucleoprotein Polypeptide B2	4180186
19475797	Small Nuclear Ribonucleoprotein D1 Polypeptide 16kDa	4180186
19475797	Small Nuclear Ribonucleoprotein Associated Protein D2	4180186
19475797	SmD Antigen	4180186
19475797	Small Nuclear Ribonucleoprotein Associated Protein B2	4180186
19475797	Antigens, Sm Nuclear	4180186
19475797	Small Nuclear Ribonucleoprotein D3 Polypeptide 18kDa	4180186
19475797	Small Nuclear Ribonucleoprotein Associated Protein B	4180186
19475797	SmD Autoantigen	4180186
19475797	Small Nuclear Ribonucleoprotein Polypeptide B'	4180186
19475797	Core Proteins, snRNP	4180186
19475797	Small Nuclear Ribonucleoprotein Associated Protein N	4180186
19475797	Small Nuclear Ribonucleoprotein-Associated Protein N	4180186
19475797	Antigen, SmD	4180186
19475797	Sm Nuclear Antigens	4180186
19475797	Small Nuclear Ribonucleoprotein-Associated Protein D3	4180186
19475797	Nuclear Antigens, Sm	4180186
19475797	Autoantigen, SmD	4180186
19475797	Small Nuclear Ribonucleoprotein Polypeptide B''	4180186
19475797	Small Nuclear Ribonucleoprotein Associated Protein D1	4180186
19475797	Small Nuclear Ribonucleoprotein D2 Polypeptide 16.5kDa	4180186
19475797	Small Nuclear Ribonucleoprotein Polypeptide E	4180186
19475797	Small Nuclear Ribonucleoprotein Associated Protein E	4180186
19475797	Small Nuclear Ribonucleoprotein Polypeptide F	4180186
19475797	Small Nuclear Ribonucleoprotein-Associated Protein F	4180186
19475797	Small Nuclear Ribonucleoprotein Associated Protein B1	4180186
19475797	Small Nuclear Ribonucleoprotein Associated Protein F	4180186
19475797	SNRPN	4180186
19475797	Small Nuclear Ribonucleoprotein-Associated Protein E	4180186
19475797	Small Nuclear Ribonucleoprotein Sm D2	4180186
19475797	Core Proteins, Sm	4180186
19475797	Small Nuclear Ribonucleoprotein-Associated Protein B2	4180186
19475798	Survival of Motor Neuron Complex	4180186
19475798	Gemin-7 Protein	4180186
19475798	Gemin 4 Protein	4180186
19475798	Gemin 5 Protein	4180186
19475798	Protein, Gemin7	4180186
19475798	Gemin-6 Protein	4180186
19475798	Gem Associated Proteins	4180186
19475798	Gemin 8 Protein	4180186
19475798	Gemin6 Protein	4180186
19475798	Gemin5 Protein	4180186
19475798	Gemin4 Protein	4180186
19475798	Gemin-4 Protein	4180186
19475798	Gemin-5 Protein	4180186
19475798	Survival of Motor Neuron Protein-Interacting Protein 1	4180186
19475798	Survival of Motor Neuron Complex Proteins	4180186
19475798	Gemin 7 Protein	4180186
19475798	Survival of Motor Neuron Protein Interacting Protein 1	4180186
19475798	Gemin-8 Protein	4180186
19475798	Component of Gems 4 Protein	4180186
19475798	SMN Complex	4180186
19475798	Gemin Proteins	4180186
19475798	Gemin7 Protein	4180186
19475798	Protein, Gemin-7	4180186
19475798	Gemin-2 Protein	4180186
19475798	Gemin8 Protein	4180186
19475798	Gemin 6 Protein	4180186
19475798	FAM51A1 Protein	4180186
19475798	Gemin 2 Protein	4180186
19475798	Gem-Associated Proteins	4180186
19475798	Gemin2 Protein	4180186
19475801	Antigen, CD1d	4180186
19475801	CD1d Antigens	4180186
19475801	CD1d Antigen	4180186
19475801	Cd1d Molecule	4180186
19475804	Cationic Lipopeptides	4180186
19475804	Anionic Lipopeptide	4180186
19475804	Lipopeptide, Anionic	4180186
19475804	Lipopeptides, Anionic	4180186
19475804	Anionic Lipopeptides	4180186
19475804	Lipopeptide, Cationic	4180186
19475804	Cationic Lipopeptide	4180186
19475804	Lipopeptide	4180186
19475804	Lipopeptides, Cationic	4180186
19475806	Incidents, Chemical	4180186
19475806	Incident, Chemical	4180186
19475806	Chemical Incidents	4180186
19475806	Hazard Release, Chemical	4180186
19475806	Accident, Chemical	4180186
19475806	Chemical Accidents	4180186
19475806	Accidents, Chemical	4180186
19475806	Chemical Hazard Releases	4180186
19475806	Chemical Accidental Releases	4180186
19475806	Release, Chemical Accidental	4180186
19475806	Releases, Chemical Accidental	4180186
19475806	Release, Chemical Hazard	4180186
19475806	Chemical Incident	4180186
19475806	Chemical Accident	4180186
19475806	Accidental Releases, Chemical	4180186
19475806	Accidental Release, Chemical	4180186
19475807	Immobilized Antibodies	4180186
19475809	Personal Medical Records	4180186
19475809	Personal Health Information	4180186
19475809	Personal Health Record	4180186
19475809	Records, Personal Health	4180186
19475809	Information, Personal Health	4180186
19475809	Personal Medical Record	4180186
19475809	Medical Records, Personal	4180186
19475809	Record, Personal Medical	4180186
19475809	Personal Health Records	4180186
19475809	Health Record, Personal	4180186
19475809	Health Information, Personal	4180186
19475809	Records, Personal Medical	4180186
19475809	Record, Personal Health	4180186
19475809	Medical Record, Personal	4180186
19475813	PrRP20	4180186
19475813	Prolactin Releasing Peptide PrRP20	4180186
19475813	Prolactin-Releasing Peptide	4180186
19475813	Prolactin-Releasing Peptide PrRP31	4180186
19475813	PrRP31	4180186
19475813	Prolactin Releasing Peptide	4180186
19475813	Prolactin-Releasing Peptide PrRP20	4180186
19475813	Prolactin Releasing Hormone	4180186
19475813	Prolactin Releasing Peptide PrRP31	4180186
19475814	Pathology, Diagnostic Molecular	4180186
19475814	Pathologies, Molecular	4180186
19475814	Diagnostic, Molecular	4180186
19475814	Diagnostic Molecular Pathologies	4180186
19475814	Molecular Diagnostic	4180186
19475814	Molecular Diagnostics	4180186
19475814	Pathologies, Diagnostic Molecular	4180186
19475814	Molecular Pathologies	4180186
19475814	Diagnostic Molecular Pathology	4180186
19475814	Molecular Pathology, Diagnostic	4180186
19475814	Molecular Pathologies, Diagnostic	4180186
19475814	Diagnostics, Molecular	4180186
19475814	Molecular Pathology	4180186
19475815	Neutralizing Antibody	4180186
19475815	Neutralizing Antibodies	4180186
19475815	Antibody, Neutralizing	4180186
19475817	Radio Frequency Identification	4180186
19475817	RFID	4180186
19475819	Webcasts	4180186
19475819	Streaming Video	4180186
19475819	Really Simple Syndication	4180186
19475819	RSS	4180186
19475819	Podcasts	4180186
19475820	Biological Oxygen Demand Analyses	4180186
19475820	Chemical Oxygen Demand	4180186
19475820	Oxygen Demand, Biological	4180186
19475820	Biological Oxygen Demand	4180186
19475820	Chemical Oxygen Demand Analysis	4180186
19475820	Oxygen Demand, Chemical	4180186
19475820	Demand, Chemical Oxygen	4180186
19475820	Chemical Oxygen Demand Analyses	4180186
19475822	Drugs, Fake	4180186
19475822	Fake Drug	4180186
19475822	Counterfeit Medicine	4180186
19475822	Counterfeit Drug	4180186
19475822	Drugs, Falsified	4180186
19475822	Medicines, Falsified	4180186
19475822	Falsified Medicines	4180186
19475822	Drug, Counterfeit	4180186
19475822	Medicine, Falsified	4180186
19475822	Counterfeit Medicines	4180186
19475822	Medicines, Counterfeit	4180186
19475822	Drug, Fake	4180186
19475822	Medicine, Counterfeit	4180186
19475822	Drugs, Counterfeit	4180186
19475822	Fake Drugs	4180186
19475822	Falsified Drugs	4180186
19475822	Falsified Drug	4180186
19475822	Drug, Falsified	4180186
19475822	Falsified Medicine	4180186
19475825	Repositioning, Drug	4180186
19475825	Drug Repurposing	4180186
19475825	Repurposing, Drug	4180186
19475825	Drug Rescue	4180186
19475825	Rescue, Drug	4180186
19475826	Microbalance, Quartz Crystal	4180186
19475826	Quartz Crystal Microbalance	4180186
19475826	Quartz Crystal Microbalance with Dissipation Monitoring	4180186
19475826	Microbalances, Quartz Crystal	4180186
19475826	Quartz Crystal Microbalances	4180186
19475826	Electrochemical Quartz Crystal Impedance Analysis	4180186
19475827	Performance-Enhancing Drug	4180186
19475827	Ergogenic Effect	4180186
19475827	Effect, Performance-Enhancing	4180186
19475827	Ergogenic Substance	4180186
19475827	Drug, Performance-Enhancing	4180186
19475827	Effect, Ergogenic	4180186
19475827	Effects, Ergogenic	4180186
19475827	Substance, Ergogenic	4180186
19475827	Substances, Performance-Enhancing	4180186
19475827	Performance-Enhancing Substance	4180186
19475827	Performance-Enhancing Effect	4180186
19475827	Drugs, Performance-Enhancing	4180186
19475827	Performance-Enhancing Effects	4180186
19475827	Performance-Enhancing Drugs	4180186
19475827	Performance Enhancing Drugs	4180186
19475827	Ergogenic Effects	4180186
19475827	Substance, Performance-Enhancing	4180186
19475827	Ergogenic Substances	4180186
19475827	Substances, Ergogenic	4180186
19475827	Performance Enhancing Substance	4180186
19475827	Effects, Performance-Enhancing	4180186
19475827	Performance Enhancing Substances	4180186
19475827	Performance Enhancing Drug	4180186
19475827	Performance Enhancing Effect	4180186
19475827	Performance Enhancing Effects	4180186
19475829	Antipyretic Effect	4180186
19475829	Effects, Antipyretic	4180186
19475829	Antipyretic Agents	4180186
19475829	Antipyretic Effects	4180186
19475829	Agents, Antipyretic	4180186
19475829	Agent, Antipyretic	4180186
19475829	Antifebrile Agents	4180186
19475829	Antipyretic Agent	4180186
19475829	Agents, Antifebrile	4180186
19475829	Effect, Antipyretic	4180186
19475829	Antipyretic	4180186
19475832	Purinergic Effect	4180186
19475832	Effects, Purinergic	4180186
19475832	Agents, Purinergic	4180186
19475832	Purinergic Effects	4180186
19475832	Effect, Purinergic	4180186
19475833	Derivatives, Thienopyridine	4180186
19475833	Thienopyridine Derivatives	4180186
19475834	Tamm Horsfall Glycoprotein	4180186
19475834	Tamm-Horsfall Glycoprotein	4180186
19475834	Tamm Horsfall Protein	4180186
19475834	Uromucoid	4180186
19475834	Tamm-Horsfall Protein	4180186
19475835	Melanoma Specific Antigens	4180186
19475835	Antigens, Melanoma	4180186
19475835	Melanoma Antigens	4180186
19475835	Antigens, Melanoma-Specific	4180186
19475836	Melanoma Associated Antigen gp100	4180186
19475836	Silver Locus Protein Homolog	4180186
19475836	Melanoma Antigen, gp100	4180186
19475836	Melanoma Associated ME20 Antigen	4180186
19475836	Pmel17 Melanoma Antigen	4180186
19475836	gp100 Melanoma Associated Antigen	4180186
19475836	Melanoma-Associated ME20 Antigen	4180186
19475836	ME20 Antigen, Melanoma-Associated	4180186
19475836	Melanocyte Lineage Specific Antigen gp100	4180186
19475836	Melanocyte Protein Pmel 17	4180186
19475836	Melanocyte Lineage-Specific Antigen gp100	4180186
19475836	gp100 Melanocyte Differentiation Antigen	4180186
19475836	Antigen, gp100 Melanoma-Associated	4180186
19475836	Melanoma-Associated Antigen, gp100	4180186
19475836	ME20 Antigen	4180186
19475836	Antigen, Melanoma-Associated ME20	4180186
19475836	gp100 Melanoma-Associated Antigen	4180186
19475836	Melanoma Antigen, Pmel17	4180186
19475836	Melanoma Antigen Glycoprotein 100	4180186
19475836	Antigen, gp100 Melanoma	4180186
19475836	MLSA gp100	4180186
19475836	Melanoma-Associated Antigen gp100	4180186
19475843	alpha-Chain, HLA-DR	4180186
19475843	MHC Class II Antigen DRA	4180186
19475843	HLA Class II Histocompatibility Antigen, DR alpha Chain	4180186
19475843	HLA-DR alpha-Chain	4180186
19475843	HLA DR alpha	4180186
19475843	HLA-DRA	4180186
19475843	HLA DR Heavy Chain	4180186
19475843	HLA DR alpha Chain	4180186
19475843	HLA-DR alpha	4180186
19475843	Heavy Chain, HLA-DR	4180186
19475843	alpha-Chains, HLA-DR	4180186
19475843	HLA-DR Heavy Chain	4180186
19475843	HLA DR alpha Chains	4180186
19475845	Provinols	4180186
19475845	Polyphenol	4180186
19475847	Antigen, HLA-DRB1	4180186
19475847	HLA-DRB1 Antigen	4180186
19475847	HLA-DRB1	4180186
19475847	Chains, HLA-DRB1	4180186
19475847	HLA DRB1	4180186
19475847	HLA DRB1 Chains	4180186
19475847	HLA DRB1 Antigen	4180186
19475848	HLA DRB3 Chains	4180186
19475848	HLA DRB3	4180186
19475848	HLA-DRB3 Antigen	4180186
19475848	HLA-DRB3	4180186
19475848	Antigen, HLA-DRB3	4180186
19475848	HLA DRB3 Antigen	4180186
19475851	alpha-Chains, HLA-DQ	4180186
19475851	HLA Class II Histocompatibility Antigen, DQ alpha Chains	4180186
19475851	HLA DQ alpha Chains	4180186
19475853	HLA DP alpha Chains	4180186
19475853	HLA Class II Histocompatibility Antigen, DP alpha Chains	4180186
19475853	alpha-Chains, HLA-DP	4180186
19475854	HLA Class II Histocompatibility Antigen, DP beta Chains	4180186
19475854	HLA DP beta Chains	4180186
19475854	beta-Chains, HLA-DP	4180186
19475855	HLA Class I Histocompatibility Antigen, A 11 alpha Chain	4180186
19475855	HLA-A11	4180186
19475855	HLA Class I Histocompatibility Antigen, A-11 alpha Chain	4180186
19475855	HLA A11	4180186
19475856	HLA A24	4180186
19475856	HLA A24 Antigen	4180186
19475856	Antigen, HLA-A24	4180186
19475856	HLA Class I Histocompatibility Antigen, A 24 alpha Chain	4180186
19475856	HLA Class I Histocompatibility Antigen, A-24 alpha Chain	4180186
19475856	HLA-A24	4180186
19475857	HLA Class I Histocompatibility Antigen, B 13 alpha Chain	4180186
19475857	HLA-B13	4180186
19475857	HLA Class I Histocompatibility Antigen, B-13 alpha Chain	4180186
19475857	Antigen, HLA-B13	4180186
19475857	HLA B13	4180186
19475857	HLA B13 Antigen	4180186
19475859	HLA B15	4180186
19475859	Antigen, HLA-B15	4180186
19475859	HLA B15 Antigen	4180186
19475859	HLA Class I Histocompatibility Antigen, B 15 alpha Chain	4180186
19475859	HLA-B15	4180186
19475859	B15 Antigen, HLA	4180186
19475859	HLA Class I Histocompatibility Antigen, B-15 alpha Chain	4180186
19475859	Antigen, HLA B15	4180186
19475860	HLA B18	4180186
19475860	HLA Class I Histocompatibility Antigen, B 18 alpha Chain	4180186
19475860	HLA Class I Histocompatibility Antigen, B-18 alpha Chain	4180186
19475860	HLA B18 Antigen	4180186
19475860	HLA-B18	4180186
19475860	Antigen, HLA-B18	4180186
19475866	HLA B51 Antigen	4180186
19475866	HLA-B51	4180186
19475866	Antigen, HLA-B51	4180186
19475866	HLA Class I Histocompatibility Antigen, B-51 alpha Chain	4180186
19475866	HLA Class I Histocompatibility Antigen, B 51 alpha Chain	4180186
19475867	B52 Antigen, HLA	4180186
19475867	Antigen, HLA B52	4180186
19475867	HLA B52 Antigen	4180186
19475867	HLA Class I Histocompatibility Antigen, B 52 alpha Chain	4180186
19475867	HLA Class I Histocompatibility Antigen, B-52 alpha Chain	4180186
19475867	Antigen, HLA-B52	4180186
19475867	HLA-B52	4180186
19475868	HLA-G2	4180186
19475868	Isoform, HLA-G4	4180186
19475868	HLA-G5	4180186
19475868	HLA-G6 Isoform	4180186
19475868	HLA G Antigen	4180186
19475868	HLA G7 Isoform	4180186
19475868	Antigens, HLA-G	4180186
19475868	Antigen, HLA-G	4180186
19475868	HLA-G3	4180186
19475868	HLA-G7 Isoform	4180186
19475868	HLA-G6	4180186
19475868	HLA G	4180186
19475868	HLA-G7	4180186
19475868	HLA-G5 Isoform	4180186
19475868	HLA G Antigens	4180186
19475868	HLA-G	4180186
19475868	HLA-G3 Isoform	4180186
19475868	HLA-G2 Isoform	4180186
19475868	HLA G7 Antigen	4180186
19475868	Isoform, HLA-G6	4180186
19475868	Isoform, HLA-G7	4180186
19475868	HLA-G1 Isoform	4180186
19475868	Antigen, HLA-G7	4180186
19475868	HLA-G1	4180186
19475868	HLA G1 Isoform	4180186
19475868	HLA G3 Isoform	4180186
19475868	HLA-G7 Antigen	4180186
19475868	HLA-G Antigen	4180186
19475868	HLA G6 Isoform	4180186
19475868	HLA-G4	4180186
19475868	HLA-G4 Isoform	4180186
19475868	HLA G2 Isoform	4180186
19475869	Cryogel	4180186
19475872	Antigen, CD151	4180186
19475872	Antigen CD151	4180186
19475872	CD151, Antigen	4180186
19475872	CD151 Antigens	4180186
19475872	Antigens, CD151	4180186
19475872	CD151 Antigen	4180186
19475874	Leukemia-Associated Cell Surface Antigen p24	4180186
19475874	CD9 Antigens	4180186
19475874	CD9 Antigen	4180186
19475874	Motility-Related Protein-1	4180186
19475874	p24-CD9 Antigen	4180186
19475874	27 kDa Diphtheria Toxin Receptor Associated Protein	4180186
19475874	Motility Related Protein 1	4180186
19475874	Antigen, CD9	4180186
19475874	27 kDa Diphtheria Toxin Receptor-Associated Protein	4180186
19475874	DRAP27 Protein	4180186
19475874	Antigens, CD9	4180186
19475874	p24 CD9 Antigen	4180186
19475874	Leukemia Associated Cell Surface Antigen p24	4180186
19475874	Tetraspanin-29	4180186
19475875	Antigen, CD53	4180186
19475875	CD53 Antigen	4180186
19475875	CD53 Antigens	4180186
19475875	Antigens, CD53	4180186
19475875	Tetraspanin-25	4180186
19475877	Syntheses, Solid-Phase	4180186
19475877	Synthesis, Solid-Phase Peptide	4180186
19475877	Solid Phase Synthesis Techniques	4180186
19475877	Solid Phase Nucleotide Synthesis	4180186
19475877	Techniques, Solid-Phase Synthesis	4180186
19475877	Peptide Synthesis, Solid Phase	4180186
19475877	Solid-Phase Peptide Syntheses	4180186
19475877	Synthesis, Solid-Phase Nucleotide	4180186
19475877	Methods, Solid-Phase Synthesis	4180186
19475877	Solid Phase Nucleotide Synthesis Techniques	4180186
19475877	Solid-Phase Nucleotide Synthesis	4180186
19475877	Peptide Synthesis, Solid-Phase	4180186
19475877	Solid-Phase Syntheses	4180186
19475877	Synthesis Techniques, Solid-Phase	4180186
19475877	Nucleotide Syntheses, Solid-Phase	4180186
19475877	Technique, Solid-Phase Synthesis	4180186
19475877	Syntheses, Solid-Phase Nucleotide	4180186
19475877	Synthesis Method, Solid-Phase	4180186
19475877	Solid-Phase Synthesis	4180186
19475877	Solid-Phase Synthesis Method	4180186
19475877	Synthesis Technique, Solid-Phase	4180186
19475877	Solid Phase Peptide Synthesis Techniques	4180186
19475877	Solid Phase Synthesis Methods	4180186
19475877	Solid-Phase Nucleotide Syntheses	4180186
19475877	Solid Phase Synthesis	4180186
19475877	Method, Solid-Phase Synthesis	4180186
19475877	Syntheses, Solid-Phase Peptide	4180186
19475877	Peptide Syntheses, Solid-Phase	4180186
19475877	Solid-Phase Synthesis Technique	4180186
19475877	Synthesis Methods, Solid-Phase	4180186
19475877	Solid-Phase Peptide Synthesis Techniques	4180186
19475877	Synthesis, Solid Phase	4180186
19475877	Solid-Phase Peptide Synthesis	4180186
19475877	Solid Phase Peptide Synthesis	4180186
19475877	Solid-Phase Nucleotide Synthesis Techniques	4180186
19475877	Nucleotide Synthesis, Solid-Phase	4180186
19475877	Solid-Phase Synthesis Methods	4180186
19475877	Synthesis, Solid-Phase	4180186
19475881	4' methoxy 7 isoflavanol	4180186
19475881	4'-O-Methyl Equol	4180186
19475881	(+-)-Isomer of Equol	4180186
19475881	6'-Hydroxy-Equol	4180186
19475881	4' O Methyl Equol	4180186
19475881	3'-Hydroxy-Equol	4180186
19475881	Equol, 4'-O-Methyl	4180186
19475881	6' Hydroxy Equol	4180186
19475881	3' Hydroxy Equol	4180186
19475881	4'-methoxy-7-isoflavanol	4180186
19475883	Activation-Inducible Lymphocyte Immunomediatory Molecule	4180186
19475883	CD278 Antigen	4180186
19475883	Inducible Costimulator (ICOS)	4180186
19475883	CD278 Antigens	4180186
19475883	Inducible T-Cell Co-Stimulator	4180186
19475883	ICOS Inducible T Cell Co Stimulator	4180186
19475883	Inducible T Cell Co Stimulator	4180186
19475883	T-Cell Co-Stimulator, Inducible	4180186
19475883	Inducible Co-Stimulator (ICOS)	4180186
19475883	Co-Stimulator, Inducible T-Cell	4180186
19475883	Antigens, CD278	4180186
19475883	ICOS Inducible T-Cell Co-Stimulator	4180186
19475883	Antigen, CD278	4180186
19475883	Activation Inducible Lymphocyte Immunomediatory Molecule	4180186
19475883	Inducible T Cell Co Stimulator Protein	4180186
19475886	B7-Related Protein 1	4180186
19475886	Antigen, B7-H2	4180186
19475886	CD275 Antigen	4180186
19475886	B7 H2 Antigen	4180186
19475886	B7 Related Protein 1	4180186
19475886	Ligand, B7-H2	4180186
19475886	B7H2 Antigen	4180186
19475886	CD275 Antigens	4180186
19475886	Antigen, B7H2	4180186
19475886	B7-H2 Ligand	4180186
19475886	B7-Related Protein-1	4180186
19475886	B7-H2 Antigen	4180186
19475886	B7 Like Protein Gl50	4180186
19475886	Antigen, CD275	4180186
19475886	B7 H2 Ligand	4180186
19475886	Protein Gl50, B7-Like	4180186
19475886	Inducible T Cell Co Stimulator Ligand	4180186
19475886	B7-Like Protein Gl50	4180186
19475886	Antigens, CD275	4180186
19475887	Evolution, Clonal	4180186
19475887	Somatic Evolution	4180186
19475887	Evolution, Somatic	4180186
19475888	Artesian Well	4180186
19475888	Wells, Artesian	4180186
19475888	Water Well	4180186
19475888	Wells, Water	4180186
19475888	Well, Water	4180186
19475888	Well, Artesian	4180186
19475888	Artesian Wells	4180186
19475891	Ligand, PD-L2	4180186
19475891	B7-DC Ligand	4180186
19475891	B7 DC Ligand	4180186
19475891	Antigen, CD273	4180186
19475891	Antigen, B7-DC	4180186
19475891	PD-L2 Ligand	4180186
19475891	B7-DC Antigen	4180186
19475891	PD L2 Ligand	4180186
19475891	Antigens, CD273	4180186
19475891	Ligand, B7-DC	4180186
19475891	B7 DC Antigen	4180186
19475891	CD273 Antigens	4180186
19475891	CD273 Antigen	4180186
19475893	Antibodies, Humanized	4180186
19475893	Humanized Antibodies	4180186
19475895	Insulin Mixtures	4180186
19475895	Mixed Insulins	4180186
19475895	Insulins, Biphasic	4180186
19475895	Insulin, Biphasic	4180186
19475895	Insulins, Mixed	4180186
19475895	Biphasic Insulin	4180186
19475896	Insulin, Rapid Acting	4180186
19475896	Insulin, Short Acting	4180186
19475896	Insulin, Rapid-Acting	4180186
19475896	Rapid-Acting Insulin	4180186
19475896	Short-Acting Insulin	4180186
19475897	Insulin B28asp	4180186
19475897	B28-Asp-Insulin	4180186
19475897	NovoRapid	4180186
19475897	Insulin-Aspart	4180186
19475897	B28asp, Insulin	4180186
19475897	Insulin, Aspartic Acid(B28)-	4180186
19475897	Aspart, Insulin	4180186
19475897	NovoLog	4180186
19475897	B28 Asp Insulin	4180186
19475898	Oil Fields	4180186
19475898	Oil Reservoirs	4180186
19475898	Gas Reservoir	4180186
19475898	Gas Well	4180186
19475898	Gas Reservoirs	4180186
19475898	Fields, Oil	4180186
19475898	Oil Field	4180186
19475898	Reservoir, Gas	4180186
19475898	Wells, Oil	4180186
19475898	Oil and Gas Wells	4180186
19475898	Gas Fields	4180186
19475898	Well, Oil	4180186
19475898	Field, Oil	4180186
19475898	Field, Gas	4180186
19475898	Oil Reservoir	4180186
19475898	Reservoirs, Gas	4180186
19475898	Wells, Gas	4180186
19475898	Fields, Gas	4180186
19475898	Well, Gas	4180186
19475898	Reservoirs, Oil	4180186
19475898	Oil and Gas Reservoirs	4180186
19475898	Oil Well	4180186
19475898	Gas Field	4180186
19475898	Gas Wells	4180186
19475898	Oil Wells	4180186
19475898	Reservoir, Oil	4180186
19475899	Insulin, Monotard	4180186
19475899	Novo Monotard, Insulin	4180186
19475899	Lente Insulin	4180186
19475899	Insulin Novo Monotard	4180186
19475899	Monotard, Insulin Novo	4180186
19475899	Monotard Insulin	4180186
19475899	Insulin, Lente, Monocomponent	4180186
19475900	Ultralente Insulin	4180186
19475901	Hospitals, Low Volume	4180186
19475901	Hospital, Low-Volume	4180186
19475901	Low Volume Hospitals	4180186
19475901	Low-Volume Hospitals	4180186
19475901	Low-Volume Hospital	4180186
19475904	Metalloproteinase Inhibitors, Matrix	4180186
19475904	Gelatinase Inhibitors	4180186
19475904	Inhibitor, Collagenase	4180186
19475904	MMP Inhibitor	4180186
19475904	Inhibitors, MMP	4180186
19475904	Inhibitors, Stromelysin	4180186
19475904	Inhibitors, Matrix Metalloproteinase	4180186
19475904	Stromelysin Inhibitors	4180186
19475904	Gelatinase Inhibitor	4180186
19475904	Inhibitors, Gelatinase	4180186
19475904	Metalloproteinase Inhibitor, Matrix	4180186
19475904	Collagenase Inhibitor	4180186
19475904	Collagenase Inhibitors	4180186
19475904	Inhibitors, Collagenase	4180186
19475904	Matrix Metalloproteinase Inhibitor	4180186
19475904	Inhibitor, MMP	4180186
19475904	MMP Inhibitors	4180186
19475904	Inhibitor, Matrix Metalloproteinase	4180186
19475904	Inhibitor, Gelatinase	4180186
19475905	Aminobenzoic Acids	4180186
19475905	Acids, Aminobenzoic	4180186
19475907	Vaccines, Adenovirus	4180186
19475907	Adenovirus Type 7 Vaccines	4180186
19475907	Vaccine, Adenovirus	4180186
19475907	Adenovirus Vaccine	4180186
19475907	Adenovirus Type 7 Vaccine	4180186
19475907	Adenovirus Type 4 and Type 7 Vaccines, Live, Oral	4180186
19475907	Adenovirus Type 4 Vaccine	4180186
19475907	Adenovirus Type 4 Vaccines	4180186
19475907	Adenovirus Type 4 and Type 7 Vaccine, Live, Oral	4180186
19475909	Pulse Wave Analyses	4180186
19475909	Pulse Wave Transit Time	4180186
19475909	Wave Analyses, Pulse	4180186
19475909	Analysis, Pulse Wave	4180186
19475909	Time, Pulse Transit	4180186
19475909	Pulse Transit Times	4180186
19475909	Velocities, Pulse Wave	4180186
19475909	Pulse Wave Velocity	4180186
19475909	Wave Analysis, Pulse	4180186
19475909	Analyses, Pulse Wave	4180186
19475909	Pulse Transit Time	4180186
19475909	Pulse Wave Velocities	4180186
19475909	Transit Time, Pulse	4180186
19475909	Wave Velocity, Pulse	4180186
19475909	Velocity, Pulse Wave	4180186
19475909	Wave Velocities, Pulse	4180186
19475909	Times, Pulse Transit	4180186
19475909	Transit Times, Pulse	4180186
19475912	Antigens, CD33	4180186
19475912	Siglec-3	4180186
19475912	CD33 Antigen	4180186
19475912	Antigen, CD33	4180186
19475912	CD33 Antigens	4180186
19475912	Sialic Acid Binding Ig like Lectin 3	4180186
19475912	gp67, Glycoprotein	4180186
19475912	Glycoprotein gp67	4180186
19475913	Imagery, Satellite	4180186
19475913	Satellite Imageries	4180186
19475913	Moderate Resolution Imaging Spectroradiometer	4180186
19475913	Imageries, Satellite	4180186
19475914	Summaries, Patient Discharge	4180186
19475914	Patient Discharge Summary	4180186
19475914	Summary, Patient Discharge	4180186
19475914	Discharge Summaries, Patient	4180186
19475914	Discharge Summary, Patient	4180186
19475916	Waste Dump	4180186
19475916	Facility, Waste Disposal	4180186
19475916	Waste Disposal Facility	4180186
19475916	Waste Dump Site	4180186
19475916	Waste Dumping Ground	4180186
19475916	Disposal Facilities, Waste	4180186
19475916	Disposal Facility, Waste	4180186
19475916	Waste Dumping Sites	4180186
19475916	Dump, Waste	4180186
19475916	Waste Dumps	4180186
19475916	Landfill	4180186
19475916	Waste Dump Sites	4180186
19475916	Dumping Grounds, Waste	4180186
19475916	Waste Dumping Site	4180186
19475916	Dump Site, Waste	4180186
19475916	Facilities, Waste Disposal	4180186
19475916	Dump Sites, Waste	4180186
19475916	Waste Dumping Grounds	4180186
19475916	Site, Waste Dumping	4180186
19475916	Sites, Waste Disposal	4180186
19475916	Site, Waste Disposal	4180186
19475916	Dumps, Waste	4180186
19475916	Sites, Waste Dump	4180186
19475916	Waste Disposal Site	4180186
19475916	Grounds, Waste Dumping	4180186
19475916	Waste Disposal Sites	4180186
19475916	Site, Waste Dump	4180186
19475916	Landfills	4180186
19475916	Disposal Site, Waste	4180186
19475916	Dumping Sites, Waste	4180186
19475916	Ground, Waste Dumping	4180186
19475916	Sites, Waste Dumping	4180186
19475916	Dumping Ground, Waste	4180186
19475916	Disposal Sites, Waste	4180186
19475916	Dumping Site, Waste	4180186
19475918	Microbial Community Structure	4180186
19475918	Community Structure, Microbial	4180186
19475918	Community Composition, Microbial	4180186
19475918	Microbiotas	4180186
19475918	Human Microbiome	4180186
19475918	Microbial Community Composition	4180186
19475918	Microbial Community Structures	4180186
19475918	Microbial Communities	4180186
19475918	Microbial Community Compositions	4180186
19475918	Microbial Community	4180186
19475918	Human Microbiomes	4180186
19475918	Composition, Microbial Community	4180186
19475918	Microbiome	4180186
19475918	Microbiome, Human	4180186
19475918	Microbiomes	4180186
19475918	Community, Microbial	4180186
19475919	Site, Hazardous Waste	4180186
19475919	Sites, Hazardous Waste	4180186
19475919	Dump, Toxic Waste	4180186
19475919	Toxic Waste Dump	4180186
19475919	Hazardous Waste Site	4180186
19475919	Waste Site, Hazardous	4180186
19475919	Waste Sites, Hazardous	4180186
19475919	Waste Dump, Toxic	4180186
19475919	Toxic Waste Dumps	4180186
19475919	Waste Dumps, Toxic	4180186
19475919	Dumps, Toxic Waste	4180186
19475920	Pro Hepcidin	4180186
19475920	Pro-Hepcidin	4180186
19475920	Liver Expressed Antimicrobial Peptide	4180186
19475920	Liver-Expressed Antimicrobial Peptide	4180186
19475920	Antimicrobial Peptide, Liver-Expressed	4180186
19475920	Peptide, Liver-Expressed Antimicrobial	4180186
19475920	Hepcidin	4180186
19475920	Prohepcidin	4180186
19475921	H-2D(q) Histocompatibility Antigen	4180186
19475921	Histocompatibility Antigen H 2D	4180186
19475921	H-2D(b) Antigen	4180186
19475921	H-2D(p) Antigen	4180186
19475921	H-2D, Histocompatibility Antigen	4180186
19475921	Histocompatibility Antigen H-2D(b)	4180186
19475921	H-2D(q)	4180186
19475921	H-2D(d) Antigen	4180186
19475921	H-2D(k) Antigen	4180186
19475921	H-2L(d)s Self Peptide Complex	4180186
19475921	H-2D(d)-Q10(b) Histocompatibility Antigen	4180186
19475921	Antigen H-2D, Histocompatibility	4180186
19475921	H-2L(d) Antigen	4180186
19475921	H-2D(b) Glycoprotein	4180186
19475924	Bunolol Hydrochloride	4180186
19475924	W6412A	4180186
19475924	W-6412A	4180186
19475924	W 6412A	4180186
19475925	Disbacterioses	4180186
19475925	Dysbacteriosis	4180186
19475925	Disbacteriosis	4180186
19475925	Dys-symbioses	4180186
19475925	Dysbacterioses	4180186
19475925	Disbiosis	4180186
19475925	Dysbioses	4180186
19475925	Dys-symbiosis	4180186
19475925	Dys symbiosis	4180186
19475925	Disbioses	4180186
19475928	Chelators, Calcium	4180186
19475928	Chelator, Calcium	4180186
19475928	Chelating Agents, Calcium	4180186
19475928	Agents, Calcium Chelating	4180186
19475928	Calcium Chelators	4180186
19475928	Calcium Chelator	4180186
19475930	3R,3'R Zeaxanthin	4180186
19475930	Beta-Carotene-3,3'-Diol	4180186
19475930	Beta Carotene 3,3' Diol	4180186
19475930	Zeaxanthin	4180186
19475930	3R,3'R-Zeaxanthin	4180186
19475931	Beta Caroten 3 ol	4180186
19475931	Beta-Caroten-3-ol	4180186
19475931	Cryptoxanthin	4180186
19475933	Metabolic Side Effects of Substances	4180186
19475933	Substance Effects on Metabolism	4180186
19475933	Drug Effects on Metabolism	4180186
19475933	Metabolic Side Effects of Drugs	4180186
19475935	Essences, Bach Flower	4180186
19475935	Remedy, Bach Rescue	4180186
19475935	Flower Remedies, Bach	4180186
19475935	Remedies, Bach Flower	4180186
19475935	Flowers, Bach	4180186
19475935	Bach Flower Remedies	4180186
19475935	Bach Flower Essences	4180186
19475935	Bach Flowers	4180186
19475935	Essences, Flower	4180186
19475935	Bach Rescue Remedy	4180186
19475935	Flower Essences, Bach	4180186
19475935	Rescue Remedy, Bach	4180186
19475936	Rubus fruticosus	4180186
19475936	Raspberries	4180186
19475936	Rubus glaucus	4180186
19475936	Blackberry Plant	4180186
19475936	Blackberries	4180186
19475936	Rubus idaeus	4180186
19475936	Blackberry Plants	4180186
19475936	Raspberry	4180186
19475936	Blackberry, Andean	4180186
19475936	Raspberry Plants	4180186
19475936	Andean Blackberries	4180186
19475936	Blackberry	4180186
19475936	Raspberry Plant	4180186
19475936	Andean Blackberry	4180186
19475937	Antarctic Tundras	4180186
19475937	Tundra, Antarctic	4180186
19475937	Tundra, Arctic	4180186
19475937	Tundras, Arctic	4180186
19475937	Tundras, Alpine	4180186
19475937	Tundra, Alpine	4180186
19475937	Alpine Tundra	4180186
19475937	Tundras	4180186
19475937	Tundras, Antarctic	4180186
19475937	Antarctic Tundra	4180186
19475937	Arctic Tundras	4180186
19475937	Arctic Tundra	4180186
19475937	Alpine Tundras	4180186
19475938	Permafrost Zone	4180186
19475938	Permafrost Soils	4180186
19475938	Permafrost Soil	4180186
19475938	Permafrosts	4180186
19475938	Soil, Permafrost	4180186
19475938	Soils, Permafrost	4180186
19475938	Permafrost Region	4180186
21490514	Esophageal; Gastro; Gastroenterology; GI; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490514	Intraluminal Esoph	4180186
21490514	腔内:压力或压强:时间点:食管:定量型	4182948
21490515	Breathing; Exp; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
21490515	Exp time	4180186
21490515	呼气:时间:时间点:呼吸系统:定量型	4182948
21490519	Carbonic anhydride; cO2; Gas DS; Gases; Lung; PCO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490519	CO2 VFr/PPres Gas DS	4180186
21490519	二氧化碳:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490523	Away adap; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490523	Isofl VFr/PPres Away adap	4180186
21490523	异氟醚:体积分数/分压:时间点:气道连接器:定量型	4182948
21490524	Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490524	Isofl during expir VFr/PPres Away adap	4180186
21490524	异氟醚^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490527	Away adap; In; Insp; Inspiratory; Laughing gas; Lung; N2O; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490527	N2O during insp VFr/PPres Away adap	4180186
21490527	氧化亚氮^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490530	Post-discharge provider name Provider	4180186
21490530	After; Chemistry; Disch; Nominal; Person name; Point in time; PST; Random	4180186
21490530	出院后服务提供者姓名:人员姓名:时间点:服务提供者:名义型	4182948
21490531	After; Chemistry; Disch; Ident; Identifier; Intradermal; Nominal; Point in time; Post-disch prov practice ID; PST; Random	4180186
21490531	出院后服务提供者执业标识符:标识符:时间点:服务提供者:名义型	4182948
21490533	Post-disch prov practice address	4180186
21490533	Address; After; Chemistry; Disch; Nominal; Point in time; Post-disch prov practice address; PST; Random	4180186
21490533	出院后服务提供者执业地址:地址:时间点:服务提供者:名义型	4182948
21490534	ADMIN; After; Disch; No; Nominal; Num; Phone #; Point in time; Post-disch prov practice phone #; PST; Random; Telecommunication number; Telephone number	4180186
21490534	Post-disch prov practice phone #	4180186
21490534	出院后服务提供者执业机构电话号码:电话号码:时间点:服务提供者:名义型	4182948
21490536	Gas DS; Gas DS.IL; Gases; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490536	Des during insp VFr/PPres Gas DS.IL	4180186
21490536	地氟醚^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490537	Desfl gas del dur case; Gas DS; Gases; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume	4180186
21490537	Desfl gas del dur case Vol Gas DS	4180186
21490537	所输送的地氟醚气体.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490539	Compound 347; Enf set; Ethrane; Gas DS; Gases; In; Insp; Inspiratory; Lung; Methylflurether; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490539	Enf set during insp VFr/PPres Gas DS	4180186
21490539	安氟醚设置^在吸气过程中:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490540	Compound 347; Ethrane; Exp; Gas DS; Gas DS.EL; Gases; Lung; Methylflurether; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490540	Enf during expir VFr/PPres Gas DS.EL	4180186
21490540	安氟醚^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490541	Compound 347; Enfl gas del dur case; Ethrane; Gas DS; Gases; Lung; Methylflurether; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume	4180186
21490541	Enfl gas del dur case Vol Gas DS	4180186
21490541	所输送的安氟醚气体.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490542	氟烷靶值^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490542	Anestan; Away adap; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; Exp; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Halan; Halotan; Halsan; Lung; Narcotan; Narkotan; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Rhodialothan; Target halo	4180186
21490542	Target halo end exp VFr/PPres Away adap	4180186
21490543	Anestan; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Gas DS; Gases; Hal set; Halan; Halotan; Halsan; In; Insp; Inspiratory; Lung; Narcotan; Narkotan; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Rhodialothan	4180186
21490543	Hal set during insp VFr/PPres Gas DS	4180186
21490543	氟烷设置^在吸气过程中:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490545	Anestan; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Gas DS; Gases; Halan; Halo gas del dur case; Halotan; Halsan; Lung; Narcotan; Narkotan; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Rhodialothan; Volume	4180186
21490545	Halo gas del dur case Vol Gas DS	4180186
21490545	所输送的氟烷气体.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490547	Gas DS; Gases; In; Insp; Inspiratory; Isof set; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490547	Isof set during insp VFr/PPres Gas DS	4180186
21490547	异氟醚设置^在吸气过程中:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490550	七氟醚靶值^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490550	Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Target sevo	4180186
21490550	Target sevo end exp VFr/PPres Away adap	4180186
21490551	Gas DS; Gases; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Sevo set	4180186
21490551	Sevo set during insp VFr/PPres Gas DS	4180186
21490551	七氟醚设置^在吸气过程中:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490552	Gas DS; Gases; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490552	Sevofl VFr/PPres Gas DS	4180186
21490552	七氟醚:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490554	Carbonic anhydride; cO2; CO2 set; Gas DS; Gases; In; Insp; Inspiratory; Lung; PCO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490554	CO2 set during insp VFr/PPres Gas DS	4180186
21490554	二氧化碳设置^在吸气过程中:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490556	Carbonic anhydride; cO2; CO2 gas del.total; Gas DS; Gases; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Tot; Totl; Volume	4180186
21490556	CO2 gas del.total RptPeriod Vol Gas DS	4180186
21490556	所输送的二氧化碳气体.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490557	Breathing; Dynamic; Flow; Gases; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
21490557	Gas flow on vent Airway	4180186
21490557	气体流量^采用呼吸机:体积速率:时间点:呼吸系统.气道:定量型	4182948
21490562	氧气靶值^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490562	Away adap; Exp; Lung; O2; O2 partial pressure; PO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Target O2; tO2	4180186
21490562	Target O2 end exp VFr/PPres Away adap	4180186
21490563	Gas DS; Gases; In; Insp; Inspiratory; Lung; O2; O2 partial pressure; O2 set; PO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2	4180186
21490563	O2 set during insp VFr/PPres Gas DS	4180186
21490563	氧设置^在吸气过程中:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490564	体积.集聚^呼气末:体积型属性:时间点:肺:定量型	4182948
21490564	Exp; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Vol; Vol.trapped; Volume	4180186
21490564	Trapped lung vol at end exp	4180186
21490568	Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490568	Sevofl during expir VFr/PPres Away adap	4180186
21490568	七氟醚^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490570	Away adap; Carbonic anhydride; cO2; Exp; Lung; PCO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490570	CO2 during expir VFr/PPres Away adap	4180186
21490570	二氧化碳^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490572	Away adap; Exp; He; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490572	Helium during expir VFr/PPres Away adap	4180186
21490572	氦^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490574	age correct; ALV; Anesthetic+N2O; Lung; MAC sum; Misc; Miscellaneous; Other; Percent; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Spec; To be specified in another part of the message; Unspecified; Volfr; Volume fraction	4180186
21490574	MAC sum age correct VFr Anesthetic+N2O	4180186
21490574	最低肺泡浓度总计^^经过针对年龄而校正的:体积分数:时间点:麻醉剂.XXX+一氧化二氮:定量型	4182948
21490579	Est; estimation; Frac; Fract; Fractionation; Fractions; Lung; Number Fraction; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490579	Shunt fract Pulmonary circulation Est	4180186
21490579	分流分数:计数型分数:时间点:肺循环:定量型:估计法	4182948
21490583	Compliance; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490583	顺应性.静态:顺应性:时间点:肺:定量型	4182948
21490584	Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature	4180186
21490584	Finger temp	4180186
21490584	体温:温度:时间点:手指:定量型	4182948
21490588	Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Esophageal; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature	4180186
21490588	Esoph temp	4180186
21490588	体温:温度:时间点:食管:定量型	4182948
21490589	Cardio; Cardiology; CARDIO-PULM; Heart Disease; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Temp; Temperature	4180186
21490589	Injectate temp	4180186
21490589	温度:温度:时间点:注射液:定量型	4182948
21490592	Base excess Extracellular fld Calc-sCnc	4180186
21490592	Base ex; BE; BSE; Calc; Calculation; Chemistry; EXS; Interstitial fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
21490592	碱剩余:物质的量浓度:时间点:细胞外液:定量型:计算法	4182948
21490593	Average; Avg; Cranial; Cranium; Head; NEURO; Neurology; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490593	ICP mean	4180186
21490593	颅内平均值:压力或压强:时间点:颅骨:定量型	4182948
21490594	Cranial; Cranium; Head; NEURO; Neurology; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490594	ICP systolic	4180186
21490594	颅内心脏收缩期:压力或压强:时间点:颅骨:定量型	4182948
21490598	Flow; Lung; O2; O2 consumption; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Volume rate; vRate	4180186
21490598	O2 consumption	4180186
21490598	氧消耗:体积速率:时间点:^患者:定量型	4182948
21490600	Cereb; Ctx; Electroencephalogram; NEURO; Neurology; Point in time; Power spec.median freq; QNT; Quan; Quant; Quantitative; Random	4180186
21490600	Median power frequency EEG	4180186
21490600	功率谱.中值频率:频率:时间点:大脑皮质:定量型:脑电图	4182948
21490601	Cereb; Ctx; Electroencephalogram; NEURO; Neurology; Point in time; Power spec.peak freq; QNT; Quan; Quant; Quantitative; Random	4180186
21490601	Peak power frequency EEG	4180186
21490601	功率谱.峰值频率:频率:时间点:大脑皮质:定量型:脑电图	4182948
21490605	Cereb; Ctx; Electroencephalogram; NEURO; Neurology; Point in time; Power.delta; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
21490605	Delta freq rel power EEG	4180186
21490605	功率谱.delta 频率/功率谱.总计:功率比率:时间点:大脑皮质:定量型:脑电图	4182948
21490606	Cereb; Ctx; Electroencephalogram; NEURO; Neurology; Point in time; Power.theta; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
21490606	Theta freq rel power EEG	4180186
21490606	功率谱.theta 频率/功率谱.总计:功率比率:时间点:大脑皮质:定量型:脑电图	4182948
21490607	Electrical potential; Musc; Muscl; NEURO; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage	4180186
21490607	Electrical potential Muscle EMG	4180186
21490607	电位:电势:时间点:肌肉:定量型:EMG	4182948
21490608	Gas DS; Gases; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490608	Des VFr/PPres Gas DS	4180186
21490608	地氟醚:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490610	Compound 347; Ethrane; Gas DS; Gas DS.IL; Gases; In; Insp; Inspiratory; Lung; Methylflurether; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490610	Enf during insp VFr/PPres Gas DS.IL	4180186
21490610	安氟醚^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490618	Away adap; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490618	Sevofl VFr/PPres Away adap	4180186
21490618	七氟醚:体积分数/分压:时间点:气道连接器:定量型	4182948
21490621	Away adap; Exp; Lung; O2; O2 partial pressure; PO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2	4180186
21490621	O2 during expir VFr/PPres Away adap	4180186
21490621	氧^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490622	Breathing; Lung; Lungs; Phys dead space; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume	4180186
21490622	Phys dead space on vent Vol Respiratory	4180186
21490622	生理死腔^采用呼吸机:体积型属性:时间点:呼吸系统:定量型	4182948
21490624	麻醉剂.XXX^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490624	Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490624	Anesthetic end exp Away adap	4180186
21490628	安氟醚^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490628	Away adap; Compound 347; Ethrane; Exp; Lung; Methylflurether; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490628	Enf end exp VFr/PPres Away adap	4180186
21490629	Away adap; Compound 347; Ethrane; In; Insp; Inspiratory; Lung; Methylflurether; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490629	Enf during insp VFr/PPres Away adap	4180186
21490629	安氟醚^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490630	氟烷^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490630	Anestan; Away adap; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; Exp; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Halan; Halotan; Halsan; Lung; Narcotan; Narkotan; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Rhodialothan	4180186
21490630	Hal end exp VFr/PPres Away adap	4180186
21490635	Away adap; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490635	Argon VFr/PPres Away adap	4180186
21490635	氩:体积分数/分压:时间点:气道连接器:定量型	4182948
21490636	Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490636	Argon during expir VFr/PPres Away adap	4180186
21490636	氩^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490643	Away adap; Carbonic anhydride; cO2; Lung; PCO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490643	CO2 VFr/PPres Away adap	4180186
21490643	二氧化碳:体积分数/分压:时间点:气道连接器:定量型	4182948
21490644	Away adap; He; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490644	Helium VFr/PPres Away adap	4180186
21490644	氦:体积分数/分压:时间点:气道连接器:定量型	4182948
21490646	Away adap; Exp; Lung; N; N2; Nit; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490646	N2 during expir VFr/PPres Away adap	4180186
21490646	氮^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490647	Away adap; Exp; Laughing gas; Lung; N2O; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490647	N2O during expir VFr/PPres Away adap	4180186
21490647	氧化亚氮^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490648	氧^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490648	Away adap; Exp; Lung; O2; O2 partial pressure; PO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2	4180186
21490648	O2 end exp VFr/PPres Away adap	4180186
21490651	Average; Avg; Breathing; In; Insp; Inspiratory; Lung; Lungs; MAP; Mean Pres; Point in time; Pressure; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
21490651	Pressure mean during insp Airway	4180186
21490651	压力均值^在吸气过程中:压力或压强:时间点:呼吸系统.气道:定量型	4182948
21490652	Airway temp	4180186
21490652	Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Breathing; Lungs; Point in time; QNT; Quan; Quant; Quantitative; Random; RS; Temp; Temperature	4180186
21490652	体温:温度:时间点:呼吸系统.气道:定量型	4182948
21490658	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp dL-V5; Voltage	4180186
21490658	ST Amp dL-V5	4180186
21490658	ST 波振幅.衍生导联 V5:电势:时间点:心脏:定量型:心电图	4182948
21490659	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp dL-V6; Voltage	4180186
21490659	ST Amp dL-V6	4180186
21490659	ST 波振幅.衍生导联 V6:电势:时间点:心脏:定量型:心电图	4182948
21490660	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-ES; Voltage	4180186
21490660	ST Amp L-ES	4180186
21490660	ST 波振幅.导联 ES:电势:时间点:心脏:定量型:心电图	4182948
21490662	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-MCL1; Voltage	4180186
21490662	ST Amp L-MCL1	4180186
21490662	ST 波振幅.导联 MCL1:电势:时间点:心脏:定量型:心电图	4182948
21490663	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-MCL6; Voltage	4180186
21490663	ST Amp L-MCL6	4180186
21490663	ST 波振幅.导联 MCL6:电势:时间点:心脏:定量型:心电图	4182948
21490664	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST amp.precordial lead; Voltage	4180186
21490664	ST amp.precordial lead	4180186
21490664	ST 波振幅.心前区导联:电势:时间点:心脏:定量型:心电图	4182948
21490666	Cardiac; Cardio; Cardiology; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Ventricular	4180186
21490666	LV Eject Time	4180186
21490666	射血时间:时间:时间点:心脏.心室.左侧:定量型:NI-ICG	4182948
21490667	Cardio; Cardiology; CARDIO-PULM; Circ; Circ sys; Heart Disease; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Resist; Resistanc; Resistance; Resistant; Resistent; Respiratory	4180186
21490667	Res Circ sys	4180186
21490667	血流阻力:阻尼:时间点:循环系统:定量型	4182948
21490669	Cardiac; Cardio; Cardiology; Energy; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Hrt; Hrt ventr; Job; L; LT; LV; Occupation; Point in time; QNT; Quan; Quant; Quantitative; Random; Ventricular	4180186
21490669	LV Work	4180186
21490669	工作:能量:时间点:心脏.心室.左侧:定量型	4182948
21490670	Count/time; Heart beat; HEART RATE.MOLEC; Ln; nRate; Number rate; Number Rate = Count/Time; Point in time; Pulse; QNT; Quan; Quant; Quantitative; Random	4180186
21490670	Heart rate Intra arterial line Invasive	4180186
21490670	心率:计数型速率:时间点:动脉内导管:定量型:侵袭性	4182948
21490671	AO; Aortic; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; Cardio; Cardiology; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490671	Aorta BP	4180186
21490671	血管内:压力或压强:时间点:主动脉:定量型	4182948
21490673	AO; Aortic; Average; Avg; Blood pressure mean; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; BP mean; Cardio; Cardiology; Heart Disease; Intravenous; IV; MBP; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490673	Aorta BP mean	4180186
21490673	血管内平均值:压力或压强:时间点:主动脉:定量型	4182948
21490674	AO; Aortic; Blood pressure; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; Blood pressure systolic; BP; BP sys; BP systolic; Cardio; Cardiology; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP	4180186
21490674	Aorta BP sys	4180186
21490674	血管内心脏收缩期:压力或压强:时间点:主动脉:定量型	4182948
21490677	Blood pressure; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; Blood pressure systolic; BP; BP sys; BP systolic; Cardio; Cardiology; Cath; CVP; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP	4180186
21490677	CVP sys	4180186
21490677	血管内心脏收缩期:压力或压强:时间点:中心静脉导管:定量型	4182948
21490678	Atrial; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; Cardiac; Cardio; Cardiology; Heart Disease; Hrt; Intrachamber pres; L; LA; LT; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490678	LA pressure	4180186
21490678	心腔内:压力或压强:时间点:心脏.心房.左侧:定量型	4182948
21490679	Atrial; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP sys; Cardiac; Cardio; Cardiology; Heart Disease; Hrt; Intrachamber pres; Intrachamber sys pres; L; LA; LT; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP	4180186
21490679	LA pressure sys	4180186
21490679	心腔内收缩期:压力或压强:时间点:心脏.心房.左侧:定量型	4182948
21490680	Atrial; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; Cardiac; Cardio; Cardiology; Heart Disease; Hrt; Intrachamber pres; Point in time; Pressure; QNT; Quan; Quant; Quantitative; R; RA; Random; RAP; RT	4180186
21490680	RA pressure	4180186
21490680	心腔内:压力或压强:时间点:心脏.心房.右侧:定量型	4182948
21490682	Atrial; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP sys; Cardiac; Cardio; Cardiology; Heart Disease; Hrt; Intrachamber pres; Intrachamber sys pres; Point in time; Pressure; QNT; Quan; Quant; Quantitative; R; RA; Random; RAP; RT; SBP; Sys BP	4180186
21490682	RA pressure sys	4180186
21490682	心腔内收缩期:压力或压强:时间点:心脏.心房.右侧:定量型	4182948
21490683	Art; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; Cardio; Cardiology; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Umb a	4180186
21490683	Umb artery BP	4180186
21490683	血管内:压力或压强:时间点:脐动脉:定量型	4182948
21490685	Average; Avg; Blood pressure mean; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; BP mean; Cardio; Cardiology; Heart Disease; Intravenous; IV; MBP; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Umb v; Ven; Venous	4180186
21490685	Umb vein BP mean	4180186
21490685	血管内平均值:压力或压强:时间点:脐静脉:定量型	4182948
21490690	Burst supp rto; Cereb; Ctx; Electroencephalogram; NEURO; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto	4180186
21490690	Burst supp rto Ctx EEG	4180186
21490690	突发抑制比率:比率:时间点:大脑皮质:定量型:脑电图	4182948
21490691	BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; Cardio; Cardiology; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Umb v; Ven; Venous	4180186
21490691	Umb vein BP	4180186
21490691	血管内:压力或压强:时间点:脐静脉:定量型	4182948
21490692	Gas DS; Gases; In; Insp; Inspiratory; Laughing gas; Lung; N2O; N2O set; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490692	N2O set during insp VFr/PPres Gas DS	4180186
21490692	氧化亚氮设置^在吸气过程中:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490693	Gas DS; Gases; Laughing gas; Lung; N2O; N2O gas del dur case; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume	4180186
21490693	N2O gas del dur case Vol Gas DS	4180186
21490693	所输送的氧化亚氮气体.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490694	Cardiac; Cardio; Cardiology; CO; Flow; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Ventricular; Volume rate; vRate	4180186
21490694	LV Output Intermitent	4180186
21490694	心输出量:体积速率:时间点:心脏.心室.左侧:定量型:间歇性指标	4182948
21490695	NEURO; Neurology; PF; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490695	Cerebral perf pres	4180186
21490695	灌注:压力或压强:时间点:大脑:定量型	4182948
21490696	Gas DS; Gases; Lung; O2; O2 partial pressure; PO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2	4180186
21490696	O2 VFr/PPres Gas DS	4180186
21490696	氧:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490697	Away adap; Compound 347; Ethrane; Exp; Lung; Methylflurether; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490697	Enf during expir VFr/PPres Away adap	4180186
21490697	安氟醚^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490698	Anestan; Away adap; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; Exp; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Halan; Halotan; Halsan; Lung; Narcotan; Narkotan; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Rhodialothan	4180186
21490698	Hal during expir VFr/PPres Away adap	4180186
21490698	氟烷^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490704	Gas DS; Gases; Laughing gas; Lung; N2O; N2O gas del.total; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Tot; Totl; Volume	4180186
21490704	N2O gas del.total RptPeriod Vol Gas DS	4180186
21490704	所输送的氧化亚氮气体.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490705	Gas DS; Gases; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Sevo gas del.total; Tot; Totl; Volume	4180186
21490705	Sevo gas del.total RptPeriod Vol Gas DS	4180186
21490705	所输送的七氟醚气体.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490706	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B parapert; B parapertussis; B pert; B pert+para.FHA; B pertussis; FHA; Filament; HA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pertussis; Point in time; PR; PT; QL; Qual; Qualitative; Random; Screen; Serum; SR; ViraStripe; Whooping cough	4180186
21490706	B pert+para.FHA IgA Ser Ql Line blot	4180186
21490706	百日咳博德特菌+百日咳博德特菌.纤维状红细胞凝集素 抗体.IgA:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
21490707	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B parapert; B parapertussis; B pert; B pert+para.FHA; B pertussis; FHA; Filament; HA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pertussis; Point in time; PR; PT; QL; Qual; Qualitative; Random; Screen; Serum; SR; ViraStripe; Whooping cough	4180186
21490707	B pert+para.FHA IgG Ser Ql Line blot	4180186
21490707	百日咳博德特菌+百日咳博德特菌.纤维状红细胞凝集素 抗体.IgG:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
21490711	Cereb; Ctx; Electroencephalogram; NEURO; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
21490711	Bispectral index Score Ctx EEG	4180186
21490711	脑电双频指数:评分:时间点:大脑皮质:定量型:脑电图	4182948
21490714	Cereb; Ctx; Electrical potential; Electroencephalogram; NEURO; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage	4180186
21490714	Electrical potential Ctx EEG	4180186
21490714	电位:电势:时间点:大脑皮质:定量型:脑电图	4182948
21490715	Fan speed Inf microenvt.incub	4180186
21490715	Finding; Findings; Inf microenvt; Inf microenvt.incub; NEONAT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
21490715	风扇转速:发现:时间点:婴儿微环境.暖箱:序数型	4182948
21490716	Dynamic; Flow; Gas DS; Gases; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Volume Rate; vRate	4180186
21490716	Fresh gas.air flow Gas DS	4180186
21490716	新鲜气体.空气气流:体积速率:时间点:气体输送系统:定量型	4182948
21490717	Dynamic; Flow; Fresh gas.N2O flow; Gas DS; Gases; Laughing gas; Lung; N2O; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Volume rate; vRate	4180186
21490717	Fresh gas.N2O flow Gas DS	4180186
21490717	新鲜气体.氧化亚氮气流:体积速率:时间点:气体输送系统:定量型	4182948
21490718	Dynamic; Flow; Fresh gas.O2 flow; Gas DS; Gases; Lung; O2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Volume rate; vRate	4180186
21490718	Fresh gas.O2 flow Gas DS	4180186
21490718	新鲜气体.氧气气流:体积速率:时间点:气体输送系统:定量型	4182948
21490719	Heater type Inf microenvt	4180186
21490719	Inf microenvt; NEONAT; Nominal; Point in time; Random; Typ	4180186
21490719	加热器类型:类型:时间点:婴儿微环境:名义型	4182948
21490720	Heater power EngRatFr Inf microenvt	4180186
21490720	Inf microenvt; NEONAT; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21490720	加热器功率:功率比率:时间点:婴儿微环境:定量型	4182948
21490722	Inf microenvt; Inf microenvt.incub; NEONAT; Point in time; QNT; Quan; Quant; Quantitative; Random; Rel; Relative mass concentration; RLMCNC	4180186
21490722	Relative humidity Inf microenvt.incub	4180186
21490722	相对湿度:相对质量浓度:时间点:婴儿微环境.暖箱:定量型	4182948
21490723	Inf microenvt; Inf microenvt.incub; NEONAT; Point in time; QNT; Quan; Quant; Quantitative; Random; Rel; Rel humidity set; Relative mass concentration; RLMCNC	4180186
21490723	Rel humidity set Inf microenvt.incub	4180186
21490723	相对湿度设置:相对质量浓度:时间点:婴儿微环境.暖箱:定量型	4182948
21490724	Breathing; Exp; In; Insp; Inspiratory; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Time ratio	4180186
21490724	Insp/Exp time Ratio	4180186
21490724	吸气/呼气:时间比率:时间点:呼吸系统:定量型	4182948
21490726	Atrial; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP diastolic; Cardiac; Cardio; Cardiology; DBP; Dias; Dias BP; Diast; Diastoli; Heart Disease; Hrt; Intrachamber dias pres; Intrachamber pres; L; LA; LT; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490726	LA pressure dias	4180186
21490726	心腔内舒张期:压力或压强:时间点:心脏.心房.左侧:定量型	4182948
21490728	Away adap; Exp; Lung; N; N2; Nit; NO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490728	NO2 during expir VFr/PPres Away adap	4180186
21490728	二氧化氮^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490729	Away adap; In; Insp; Inspiratory; Lung; N; N2; Nit; NO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490729	NO2 during insp VFr/PPres Away adap	4180186
21490729	二氧化氮^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490733	Blood; Chemistry; k; K+; Level; Mass concentration; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
21490733	Potassium Bld-mCnc	4180186
21490733	钾:质量浓度:时间点:全血:定量型	4182948
21490736	Cardio; Cardiology; Count/time; Heart beat; Heart Disease; Misc; Miscellaneous; nRate; Number rate; Number Rate = Count/Time; Other; Point in time; PULMONARY; Pulse; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
21490736	Heart rate Noninvasive	4180186
21490736	心率:计数型速率:时间点:XXX:定量型:无创法	4182948
21490737	Breathing; during resp pause; Lung; Lungs; Point in time; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
21490737	Press during resp pause Airway	4180186
21490737	压力^在呼吸间歇期间:压力或压强:时间点:呼吸系统.气道:定量型	4182948
21490740	Airway resist; Breathing; Fluid resistance; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; RAW; Resist; Resistanc; Resistant; Resistent; Respiratory; RS	4180186
21490740	Airway resist	4180186
21490740	阻力.气道:液体阻力:时间点:呼吸系统.气道:定量型	4182948
21490744	Calc; Calculation; NEURO; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto	4180186
21490744	Signal quality index EEG device Calc	4180186
21490744	信号质量指数:比率:时间点:EEG 装置:定量型:计算法	4182948
21490747	Cereb; Count/time; Ctx; Electroencephalogram; NEURO; Neurology; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21490747	Spike count nRate Ctx EEG	4180186
21490747	尖峰计数:计数型速率:时间点:大脑皮质:定量型:脑电图	4182948
21490749	Temp Inf microenvt.incub	4180186
21490749	Inf microenvt; Inf microenvt.incub; NEONAT; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature	4180186
21490749	温度:温度:时间点:婴儿微环境.暖箱:定量型	4182948
21490750	Inf microenvt; NEONAT; Point in time; QNT; Quan; Quant; Quantitative; Random; Resist; Resistanc; Resistance; Resistant; Resistent; Temp	4180186
21490750	Temperature sensor Inf microenvt	4180186
21490750	温度传感器:阻尼:时间点:婴儿微环境:定量型	4182948
21490754	1 minute; Breathing; Flow; Lung; Lungs; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; RS; Vol; Volume rate; vRate	4180186
21490754	Vol.insp/M Resp system	4180186
21490754	体积.每分钟吸入:体积速率:1分钟:呼吸系统:定量型	4182948
21490755	Temp control mode Inf microenvt	4180186
21490755	Inf microenvt; NEONAT; Nominal; Point in time; Random; Temp; Temp control mode; Typ	4180186
21490755	温度控制方式:类型:时间点:婴儿微环境:名义型	4182948
21490756	Chorionic villi; Chorionic villus sample; Pan; PANEL.IEEE ROSETTA; Panl; Pnl; Rosetta CVS Pnl	4180186
21490756	Rosetta CVS Pnl CVS	4180186
21490756	IEEE Rosetta 心血管组套:-:-:绒毛膜绒毛样本:-	4182948
21490758	Gas DS; Gases; Pan; PANEL.IEEE ROSETTA; Panl; Pnl; Point in time; Random; Rosetta GASDLV Pnl	4180186
21490758	Rosetta GASDLV Pnl Gas DS	4180186
21490758	IEEE Rosetta 气体输送组套:-:时间点:气体输送系统:-	4182948
21490759	Rosetta TEMP panel	4180186
21490759	Pan; PANEL.IEEE ROSETTA; Panl; Pnl; Point in time; Random; Rosetta TEMP panel; Temp	4180186
21490759	IEEE Rosetta 温度组套:-:时间点:^患者:-	4182948
21490760	Blood; Pan; PANEL.IEEE ROSETTA; Panl; Pnl; Point in time; Random; Rosetta lab Pnl; WB; Whole blood	4180186
21490760	Rosetta lab Pnl Bld	4180186
21490760	IEEE Rosetta 实验室组套:-:时间点:全血:-	4182948
21490762	Pan; PANEL.IEEE ROSETTA; Panl; Pnl; Rosetta RESP Pnl	4180186
21490762	Rosetta RESP Pnl	4180186
21490762	IEEE Rosetta 呼吸组套:-:-:^患者:-	4182948
21490764	Rosetta SKIN_TCUT Pnl TC monitor	4180186
21490764	Integument; Pan; PANEL.IEEE ROSETTA; Panl; Pnl; Point in time; Random; Rosetta SKIN_TCUT Pnl; TC monitor	4180186
21490764	IEEE Rosetta 皮肤经皮组套:-:时间点:经皮肤监测仪:-	4182948
21490765	Inf microenvt; Pan; PANEL.IEEE ROSETTA; Panl; Pnl; Point in time; Random; Rosetta INFANT Pnl	4180186
21490765	Rosetta INFANT Pnl Inf microenvt	4180186
21490765	Rosetta 婴儿微环境组套:-:时间点:婴儿微环境:-	4182948
21490767	Air del.total; Gas DS; Gases; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Tot; Totl; Volume	4180186
21490767	Air del.total RptPeriod Vol Gas DS	4180186
21490767	所输送的空气.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490769	Bdy temp; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; bod; Bodies; BODY TEMPERATURE.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature; Venous	4180186
21490769	Venous blood temp	4180186
21490769	体温:温度:时间点:静脉全血:定量型	4182948
21490772	Energy/time; Ind; Ind calorimetry; Indir; Lung; Power; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory	4180186
21490772	Energy expend RptPeriod Ind calorimetry	4180186
21490772	所消耗的能量:功率:报告期:^患者:定量型:间接测热法	4182948
21490774	Energy/time; Point in time; Power; QNT; Quan; Quant; Quantitative; Random; TC monitor	4180186
21490774	TC monitor Heater power	4180186
21490774	加热器功率:功率:时间点:经皮肤监测仪:定量型	4182948
21490779	Art sys; Blood pressure; BLOOD PRESSURE MEASUREMENTS.MOLEC; Blood pressure systolic; BP; BP sys; BP systolic; Cardio; Cardiology; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP	4180186
21490779	BP sys by CNAP	4180186
21490779	血管内心脏收缩期:压力或压强:时间点:动脉系统:定量型:CNAP	4182948
21490781	Gas DS; Gases; Lung; O2; O2 gas del.total; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; tO2; Tot; Totl; Volume	4180186
21490781	O2 gas del.total RptPeriod Vol Gas DS	4180186
21490781	所输送的氧气.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490782	Cardiac; Cardio; Cardiology; Count/time; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21490782	Paced HR EKG	4180186
21490782	心跳.起搏:计数型速率:时间点:心脏:定量型:心电图	4182948
21490785	Breathing; dur insp on vent; In; Insp; Inspiratory; Lung; Lungs; Point in time; Pressure; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
21490785	Press dur insp on vent Airway	4180186
21490785	压力^在借助呼吸机吸气时:压力或压强:时间点:呼吸系统.气道:定量型	4182948
21490786	Breathing; Lung; Lungs; Point in time; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
21490786	Airway occlusion press	4180186
21490786	压力.闭合:压力或压强:时间点:呼吸系统.气道:定量型	4182948
21490788	Temp diff	4180186
21490788	BODY TEMPERATURE.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temp diff	4180186
21490788	温度差:温度差:时间点:^患者:定量型	4182948
21490790	Gas DS; Gases; Liquids; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Sevo liq del.total; Tot; Totl; Volume	4180186
21490790	Sevo liq del.total RptPeriod Vol Gas DS	4180186
21490790	所输送的七氟醚液体.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490792	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-V1; Voltage	4180186
21490792	ST Amp L-V1	4180186
21490792	ST 波振幅.导联 V1:电势:时间点:心脏:定量型:心电图	4182948
21490795	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-V4; Voltage	4180186
21490795	ST Amp L-V4	4180186
21490795	ST 波振幅.导联 V4:电势:时间点:心脏:定量型:心电图	4182948
21490797	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-V6; Voltage	4180186
21490797	ST Amp L-V6	4180186
21490797	ST 波振幅.导联 V6:电势:时间点:心脏:定量型:心电图	4182948
21490798	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-I; Voltage	4180186
21490798	ST Amp L-I	4180186
21490798	ST 波振幅.导联 I:电势:时间点:心脏:定量型:心电图	4182948
21490799	2; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-II; Voltage	4180186
21490799	ST Amp L-II	4180186
21490799	ST 波振幅.导联 II:电势:时间点:心脏:定量型:心电图	4182948
21490802	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-aVL; Voltage	4180186
21490802	ST Amp L-aVL	4180186
21490802	ST 波振幅.导联 aVL:电势:时间点:心脏:定量型:心电图	4182948
21490805	AO; AoV; AV; Avg; Cardio; Cardiology; CARDIO-PULM; Gradient sys; Heart Disease; Largest; Lung; Max grad sys; Maximal; Maximum; Peak; PG; Point in time; Pressure; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Sys; Sys.max; Syst	4180186
21490805	Max grad sys AV	4180186
21490805	梯度.收缩期.最大值:压力或压强:时间点:主动脉瓣:定量型	4182948
21490806	Away adap; Lung; NO; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490806	NO VFr/PPres Away adap	4180186
21490806	一氧化氮:体积分数/分压:时间点:气道连接器:定量型	4182948
21490807	Away adap; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Xe	4180186
21490807	Xe VFr/PPres Away adap	4180186
21490807	氙:体积分数/分压:时间点:气道连接器:定量型	4182948
21490810	Exp; Gas DS; Gas DS.EL; Gases; He; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490810	Helium during expir VFr/PPres Gas DS.EL	4180186
21490810	氦^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490811	Gas DS; Gas DS.IL; Gases; He; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490811	Helium during insp VFr/PPres Gas DS.IL	4180186
21490811	氦^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490813	Gas DS; Gas DS.IL; Gases; In; Insp; Inspiratory; Lung; NO; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490813	NO during insp VFr/PPres Gas DS.IL	4180186
21490813	一氧化氮^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490814	Exp; Gas DS; Gas DS.EL; Gases; Lung; N; N2; Nit; NO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490814	NO2 during expir VFr/PPres Gas DS.EL	4180186
21490814	二氧化氮^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490815	Gas DS; Gas DS.IL; Gases; In; Insp; Inspiratory; Lung; N; N2; Nit; NO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490815	NO2 during insp VFr/PPres Gas DS.IL	4180186
21490815	二氧化氮^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490818	Exp; Gas DS; Gas DS.EL; Gases; Lung; O2; O2 partial pressure; PO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2	4180186
21490818	O2 during expir VFr/PPres Gas DS.EL	4180186
21490818	氧^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490819	Gas DS; Gas DS.IL; Gases; In; Insp; Inspiratory; Lung; O2; O2 partial pressure; PO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2	4180186
21490819	O2 during insp VFr/PPres Gas DS.IL	4180186
21490819	氧^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490820	Exp; Gas DS; Gas DS.EL; Gases; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490820	Sevofl during expir VFr/PPres Gas DS.EL	4180186
21490820	七氟醚^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490821	Exp; Gas DS; Gas DS.EL; Gases; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Xe	4180186
21490821	Xe during expir VFr/PPres Gas DS.EL	4180186
21490821	氙^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490822	Gas DS; Gas DS.IL; Gases; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Xe	4180186
21490822	Xe during insp VFr/PPres Gas DS.IL	4180186
21490822	氙^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490823	Gas DS; Gases; He; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490823	Helium VFr/PPres Gas DS	4180186
21490823	氦:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490827	Gas DS; Gases; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Xe	4180186
21490827	Xe VFr/PPres Gas DS	4180186
21490827	氙:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490829	氙^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490829	Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Xe	4180186
21490829	Xe end exp VFr/PPres Away adap	4180186
21490830	Away adap; Exp; Lung; NO; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490830	NO during expir VFr/PPres Away adap	4180186
21490830	一氧化氮^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490831	Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Xe	4180186
21490831	Xe during expir VFr/PPres Away adap	4180186
21490831	氙^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490832	Gas DS; Gases; He; He gas del dur case; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume	4180186
21490832	He gas del dur case Vol Gas DS	4180186
21490832	所输送的氦气.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490834	Away adap; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Xe	4180186
21490834	Xe during insp VFr/PPres Away adap	4180186
21490834	氙^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490835	Gas DS; Gases; He; He gas del.total; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Tot; Totl; Volume	4180186
21490835	He gas del.total RptPeriod Vol Gas DS	4180186
21490835	所输送的氦气.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490837	Gas DS; Gases; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume; Xe; Xe gas del dur case	4180186
21490837	Xe gas del dur case Vol Gas DS	4180186
21490837	所输送的氙气.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490839	Cardiac; Cardio; Cardiology; Cnt; Count; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Number; PVC; PVCs; QNT; Quan; Quant; Quantitative	4180186
21490839	PVCs	4180186
21490839	期外心室收缩:数量(计数):操作持续时间:心脏:定量型:心电图	4182948
21490841	Sucrose p sug sol 5h Ur-sRate	4180186
21490841	5 hours; 5.0Hr; 5HR; After; Chemistry; p sug sol; PST; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; Sucro; UA; UR; Urn	4180186
21490841	蔗糖^在口服XXX g糖溶液之后:物质的量速率:5小时:尿液:定量型	4182948
21490842	Inositol Free/Creat p sug sol 5h Ur-sRto	4180186
21490842	5 hours; 5.0Hr; 5HR; After; Chemistry; CR; Crea; Creat; Cyclohexane-1,2,3,4,5,6-hexol; FR; Inositol Free; Myoinositol; myo-inositol; Non-protein bound; p sug sol; PST; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21490842	肌醇.游离型/肌酐^在口服XXX g糖溶液之后:物质的量比率:5小时:尿液:定量型	4182948
21490843	5 hours; 5.0Hr; 5HR; After; Chemistry; p sug sol; PST; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
21490843	Lactulose p sug sol 5h Ur-sRate	4180186
21490843	乳果糖^在口服XXX g糖溶液之后:物质的量速率:5小时:尿液:定量型	4182948
21490845	Breathing; Count/time; Lung; Lungs; nRate; Number rate; Number Rate = Count/Time; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Respiratory rate; RS	4180186
21490845	Resp rate Acoustic meas	4180186
21490845	呼吸:计数型速率:时间点:呼吸系统:定量型:声学测量法	4182948
21490846	Away flow meas; Breathing; Count/time; Dynamic; Lung; Lungs; nRate; Number rate; Number Rate = Count/Time; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Respiratory rate; RS	4180186
21490846	Resp rate Away flow meas	4180186
21490846	呼吸:计数型速率:时间点:呼吸系统:定量型:气道流量测定法	4182948
21490847	Breathing; CO2 meas; Count/time; Lung; Lungs; nRate; Number rate; Number Rate = Count/Time; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Respiratory rate; RS	4180186
21490847	Resp rate CO2 meas	4180186
21490847	呼吸:计数型速率:时间点:呼吸系统:定量型:二氧化碳测定法	4182948
21490848	Art; Carbonic anhydride; Cardio; Cardiology; CO2; Heart Disease; Lung; PA; Partial pressure; PCO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490848	pCO2 PA	4180186
21490848	二氧化碳:分压:时间点:肺动脉:定量型	4182948
21490849	Breathing; Dynamic; Flow; Gases; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
21490849	Deprecated Gas flow Airway	4180186
21490856	N2O cylinder Press	4180186
21490856	Cyl.N2O; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490856	压力:压力或压强:时间点:压缩气体钢瓶.一氧化氮:定量型	4182948
21490857	Pipe.N2O; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490857	N2O pipeline Press	4180186
21490857	压力:压力或压强:时间点:管道.一氧化氮:定量型	4182948
21490861	Air pipeline Press	4180186
21490861	Pipe.air; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490861	压力:压力或压强:时间点:管道.空气:定量型	4182948
21490863	Bdy surface; bod; Bodies; Breathing; BSA; Carbonic anhydride; cO2; CO2 production; Flow; Lung; Lungs; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Surf; Volume rate; vRate	4180186
21490863	CO2 production/BSA Respiratory	4180186
21490863	二氧化碳产生/体表面积:体积速率:时间点:呼吸系统:定量型	4182948
21490866	Breathing; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Resp quot; Respiratory; RS; Volume ratio	4180186
21490866	Resp quot Respiratory	4180186
21490866	呼吸商:体积比率:时间点:呼吸系统:定量型	4182948
21490867	Breathing; Count/time; Imped.transthoracic; Lung; Lungs; nRate; Number rate; Number Rate = Count/Time; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Respiratory rate; RS	4180186
21490867	Resp rate Imped.transthoracic	4180186
21490867	呼吸:计数型速率:时间点:呼吸系统:定量型:阻抗.经胸壁	4182948
21490868	Fatty acid oxidation Pnl Fib	4180186
21490868	Acd; Acids; Chemistry; FA Oxidation; FAO; Fatty acid oxidation Pnl; Fib; Fibr; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random	4180186
21490868	脂肪酸氧化组套:-:时间点:成纤维细胞:-	4182948
21490869	Breathing; Lung; Lungs; PF; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume ratio; VQI	4180186
21490869	VQI Respiratory	4180186
21490869	通气-灌注指数:体积比率:时间点:呼吸系统:定量型	4182948
21490870	Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; in vitro urine temp; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature	4180186
21490870	Bladder temp via Foley	4180186
21490870	体温:温度:时间点:膀胱:定量型:通过 Foley 导尿管	4182948
21490871	Cardiac; Cardio; Cardiology; ECG; EKG.IMPRESSION; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Nominal; Point in time; Random; Typ	4180186
21490871	Arrhythmia type EKG	4180186
21490871	心律失常:类型:时间点:心脏:名义型:心电图	4182948
21490872	Cardiac; Cardio; Cardiology; Count/time; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart beat; Heart Disease; Heart rate.btb; Hrt; nRate; Number rate; Number Rate = Count/Time; Point in time; Pulse; QNT; Quan; Quant; Quantitative; Random	4180186
21490872	Heart rate.btb by EKG	4180186
21490872	心率.瞬时:计数型速率:时间点:心脏:定量型:心电图	4182948
21490874	Art; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; Cardio; Cardiology; Heart Disease; Intravenous; IV; PA; PAP; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490874	PA BP	4180186
21490874	血管内:压力或压强:时间点:肺动脉:定量型	4182948
21490878	Blood pressure; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; Blood pressure systolic; BP; BP sys; BP systolic; Cardio; Cardiology; Est; estimation; Heart Disease; Intravenous; IV; Point in time; Pressure; Pulm cap; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP	4180186
21490878	Pulm cap sys BP	4180186
21490878	血管内心脏收缩期:压力或压强:时间点:肺毛细血管:定量型:估计法	4182948
21490879	Flow; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Vent airway circuit; Vent away; Volume Rate; vRate	4180186
21490879	Vent away circuit leakage vol	4180186
21490879	泄漏:体积速率:时间点:呼吸机气道线路:定量型	4182948
21490880	Bdy surface; bod; Bodies; BSA; Cardiac; Cardiac output/Heart beat; Cardio; Cardiology; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Surf; SV; Ventricular; Vol; Volume/area	4180186
21490880	LV SVI	4180186
21490880	心搏量/体表面积:体积/面积:时间点:心脏.心室.左侧:定量型	4182948
21490884	Cnt; Count; IO_IN.INFUS; IO_INTAKE; Number; QNT; Quan; Quant; Quantitative; Report period	4180186
21490884	Doses.req RptPeriod	4180186
21490884	剂量药物.所申请:数量(计数):报告期:^患者:定量型	4182948
21490885	Inf vol.seg	4180186
21490885	Inf vol.seg; IO_IN.INFUS; IO_INTAKE; QNT; Quan; Quant; Quantitative; Vol; Volume	4180186
21490885	已输注体积.节段:体积型属性:操作项目:^患者:定量型	4182948
21490886	PCA dose num.max 1h nRate Inf pump	4180186
21490886	1 hour; 1.0Hr; 1HR; 60 min; 60 minutes; 60M; 60min; Count/time; Dose #; Inf pump; IO_IN.INFUS; IO_INTAKE; Largest; Maximal; Maximum; No; nRate; Num; Number rate; Number Rate = Count/Time; PCA dose num.max; Peak; QNT; Quan; Quant; Quantitative	4180186
21490886	PCA 剂量数.最大值:计数型速率:1小时:输液泵:定量型	4182948
21490889	Syringe Vol.act	4180186
21490889	Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Vol.act; Volume	4180186
21490889	体积.实际:体积型属性:时间点:注射器:定量型	4182948
21490890	Inf pump Vol.remain	4180186
21490890	Inf pump; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Vol.remain; Volume	4180186
21490890	体积.剩余:体积型属性:时间点:输液泵:定量型	4182948
21490893	Inf pump; Nominal; Point in time; Random; Typ	4180186
21490893	Inf pump Pump status	4180186
21490893	泵状态:类型:时间点:输液泵:名义型	4182948
21490894	Breathing; Dynamic; Flow; Gases; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
21490894	Exp airway gas flow	4180186
21490894	呼气气体流量:体积速率:时间点:呼吸系统.气道:定量型	4182948
21490898	Inf pump Comm status	4180186
21490898	Comm status; Inf pump; Nominal; Point in time; Random; Typ	4180186
21490898	通讯状态:类型:时间点:输液泵:名义型	4182948
21490899	Inf pump Alarm state	4180186
21490899	Inf pump; Nominal; Point in time; Random; Typ	4180186
21490899	警示状态:类型:时间点:输液泵:名义型	4182948
21490905	Inf pump; Nominal; Point in time; Random; Reason pump stop infus; Typ	4180186
21490905	Inf pump Reason pump stop infus	4180186
21490905	泵停止输注的原因:类型:时间点:输液泵:名义型	4182948
21490908	Desfl liq del dur case; Gas DS; Gases; Liquids; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume	4180186
21490908	Desfl liq del dur case Vol Gas DS	4180186
21490908	所输送的地氟醚液体.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490913	Anestan; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Gas DS; Gases; Halan; Halo liq del.total; Halotan; Halsan; Liquids; Lung; Narcotan; Narkotan; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Rhodialothan; Tot; Totl; Volume	4180186
21490913	Halo liq del.total RptPeriod Vol Gas DS	4180186
21490913	所输送的氟烷液体.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490915	Gas DS; Gases; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490915	Argon VFr/PPres Gas DS	4180186
21490915	氩:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490917	Exp; Gas DS; Gas DS.EL; Gases; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490917	Argon during expir VFr/PPres Gas DS.EL	4180186
21490917	氩^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490918	Gas DS; Gases; Isofl liq del dur case; Liquids; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume	4180186
21490918	Isofl liq del dur case Vol Gas DS	4180186
21490918	所输送的异氟醚液体.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490919	Gas DS; Gases; Isofl liq del.tot; Liquids; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Tot; Totl; Volume	4180186
21490919	Isofl liq del.tot RptPeriod Vol Gas DS	4180186
21490919	所输送的异氟醚液体.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490921	Inf pump; Inf vol.tot; IO_IN.INFUS; IO_INTAKE; QNT; Quan; Quant; Quantitative; Report period; Tot; Totl; Vol; Volume	4180186
21490921	Inf vol.tot RptPeriod Inf pump	4180186
21490921	已输注体积.总计:体积型属性:报告期:输液泵:定量型	4182948
21490923	Inf dose.remain; Inf pump; IO_IN.INFUS; IO_INTAKE; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21490923	Inf dose.remain Inf pump	4180186
21490923	输注剂量.剩余:质量:时间点:输液泵:定量型	4182948
21490924	Inf pump; Inf time.prog; IO_IN.INFUS; IO_INTAKE; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21490924	Inf time.prog Inf pump	4180186
21490924	输注时间.程序化:时间:时间点:输液泵:定量型	4182948
21490927	Inf pump; Inf vol.prog; IO_IN.INFUS; IO_INTAKE; QNT; Quan; Quant; Quantitative; Vol; Volume	4180186
21490927	Inf vol.prog Inf pump	4180186
21490927	输注体积.程序化:体积型属性:操作项目:输液泵:定量型	4182948
21490928	Inf vol.remain Inf pump	4180186
21490928	Inf pump; Inf vol.remain; IO_IN.INFUS; IO_INTAKE; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Vol.remain; Volume	4180186
21490928	输注体积.剩余:体积型属性:时间点:输液泵:定量型	4182948
21490929	Gas DS; Gases; Lung; NO; NO gas del dur case; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume	4180186
21490929	NO gas del dur case Vol Gas DS	4180186
21490929	所输送的一氧化氮气体.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490931	IEEE Rosetta Pnl; Pan; PANEL.IEEE ROSETTA; Panl; Pnl	4180186
21490931	IEEE Rosetta Pnl	4180186
21490931	IEEE Rosetta 组套:-:-:^患者:-	4182948
21490932	B; Blood; B-NAH; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; GM2-gangliosidosis; Hex A; Hex B; HEXA; Hexosaminidase; Point in time; QNT; Quan; Quant; Quantitative; Random; Sandhoff disease; Tay Sachs Disease; WB; Whole blood	4180186
21490932	B-NAH DBS-cCnc	4180186
21490932	Beta-N-乙酰己糖胺酶:催化浓度:时间点:全血.斑点:定量型	4182948
21490935	HPRT cSub RBC	4180186
21490935	Chemistry; Erythrocytes; HGPRT; HPRT; hypoxanthine-guanine phosphoribosyltransferase; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21490935	次黄嘌呤-鸟嘌呤磷酸核糖转移酶:单位物质的量相对型催化活性:时间点:红细胞:定量型	4182948
21490937	PNP DBS-cCnc	4180186
21490937	Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; PNP; PNPase; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
21490937	嘌呤核苷酸磷酸化酶:催化浓度:时间点:全血.斑点:定量型	4182948
21490938	Chemistry; Erythrocytes; Methyl transferase; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; TPMT	4180186
21490938	TPMT cSub RBC	4180186
21490938	硫嘌呤甲基转移酶:单位物质的量相对型催化活性:时间点:红细胞:定量型	4182948
21490939	UDPG4Epimerase RBC-cCnt	4180186
21490939	Catalytic Content; Chemistry; Erythrocytes; GALE; Glu; Gluc; Glucoseur; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; UDPG4Epimerase; UDP-glucose 4-epimerase; Uridine diphosphate galactose 4-epimerase	4180186
21490939	尿苷二磷酸葡糖-4-表异构酶:催化含量:时间点:红细胞:定量型	4182948
21490940	UMP synthetase RBC-cCnt	4180186
21490940	Catalytic Content; Chemistry; Erythrocytes; OMP decarboxylase; Orotate phosphoribosyl transferase; orotate phosphoribosyltransferase; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; UMP synthetase; Uridine 5-monophosphate synthetase; Uridine monophosphate synthase	4180186
21490940	尿苷单磷酸合成酶:催化含量:时间点:红细胞:定量型	4182948
21490941	1,4-Cyclohexanediol/Creat Ur-sRto	4180186
21490941	Chemistry; cis-1,4-cyclohexanediol; CR; Crea; Creat; Cyclohexane-1,4-diol; i; Point in time; QNT; Quan; Quant; Quantitative; Quinitol; Random; Scrto; Substance concentration ratio; Substance ratio; trans-1,4-cyclohexanediol; UA; UCr; UR; Urn	4180186
21490941	1,4-环己二醇/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21490943	Hexanoylgly SerPl-sCnc	4180186
21490943	Chemistry; Hexanoyl-glycine; Level; N-caproylglycine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21490943	己酰甘氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21490946	Chemistry; EMA; Ethylmalonic acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21490946	Ethylmalonate SerPl-sCnc	4180186
21490946	乙基丙二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21490947	(2S)-2-amino-5-(3-methylcarbamimidamido)pentanoic acid; Chemistry; Esoteric; Level; L-Monomethylarginine; L-NMMA; L-targinine; N(G)-Monomethyl-L-arginine; N-Monomethyl-L-arginine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Targinine	4180186
21490947	N-monomethylarginine SerPl-sCnc	4180186
21490947	N-单甲基精氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21490948	3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; R-B-AIB; Right; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21490948	R-B-AIB SerPl-sCnc	4180186
21490948	R-beta 氨基异丁酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21490949	3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Esoteric; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S-B-AIB; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21490949	S-B-AIB CSF-sCnc	4180186
21490949	S-beta 氨基异丁酸:物质的量浓度:时间点:脑脊液:定量型	4182948
21490952	3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Chemistry; CR; Crea; Creat; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S-B-AIB; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21490952	S-B-AIB/Creat Ur-sRto	4180186
21490952	S-beta 氨基异丁酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21490953	Chemistry; CR; Crea; Creat; Esoteric; FIGLU; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21490953	Formiminoglutamate/Creat Ur-sRto	4180186
21490953	亚胺甲基谷氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21490955	3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Chemistry; CR; Crea; Creat; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; R-B-AIB; Right; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21490955	R-B-AIB/Creat Ur-sRto	4180186
21490955	R-beta 氨基异丁酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21490956	2-aminoisobutyrate; 2-aminoisobutyric acid; 2-methylalanine; A-AIB; AIB; Alfa; alpha aminoisobutyric acid; Chemistry; CR; Crea; Creat; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21490956	A-AIB/Creat Ur-sRto	4180186
21490956	Alpha 氨基异丁酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21490957	at final dis stage; Dis; Disease stg; Diseases; Dz; Extraocular RB class; Eye; EYE.HX; EYE.HX.NEI; Eyeball; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vision; Visual	4180186
21490957	Reese-Ells class final dis stage Eye-L	4180186
21490957	眼外视网膜母细胞瘤分类^最终疾病分期时:分类:时间点:眼睛.左侧:序数型:Reese-Ellsworth 系统	4182948
21490958	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; R; R eye; Random; RT; Vision; Visual	4180186
21490958	R eye Jaw winking	4180186
21490958	颌动瞬目:存在情况:时间点:眼睛.右侧:名义型	4182948
21490959	Eye; EYE.PX; EYE.PX.NEI; Eyeball; L; L eye; LT; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Vision; Visual	4180186
21490959	L eye Jaw winking	4180186
21490959	颌动瞬目:存在情况:时间点:眼睛.左侧:名义型	4182948
21490960	Eye; EYE.HX; EYE.HX.NEI; Fam Mem; History; Narrative; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Report	4180186
21490960	Family hx Eye problems	4180186
21490960	眼睛问题:历史记录:时间点:^家庭成员:叙述型	4182948
21490964	EYE; EYE.OCT; EYE.OCT.NEI; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT; Thick	4180186
21490964	R ret Foveal thickness OCT	4180186
21490964	黄斑中心凹厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
21490966	AO; AoV; AV; AVA; Bdy surface; bod; Bodies; BSA; Calc; Calculation; CARD.US; CARD.US.DICOM; Cardio; Cardiology; DOP; DUPLEX; Echography; EOA sys; Heart Disease; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Surf; Sys; Syst; ULS; Ultrasound; Velocity Time Integral	4180186
21490966	AV EOA sys (Continuity VTI)/BSA	4180186
21490966	有效口面积.收缩期/体表面积:面积比:时间点:主动脉瓣:定量型:超声.多普勒+连续性血流速度时间积分计算法	4182948
21490967	AO; AoV; AV; AVA; Calc; Calculation; CARD.US; CARD.US.DICOM; Cardio; Cardiology; Dias; Diast; Diastoli; DOP; DUPLEX; Echography; ERO; EROA; EROA dias; Heart Disease; Point in time; Proximal Isovelocity Surface Area; QNT; Quan; Quant; Quantitative; Random; ROA; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
21490967	AV EROA dias PISA	4180186
21490967	有效反流口面积.舒张期:面积:时间点:主动脉瓣:定量型:超声.多普勒+近端等速表面积计算法	4182948
21490968	AO; AoV; AV; Average; Avg; Bld flow; Bld flow vel; Bld flow.velocity; CARD.US; CARD.US.DICOM; Cardio; Cardiology; DOP; DUPLEX; Dynamic; Echography; Heart Disease; Mean flow vel sys; Mean V; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Sys; Sys.mean; Syst; ULS; Ultrasound; V mean; V sys; Vel; Velocity; Vmean	4180186
21490968	AV Mean flow vel sys	4180186
21490968	血流速度.收缩期.平均值:速度:时间点:主动脉瓣:定量型:超声.多普勒	4182948
21490970	CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; L; Largest; LT; LV; LV.basal ant; LV.basal ant septum; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Sys; Syst; TDI; Time to S Vmax; ULS; Ultrasound; V sys; Vel; Ventricular	4180186
21490970	LV.basal ant septum Time to S Vmax TDI	4180186
21490970	达到最大组织速度的时间.收缩期:时间:时间点:心脏.心室.左侧.前底部间隔:定量型:超声.组织多普勒	4182948
21490971	CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; Inf; L; Largest; LT; LV; LV.basal inf; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Sys; Syst; TDI; Time to S Vmax; ULS; Ultrasound; V sys; Vel; Ventricular	4180186
21490971	LV.basal inf Time to S Vmax TDI	4180186
21490971	达到最大组织速度的时间.收缩期:时间:时间点:心脏.心室.左侧.下底部:定量型:超声.组织多普勒	4182948
21490973	CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; L; Largest; LT; LV; LV.basal post; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Sys; Syst; TDI; Time to S Vmax; ULS; Ultrasound; V sys; Vel; Ventricular	4180186
21490973	LV.basal post Time to S Vmax TDI	4180186
21490973	达到最大组织速度的时间.收缩期:时间:时间点:心脏.心室.左侧.后底部:定量型:超声.组织多普勒	4182948
21490975	CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; L; Largest; LT; LV; LV.mid ant; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Sys; Syst; TDI; Time to S Vmax; ULS; Ultrasound; V sys; Vel; Ventricular	4180186
21490975	LV.mid ant Time to S Vmax TDI	4180186
21490975	达到最大组织速度的时间.收缩期:时间:时间点:心脏.心室.左侧.中前部:定量型:超声.组织多普勒	4182948
21490977	2-Furaldehyde metabolite; 5-hydroxymethyl-2-furoic acid; 5OH-methyl-2-furoate; Chemistry; CR; Crea; Creat; Furancarboxylic Acid; Furfural metabolite; Furoic acid; II; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21490977	5OH-methyl-2-furoate/Creat Ur-sRto	4180186
21490977	5-羟甲基-2-糠酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21490978	2-hydroxybenzoylglycine; Chemistry; CR; Crea; Creat; N-(2-hydroxybenzoyl)glycine; N-(o-hydroxybenzoyl)glycine; o-hydroxyhippurate; o-hydroxyhippuric acid; Point in time; QNT; Quan; Quant; Quantitative; Random; salicylglycine; salicyluric acid; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21490978	Salicylurate/Creat Ur-sRto	4180186
21490978	水杨尿酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21490980	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21490982	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21490984	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21490985	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21490987	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21490988	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21490989	CARD.US; Cardio; Cardiology; Echography; Finding; Findings; Heart Disease; Ordinal; Point in time; PV; Ql; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Sten deg; ULS; Ultrasound	4180186
21490989	PV Sten deg US	4180186
21490989	狭窄程度:发现:时间点:肺动脉瓣:序数型:超声	4182948
21490991	Blood flow.diastolic.early wave.max; CARD.US; Cardio; Cardiology; Early wave; Echography; e-prime Vmax; E-wave; Heart Disease; Largest; Max V; Maximal; Maximum; MV; MV ann; MV med ann; Peak; Peak E-wave; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; TDI; ULS; Ultrasound; V max; Vel; Velocity; Vmax	4180186
21490991	MV med ann Peak e' wave US.TDI	4180186
21490991	组织速度.E 波.最大值:速度:时间点:二尖瓣.环.中部:定量型:超声.组织多普勒	4182948
21490992	Orthopaedic surgery Admit H&P note	4180186
21490992	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Orthopedic; Orthopedic surgery; Point in time; Random; Surg; Visit note	4180186
21490992	入院史与体格检查记录:发现:时间点:{环境}:文档型:矫形外科学	4182948
21490993	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Surg; Visit note	4180186
21490993	Vascular surgery Admit H&P note	4180186
21490993	入院史与体格检查记录:发现:时间点:{环境}:文档型:血管外科学	4182948
21490994	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; OMS; Point in time; Random; Surg; Visit note	4180186
21490994	OMS Admit H&P note	4180186
21490994	入院史与体格检查记录:发现:时间点:{环境}:文档型:口腔颌面外科学	4182948
21490998	15M p Lac PO; After; CHEMISTRY.CHALLENGE TESTING; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21490998	Lactose 15M p Lac PO SerPl-sCnc	4180186
21490998	乳糖^在口服剂量乳糖之后15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
21490999	Lactose 45M p Lac PO SerPl-sCnc	4180186
21490999	45M p Lac PO; After; CHEMISTRY.CHALLENGE TESTING; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21490999	乳糖^在口服剂量乳糖之后45分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491000	Renin 2h p chal Plas-mCnc	4180186
21491000	120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; Angiotensin forming enzyme; Angiotensinogenase; CHEMISTRY.CHALLENGE TESTING; Direct renin; DRC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random	4180186
21491000	肾素^在XXX刺激之后2小时:质量浓度:时间点:血浆:定量型	4182948
21491001	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; Level; Lipid; PCAR; Pericardial Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
21491001	Cholest Pcar-sCnc	4180186
21491001	胆固醇:物质的量浓度:时间点:心包液:定量型	4182948
21491004	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Clopidogrel response assay; COAGULATION; Hematology; Heme; Left; Levo; Medication stress; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; Pl; Platelet rich plasma; Platelets; Platelt; Plavix response assay; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
21491004	PA ADP 4 umol/L PRP	4180186
21491004	血小板聚集.二磷酸腺苷诱导型^4 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
21491005	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Clopidogrel response assay; COAGULATION; Hematology; Heme; Left; Levo; Medication stress; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; Pl; Platelet rich plasma; Platelets; Platelt; Plavix response assay; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
21491005	PA ADP 5 umol/L PRP	4180186
21491005	血小板聚集.二磷酸腺苷诱导型^5 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
21491006	Adrenalin; Adrenaline; Adreneline; Agg; Aggr; COAGULATION; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Hematology; Heme; Left; Levo; PA; PA Epineph; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
21491006	PA Epineph 100 umol/L PRP	4180186
21491006	血小板聚集.肾上腺素诱导型^100 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
21491007	Adrenalin; Adrenaline; Adreneline; Agg; Aggr; COAGULATION; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Hematology; Heme; Left; Levo; PA; PA Epineph; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
21491007	PA Epineph 6 umol/L PRP	4180186
21491007	血小板聚集.肾上腺素诱导型^6 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
21491009	Agg; Aggr; COAGULATION; Hematology; Heme; mcg; PA; PA Coll; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
21491009	PA Coll 1.25 ug/ml PRP	4180186
21491009	血小板聚集.胶原诱导型^1.25 微克/毫升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
21491010	Agg; Aggr; COAGULATION; Hematology; Heme; mcg; PA; PA Coll; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
21491010	PA Coll 5 ug/mL PRP	4180186
21491010	血小板聚集.胶原诱导型^5 微克/毫升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
21491012	Adeno virus; Antigen; Antigens; Bowel movement; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; HAdV; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; SUDS	4180186
21491012	HAdV Ag Stl Ql IA.rapid	4180186
21491012	腺病毒 抗原:存在情况或阈值:时间点:大便:序数型:免疫测定法.快速	4182948
21491013	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; VS; VSNJV; VSV-NJ	4180186
21491013	VSNJV RNA Ct Spec Qn NAA+probe	4180186
21491013	水泡性口炎病毒 New Jersey 型 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
21491022	DOC.ONT; Document; Finding; Findings; Point in time; Random; Surg; Transpl surg	4180186
21491022	Transpl surg Checklist	4180186
21491022	检查清单:发现:时间点:{环境}:文档型:移植外科学	4182948
21491024	DOC.ONT; Document; Finding; Findings; Orthopedic; Orthopedic surgery; Point in time; Random; Surg	4180186
21491024	检查清单:发现:时间点:{环境}:文档型:矫形外科学	4182948
21491033	Rheumatology Diag study note	4180186
21491033	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
21491033	诊断性检查记录:发现:时间点:{环境}:文档型:风湿病学	4182948
21491035	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye; Eye care; Finding; Findings; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Study report; Visit note	4180186
21491035	Ophthalmol Diag study note	4180186
21491035	诊断性检查记录:发现:时间点:{环境}:文档型:眼科学	4182948
21491038	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genitourinary; GU; notes; Point in time; Random; Study report; URO; Urology; Visit note	4180186
21491038	Urology Diag study note	4180186
21491038	诊断性检查记录:发现:时间点:{环境}:文档型:泌尿外科学	4182948
21491039	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
21491039	Podiatry Diag study note	4180186
21491039	诊断性检查记录:发现:时间点:{环境}:文档型:足病学	4182948
21491040	Peds Discharge instruct	4180186
21491040	Disch; DOC.ONT; Document; Finding; Findings; Peds; Point in time; Random	4180186
21491040	出院指导:发现:时间点:{环境}:文档型:儿科学	4182948
21491041	Palliative care Discharge instruct	4180186
21491041	Continuity assessment record and evaluation; Disch; DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
21491041	出院指导:发现:时间点:{环境}:文档型:缓和照顾	4182948
21491042	Disch; DOC.ONT; Document; Finding; Findings; Lung; Point in time; Pulmonary; Pulmonology; Random; Resp therapy; Respiratory	4180186
21491042	Resp therapy Discharge instruct	4180186
21491042	出院指导:发现:时间点:{环境}:文档型:呼吸疗法	4182948
21491044	3,4-DHCA; 3,4-Dihydroxyphenylpropionate; 3,4-Dihydroxyphenylpropionic acid; Chemistry; Dihydrocaffeic acid; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491044	3,4-DHCA SerPl-sCnc	4180186
21491044	3,4-二羟基氢化肉桂酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491045	3-(2,5-dioxoimidazolidin-4-yl)propanoic acid; Chemistry; CR; Crea; Creat; Formiminoglutamic aciduria; Hydantoin-propionate; Point in time; Propanoic acid; Propioate; Propioic acid; Propionic acid; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491045	Hydantoin-5-propionate/Creat Ur-sRto	4180186
21491045	乙内酰脲-5-丙酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491046	hMPP/Creat Ur-sRto	4180186
21491046	3-(3-Hydroxyphenyl)propanoic acid; 3-Hydroxyphenylpropanoate; Chemistry; CR; Crea; Creat; hMPP; III; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491046	3-(3-羟基苯基)丙酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491048	Levulinate SerPl-sCnc	4180186
21491048	Chemistry; Level; Levulinic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491048	戊酮酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491052	3,4-Dihydroxybutyrate SerPl-sCnc	4180186
21491052	Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491052	3,4-二羟基丁酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491054	4OH-hippurate/Creat Ur-sRto	4180186
21491054	4-Hydroxyhippuric acid; 4OH-hippurate; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491054	4-羟基马尿酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491055	Catecholamine metab Pnl SerPl	4180186
21491055	Catecholamine metab Pnl; Chemistry; Metabolite; Metb; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491055	儿茶酚胺代谢产物组套:-:时间点:血清/血浆:-	4182948
21491056	2-Furoylglycine; Chemistry; CR; Crea; Creat; Furfuroylglycine; Point in time; Pyromucurate; Pyromucuric acid; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491056	Furoylglycine/Creat Ur-sRto	4180186
21491056	呋喃甲酰基甘氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491058	4OH-valerate; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491058	4OH-valerate SerPl-sCnc	4180186
21491058	4-羟基戊酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491059	4OH-hippurate SerPl-sCnc	4180186
21491059	4-Hydroxyhippuric acid; 4OH-hippurate; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491059	4-羟基马尿酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491060	Chemistry; CR; Crea; Creat; Levulinic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491060	Levulinate/Creat Ur-sRto	4180186
21491060	戊酮酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491062	Desaminotyrosine SerPl-sCnc	4180186
21491062	3-(para-Hydroxyphenyl)propionate; 4-Hydroxy-(9CI)benzenepropanoate; Chemistry; Level; Phloretate; Phloretic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491062	脱氨基酪氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491063	1-hydroxy-4-methylbenzene; 1-methyl-4-hydroxybenzene; 4-cresol; 4-hydroxytoluene; 4-methylphenol; Chemistry; CR; Crea; Creat; P prime; Paracresol; para-cresol; para-cresylic acid; paramethyl phenol; p-hydroxytoluene; p-methylhydroxybenzene; p-methylphenol; Point in time; p-toluol; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491063	p-Cresol/Creat Ur-sRto	4180186
21491063	对-甲酚/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491064	4OHMandelate SerPl-sCnc	4180186
21491064	2-Hydroxy-2-(4-hydroxyphenyl)acetate; 4-Hydroxy mandelate; 4-hydroxymanelic acid; 4OHMandelate; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491064	4-羟基扁桃酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491066	3-Hydroxyhippuric acid; 3OH-hippurate; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491066	3OH-hippurate SerPl-sCnc	4180186
21491066	3-羟基马尿酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491067	Suberylgly SerPl-sCnc	4180186
21491067	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491067	环庚基甘氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491069	1,4-Cyclohexanediol SerPl-sCnc	4180186
21491069	Chemistry; cis-1,4-cyclohexanediol; Cyclohexane-1,4-diol; i; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Quinitol; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; trans-1,4-cyclohexanediol	4180186
21491069	1,4-环己二醇:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491070	(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoic acid; Acetyl-L-tyrosine; Chemistry; Level; L-N-Acetyltyrosine; N-Acetyl-L-tyrosine; NAT; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491070	NAT SerPl-sCnc	4180186
21491070	N-乙酰酪氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491071	2,5-dihydroxybenzoic acid; Chemistry; Gentisic acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491071	Gentisate SerPl-sCnc	4180186
21491071	龙胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491072	Octenedioate SerPl-sCnc	4180186
21491072	Chemistry; Level; Octenedioic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491072	辛烯二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491074	3OH-benzoate; Chemistry; CR; Crea; Creat; Hydroxybenzoic acid; III; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491074	3OH-benzoate/Creat Ur-sRto	4180186
21491074	3-羟基苯甲酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491076	4-Deoxythreonate SerPl-sCnc	4180186
21491076	(2S,3R)-2,3-dihydroxybutanoic acid; 2,3-dihydroxybutanoate; 2,3-Dihydroxybutyrate; 2,3-Threo-dihydroxybutyrate; 4-deoxy-threonic acid; Chemistry; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Type I; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491076	4-脱氧苏氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491080	p-Cresol SerPl-sCnc	4180186
21491080	1-hydroxy-4-methylbenzene; 1-methyl-4-hydroxybenzene; 4-cresol; 4-hydroxytoluene; 4-methylphenol; Chemistry; Level; P prime; Paracresol; para-cresol; para-cresylic acid; paramethyl phenol; p-hydroxytoluene; Pl; Plasma; Plsm; p-methylhydroxybenzene; p-methylphenol; Point in time; p-toluol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491080	对-甲酚:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491082	3,5-Dihydroxybenzoic acid; Benzoate; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491082	3,5-Dihydroxybenzoate SerPl-sCnc	4180186
21491082	3,5-二羟基苯甲酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491085	APTA; Physical Therapy; Point in time; Post Acute Care; PT; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
21491088	Activ; Activity; Actvty; APTA; Exercise; Movements; Physical Therapy; Point in time; Post Acute Care; PT; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
21491089	Activ; Activity; Actvty; APTA; Daily activity score SE; Exercise; Movements; Physical Therapy; Point in time; Post Acute Care; PT; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
21491089	Daily activity score SE [AM-PAC]	4180186
21491090	Activ; Activity; Actvty; APTA; Cnt; Count; Exercise; Movements; Number; Physical Therapy; Point in time; Post Acute Care; PT; QNT; Quan; Quant; Quantitative; Random	4180186
21491090	Daily activity items # [AM-PAC]	4180186
21491092	Applied cognitive score SE; APTA; Physical Therapy; Point in time; Post Acute Care; PT; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
21491092	Applied cognitive score SE [AM-PAC]	4180186
21491093	APTA; Cnt; Count; Number; Physical Therapy; Point in time; Post Acute Care; PT; QNT; Quan; Quant; Quantitative; Random	4180186
21491093	Applied cognitive items # [AM-PAC]	4180186
21491097	HEDIS 2016-20 Lead Tests; Painter's colic; Pan; Panel; PANEL.HEDIS; Panl; PB; Plumbism; Pnl; Point in time; Random	4180186
21491097	HEDIS 2016-20 Lead Tests	4180186
21491097	HEDIS 2016-2019 取值集合 - 铅检验项目:-:时间点:^患者:-	4182948
21491098	HEDIS 2016 HPV Vacc Admin	4180186
21491098	HEDIS 2016 HPV Vacc Admin; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
21491098	HEDIS 2016 取值集合 - 已施用的人乳头状瘤病毒疫苗:-:时间点:^患者:-	4182948
21491101	Blood flow.diastolic.early wave.max; CARD.US; Cardio; Cardiology; Early wave; Echography; e-prime Vmax; E-wave; Heart Disease; Largest; Lat; Max V; Maximal; Maximum; MV; MV ann; MV lat ann; Peak; Peak E-wave; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; TDI; ULS; Ultrasound; V max; Vel; Velocity; Vmax	4180186
21491101	MV lat ann e-prime Vmax TDI	4180186
21491101	组织速度.E 波.最大值:速度:时间点:二尖瓣.环.侧部:定量型:超声.组织多普勒	4182948
21491102	CARD.US; Cardio; Cardiology; Echography; Heart Disease; Largest; Max V; Maximal; Maximum; MV; MV ann; MV med ann; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Sonogram; Sonograph; Sonography; s-prime Vmax; TDI; ULS; Ultrasound; V max; Vel; Velocity; Vmax	4180186
21491102	MV med ann s-prime Vmax TDI	4180186
21491102	组织速度.S 波.最大值:速度:时间点:二尖瓣.环.中部:定量型:超声.组织多普勒	4182948
21491103	C&S; Cult; Cultures; Drugs; ID; Identity or presence; Infectious Disease; InfectiousDisease; MDR; MDR gram neg org; Microbiology; Misc; Miscellaneous; Mult; Multi; NEG; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
21491103	MDR gram neg org Spec Cult	4180186
21491103	多重耐药性革兰氏阴性细菌:存在与否或特征标识:时间点:XXX:名义型:培养	4182948
21491104	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
21491104	Sports medicine Diag study note	4180186
21491104	诊断性检查记录:发现:时间点:{环境}:文档型:运动医学	4182948
21491110	Pharmacology Discharge instruct	4180186
21491110	Disch; DOC.ONT; Document; Finding; Findings; Pharmacy; Point in time; Random	4180186
21491110	出院指导:发现:时间点:{环境}:文档型:药理学	4182948
21491112	Continuity assessment record and evaluation; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491112	Palliative care D/C sum	4180186
21491112	出院摘要记录:发现:时间点:{环境}:文档型:缓和照顾	4182948
21491116	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Pharmacy; Point in time; Random; Visit note	4180186
21491116	Pharmacology Discharge teach note	4180186
21491116	出院宣教记录:发现:时间点:{环境}:文档型:药理学	4182948
21491117	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Peds; Point in time; Random; Visit note	4180186
21491117	Peds Discharge teach note	4180186
21491117	出院宣教记录:发现:时间点:{环境}:文档型:儿科学	4182948
21491119	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Path; Point in time; Random; Speech pathology; Speech therapy; Speech-lang path; Visit note	4180186
21491119	Speech-lang path Discharge teach note	4180186
21491119	出院宣教记录:发现:时间点:{环境}:文档型:言语-语言病理学	4182948
21491121	OMS Educ note	4180186
21491121	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OMS; Point in time; Random; Surg; Visit note	4180186
21491121	教育记录:发现:时间点:{环境}:文档型:口腔颌面外科学	4182948
21491122	Cancer; DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oncology; Point in time; Random; Visit note	4180186
21491122	Radiation Onc Educ note	4180186
21491122	教育记录:发现:时间点:{环境}:文档型:放射肿瘤学	4182948
21491125	Transpl surg Educ note	4180186
21491125	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Transpl surg; Visit note	4180186
21491125	教育记录:发现:时间点:{环境}:文档型:移植外科学	4182948
21491126	Palliative care Educ note	4180186
21491126	Continuity assessment record and evaluation; DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491126	教育记录:发现:时间点:{环境}:文档型:缓和照顾	4182948
21491127	Rheumatology Educ note	4180186
21491127	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491127	教育记录:发现:时间点:{环境}:文档型:风湿病学	4182948
21491129	Sports medicine Educ note	4180186
21491129	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491129	教育记录:发现:时间点:{环境}:文档型:运动医学	4182948
21491134	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Social work; SW; Visit note	4180186
21491134	SW Educ note	4180186
21491134	教育记录:发现:时间点:{环境}:文档型:社会工作者	4182948
21491137	Cancer; DOC.ONT; Document; Finding; Findings; Oncology; Point in time; Random	4180186
21491137	Radiation Onc Flowsheet	4180186
21491137	流程记录单:发现:时间点:{环境}:文档型:放射肿瘤学	4182948
21491140	DOC.ONT; Document; Finding; Findings; Orthopedic; Orthopedic surgery; Point in time; Random; Surg	4180186
21491140	流程记录单:发现:时间点:{环境}:文档型:矫形外科学	4182948
21491141	Speech-lang path Flowsheet	4180186
21491141	DOC.ONT; Document; Finding; Findings; Path; Point in time; Random; Speech pathology; Speech therapy; Speech-lang path	4180186
21491141	流程记录单:发现:时间点:{环境}:文档型:言语-语言病理学	4182948
21491143	Peds Flowsheet	4180186
21491143	DOC.ONT; Document; Finding; Findings; Peds; Point in time; Random	4180186
21491143	流程记录单:发现:时间点:{环境}:文档型:儿科学	4182948
21491147	DOC.ONT; Document; Eye; Eye care; Finding; Findings; Ophthalmology; Ophtho; Ophthy; Point in time; Random	4180186
21491147	Ophthalmol Flowsheet	4180186
21491147	流程记录单:发现:时间点:{环境}:文档型:眼科学	4182948
21491148	DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
21491148	流程记录单:发现:时间点:{环境}:文档型:风湿病学	4182948
21491149	DOC.ONT; Document; Finding; Findings; Lung; Point in time; Pulmonary; Pulmonology; Random; Resp therapy; Respiratory	4180186
21491149	Resp therapy Flowsheet	4180186
21491149	流程记录单:发现:时间点:{环境}:文档型:呼吸疗法	4182948
21491150	Psych Flowsheet	4180186
21491150	DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
21491150	流程记录单:发现:时间点:{环境}:文档型:心理学	4182948
21491153	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Peds; Point in time; Random; Visit note	4180186
21491153	Peds Initial eval note	4180186
21491153	初步评价记录:发现:时间点:{环境}:文档型:儿科学	4182948
21491154	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; Genitourinary; GU; H&P; History and physical; Initial eval note; notes; Point in time; Random; URO; Urology; Visit note	4180186
21491154	Urology Initial eval note	4180186
21491154	初步评价记录:发现:时间点:{环境}:文档型:泌尿外科学	4182948
21491158	Assessment; DOC.ONT; Document; Ear Nose Throat; Encounter; ENT; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Oto; Otolaryngology; Otorhinolaryngology; Point in time; Random; Visit note	4180186
21491158	Otolaryngology Initial eval note	4180186
21491158	初步评价记录:发现:时间点:{环境}:文档型:耳鼻喉科学	4182948
21491160	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
21491160	Pain medicine Initial eval note	4180186
21491160	初步评价记录:发现:时间点:{环境}:文档型:疼痛医学	4182948
21491162	Assessment; Cancer; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Oncology; Point in time; Random; Visit note	4180186
21491162	Radiation Onc Initial eval note	4180186
21491162	初步评价记录:发现:时间点:{环境}:文档型:放射肿瘤学	4182948
21491164	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; Rec therapy; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21491164	Rec therapy Prog note	4180186
21491164	病程记录:发现:时间点:{环境}:文档型:娱乐疗法	4182948
21491165	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oncology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21491165	Radiation Onc Prog note	4180186
21491165	病程记录:发现:时间点:{环境}:文档型:放射肿瘤学	4182948
21491168	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21491168	Pain medicine Prog note	4180186
21491168	病程记录:发现:时间点:{环境}:文档型:疼痛医学	4182948
21491169	Oral med fluid in Vol Meas	4180186
21491169	Fld; Fluid intake oral; Fluid intake oral med; IO_INTAKE; IO_INTAKE.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; UGI; Up; Upr GI Tract; Volume	4180186
21491169	液体摄入.口腔.药物:体积型属性:时间点:上消化道:定量型:测量法	4182948
21491174	Num voids	4180186
21491174	Cnt; Count; IO_OUTPUT; IO_OUTPUT.ATOM; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491174	排尿:数量(计数):时间点:尿路:定量型	4182948
21491176	Num incont stools	4180186
21491176	Cnt; Count; IO_OUTPUT; IO_OUTPUT.ATOM; LGI; Low; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491176	大便.失禁:数量(计数):时间点:下消化道:定量型	4182948
21491181	Fluid output musculoskel drain Vol Meas	4180186
21491181	Fld; Fluid output musculoskel drain; IO_OUTPUT; IO_OUTPUT.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
21491181	液体排出.肌肉骨骼系统引流:体积型属性:时间点:肌肉骨骼系统:定量型:测量法	4182948
21491182	Dermatologic; Epidermis; Fld; Fluid output pressure injury; Integument; IO_OUTPUT; IO_OUTPUT.MOLEC; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Skn; Ulcer; Volume	4180186
21491182	Fluid output pressure injury Vol Meas	4180186
21491182	液体排出.压力性损伤:体积型属性:时间点:皮肤:定量型:测量法	4182948
21491183	Fld; Fluid output GI drain; GI; IO_OUTPUT; IO_OUTPUT.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
21491183	Fluid output GI drain Vol Meas	4180186
21491183	液体排出.胃肠道引流:体积型属性:时间点:胃肠道系统:定量型:测量法	4182948
21491184	Fluid output GI ostomy Vol Meas	4180186
21491184	Fld; Fluid output GI ostomy; GI; IO_OUTPUT; IO_OUTPUT.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
21491184	液体排出.胃肠道:体积型属性:时间点:胃肠道系统:定量型:测量法	4182948
21491185	Fluid output enteral tube Vol Meas	4180186
21491185	Fld; Fluid output enteral tube; IO_OUTPUT; IO_OUTPUT.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; UGI; Up; Upr GI Tract; Volume	4180186
21491185	液体排出.肠内管:体积型属性:时间点:上消化道:定量型:测量法	4182948
21491187	alpha-L-Iduronidase; Asympt; Asymptomatic; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; IDUA; MPS I; MPS I NBS Pnl; MPS-I; NB Screen Pnl; NBS; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood	4180186
21491187	MPS I NBS Pnl DBS	4180186
21491187	粘多糖贮积症 I 型新生儿筛查组套:-:时间点:全血.斑点:-	4182948
21491190	Collection method DBS	4180186
21491190	Blood; Coll; Collect; Collected; DBS; Dried blood spot; Filter paper; FP; Meth; Method of; Nominal; Point in time; Random; SPEC; Typ; WB; Whole blood	4180186
21491190	采集方法:类型:时间点:全血.斑点:名义型	4182948
21491192	ABC42; Adrenoleukodystrophy; Adrenoleukodystrophy protein; ALD; ALDP; AMN; ATP-binding cassette, sub-family D; ATP-binding cassette, sub-family D (ALD), member 1; Blood; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491192	ABCD1 gene Mut Anl Bld/T	4180186
21491192	ABCD1 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
21491194	Amplification; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Hereditary Nonpolyposis Colorectal Cancer; HNPCC4; Lynch syndrome; MLH1+MSH2+MSH6+PMS2 del+dup; MLH4; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; PMS2CL; PMSL2; Point in time; Primitive Neuroectodermal Tumor; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; Turcot syndrome; WB; Whole blood; Whole blood or Tissue	4180186
21491194	MLH1+MSH2+MSH6+PMS2 gn Del+Dup+Ful M	4180186
21491194	MLH1+MSH2+MSH6+PMS2 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
21491200	Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491200	Allocystathionine SerPl-sCnc	4180186
21491200	别胱硫醚:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491202	(2S)-6-acetamido-2-ammoniohexanoate; (2S)-6-acetamido-2-azaniumylhexanoate; 2,6-diaminohexanoic acid; Chemistry; Epsilon-N-acetyl-L-lysine; Esoteric; Left; Level; Levo; Lys; N(6)-acetyllsine; N6-Ac-L-lys; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; S-6-acetamido-2-aminohexanoic acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491202	N6-Ac-L-lys SerPl-sCnc	4180186
21491202	N6-乙酰-L-赖氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491203	Chemistry; CR; Crea; Creat; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491203	Alanylproline/Creat Ur-sRto	4180186
21491203	丙氨酰脯氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491204	3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Chemistry; Dextro; Esoteric; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Left; Levo; Levo-serine; Narrative; Point in time; R- + S-BAIB + D- + L-ser patt; R prime; Random; Report; Right; S prime; S-B-AIB; Ser; UA; UR; Urn	4180186
21491204	R- + S-BAIB + D- + L-ser patt Ur-Imp	4180186
21491204	R- 与 S-beta 氨基异丁酸与 D- 与 L-丝氨酸模式:印象:时间点:尿液:叙述型	4182948
21491205	Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491205	Alanylproline SerPl-sCnc	4180186
21491205	丙氨酰脯氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491206	3-(carbamoylamino)-2-methylpropanoic acid; 3-carbamoylamino-2-methylpropanoic acid; 3-Ureidoisobutyrate; B; Beta-Uba; Beta-UIB; Chemistry; DL-beta-Ureidoisobutyric acid; Esoteric; Level; N-carbamoyl beta amino-isobutyrate; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Ureidoisobutyric acid	4180186
21491206	Beta-UIB SerPl-sCnc	4180186
21491206	Beta-脲基异丁酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491207	3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Chemistry; Dextro; Left; Levo; Levo-serine; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; R- + S-BAIB + D- + L-serine panel; R prime; Random; Right; S prime; S-B-AIB; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491207	R- + S-BAIB + D- + L-serine panel SerPl	4180186
21491207	R- 与 S-beta 氨基异丁酸与 D- 与 L-丝氨酸组套:-:时间点:血清/血浆:-	4182948
21491208	3-aminoisobutyrate; 3-aminoisobutyric acid; 4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Ala; Alpha alanine; Aminobutric; Aminobutyric; Amino-n-butyrate; B; B-AIB; Bala; B-Ala; B-Alanine; B-Alanine + B-AIB + GABA Pnl; Chemistry; GABA; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; L-alanine; Pan; PANEL.CHEMISTRY; Panl; Piperidic acid; Pnl; Point in time; Random; UA; UR; Urn	4180186
21491208	B-Alanine + B-AIB + GABA Pnl Ur	4180186
21491208	Beta 丙氨酸与 Beta 氨基异丁酸与 Gamma 氨基丁酸组套:-:时间点:尿液:-	4182948
21491209	Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491209	Aspartylglycine SerPl-sCnc	4180186
21491209	天冬氨酰甘氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491211	1-(2-aminoacetyl)pyrrolidine-2-carboxylic acid; 1-(Aminoacetyl)proline; 1-Glycyl-L-proline; 1-Glycylproline; Chemistry; CR; Crea; Creat; Esoteric; Glycyl-L-proline; Gly-pro; N-glycylproline; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491211	Gly-pro/Creat Ur-sRto	4180186
21491211	甘氨酰脯氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491215	3-aminoisobutyrate; 3-aminoisobutyric acid; 4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Ala; Alpha alanine; Aminobutric; Aminobutyric; Amino-n-butyrate; B; B-AIB; Bala; B-Ala; B-Alanine; B-Alanine + B-AIB + GABA patt; Chemistry; Esoteric; GABA; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; L-alanine; Narrative; Piperidic acid; Point in time; Random; Report; UA; UR; Urn	4180186
21491215	B-Alanine + B-AIB + GABA patt Ur-Imp	4180186
21491215	Beta 丙氨酸与 Beta 氨基异丁酸与 Gamma 氨基丁酸模式:印象:时间点:尿液:叙述型	4182948
21491217	Chemistry; Esoteric; GSH; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491217	GSH SerPl-sCnc	4180186
21491217	谷胱甘肽.还原型:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491218	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Esoteric; Left; Level; Levo; Levo-serine; Point in time; QNT; Quan; Quant; Quantitative; Random; Ser; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491218	L-serine CSF-sCnc	4180186
21491218	L-丝氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
21491220	3-aminoisobutyrate; 3-aminoisobutyric acid; 4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Ala; Alpha alanine; Aminobutric; Aminobutyric; Amino-n-butyrate; B; B-AIB; Bala; B-Ala; B-Alanine; B-Alanine + B-AIB + GABA Pnl; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; GABA; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; L-alanine; Pan; PANEL.CHEMISTRY; Panl; Piperidic acid; Pnl; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
21491220	B-Alanine + B-AIB + GABA Pnl CSF	4180186
21491220	Beta 丙氨酸与 Beta 氨基异丁酸与 Gamma 氨基丁酸组套:-:时间点:脑脊液:-	4182948
21491222	3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Chemistry; Dextro; Left; Levo; Levo-serine; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; R- + S-BAIB + D- + L-serine panel; R prime; Random; Right; S prime; S-B-AIB; Ser; UA; UR; Urn	4180186
21491222	R- + S-BAIB + D- + L-serine panel Ur	4180186
21491222	R- 与 S-beta 氨基异丁酸与 D- 与 L-丝氨酸组套:-:时间点:尿液:-	4182948
21491224	(2S)-2-[[(5S)-5-azaniumyl-5-carboxylatopentyl]azaniumyl]pentanedioate; Chemistry; Esoteric; Level; L-saccharopinate; L-saccharopine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491224	Saccharopine SerPl-sCnc	4180186
21491224	酵母氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491230	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491230	转诊记录:发现:时间点:{环境}:文档型:公共卫生	4182948
21491233	Transpl surg Referral note	4180186
21491233	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Transpl surg; Visit note	4180186
21491233	转诊记录:发现:时间点:{环境}:文档型:移植外科学	4182948
21491236	Vascular surgery Transfer sum note	4180186
21491236	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Transfer sum note; Visit note	4180186
21491236	移交摘要记录:发现:时间点:{环境}:文档型:血管外科学	4182948
21491239	Transpl surg Transfer sum note	4180186
21491239	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Transfer sum note; Transpl surg; Visit note	4180186
21491239	移交摘要记录:发现:时间点:{环境}:文档型:移植外科学	4182948
21491240	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OMS; Point in time; Random; Surg; Transfer sum note; Visit note	4180186
21491240	OMS Transfer sum note	4180186
21491240	移交摘要记录:发现:时间点:{环境}:文档型:口腔颌面外科学	4182948
21491242	Agg; Aggr; Arbitrary concentration; Blood; COAGULATION; Hematology; Heme; hi dose; PA; PA Rist; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RIPA; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
21491242	PA Rist hi dose Bld-aCnc	4180186
21491242	血小板聚集.瑞斯托菌素诱导型^大剂量:任意型浓度:时间点:全血:定量型	4182948
21491244	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; Alprostadil; ANED; Arbitrary concentration; Blood; COAGULATION; Hematology; Heme; Medication stress; PA; PA ADP+PGE1 induced; PG; PGE1; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
21491244	PA ADP+PGE1 induced Bld-aCnc	4180186
21491244	血小板聚集.二磷酸腺苷+前列腺素 E1 诱导型:任意型浓度:时间点:全血:定量型	4182948
21491246	5OH-methyluracil; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491246	5OH-methyluracil/Creat Ur-sRto	4180186
21491246	5-羟甲基尿嘧啶/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491250	2,6-dioxo-1,3-diazinane-4-carboxylate; 4,5-dihydroorotate; 5,6-dihydroorotate; Chemistry; CR; Crea; Creat; Hydroorotic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491250	Dihydroorotate/Creat Ur-sRto	4180186
21491250	二氢乳清酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491252	Selenium Bld-sCnc	4180186
21491252	Blood; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; SE; Substance concentration; WB; Whole blood	4180186
21491252	硒:物质的量浓度:时间点:全血:定量型	4182948
21491253	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Black olive; f342; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Olive; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
21491253	Olive IgG-mCnc	4180186
21491253	橄榄 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
21491256	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491256	转诊记录:发现:时间点:{环境}:文档型:运动医学	4182948
21491257	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cedar elm; Elm; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t45; Texas cedar elm	4180186
21491257	Cedar elm IgE Qn	4180186
21491257	硬叶榆 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
21491258	Daily/end shift signout note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491258	Daily/end shift signout note	4180186
21491258	每日或班次结束注销记录:发现:时间点:{环境}:文档型:{角色}	4182948
21491259	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491259	危机干预记录:发现:时间点:{环境}:文档型:{角色}	4182948
21491261	DOC.ONT; Document; Finding; Findings; Gyn; Gynecology; OB; OBGYN; Obstetric; Obstetrics; Point in time; Prenatal; Random	4180186
21491261	OBGYN Flowsheet	4180186
21491261	流程记录单:发现:时间点:{环境}:文档型:产科学与妇科学	4182948
21491262	DOC.ONT; Document; Eye; Eye care; Finding; Findings; Ophthalmology; Ophtho; Ophthy; Point in time; Random	4180186
21491262	Ophthalmol Checklist	4180186
21491262	检查清单:发现:时间点:{环境}:文档型:眼科学	4182948
21491264	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye; Eye care; Finding; Findings; notes; Operative note; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Surg; Visit note	4180186
21491264	Ophthalmol Operative note	4180186
21491264	外科手术记录:发现:时间点:{环境}:文档型:眼科学	4182948
21491266	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nutr+diet; Nutrition+Dietetics; Point in time; Random; Visit note	4180186
21491266	Nutr+diet Counseling note	4180186
21491266	咨询记录:发现:时间点:{环境}:文档型:营养学与膳食学	4182948
21491273	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; H&P; History and physical; Initial eval note; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
21491273	OBGYN Initial eval note	4180186
21491273	初步评价记录:发现:时间点:{环境}:文档型:产科学与妇科学	4182948
21491276	Peds Consult note	4180186
21491276	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Peds; Point in time; Random; Visit note	4180186
21491276	会诊记录:发现:时间点:{环境}:文档型:儿科学	4182948
21491279	Surgery Transfer sum note	4180186
21491279	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Transfer sum note; Visit note	4180186
21491279	移交摘要记录:发现:时间点:{环境}:文档型:外科学	4182948
21491280	Assessment; Cardio; Cardiology; Cardiothor surg; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; Heart Disease; History and physical; notes; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; Surg; Visit note	4180186
21491280	Cardiothor surg Pre-op note	4180186
21491280	术前评价与管理记录:发现:时间点:{环境}:文档型:胸心外科学	4182948
21491282	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491282	会诊记录:发现:时间点:{环境}:文档型:创伤专业	4182948
21491286	(2S,4R)-4-hydroxy-1-[(2S)-pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid; Chemistry; CR; Crea; Creat; Esoteric; H-Pro-Hyp-OH; L-Pro-L-Hyp; L-Prolyl-L-hydroxyproline; Point in time; Proline-hydroxyproline; Prolyl-OH-proline; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491286	Prolyl-OH-proline/Creat Ur-sRto	4180186
21491286	脯氨酰羟脯氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491287	(S)-2-Amino-6-guanidinohexanoic acid; Chemistry; Esoteric; Homoarginine; Homo-L-arginine; Left; Level; Levo; N6-(Aminoiminomethyl)-L-lysine; N6-amidino-L-Lysine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491287	L-homoarginine SerPl-sCnc	4180186
21491287	L-高精氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491288	3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dextro; Esoteric; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Left; Levo; Levo-serine; Narrative; Point in time; R- + S-BAIB + D- + L-ser patt; R prime; Random; Report; Right; S prime; S-B-AIB; Ser; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
21491288	R- + S-BAIB + D- + L-ser patt CSF-Imp	4180186
21491288	R- 与 S-beta 氨基异丁酸与 D- 与 L-丝氨酸模式:印象:时间点:脑脊液:叙述型	4182948
21491289	5-S-Cysteinyldopa; 5-S-Cysteinyl-DOPA; Chemistry; Cysteinyl-dihydroxyphenylalanine; Cysteinyldopa; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491289	5-S-cysteinyldopa SerPl-sCnc	4180186
21491289	5-S-半胱氨酰多巴:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491294	3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Esoteric; Level; Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; R-B-AIB; Right; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491294	R-B-AIB CSF-sCnc	4180186
21491294	R-beta 氨基异丁酸:物质的量浓度:时间点:脑脊液:定量型	4182948
21491295	3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Chemistry; Dextro; Esoteric; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Left; Levo; Levo-serine; Narrative; Pl; Plasma; Plsm; Point in time; R- + S-BAIB + D- + L-ser patt; R prime; Random; Report; Right; S prime; S-B-AIB; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491295	R- + S-BAIB + D- + L-ser patt SerPl-Imp	4180186
21491295	R- 与 S-beta 氨基异丁酸与 D- 与 L-丝氨酸模式:印象:时间点:血清/血浆:叙述型	4182948
21491298	(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidine-2-carboxylic acid; Chemistry; Esoteric; Left; Leucylproline; Level; Levo; L-leu-L-pro; Pl; Plasma; Plsm; Point in time; Pro; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491298	L-leu-L-pro SerPl-sCnc	4180186
21491298	L-亮氨酰-L-脯氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491299	(2S)-6-acetamido-2-ammoniohexanoate; (2S)-6-acetamido-2-azaniumylhexanoate; 2,6-diaminohexanoic acid; Chemistry; CR; Crea; Creat; Epsilon-N-acetyl-L-lysine; Esoteric; Left; Levo; Lys; N(6)-acetyllsine; N6-Ac-L-lys; Point in time; QNT; Quan; Quant; Quantitative; Random; S-6-acetamido-2-aminohexanoic acid; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491299	N6-Ac-L-lys/Creat Ur-sRto	4180186
21491299	N6-乙酰-L-赖氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491300	ADMA; Asymmetric Dimethylarginine; Chemistry; CR; Crea; Creat; dimethyl-L-arginine; Esoteric; guanidino-N(1),N(2)-dimethylarginine; N(G)-dimethylarginine; N(G1),N(G1)-dimethylarginine; N(G1),N(G2)-dimethylarginine; N,N'-dimethylarginine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SDMA; sDMA arginine; Substance concentration ratio; Substance ratio; symmetric dimethylarginine; UA; UCr; UR; Urn	4180186
21491300	N,N-dimethylarginine/Creat Ur-sRto	4180186
21491300	N,N-二甲基精氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491303	3-aminoisobutyrate; 3-aminoisobutyric acid; 4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Ala; Alpha alanine; Aminobutric; Aminobutyric; Amino-n-butyrate; B; B-AIB; Bala; B-Ala; B-Alanine; B-Alanine + B-AIB + GABA patt; Chemistry; Esoteric; GABA; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; L-alanine; Narrative; Piperidic acid; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491303	B-Alanine + B-AIB + GABA patt SerPl-Imp	4180186
21491303	Beta 丙氨酸与 Beta 氨基异丁酸与 Gamma 氨基丁酸模式:印象:时间点:血清/血浆:叙述型	4182948
21491305	(2S)-2-[[(5S)-5-azaniumyl-5-carboxylatopentyl]azaniumyl]pentanedioate; Chemistry; CR; Crea; Creat; Esoteric; L-saccharopinate; L-saccharopine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491305	Saccharopine/Creat Ur-sRto	4180186
21491305	酵母氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491306	Chemistry; CR; Crea; Creat; Esoteric; GSH; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491306	GSH/Creat Ur-sRto	4180186
21491306	谷胱甘肽.还原型/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491308	5-S-Cysteinyldopa; 5-S-Cysteinyl-DOPA; Chemistry; CR; Crea; Creat; Cysteinyl-dihydroxyphenylalanine; Cysteinyldopa; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491308	5-S-cysteinyldopa/Creat Ur-sRto	4180186
21491308	5-S-半胱氨酰多巴/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491309	(S)-2-amino-4-hydroxybutanoic acid; (S)-homoserine; 2-Amino-4-hydroxybutyric acid; Chemistry; CR; Crea; Creat; Esoteric; Homo-L-serine; Homoserine; Isothreonine; Left; Levo; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491309	L-homoserine/Creat Ur-sRto	4180186
21491309	L-高丝氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491311	5-ALA; 5-aminolevulinate; 5-aminolevulinic acid; ALA; Aminolevulinic acid; Amnolev; Amnolevuunc; Chemistry; D-ALA; Delta-ala; Delta-aminolevulinic acid; Esoteric; Hematology; Heme; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491311	D-ALA SerPl-sCnc	4180186
21491311	Delta 氨基酮戊酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491312	3-(carbamoylamino)-2-methylpropanoic acid; 3-carbamoylamino-2-methylpropanoic acid; 3-Ureidoisobutyrate; B; Beta-Uba; Beta-UIB; Chemistry; CR; Crea; Creat; DL-beta-Ureidoisobutyric acid; Esoteric; N-carbamoyl beta amino-isobutyrate; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Ureidoisobutyric acid; Urn	4180186
21491312	Beta-UIB/Creat Ur-sRto	4180186
21491312	Beta-脲基异丁酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491317	4-Amino-1H-imidazole-5-carboxamide; 4-Amino-5-Imidazolecarboxamide; 4-Carbamoyl-5-aminoimidazole; AICA; AICAR; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Colahepat; Diazol-C; Esoteric; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491317	5-Aminoimidazole-4-carboxamide CSF-sCnc	4180186
21491317	5-氨基咪唑-4-氨甲酰:物质的量浓度:时间点:脑脊液:定量型	4182948
21491319	2,6-dioxo-1,3-diazinane-4-carboxylate; 4,5-dihydroorotate; 5,6-dihydroorotate; Chemistry; Esoteric; Hydroorotic acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491319	Dihydroorotate SerPl-sCnc	4180186
21491319	二氢乳清酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491321	Ala; Alpha alanine; B; Bala; B-Ala; B-Alanine; Chemistry; Esoteric; L-alanine; Level; N-carbamoyl B-alanine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491321	N-carbamoyl B-alanine SerPl-sCnc	4180186
21491321	N-氨甲酰基 beta 丙氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491323	Chemistry; CR; Crea; Creat; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491323	Cytosine/Creat Ur-sRto	4180186
21491323	胞嘧啶/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491324	Chemistry; Esoteric; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Pl; Plasma; Plsm; Point in time; Purine + Pyrimidine pattern; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491324	Purine + Pyrimidine pattern SerPl-Imp	4180186
21491324	嘌呤与嘧啶模式:印象:时间点:血清/血浆:叙述型	4182948
21491325	2-Amino-9-Beta-D-Ribofuranosyl-9H-Purine-6(1H)-One; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Esoteric; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491325	Guanosine CSF-sCnc	4180186
21491325	鸟嘌呤核苷:物质的量浓度:时间点:脑脊液:定量型	4182948
21491327	Allopurinol SerPl-sCnc	4180186
21491327	DRUG/TOXICOLOGY; Drugs; Level; Lopurin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Zyloprim	4180186
21491327	别嘌呤醇:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491329	Ala; Alpha alanine; B; Bala; B-Ala; B-Alanine; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Esoteric; L-alanine; Level; N-carbamoyl B-alanine; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491329	N-carbamoyl B-alanine CSF-sCnc	4180186
21491329	N-氨甲酰基 beta 丙氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
21491332	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazinane-2,4-dione; 1-beta-D-ribofuranosylhydrouracil; 3,4-Dihydrouridine; Chemistry; Dihydrouridine; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491332	5,6-Dihydrouridine SerPl-sCnc	4180186
21491332	5,6-二氢尿嘧啶核苷:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491335	2-Amino-9-Beta-D-Ribofuranosyl-9H-Purine-6(1H)-One; Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491335	Guanosine SerPl-sCnc	4180186
21491335	鸟嘌呤核苷:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491336	1-beta-D-Ribofuranosylcytosine; 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Cytosine Riboside; Esoteric; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491336	Cytidine CSF-sCnc	4180186
21491336	胞嘧啶核苷:物质的量浓度:时间点:脑脊液:定量型	4182948
21491337	4-Amino-1H-imidazole-5-carboxamide; 4-Amino-5-Imidazolecarboxamide; 4-Carbamoyl-5-aminoimidazole; AICA; AICAR; Chemistry; Colahepat; CR; Crea; Creat; Diazol-C; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491337	5-Aminoimidazole-4-carboxamide/Cr U-sCnc	4180186
21491337	5-氨基咪唑-4-氨甲酰/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491338	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genitourinary; GU; H&P note; Hx; notes; Point in time; Random; URO; Urology; Visit note	4180186
21491338	Urology Admit H&P note	4180186
21491338	入院史与体格检查记录:发现:时间点:{环境}:文档型:泌尿外科学	4182948
21491339	DOC.ONT; Document; Finding; Findings; Genitourinary; GU; Point in time; Random; URO; Urology	4180186
21491339	检查清单:发现:时间点:{环境}:文档型:泌尿外科学	4182948
21491340	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; Genitourinary; GU; H&P; History and physical; notes; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; URO; Urology; Visit note	4180186
21491340	Urology Pre-op note	4180186
21491340	术前评价与管理记录:发现:时间点:{环境}:文档型:泌尿外科学	4182948
21491343	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491343	会诊记录:发现:时间点:{环境}:文档型:运动医学	4182948
21491346	#; ABS; absolute; absolutes; Auto; Automated detection; Cast; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Kidney; Nephrology; Number concentration; Number Concentration (count/vol); Path; Path casts; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urn	4180186
21491346	Path casts # Ur Auto	4180186
21491346	病理性管型:计数型浓度:时间点:尿液:定量型:自动化计数方法	4182948
21491348	Steroid Fract Ur-Imp	4180186
21491348	Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Narrative; Point in time; Random; Report; UA; UR; Urn	4180186
21491348	类固醇类成分解释:印象:时间点:尿液:叙述型	4182948
21491351	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Location; Nominal; Point in time; Random	4180186
21491351	Country of birth	4180186
21491351	出生国家:位置:时间点:^患者:名义型	4182948
21491352	Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Pan; PANEL.CHEMISTRY; Panl; Peritoneal Dialysis fluid; PET Pnl; Pnl; Point in time; Random	4180186
21491352	PET Pnl DiafP	4180186
21491352	腹膜平衡试验组套:-:时间点:腹膜透析液:-	4182948
21491353	Hgb Fract Bld CE-Imp	4180186
21491353	Blood; CE; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Fract; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; WB; Whole blood	4180186
21491353	血红蛋白模式:印象:时间点:全血:名义型:毛细管电泳	4182948
21491354	Chemistry; Gas chromatography; Glycolic acid; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491354	Glycolate SerPl GC-mCnc	4180186
21491354	羟乙酸:质量浓度:时间点:血清/血浆:定量型:气相色谱分析法	4182948
21491355	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Hep; Hep E; Hepatis; Hepatit; Hepatology; HEV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Log ACNC; Log IU; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
21491355	HEV RNA SerPl NAA+probe-Log IU	4180186
21491355	戊型肝炎病毒 RNA:对数型任意浓度:时间点:血清/血浆:定量型:探针法.基因扩增.靶向	4182948
21491356	11OH-THC Hair-mCnt	4180186
21491356	11-hydroxy-delta(9)-THC; 11-hydroxytetrahydrocannabinol; 11-hydroxy-THC; 11-OH-THC; 11OH-THC; 7-hydroxy-delta(1)-tetrahydrocannabinol; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Delta-9-tetrahydrocannabinol metabolite; Dronabinol; DRUG/TOXICOLOGY; Drugs; Har; Hydrox; Marijuana; Mass content; Nabilone; OH; Point in time; QNT; Quan; Quant; Quantitative; Random; THC; THC metabolite	4180186
21491356	11-羟基-δ-9-四氢大麻酚:质量含量:时间点:毛发:定量型	4182948
21491359	11OH-THC Ur Ql Scn	4180186
21491359	11-hydroxy-delta(9)-THC; 11-hydroxytetrahydrocannabinol; 11-hydroxy-THC; 11-OH-THC; 11OH-THC; 7-hydroxy-delta(1)-tetrahydrocannabinol; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Delta-9-tetrahydrocannabinol metabolite; Dronabinol; DRUG/TOXICOLOGY; Drugs; Hydrox; Marijuana; Nabilone; OH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; THC; THC metabolite; UA; UR; Urn	4180186
21491359	11-羟基-δ-9-四氢大麻酚:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
21491360	1-Hydroxy midazolam; 1OH-midazolam; Alpha hydroxymidazolam; Alpha-hydroxymidazolam; Blood; Chlonazepam metabolite; DRUG/TOXICOLOGY; Drugs; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
21491360	1OH-midazolam Bld-mCnc	4180186
21491360	1-羟基咪达唑仑:质量浓度:时间点:全血:定量型	4182948
21491362	2-oxo-3-OH-LDS; DRUG/TOXICOLOGY; Drugs; Hydrox; II; III; LSD; LSD metabolite; Lysergic acid; Lysergic acid diethylamide; OH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
21491362	2-oxo-3-OH-LDS Ur Ql Scn	4180186
21491362	2-氧代-3-羟基-麦角二乙胺:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
21491363	4OH-midazolam Ur-mCnc	4180186
21491363	4-Hydroxy midazolam; 4OH-midazolam; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Midazolam metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491363	4-羟基咪达唑仑:质量浓度:时间点:尿液:定量型	4182948
21491364	6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin metabolite; Illicit; MAM; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; WB; Whole blood	4180186
21491364	6MAM Bld Ql Scn	4180186
21491364	6-单乙酰吗啡:存在情况或阈值:时间点:全血:序数型:毒理学筛查试验	4182948
21491365	6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Heroin metabolite; Illicit; MAM; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
21491365	6MAM Fld Ql Scn	4180186
21491365	6-单乙酰吗啡:存在情况或阈值:时间点:体液:序数型:毒理学筛查试验	4182948
21491367	7-amino flunitrazepam; 7Aminoflunitrazepam; DRUG/TOXICOLOGY; Drugs; Flunitrazepam metabolite; Har; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491367	7Aminoflunitrazepam Hair-mCnt	4180186
21491367	7-氨基氟硝安定:质量含量:时间点:毛发:定量型	4182948
21491368	OPC3373 adj bodymass+crea Ur-mCnc	4180186
21491368	adj; adj bodymass+crea; Aripiprazole metabolite; bod; Bodies; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
21491368	OPC3373^^经过针对瘦体重+尿液肌酐而调整的:质量浓度:时间点:尿液:定量型	4182948
21491369	7-Hydroxy Quetiapine; 7OH-quetiapine; adj; adj bodymass+crea; bod; Bodies; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Quetiapine metabolite; Random; UA; UCr; UR; Urn	4180186
21491369	7OH-quetiapine adj bodymass+crea Ur-mCnc	4180186
21491369	7-羟基喹硫平^^经过针对瘦体重+尿液肌酐而调整的:质量浓度:时间点:尿液:定量型	4182948
21491370	oxyMORphone adj bodymass+crea Ur-mCnc	4180186
21491370	14-Hydroxydihydromorphinone; adj; adj bodymass+crea; bod; Bodies; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Numorphan; Numorphone; Opana; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
21491370	羟吗啡酮^^经过针对瘦体重+尿液肌酐而调整的:质量浓度:时间点:尿液:定量型	4182948
21491371	Actiq; adj; adj bodymass+crea; bod; Bodies; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Duragesic; Durogesic; Fenpat; fentanil; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sublimaze; UA; UCr; UR; Urn	4180186
21491371	fentaNYL adj bodymass+crea Ur-mCnc	4180186
21491371	芬太尼^^经过针对瘦体重+尿液肌酐而调整的:质量浓度:时间点:尿液:定量型	4182948
21491372	oxyCODONE adj bodymass+crea Ur-mCnc	4180186
21491372	adj; adj bodymass+crea; bod; Bodies; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Level; Lortab; Mass concentration; OxyContin; Percocet; Percodan; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; Vicodin	4180186
21491372	羟考酮^^经过针对瘦体重+尿液肌酐而调整的:质量浓度:时间点:尿液:定量型	4182948
21491373	Morphine adj bodymass+crea Ur-mCnc	4180186
21491373	adj; adj bodymass+crea; bod; Bodies; c260; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Morphine sulfate; MS; MSO4; OMPH; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
21491373	吗啡^^经过针对瘦体重+尿液肌酐而调整的:质量浓度:时间点:尿液:定量型	4182948
21491374	HYDROcodone adj bodymass+crea Ur-mCnc	4180186
21491374	adj; adj bodymass+crea; Anexsia; bod; Bodies; CR; Crea; Creat; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; Vicodin	4180186
21491374	氢可酮^^经过针对瘦体重+尿液肌酐而调整的:质量浓度:时间点:尿液:定量型	4182948
21491375	Methadone adj bodymass+crea Ur-mCnc	4180186
21491375	adj; adj bodymass+crea; bod; Bodies; CR; Crea; Creat; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; METD; Methadose; MTD; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
21491375	美沙酮^^经过针对瘦体重+尿液肌酐而调整的:质量浓度:时间点:尿液:定量型	4182948
21491376	9-Hydroxy risperidone; 9-Hydroxy-risperidone; 9-OH-Risperidone; 9OH-risperidone; DRUG/TOXICOLOGY; Drugs; Har; Invega; Mass content; Paliperidone; Point in time; QNT; Quan; Quant; Quantitative; Random; Risperidone metabolite	4180186
21491376	9OH-risperidone Hair-mCnt	4180186
21491376	9-羟基利培酮:质量含量:时间点:毛发:定量型	4182948
21491378	Abacavir SerPl-mCnc	4180186
21491378	1592U89; ABC; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Ziagen	4180186
21491378	阿巴卡韦:质量浓度:时间点:血清/血浆:定量型	4182948
21491379	Acenocoumarol Bld-mCnc	4180186
21491379	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Nicoumalone; Point in time; QNT; Quan; Quant; Quantitative; Random; Sinthrome; WB; Whole blood	4180186
21491379	新抗凝:质量浓度:时间点:全血:定量型	4182948
21491380	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Nicoumalone; Point in time; QNT; Quan; Quant; Quantitative; Random; Sinthrome; UA; UR; Urn	4180186
21491380	Acenocoumarol Ur-mCnc	4180186
21491380	新抗凝:质量浓度:时间点:尿液:定量型	4182948
21491382	Alfenta; DRUG/TOXICOLOGY; Drugs; Fanaxal; Har; Limefen; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Rapifen	4180186
21491382	Alfentanil Hair-mCnt	4180186
21491382	阿芬太尼:质量含量:时间点:毛发:定量型	4182948
21491383	Alfenta; Blood; DRUG/TOXICOLOGY; Drugs; Fanaxal; Limefen; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rapifen; Scn; Scr; Screen; Scrn; WB; Whole blood	4180186
21491383	Alfentanil Bld Ql Scn	4180186
21491383	阿芬太尼:存在情况或阈值:时间点:全血:序数型:毒理学筛查试验	4182948
21491384	Blood; DRUG/TOXICOLOGY; Drugs; Level; Litican; Mass concentration; Plitican; Point in time; QNT; Quan; Quant; Quantitative; Random; Superan; Vergentan; WB; Whole blood	4180186
21491384	Alizapride Bld-mCnc	4180186
21491384	阿立必利:质量浓度:时间点:全血:定量型	4182948
21491386	Alpraz CtO Ur Cfm-mCnc	4180186
21491386	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Niravam; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Xanax	4180186
21491386	阿普唑仑 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491389	Amiodarone Ur-mCnc	4180186
21491389	Cordarone; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pacerone; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491389	胺碘酮:质量浓度:时间点:尿液:定量型	4182948
21491390	Amitrip Hair-mCnt	4180186
21491390	Amit; Amitrip; Amitriptylene; Amitriptyln; DRUG/TOXICOLOGY; Drugs; Elatrol; Elavil; Endep; Har; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Trepiline; Tryptanol; Tryptizol	4180186
21491390	阿米替林:质量含量:时间点:毛发:定量型	4182948
21491391	Amit; Amitrip; Amitriptylene; Amitriptyln; Blood; DRUG/TOXICOLOGY; Drugs; Elatrol; Elavil; Endep; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Trepiline; Tryptanol; Tryptizol; WB; Whole blood	4180186
21491391	Amitrip Bld-mCnc	4180186
21491391	阿米替林:质量浓度:时间点:全血:定量型	4182948
21491392	amLODIPine Bld-mCnc	4180186
21491392	AM; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Norvasc; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
21491392	阿莫洛地平:质量浓度:时间点:全血:定量型	4182948
21491393	Purine + Pyrimidine Pnl Ur	4180186
21491393	Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Purine + Pyrimidine Pnl; Random; UA; UR; Urn	4180186
21491393	嘌呤与嘧啶组套:-:时间点:尿液:-	4182948
21491394	(1S)-1,4-Anhydro-1-(2,4-dihydroxy-5-pyrimidinyl)-D-ribitol; 5-ribosyluracil; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Esoteric; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491394	Pseudouridine CSF-sCnc	4180186
21491394	假尿嘧啶核苷:物质的量浓度:时间点:脑脊液:定量型	4182948
21491396	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazinane-2,4-dione; 1-beta-D-ribofuranosylhydrouracil; 3,4-Dihydrouridine; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dihydrouridine; Esoteric; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491396	5,6-Dihydrouridine CSF-sCnc	4180186
21491396	5,6-二氢尿嘧啶核苷:物质的量浓度:时间点:脑脊液:定量型	4182948
21491397	Chemistry; Esoteric; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Purine + Pyrimidine pattern; Random; Report; UA; UR; Urn	4180186
21491397	Purine + Pyrimidine pattern Ur-Imp	4180186
21491397	嘌呤与嘧啶模式:印象:时间点:尿液:叙述型	4182948
21491398	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazinane-2,4-dione; 1-beta-D-ribofuranosylhydrouracil; 3,4-Dihydrouridine; Chemistry; CR; Crea; Creat; Dihydrouridine; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491398	5,6-Dihydrouridine/Creat Ur-sRto	4180186
21491398	5,6-二氢尿嘧啶核苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491399	4-Amino-1H-imidazole-5-carboxamide; 4-Amino-5-Imidazolecarboxamide; 4-Carbamoyl-5-aminoimidazole; AICA; AICAR; Chemistry; Colahepat; Diazol-C; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491399	5-Aminoimidazole-4-carboxamide SrPl-sCnc	4180186
21491399	5-氨基咪唑-4-氨甲酰:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491400	6-amino-2,8-dihydroxypurine; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Esoteric; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491400	2,8-dihydroxyadenine CSF-sCnc	4180186
21491400	2,8-二羟基腺嘌呤:物质的量浓度:时间点:脑脊液:定量型	4182948
21491401	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Lopurin; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn; Zyloprim	4180186
21491401	Allopurinol/Creat Ur-sRto	4180186
21491401	别嘌呤醇/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491403	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Esoteric; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491403	Cytosine CSF-sCnc	4180186
21491403	胞嘧啶:物质的量浓度:时间点:脑脊液:定量型	4182948
21491404	1-beta-D-Ribofuranosylcytosine; 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; Chemistry; CR; Crea; Creat; Cytosine Riboside; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491404	Cytidine/Creat Ur-sRto	4180186
21491404	胞嘧啶核苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491406	5OH-methyluracil; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Esoteric; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491406	5OH-methyluracil CSF-sCnc	4180186
21491406	5-羟甲基尿嘧啶:物质的量浓度:时间点:脑脊液:定量型	4182948
21491408	5OH-methyluracil; Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491408	5OH-methyluracil SerPl-sCnc	4180186
21491408	5-羟甲基尿嘧啶:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491409	Allopurinol CSF-sCnc	4180186
21491409	Cerebral spinal fluid; Cerebrospinal Fl; DRUG/TOXICOLOGY; Drugs; Level; Lopurin; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; Zyloprim	4180186
21491409	别嘌呤醇:物质的量浓度:时间点:脑脊液:定量型	4182948
21491413	1,3-diazinane-2,4-dione; 5,6-Dihydro-2,4-dihydroxypyrimidine; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dihydrouracil; Esoteric; Hydrouracil; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491413	5,6-Dihydrouracil CSF-sCnc	4180186
21491413	5,6-二氢尿嘧啶:物质的量浓度:时间点:脑脊液:定量型	4182948
21491414	Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491414	Eicosadienoate SerPl-sCnc	4180186
21491414	二十碳二烯酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491416	Chemistry; Entitic substance; Erythrocytes; Esoteric; Gondoic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21491416	cis-11-Eicosenoate EntSub RBC	4180186
21491416	cis-11-二十碳烯酸:实体物质的量:时间点:红细胞:定量型	4182948
21491418	Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491418	Docosadienoate SerPl-sCnc	4180186
21491418	二十二碳二烯酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491420	Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491420	cis-11,14-Eicosadienoate SerPl-sCnc	4180186
21491420	cis-11,14-二十碳二烯酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491421	Acd; Acid; Aliphatic carboxylate; Chains; Chemistry; Chn; Erucate; Erucic acid; Esoteric; Fatty acid; Level; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VLC; VLCF; VLCFA; VLCFA.C22:1n9	4180186
21491421	VLCFA.C22:1n9 SerPl-sCnc	4180186
21491421	脂肪酸类.极长链型.C22:1n9:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491424	8,11,14 Eicosatrienoic acid; C18:3w6; C20:3w6; Chemistry; DHGLA; dihomo-g-linolenic acid; Eicosatrienoate; Entitic substance; Erythrocytes; Esoteric; Gamma linolenic acid; Gamoleic acid; G-Linolenate; Homo-G Linolenate; Homo-gamma linolenic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21491424	Homo-G Linolenate EntSub RBC	4180186
21491424	同型γ亚麻酸:实体物质的量:时间点:红细胞:定量型	4182948
21491425	Chemistry; Entitic substance; Erythrocytes; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21491425	Eicosadienoate EntSub RBC	4180186
21491425	二十碳二烯酸:实体物质的量:时间点:红细胞:定量型	4182948
21491426	Chemistry; Entitic substance; Erythrocytes; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21491426	Octadecatetraenoate EntSub RBC	4180186
21491426	十八碳四烯酸:实体物质的量:时间点:红细胞:定量型	4182948
21491427	Acd; Acid; Aliphatic carboxylate; C26:1; Chains; Chemistry; Chn; Esoteric; Fatty acid; Hexacosenoate; Hexacosenoic acid; i; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio; VLC; VLCF; VLCFA; VLCFA C26:1; VLCFA C26:1/C22:0	4180186
21491427	VLCFA C26:1/C22:0 SerPl-sRto	4180186
21491427	脂肪酸类.极长链型.C26:1/C22:0:物质的量比率:时间点:血清/血浆:定量型	4182948
21491432	Blood; Human Leukocyte Antigen; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491432	HLA-A*31:01 Bld/T Ql	4180186
21491432	HLA-A*31:01:存在情况或阈值:时间点:全血/组织:序数型	4182948
21491433	Tricyclics SerPl Ql Scn	4180186
21491433	Antidepres; Antidepressant; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCA; Tricyclics	4180186
21491433	三环类抗抑郁药:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
21491436	B abortus IgG Titr Ser Aggl	4180186
21491436	牛种布鲁氏菌 抗体.IgG:滴定度:时间点:血清:定量型:凝集试验法	4182948
21491436	Abort; ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; Bruc; Brucellosis; Contagious abortion; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Undulant fever	4180186
21491437	Me-histamine/Creat 24h Ur-sRto	4180186
21491437	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Me-histamine; Methylhistamine; N-MH; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491437	N-甲基组胺/肌酐:物质的量比率:24小时:尿液:定量型	4182948
21491438	Arbitrary concentration; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; S152; sCD27; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T14	4180186
21491438	sCD27 CSF-aCnc	4180186
21491438	可溶性 CD27:任意型浓度:时间点:脑脊液:定量型	4182948
21491439	Blood; Cardio; Cardiolip; Cardiolipn; Cardiolpn; Chemistry; CL; DBS; Dried blood spot; Filter paper; FP; MLCL; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
21491439	MLCL/CL DBS-sRto	4180186
21491439	单溶血心磷脂/心磷脂:物质的量比率:时间点:全血.斑点:定量型	4182948
21491441	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxythymidine; DNA NUCLEIC ACID PROBE; DNA probe; gG; Glycoprot; Glycoproteins; GP; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV 2 glyco B 3'+TK reg C; HSV2; ID; II; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TK; TMA; Transcription mediated amplification	4180186
21491441	HSV 2 glyco B 3'+TK regC Anogn Ql NAA+pr	4180186
21491441	单纯疱疹病毒 2 基因组糖蛋白 B 3' 端区域+胸腺嘧啶核苷激酶区域 C:存在情况或阈值:时间点:肛门生殖器:序数型:探针法.基因扩增.靶向	4182948
21491442	Auto; Automated detection; Elec; Elect; Electr; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
21491443	Auto; Automated detection; Elec; Elect; Electr; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
21491444	Auto; Automated detection; Elec; Elect; Electr; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
21491445	Finding; Findings; Manl; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
21491447	AM; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Norvasc; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491447	amLODIPine Ur-mCnc	4180186
21491447	阿莫洛地平:质量浓度:时间点:尿液:定量型	4182948
21491449	Addiction; Amph; Amphet; Amphetam; Amphetamines; Ampht; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Speed	4180186
21491449	Amphet Fld Ql Scn	4180186
21491449	苯丙胺:存在情况或阈值:时间点:体液:序数型:毒理学筛查试验	4182948
21491452	Abilify; DRUG/TOXICOLOGY; Drugs; Har; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491452	ARIPiprazole Hair-mCnt	4180186
21491452	阿立哌唑:质量含量:时间点:毛发:定量型	4182948
21491453	ARIPiprazole Bld-mCnc	4180186
21491453	Abilify; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
21491453	阿立哌唑:质量浓度:时间点:全血:定量型	4182948
21491459	Barium Tiss-sCnt	4180186
21491459	Ba; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content; Tissue; Tissue, unspecified	4180186
21491459	钡:物质的量含量:时间点:组织与涂片:定量型	4182948
21491462	Benzodiaz SerPl Ql Scn>200 ng/mL	4180186
21491462	Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Nasogastric; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;200 ng/mL; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491462	苯并二氮:存在情况或阈值:时间点:血清/血浆:序数型:筛查试验 > 200 纳克/毫升	4182948
21491464	Beryllium Tiss-sCnt	4180186
21491464	Be; Berylliosis; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content; Tissue; Tissue, unspecified	4180186
21491464	铍:物质的量含量:时间点:组织与涂片:定量型	4182948
21491466	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Wellbutrin; Zyban	4180186
21491466	buPROPion CtO Ur Cfm-mCnc	4180186
21491466	丁氨苯丙酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491467	Addiction; CCH; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CP 47; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spice; UA; UR; Urn	4180186
21491467	Cannabicyclohexanol Ur Cfm-mCnc	4180186
21491467	大麻环己醇:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491473	Anafranil; Anofranil; Cfm; Clom; Clomip; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491473	clomiPRAMINE CtO Ur Cfm-mCnc	4180186
21491473	氯米帕明 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491475	Desipramine CtO Ur Cfm-mCnc	4180186
21491475	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Desi; Desip; Desipra; Desmethylimipramine; DRUG/TOXICOLOGY; Drugs; GCMS; Imipramine metabolite; Level; Mass concentration; Norpramin; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491475	去甲丙咪嗪 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491481	Actiq; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; Duragesic; Durogesic; Fenpat; fentanil; GCMS; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Sublimaze	4180186
21491481	fentaNYL CtO Sal Cfm-mCnc	4180186
21491481	芬太尼 截止点:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
21491483	4-hydroxybutyrate; 4-hydroxybutyric acid; DRUG/TOXICOLOGY; Drugs; Gamma hydroxy butyrate; Gamma-hydroxybutyrate; Gamma-OH; GBH; Georgia home boy; GHb; G-OH-Butyr; Goop; Har; Hydroxybutyric acid; Liquidx; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491483	G-OH-Butyr Hair-mCnt	4180186
21491483	Gamma 羟基丁酸:质量含量:时间点:毛发:定量型	4182948
21491487	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Lurasidone metabolite; Mass concentration; OH-Lurasidone; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491487	OH-Lurasidone Ur Cfm-mCnc	4180186
21491487	羟基鲁拉西酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491489	Imipramine CtO Ur Cfm-mCnc	4180186
21491489	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Imipra; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Tofranil; UA; UR; Urn	4180186
21491489	丙咪嗪 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491492	JWH-073 4OH-butyl CtO Ur Cfm-mCnc	4180186
21491492	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; JWH-073 4OH-butyl; JWH-073 N-(4-hydroxybutyl) metabolite; K2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491492	JWH-073 4-羟丁基 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491493	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; JWH-073 N-Butanoic acid metabolite; K2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491493	JWH-073 butanoate CtO Ur Cfm-mCnc	4180186
21491493	JWH-073 丁酸 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491495	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-122 5OH-pentyl; JWH-122 N-(5-hydroxypentyl) metabolite; K2; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491495	JWH-122 5OH-pentyl Ur Cfm-mCnc	4180186
21491495	JWH-122 5-羟戊基:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491496	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; JWH-122 5OH-pentyl; JWH-122 N-(5-hydroxypentyl) metabolite; K2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491496	JWH-122 5OH-pentyl CtO Ur Cfm-mCnc	4180186
21491496	JWH-122 5-羟戊基 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491497	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-200 4OH-indole; K2; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491497	JWH-200 4OH-indole Ur Cfm-mCnc	4180186
21491497	JWH-200 4-羟基吲哚:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491498	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; JWH-200 4OH-indole; K2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491498	JWH-200 4OH-indole CtO Ur Cfm-mCnc	4180186
21491498	JWH-200 4-羟基吲哚 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491501	Breathing; CARDIO-PULM; Electrical potential; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Resp wave amp; Respiratory; RS; Voltage	4180186
21491501	Resp wave amp	4180186
21491501	呼吸波振幅:电势:时间点:呼吸系统:定量型	4182948
21491502	Cardiac; Cardio; Cardiology; Heart Disease; Heart Rate; Heart rate variability; HEART RATE.ATOM; HR variability; Hrt; Point in time; QNT; Quan; Quant; Quantitative; Random; R-R interval; RR.sd (HR var)	4180186
21491502	RR.sd (HR var)	4180186
21491502	RR 间期.标准差:时间:时间点:心脏:定量型	4182948
21491504	TmStp initial encounter	4180186
21491504	Date and time; Date+time; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp; TmStp initial encounter	4180186
21491504	初次就医日期和时间:时间戳:时间点:^患者:定量型	4182948
21491505	Contam+radiation+contagion status	4180186
21491505	Contam+radiation+contagion status; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
21491505	污染+辐射+传染状态:发现:时间点:^患者:序数型	4182948
21491507	CLIN; Nominal; Point in time; Random; Typ	4180186
21491507	床位类型:类型:时间点:^患者:名义型	4182948
21491508	Date+time trans departure	4180186
21491508	Date and time; Date+time; Date+time trans departure; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
21491508	移交离开的日期和时间:时间戳:时间点:^患者:定量型	4182948
21491513	Bdy weight; Bdy weight growth Prctl; bod; Bodies; BWP; Echography; EFW; Est; Estimated fetal weight; estimation; Fetal; FWP; Gyn; Gynecology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Percentile; Point in time; predicted; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Wt	4180186
21491513	FWP by Hadlock91	4180186
21491513	体重增长百分位数:百分位数:时间点:^胎儿:定量型:超声+依据 Hadlock 1991 的估计法	4182948
21491514	Abd; Abdo; Abdomen; AC; Echoencephalogram; Echoencephalography; Echography; Est; estimation; Fetal; Girth; Gyn; Gynecology; HC; Length Ratio; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; predicted; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
21491514	HC/AC from Campbell 1977	4180186
21491514	头围/腹围:长度比率:时间点:^胎儿:定量型:超声+依据 Campbell 1977 的估计法	4182948
21491515	Comm hlth care Risk assess+scrn note	4180186
21491515	Asympt; Asymptomatic; Comm hlth care; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Risk assess and screen; Risk assess+scrn note; Scn; Visit note	4180186
21491515	风险评估与筛查记录:发现:时间点:{环境}:文档型:社区医疗保健服务	4182948
21491518	AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Blood; Deoxyribonucleic acid; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; HIV1 proviral DNA tropism; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; Nominal; PBMC; Peripheral blood mononuclear cells; Point in time; Random; WB; Whole blood	4180186
21491518	HIV1 proviral DNA tropism Bld MC	4180186
21491518	HIV 1 型前病毒 DNA 嗜性:存在与否或特征标识:时间点:全血单个核细胞:名义型	4182948
21491526	1 day; 24 hours; 24HR; Diet; Dietetics; Est; estimation; Mass rate; mRate; Nutrition; QNT; Quan; Quant; Quantitative; Val	4180186
21491526	Valine intake 24h Est	4180186
21491526	缬氨酸摄入:质量速率:24小时:^患者:定量型:估计法	4182948
21491527	1 day; 24 hours; 24HR; Diet; Dietetics; Mass Rate; mRate; Nutrition; QNT; Quan; Quant; Quantitative; Val	4180186
21491527	Valine intake 24h Measured	4180186
21491527	缬氨酸摄入:质量速率:24小时:^患者:定量型:测量法	4182948
21491529	DNR; DNR, DNAR, or AND exists; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
21491530	Finding; Findings; MOLST, POLST or similar exists; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Tx	4180186
21491531	Finding; Findings; Narrative; Point in time; Random; Report; Survey; Thoughts hastening death	4180186
21491532	Finding; Findings; Nominal; Point in time; Random; Survey	4180186
21491533	Finding; Findings; Loc of anticipatory medication; Narrative; Point in time; Random; Report; Survey	4180186
21491534	Finding; Findings; Narrative; Point in time; Random; Report; Survey	4180186
21491535	Finding; Findings; Messages delivered after death; Narrative; Point in time; Random; Report; Survey	4180186
21491537	Activ; Actvty; Blood; CPCJ; CYP2C; CYP2C19 gene prod met act imp; CYPIIC17; CYPIIC19; cytochrome P-450 II C; cytochrome P450, family 2, subfamily C, polypeptide 19; Drug metabolism; Gene prod met act imp; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; P450C2C; P450IIC19; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491537	CYP2C19 gene prod met act imp Bld/T-Imp	4180186
21491537	CYP2C19 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
21491538	Activ; Actvty; Blood; CPD6; CYP2D; CYP2D@; CYP2D6 gene prod met act imp; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID6; Cytochrome p450; cytochrome P450, family 2, subfamily D, polypeptide 6; Debrisoquine hydroxylation gene; Drug metabolism; Gene prod met act imp; HGNC:2629; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; P450C2D; P450DB1; P450-DB1; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491538	CYP2D6 gene prod met act imp Bld/T-Imp	4180186
21491538	CYP2D6 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
21491540	Activ; Actvty; Blood; CP35; CYP3A5 gene prod met act imp; CYPIIIA5; cytochrome P450, family 3, subfamily A, polypeptide 5; Drug metabolism; Gene prod met act imp; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; P450PCN3; PCN3; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491540	CYP3A5 gene prod met act imp Bld/T-Imp	4180186
21491540	CYP3A5 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
21491541	Activ; Actvty; BILIQTL1; Blood; Crigler-Najjar syndrome, type I; Drug metabolism; Gene prod met act imp; Gilbert Syndrome; GNT1; HUG-BR1; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; UDP glucuronosyltransferase 1 family, polypeptide A1; UDP glycosyltransferase 1 family, polypeptide A1 gene; UDPGT; UDPGT 1-1; UGT1; UGT1A; UGT1A1 gene prod met act imp; UGT1A5; WB; Whole blood; Whole blood or Tissue	4180186
21491541	UGT1A1 gene prod met act imp Bld/T-Imp	4180186
21491541	UGT1A1 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
21491543	Activ; Actvty; Blood; CPB6; CYP2B; CYP2B6 gene prod met act imp; CYP2B7; CYP2B7P; CYPIIB6; cytochrome P450, family 2, subfamily B, polypeptide 6; Drug metabolism; EFVM; Gene prod met act imp; IIB1; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; P450; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491543	CYP2B6 gene prod met act imp Bld/T-Imp	4180186
21491543	CYP2B6 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
21491544	Activ; Actvty; Blood; CYP4F2 gene prod met activ imp; Drug metabolism; Gene prod met act imp; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491544	CYP4F2 gene prod met activ imp Bld/T-Imp	4180186
21491544	CYP4F2 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
21491545	Blood; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; SLCO1B1 gene prod fnc imp; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491545	SLCO1B1 gene prod funct imp Bld/T	4180186
21491545	SLCO1B1 基因产物功能解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
21491546	Age 2nd eye in initial unilat RB; Eye; EYE.HX; EYE.HX.NEI; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Second	4180186
21491546	Age 2nd eye in initial unilat RB	4180186
21491546	最初单侧视网膜母细胞瘤患者第二次眼部受累时的年龄:时间:时间点:^患者:定量型	4182948
21491547	Age at 1st night blindness aware; EYE; EYE.HX; EYE.HX.NEI; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491547	Age at 1st night blindness aware	4180186
21491547	意识到夜盲症时的年龄:时间:时间点:^患者:定量型	4182948
21491550	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Finding; Findings; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vision; Visual	4180186
21491550	Eye-L Can elevate above midline	4180186
21491550	能够抬升至中线以上:发现:时间点:眼睛.左侧:序数型	4182948
21491552	3 Self-Sustaining Sequence Replication; 3SR SR; American plague; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; yellow jack; YFV; YFV ns5 gene	4180186
21491552	YFV ns5 gene CSF Ql NAA+non-probe	4180186
21491552	黄热病病毒 ns5 基因:存在情况或阈值:时间点:脑脊液:序数型:非探针法.基因扩增.靶向	4182948
21491554	1,3 - Chlorophenyl piperazine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; mCPP; m-CPP; meta-chlorophenylpiperazine; Nefazodone metabolite; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Trazodone metabolite	4180186
21491554	m-CPP SerPl-mCnc	4180186
21491554	间氯苯哌嗪:质量浓度:时间点:血清/血浆:定量型	4182948
21491555	1,3 - Chlorophenyl piperazine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; mCPP; m-CPP; meta-chlorophenylpiperazine; Nefazodone metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; Trazodone metabolite; UA; UR; Urn	4180186
21491555	m-CPP Ur-mCnc	4180186
21491555	间氯苯哌嗪:质量浓度:时间点:尿液:定量型	4182948
21491556	Addiction; Blood; Carisoprodol metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
21491556	Meprobamate Bld Cfm-mCnc	4180186
21491556	氨甲丙二酯:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
21491558	Addiction; Bath salts; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; ephedrone; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491558	Methcathinone Ur Cfm-mCnc	4180186
21491558	甲卡西酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491559	Mirtazapine Ur Ql Cfm	4180186
21491559	Avanza; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Reflex; Remeron; Screen; UA; UR; Urn; Zispin	4180186
21491559	米氮平:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
21491562	Naloxol Ur Cfm-mCnc	4180186
21491562	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Naloxone metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491562	纳洛醇:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491563	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Naloxone metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491563	Naloxol CtO Ur Cfm-mCnc	4180186
21491563	纳洛醇 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491565	Naltrexol CtO Ur Cfm-mCnc	4180186
21491565	6 alpha-hydroxynaltrexone; 6 beta-Naltrexol; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Naltrexone metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491565	纳曲醇 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491567	Norfentanyl CtO Sal Cfm-mCnc	4180186
21491567	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; Fentanyl metabolite; GCMS; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
21491567	去甲基芬太尼 截止点:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
21491569	O-去甲基文拉法新 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491569	ODV CtO Ur Cfm-mCnc	4180186
21491569	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Desmeth; Desvenlafaxine; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Norvenlafaxin; Norvenlafaxine; O-desmethylvenlafaxine; ODV; Point in time; Pristiq; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Venlafaxine metabolite	4180186
21491571	OPC3373 CtO Ur Cfm-mCnc	4180186
21491571	Aripiprazole metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491571	OPC3373 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491573	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Lortab; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Standard score; UA; UR; Urn; Vicodin; Z score; Z value; Z-score	4180186
21491573	oxyCODONE Z-score Ur	4180186
21491573	羟考酮:Z评分:时间点:尿液:定量型	4182948
21491576	Pheniramine Ur Ql	4180186
21491576	Avil; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; Prophenpyridamine; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
21491576	非尼拉敏:存在情况或阈值:时间点:尿液:序数型	4182948
21491578	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; RCS-4 N-(5-carboxypentyl) metabolite; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491578	RCS-4 5-carboxypentyl Ur Cfm-mCnc	4180186
21491578	RCS-4 5-羧戊基:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491584	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Latuda; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491584	Lurasidone Ur Cfm-mCnc	4180186
21491584	鲁拉西酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491585	traZODone CtO Ur Cfm-mCnc	4180186
21491585	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Desyrel; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Trazon; Trialodine; UA; UR; Urn	4180186
21491585	曲唑酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491586	Venlafaxine CtO Ur Cfm-mCnc	4180186
21491586	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; Efexor; Effexor; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Venlafaxin	4180186
21491586	文拉法辛 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491592	Ag; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Silv; Substance content; Tissue; Tissue, unspecified	4180186
21491592	Silver Tiss-sCnt	4180186
21491592	银:物质的量含量:时间点:组织与涂片:定量型	4182948
21491594	Calc; Calc.HepaScore; Calculation; Chemistry; Liver fibr score; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491594	Liver fibr score SerPl Calc HepaScore	4180186
21491594	肝纤维化评分:评分:时间点:血清/血浆:定量型:计算法.HepaScore	4182948
21491595	Ang; Angio; Angm; Cardio; Cardiology; Coronary aa; Coronary segment stenosis Pnl; Heart; Heart Disease; Pan; PANEL.CARDIAC; Panl; Pnl; Point in time; Random	4180186
21491595	冠状动脉节段性狭窄:-:时间点:冠状动脉类:-:血管造影	4182948
21491597	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 1; Heart Disease; Length Fraction; Percent; Point in time; pRCA; QNT; Quan; Quant; Quantitative; R; Random; RT; Sten deg	4180186
21491597	Percent sten of pRCA by Angiogram	4180186
21491597	狭窄程度:长度分数:时间点:近段右侧冠状动脉:定量型:血管造影	4182948
21491598	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 2; Heart Disease; Length Fraction; mRCA; Percent; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; Sten deg	4180186
21491598	Percent sten of mRCA by Angiogram	4180186
21491598	狭窄程度:长度分数:时间点:中段右侧冠状动脉:定量型:血管造影	4182948
21491605	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 8; dLAD; Heart Disease; L; Length Fraction; LT; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
21491605	Percent sten of dLAD by Angiogram	4180186
21491605	狭窄程度:长度分数:时间点:远段左侧前降动脉:定量型:血管造影	4182948
21491606	所遵循的视网膜电图操作标准:类型:时间点:^患者:名义型:视网膜电图	4182948
21491606	ERG; ERG proc standard followed; EYE; EYE.ERG; EYE.ERG.NEI; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Typ	4180186
21491606	ERG study standard proc used	4180186
21491607	Electrical potential; ERG; EYE; EYE.ERG; EYE.ERG.NEI; Flicker resp amp; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT; Voltage	4180186
21491607	Flicker resp amp R ret light-adapt ERG	4180186
21491607	闪烁光反应波振幅^明适应型:电势:时间点:视网膜.右侧:定量型:视网膜电图	4182948
21491608	Electrical potential; ERG; EYE; EYE.ERG; EYE.ERG.NEI; Flicker resp amp; L; L ret; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage	4180186
21491608	Flicker resp amp L ret light-adapt ERG	4180186
21491608	闪烁光反应波振幅^明适应型:电势:时间点:视网膜.左侧:定量型:视网膜电图	4182948
21491610	ERG; EYE; EYE.ERG; EYE.ERG.NEI; Flicker resp wave impl time; L; L ret; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491610	Flick resp wave imp time Ret-L lt-ad ERG	4180186
21491610	闪烁光反应波潜伏时间^明适应型:时间:时间点:视网膜.左侧:定量型:视网膜电图	4182948
21491611	厂商名称:标识符:时间点:视网膜电图装置:名义型	4182948
21491611	EYE; EYE.ERG; EYE.ERG.NEI; Ident; Identifier; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random	4180186
21491611	ERG device Vendor name	4180186
21491614	参比电极:类型:时间点:视网膜电图装置:名义型	4182948
21491614	EYE; EYE.ERG; EYE.ERG.NEI; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Ref electrode; Typ	4180186
21491614	Type of ERG ref electrode	4180186
21491615	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Finding; Findings; Mot; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Vision; Visual	4180186
21491615	Ocular motility Eye by Finger follow	4180186
21491615	眼球能动性:发现:时间点:眼睛:名义型:手指追随法	4182948
21491616	Eye; EYE.VISUAL_FIELD; EYE.VISUAL_FIELD.NEI; Eyeball; Finding; Findings; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; R; R eye; Random; RT; Vision; Visual	4180186
21491616	Visual field defects Eye-R	4180186
21491616	视野缺损:发现:时间点:眼睛.右侧:名义型	4182948
21491617	Eye; EYE.VISUAL_FIELD; EYE.VISUAL_FIELD.NEI; Eyeball; Finding; Findings; L; L eye; LT; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Vision; Visual	4180186
21491617	Visual field defects Eye-L	4180186
21491617	视野缺损:发现:时间点:眼睛.左侧:名义型	4182948
21491620	Eye; EYE.VISUAL_FIELD; EYE.VISUAL_FIELD.NEI; Eyeball; Finding; Findings; L; L eye; LT; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Vision; Visual	4180186
21491620	L eye Visual field def Confrontation	4180186
21491620	视野缺损:发现:时间点:眼睛.左侧:名义型:面对面视野检查法	4182948
21491622	Angio; EYE; EYE.ANGIO; EYE.ANGIO.NEI; Finding; Findings; L; L ocular fund; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Study report; W fluoresc IV	4180186
21491622	Study obs Ocular fund-L Angio W fluor IV	4180186
21491622	检查观察结果^采用静脉注射荧光素:发现:时间点:眼底.左侧:名义型:血管造影术	4182948
21491623	Angio; EYE; EYE.ANGIO; EYE.ANGIO.NEI; Finding; Findings; ICG; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; R ocular fund; Random; RT; Study report; W indocyan green IV	4180186
21491623	Study obs Ocul fund-R Angio W indocy gr	4180186
21491623	检查观察结果^采用静脉注射靛氰绿:发现:时间点:眼底.右侧:名义型:血管造影术	4182948
21491627	Exam; Examination; EYE; EYE.PX; EYE.PX.NEI; Finding; Findings; Nominal; Ophthalmology; Ophtho; Ophthy; Phys find; Point in time; R; R macula; Random; RT	4180186
21491627	R macula Phys find Ophthalmoscopy	4180186
21491627	体格检查发现:发现:时间点:黄斑.右侧:名义型:检眼镜检查法	4182948
21491629	Epithelia; EYE; EYE.PX; EYE.PX.NEI; Finding; Findings; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; RPE; Screen	4180186
21491629	RPE Fundus hypopig Ophthalmoscopy	4180186
21491629	眼底色素减退:发现:时间点:视网膜色素上皮细胞:序数型:检眼镜检查法	4182948
21491631	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Meth; Method of; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Typ; Vision; Visual	4180186
21491631	检眼镜检查方法:类型:时间点:眼睛:名义型:*	4182948
21491632	Cent corn thickness; Corneal; EYE; EYE.PX; EYE.PX.NEI; Length; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT; Thick	4180186
21491632	R cornea Cent corn thickness Pachymetry	4180186
21491632	中央角膜厚度:长度:时间点:角膜.右侧:定量型:角膜厚度测量法	4182948
21491634	c; Contr; Contr sens; Contra; Contrst; Eye; EYE.PX; EYE.PX.NEI; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
21491634	R eye Contr sens Pelli-Robson	4180186
21491634	对比敏感度:对数型逆百分数:时间点:眼睛.右侧:定量型:Pelli-Robson 对比敏感度视力表	4182948
21491637	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; L; L eye; LT; Obj refraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
21491637	L eye Axis--W cyclo Obj refraction	4180186
21491637	轴^采用睫状肌麻痹:角度:时间点:眼睛.左侧:定量型:客观式屈光度检测方法	4182948
21491639	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; L; L eye; LT; Obj refraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
21491639	L eye Axis--WO cyclo Obj refraction	4180186
21491639	轴^不采用睫状肌麻痹:角度:时间点:眼睛.左侧:定量型:客观式屈光度检测方法	4182948
21491646	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; Obj refraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
21491646	R eye Sphere--WO cyclo Obj refraction	4180186
21491646	球面^不采用睫状肌麻痹:长度倒数:时间点:眼睛.右侧:定量型:客观式屈光度检测方法	4182948
21491647	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; L; L eye; LT; Obj refraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
21491647	L eye Sphere--WO cyclo Obj refraction	4180186
21491647	球面^不采用睫状肌麻痹:长度倒数:时间点:眼睛.左侧:定量型:客观式屈光度检测方法	4182948
21491649	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Subj refraction; Vision; Visual	4180186
21491649	R eye Axis--W cyclo Subj refraction	4180186
21491649	轴^采用睫状肌麻痹:角度:时间点:眼睛.右侧:定量型:主观式屈光度检测方法	4182948
21491650	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Subj refraction; Vision; Visual	4180186
21491650	L eye Axis--W cyclo Subj refraction	4180186
21491650	轴^采用睫状肌麻痹:角度:时间点:眼睛.左侧:定量型:主观式屈光度检测方法	4182948
21491653	CYL; Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Subj refraction; Vision; Visual	4180186
21491653	R eye Cylinder--W cyclo Subj refraction	4180186
21491653	柱镜^采用睫状肌麻痹:长度倒数:时间点:眼睛.右侧:定量型:主观式屈光度检测方法	4182948
21491661	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 9; D1; Heart Disease; i; Length Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
21491661	Percent sten of D1 by Angiogram	4180186
21491661	狭窄程度:长度分数:时间点:对角动脉 1:定量型:血管造影	4182948
21491663	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 11; Heart Disease; L; Length Fraction; LT; pCx; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
21491663	Percent sten of pCx by Angiogram	4180186
21491663	狭窄程度:长度分数:时间点:近段左侧旋动脉:定量型:血管造影	4182948
21491664	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 12; Heart Disease; Length Fraction; OM; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
21491664	Percent sten of OM by Angiogram	4180186
21491664	狭窄程度:长度分数:时间点:钝缘支动脉:定量型:血管造影	4182948
21491667	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 15; Heart Disease; L; Length Fraction; L-PDA; LT; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
21491667	Percent sten of L-PDA by Angiogram	4180186
21491667	狭窄程度:长度分数:时间点:左侧旋动脉后降支:定量型:血管造影	4182948
21491671	Basic fibroblast growth factor receptor 1 precursor; BFGFR; bFGF-R-1; Blood; CD331; CEK; C-FGR; FGFBR; FGFR-1; fibroblast growth factor receptor 1; fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome); FLG; FLT2; FLT-2; Fluorescent in situ hybridization; Genetics; H2; H3; H4; H5; HBGFR; Heredity; Heritable; HH2; HRTFDS; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; KAL2; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Narrative; N-SAM; OGD; Point in time; Random; Rearr; Rearrangement; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491671	FGFR1 gene rearr Bld/T FISH-Imp	4180186
21491671	FGFR1 基因重排:印象:时间点:全血/组织:叙述型:FISH	4182948
21491672	Basic fibroblast growth factor receptor 1 precursor; BFGFR; bFGF-R-1; Blood; CD331; CEK; Cell; Cellularity; C-FGR; FGFBR; FGFR-1; fibroblast growth factor receptor 1; fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome); FLG; FLT2; FLT-2; Fluorescent in situ hybridization; Genetics; H2; H3; H4; H5; HBGFR; Heredity; Heritable; HH2; HRTFDS; Inherited; KAL2; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; N-SAM; Number fraction; OGD; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Rearr; Rearrangement; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491672	Cells.FGFR1 rearr/Cells cnt Bld/T FISH	4180186
21491672	细胞.FGFR1 基因重排/已计数的细胞:计数型分数:时间点:全血/组织:定量型:FISH	4182948
21491677	1 day; 24 hours; 24H; 24HR; Finding; Findings; H+P; H+P.HX; Last; MI in past 24H; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
21491677	MI in past 24H	4180186
21491677	在过去的24小时当中的心肌梗死:发现:1天:^患者:序数型	4182948
21491679	Teaching phys name	4180186
21491679	CLIN; Nominal; Person name; Point in time; Random; Teaching phys name	4180186
21491679	教学医师姓名:人员姓名:时间点:服务提供者:名义型	4182948
21491681	CARD.PROC; Cardio; Cardiology; Finding; Findings; Heart Disease; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; Right heart cath performed; RT; Screen	4180186
21491681	Right heart cath performed	4180186
21491681	已执行右侧心脏导管插入术:发现:时间点:^患者:序数型	4182948
21491685	CARD.PROC; Cardio; Cardiology; Finding; Findings; Heart Disease; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Temp pacing perf	4180186
21491685	Temp pacing perf	4180186
21491685	已执行临时起搏:发现:时间点:^患者:序数型	4182948
21491687	CARD.PROC; Cardiac proc comp; Cardio; Cardiology; Heart Disease; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
21491687	Cardiac proc comp	4180186
21491687	心脏操作项目并发症:存在情况或阈值:时间点:^患者:序数型	4182948
21491688	CARD.PROC; Cardiac proc comp; Cardio; Cardiology; Heart Disease; Nominal; Point in time; Random; Typ	4180186
21491688	Cardiac proc comp type	4180186
21491688	心脏操作项目并发症:类型:时间点:^患者:名义型	4182948
21491689	CARD.PROC; Cardiac proc comp; Cardio; Cardiology; Finding; Findings; Heart Disease; Narrative; Point in time; Random; Report	4180186
21491689	Cardiac proc comp nar	4180186
21491689	心脏操作项目并发症:发现:时间点:^患者:叙述型	4182948
21491692	CVD hx Pnl	4180186
21491692	CVD; CVD hx Pnl; Dis; Diseases; Dz; H+P; Hx; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random	4180186
21491692	心血管疾病史组套:-:时间点:^患者:-	4182948
21491695	CARD.PROC; Cardiology; Date and time; Point in time; Proc start time; QNT; Quan; Quant; Quantitative; Random; Started; Time stamp; Timestamp	4180186
21491695	Proc start time	4180186
21491695	操作开始时间:时间戳:时间点:^患者:定量型	4182948
21491696	Cath device Guid cath size	4180186
21491696	Cath; Cath device; Circumference; Guid cath size; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491696	导引导管尺寸:周长:时间点:导管插入术装置:定量型	4182948
21491697	Angio device; Cor stent diam; DIA; Diam; Length; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491697	Cor stent diam	4180186
21491697	冠状动脉支架直径:长度:时间点:血管成形术装置:定量型	4182948
21491701	Ang; Angio; Angm; CARD.PROC; Cardiac; Cardio; Cardiology; Finding; Findings; Heart Disease; Hrt; Hrt ventr; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Segment; Segment appearance; SWM; Ventricular; VS; WM	4180186
21491701	VS SWM by Angiogram	4180186
21491701	节段性壁运动:发现:时间点:心脏.心室.室间隔:序数型:血管造影	4182948
21491703	Cathepsin A WBC-cCnt	4180186
21491703	Catalytic Content; Chemistry; Galactosialidosis; Galactosidase; Leukocytes; Lysosomal Protective Protein; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
21491703	组织蛋白酶 A:催化含量:时间点:白细胞:定量型	4182948
21491704	Hyocholate SerPl-sCnc	4180186
21491704	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491704	猪胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491706	Alb; Alb clear; Chemistry; Cl; Clear; Clearanc; Clearances; Clr; Immune globulin G; Immunoglobulin G; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn	4180186
21491706	IgG/Alb clear Ur+SerPl-Rto	4180186
21491706	IgG 清除/白蛋白 清除:比率:时间点:尿液+血清/血浆:定量型	4182948
21491707	IgG/Transf clear Ur+SerPl-Rto	4180186
21491707	Chemistry; Cl; Clear; Clearanc; Clearances; Clr; Immune globulin G; Immunoglobulin G; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; SerP; SerPl; SerPlas; Serum; Serum or plasma; Siderophilin; SR; Tf; Transf clear; Trf; TRFRN; UA; UR; Ur+SerPl; Urn	4180186
21491707	IgG 清除/转铁蛋白 清除:比率:时间点:尿液+血清/血浆:定量型	4182948
21491708	M6PI WBC-cCnt	4180186
21491708	Catalytic Content; Chemistry; i Phos; Inorganic phosphate; Isom; Leukocytes; M6PI; MPI; Phos; Phosphate total; Phosphomannose isomerase; Phosphomannose isomerase deficiency; Phosphorous; Phosphorus; Phosphrous; Pi; PMI; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
21491708	甘露糖-6-磷酸异构酶:催化含量:时间点:白细胞:定量型	4182948
21491712	CorePlaybook; Document; EXT; Films; Finding; Findings; GE 2V; II; Imaging; LE; Leg; Low; Lower extremity joint; Minimum 2 views; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Playbook; Point in time; Rad; Radiology; Random; View; VWS; Xray; X-ray	4180186
21491712	XR Hip GE 2V	4180186
21491712	多重视图 GE 双重:发现:时间点:下肢>髋关节:文档型:X射线摄影术	4182948
21491713	Arm; Document; EXT; Films; Finding; Findings; GE 2V; II; Imaging; Minimum 2 views; Plain Films; Point in time; Rad; RADIOLOGY; Random; UE; Up; Upper arm; Upper extremity; View; VWS; Xray; X-ray	4180186
21491713	XR Humerus GE 2V	4180186
21491713	多重视图 GE 双重:发现:时间点:上肢>肱骨:文档型:X射线摄影术	4182948
21491714	Anterio-Posterior; Anteroposterior; AP+Lat; AP+Lat+Merchants; AP+lat+Merchants+(views; AP+lat+Merchants+stand; Bil; Bilat; Both; Document; EXT; Extr-Bl; Films; Finding; Findings; Imaging; Kn; Knee-Bl; Knees; Lat; LE; LE-Bl; Leg; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Rad; Radiology; Random; Stand); View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; WB; Weight bearing; Xray; X-ray	4180186
21491714	XR Knee-Bl AP+Lat+Merch+views Stand	4180186
21491714	(多重视图 前后位 + 侧位 + Merchant仰卧位髌骨轴位) + (多重视图^采用直立位):发现:时间点:下肢.双侧>膝关节:文档型:X射线摄影术	4182948
21491715	CorePlaybook; Document; EXT; Films; Finding; Findings; GE 4V; Imaging; Kn; LE; Leg; Low; Lower extremity joint; Minimum 4 views; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Playbook; Point in time; Rad; Radiology; Random; View; VWS; Xray; X-ray	4180186
21491715	XR Knee GE 4V	4180186
21491715	多重视图 GE 四重:发现:时间点:下肢>膝关节:文档型:X射线摄影术	4182948
21491717	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Subj refraction; Vision; Visual	4180186
21491717	L eye Sphere--WO cyclo Subj refraction	4180186
21491717	球面^不采用睫状肌麻痹:长度倒数:时间点:眼睛.左侧:定量型:主观式屈光度检测方法	4182948
21491718	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Meth; Method of; Nominal; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Refract method; Subj refract method; Typ; Vision; Visual	4180186
21491718	Type of Subj refract method	4180186
21491718	主观式屈光度检测方法:类型:时间点:眼睛类:名义型	4182948
21491721	Ant chamber; EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; R ant chamber; Random; RT; Study report	4180186
21491721	Study obs R ant chamber Slit lamp	4180186
21491721	检查观察结果:发现:时间点:前房.右侧:名义型:裂隙灯活组织显微镜检查	4182948
21491722	Ant chamber; EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; L; L Ant chamber; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Study report	4180186
21491722	Study obs L Ant chamber Slit lamp	4180186
21491722	检查观察结果:发现:时间点:前房.左侧:名义型:裂隙灯活组织显微镜检查	4182948
21491724	Conj+Sclera; EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; L; L conj+sclera; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Study report	4180186
21491724	Study obs L conj+sclera Slit lamp	4180186
21491724	检查观察结果:发现:时间点:结膜+巩膜.左侧:名义型:裂隙灯活组织显微镜检查	4182948
21491728	EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; L; L iris; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Study report	4180186
21491728	Study obs L iris Slit lamp	4180186
21491728	检查观察结果:发现:时间点:虹膜.左侧:名义型:裂隙灯活组织显微镜检查	4182948
21491730	EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; L; L optic lens; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Study report	4180186
21491730	Study obs L optic lens Slit lamp	4180186
21491730	检查观察结果:发现:时间点:晶状体.左侧:名义型:裂隙灯活组织显微镜检查	4182948
21491731	EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; R optic lens; Random; RT; Typ	4180186
21491731	Type of Opac Optic lens-R by Slit lamp	4180186
21491731	不透明性:类型:时间点:晶状体.右侧:名义型:裂隙灯活组织显微镜检查	4182948
21491733	Eye; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Identity or presence; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Study report	4180186
21491733	Stu obs Lids & Lashes & Adnexa Slit lamp	4180186
21491733	检查观察结果:存在与否或特征标识:时间点:眼睑与眼睫毛与眼附属器:名义型:裂隙灯活组织显微镜检查	4182948
21491735	EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; L; L pupil; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random	4180186
21491735	Pupil shape eye-L Slit lamp	4180186
21491735	瞳孔形状:形状:时间点:瞳孔.左侧:名义型:裂隙灯活组织显微镜检查	4182948
21491736	bod; Bodies; EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Identity or presence; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; Random; RT; Study report; Vitreous body-R	4180186
21491736	Study obs Vitreous body-R Slit lamp	4180186
21491736	检查观察结果:存在与否或特征标识:时间点:玻璃体.右侧:名义型:裂隙灯活组织显微镜检查	4182948
21491737	bod; Bodies; EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Identity or presence; L; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Study report; Vitreous body-L	4180186
21491737	Study obs Vitreous body-L Slit lamp	4180186
21491737	检查观察结果:存在与否或特征标识:时间点:玻璃体.左侧:名义型:裂隙灯活组织显微镜检查	4182948
21491738	EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; R; R iris; Random; RT; Screen	4180186
21491738	R iris Transillumination Slit lamp	4180186
21491738	透照度:发现:时间点:虹膜.右侧:序数型:裂隙灯活组织显微镜检查	4182948
21491742	R eye VA--uncorr ETDRS	4180186
21491742	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; Refraction; RT; VA; Vision; Visual	4180186
21491742	视力^未经校正的:对数型长度比率:时间点:眼睛.右侧:定量型:ETDRS 视力表	4182948
21491743	L eye VA--uncorr ETDRS	4180186
21491743	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
21491743	视力^未经校正的:对数型长度比率:时间点:眼睛.左侧:定量型:ETDRS 视力表	4182948
21491744	R eye VA--corr Snellen	4180186
21491744	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Length Ratio; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; Refraction; RT; VA; Vision; Visual	4180186
21491744	视力^经过最佳校正的:长度比率:时间点:眼睛.右侧:定量型:Snellen 视力表	4182948
21491746	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Length Ratio; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; Refraction; RT; VA; Vision; Visual	4180186
21491746	R eye VA--uncorr Snellen	4180186
21491746	视力^未经校正的:长度比率:时间点:眼睛.右侧:定量型:Snellen 视力表	4182948
21491747	L eye VA--uncorr Snellen	4180186
21491747	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; L; L eye; Length Ratio; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
21491747	视力^未经校正的:长度比率:时间点:眼睛.左侧:定量型:Snellen 视力表	4182948
21491748	EYE; EYE.PX; EYE.PX.NEI; Finding; Findings; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Study report; Visual pathway-R	4180186
21491748	Study obs Visual pathway-R VEP	4180186
21491748	检查观察结果:发现:时间点:视觉通路.右侧:序数型:视觉诱发电位	4182948
21491749	EYE; EYE.PX; EYE.PX.NEI; Finding; Findings; L; LT; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Study report; Visual pathway-L	4180186
21491749	Study obs Visual pathway-L VEP	4180186
21491749	检查观察结果:发现:时间点:视觉通路.左侧:序数型:视觉诱发电位	4182948
21491751	Ant chamber; Cell; Cellularity; Cnt; Count; EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; L; L Ant chamber; LT; Number; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491751	L Ant chamber Cells Slit lamp	4180186
21491751	细胞:数量(计数):时间点:前房.左侧:定量型:裂隙灯活组织显微镜检查	4182948
21491752	Ant chamber; EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; R; R ant chamber; Random; RT; Screen	4180186
21491752	R ant chamber Flare Slit lamp	4180186
21491752	闪辉:发现:时间点:前房.右侧:序数型:裂隙灯活组织显微镜检查	4182948
21491754	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Len; Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Skyline; Tangential; Vision; Visual	4180186
21491754	Deprecated Axial length Eye-R	4180186
21491755	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Typ; Vision; Visual	4180186
21491755	眼球震颤:类型:时间点:眼睛:名义型	4182948
21491756	Eye; EYE.TONOMETRY; EYE.TONOMETRY.NEI; Eyeball; Glaucoma testing; IOP; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Pressure; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
21491756	R eye IOP Tono	4180186
21491756	眼内压:压力或压强:时间点:眼睛.右侧:定量型:眼压测量法	4182948
21491757	Eye; EYE.TONOMETRY; EYE.TONOMETRY.NEI; Eyeball; Glaucoma testing; IOP; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
21491757	L eye IOP Tono	4180186
21491757	眼内压:压力或压强:时间点:眼睛.左侧:定量型:眼压测量法	4182948
21491758	视网膜电图组套:-:时间点:眼睛:-:视网膜电图	4182948
21491758	ERG; ERG Pnl; Eye; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Pan; PANEL.EYE; Panl; Pnl; Point in time; Random; Vision; Visual	4180186
21491758	ERG Pnl	4180186
21491759	主观式屈光度组套:-:时间点:眼睛:-:主观式屈光度检测方法	4182948
21491759	Subj refraction Pnl	4180186
21491759	Eye; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Pan; PANEL.EYE; Panl; Pnl; Point in time; Random; Subj refraction; Subj refraction Pnl; Vision; Visual	4180186
21491761	Exam; Examination; Eye; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Pan; PANEL.EYE; Panl; Phys find; Phys find Pnl; Pnl; Point in time; Random; Vision; Visual	4180186
21491761	Eye Phys find Pnl	4180186
21491761	体格检查发现组套:-:时间点:眼睛:-	4182948
21491762	客观式屈光度组套:-:时间点:眼睛:-	4182948
21491762	Eye; Eyeball; Obj refraction Pnl; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Pan; PANEL.EYE; Panl; Pnl; Point in time; Random; Vision; Visual	4180186
21491762	Obj refraction Pnl	4180186
21491764	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Finding; Findings; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vision; Visual	4180186
21491764	Eye Nystagmus amp	4180186
21491764	眼球震颤幅度:发现:时间点:眼睛:序数型	4182948
21491766	Exam; Examination; EYE; EYE.PX; EYE.PX.NEI; Finding; Findings; L; L retinal ves; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Phys find; Point in time; Random; Vesl; ves-L; Vessels.XXX	4180186
21491766	L retinal ves Phys find Ophthalmoscopy	4180186
21491766	体格检查发现:发现:时间点:视网膜血管类.左侧:名义型:检眼镜检查法	4182948
21491768	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Length Ratio; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ped visual acuity; PEDS; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; Refraction; RT; VA; Vision; Visual	4180186
21491768	R eye Ped visual acuity--uncorr	4180186
21491768	儿童视力^未经校正的:长度比率:时间点:眼睛.右侧:定量型	4182948
21491772	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491774	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491775	2; Finding; Findings; III; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491776	Finding; Findings; III; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491779	Finding; Findings; II; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491780	Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS; Upper extremity joint	4180186
21491783	Finding; Findings; Limit climbing sev flights stairs; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491784	120 min; 120 minutes; 120min; 2 hours; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491785	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491786	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491788	Finding; Findings; Limit walking &gt; mile; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491790	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491791	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491798	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491799	Are you able to carry a heavy object (over 10 pounds); Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491800	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491803	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491804	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491805	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491807	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491808	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491809	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491811	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; ATV; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Reyataz	4180186
21491811	Atazanavir Amn-mCnc	4180186
21491811	阿他那韦:质量浓度:时间点:羊水:定量型	4182948
21491812	ATV; DRUG/TOXICOLOGY; Drugs; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Reyataz; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491812	Atazanavir Trough SerPl-mCnc	4180186
21491812	阿他那韦^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
21491813	DRUG/TOXICOLOGY; Drugs; Har; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tenormin	4180186
21491813	Atenolol Hair-mCnt	4180186
21491813	氨酰心安:质量含量:时间点:毛发:定量型	4182948
21491815	Atropine Hair-mCnt	4180186
21491815	DRUG/TOXICOLOGY; Drugs; Enlon; Har; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491815	阿托品:质量含量:时间点:毛发:定量型	4182948
21491817	Comorbid cond Pnl	4180186
21491817	Comorbid cond Pnl; H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random	4180186
21491817	共病情况组套:-:时间点:^患者:-	4182948
21491818	Hx of Hyperuricemia	4180186
21491818	H+P; H+P.HX; History; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
21491818	高尿酸血症:历史记录:时间点:^患者:序数型	4182948
21491819	2V; 2VW; CXR; Document; Films; Finding; Findings; II; Imaging; Lung; Plain Films; Point in time; Pulmonary; Pulmonology; Rad; Radiology; Random; Respiratory; Ribs-Ul; Ribs-Ul + Chest; Ribs-Ul+chest; Thorax; View; VWS; Xray; X-ray	4180186
21491819	XR Ribs-Ul + Chest 2V	4180186
21491819	多重视图 双重:发现:时间点:胸部>肋骨.单侧 & 胸部:文档型:X射线摄影术	4182948
21491821	Arm; Document; EXT; Extr-L; Films; Finding; Findings; GE 2V; II; Imaging; L; LT; LUE; Minimum 2 views; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Rad; RADIOLOGY; Random; Should-L; UE; UE-L; Up; Upper extremity joint; View; VWS; Xray; X-ray	4180186
21491821	XR Should-L GE 2V	4180186
21491821	多重视图 GE 双重:发现:时间点:上肢.左侧>肩部:文档型:X射线摄影术	4182948
21491823	Arm; CorePlaybook; Document; EXT; Films; Finding; Findings; GE 2V; II; Imaging; Minimum 2 views; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Playbook; Point in time; Rad; Radiology; Random; UE; Up; Upper extremity joint; View; VWS; Xray; X-ray	4180186
21491823	XR Should GE 2V	4180186
21491823	多重视图 GE 双重:发现:时间点:上肢>肩部:文档型:X射线摄影术	4182948
21491828	Anatomy; Eye; EYE.PX; EYE.PX.NEI; Eyeball; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; R; R eye; Random; RT; Vision; Visual	4180186
21491828	R eye Coloboma loc	4180186
21491828	缺损位置:解剖学:时间点:眼睛.右侧:名义型	4182948
21491829	Anatomy; Eye; EYE.PX; EYE.PX.NEI; Eyeball; L; L eye; LT; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Vision; Visual	4180186
21491829	L eye Coloboma loc	4180186
21491829	缺损位置:解剖学:时间点:眼睛.左侧:名义型	4182948
21491831	Appearance; Colour; Eye; EYE.PX; EYE.PX.NEI; Eyeball; L; L eye; LT; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Typ; Vision; Visual	4180186
21491831	L eye Color vision	4180186
21491831	色觉:类型:时间点:眼睛.左侧:名义型	4182948
21491833	Calc; Calculation; CARD.US; CARD.US.DICOM; Cardio; Cardiology; Continuous wave; DOP; DOP.CW; DUPLEX; Echography; Grad; Gradient sys; Heart Disease; Largest; Max grad sys; Max press grad sys; Maximal; Maximum; Peak; Point in time; Press grad; QNT; Quan; Quant; Quantitative; Random; Simp Bern; Sonogram; Sonograph; Sonography; Sys; Sys.max; Syst; TV; ULS; Ultrasound	4180186
21491833	TV Max press grad sys Simp Bern	4180186
21491833	压力梯度.收缩期.最大值:压差:时间点:三尖瓣:定量型:超声.多普勒.CW+简化 Bernoulli 公式计算法	4182948
21491834	Average; Avg; Calc; Calculation; CARD.US; CARD.US.DICOM; Cardio; Cardiology; Dias; Diast; Diastoli; DOP; DUPLEX; Echography; Grad; Gradient dia; Heart Disease; Mean grad dia; Mean press grad dias; Point in time; Press grad; QNT; Quan; Quant; Quantitative; Random; Simp Bern; Sonogram; Sonograph; Sonography; TV; TVG mean; ULS; Ultrasound	4180186
21491834	TV Mean press grad dias Simp Bern	4180186
21491834	压力梯度.舒张期.平均值:压差:时间点:三尖瓣:定量型:超声.多普勒+简化 Bernoulli 公式计算法	4182948
21491836	2D US; CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Dias; Diast; Diastoli; Echography; ED; ED area; ED epicard area; Evening; Heart Disease; Hrt; Hrt ventr; L; LT; LV; LVAD; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular	4180186
21491836	LV ED epicard area SAX at PM	4180186
21491836	心外膜面积.舒张末期:面积:时间点:心脏.心室.左侧:定量型:超声.2D.乳头肌处短轴+面积测量法	4182948
21491841	2D US; CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Dias; Diast; Diastoli; Echography; ED; ED minor axis; Heart Disease; Hrt; Hrt ventr; Length; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; RV; RV basal; SAX; short axis; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular	4180186
21491841	RV basal ED minor axis A4C	4180186
21491841	短轴.舒张末期:长度:时间点:心脏.心室.右侧.心底:定量型:超声.2D.A4C	4182948
21491842	2D US; CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Dias; Diast; Diastoli; Echography; ED; ED area; Heart Disease; Hrt; Hrt ventr; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; RV; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular	4180186
21491842	RV ED area A4C	4180186
21491842	面积.舒张末期:面积:时间点:心脏.心室.右侧:定量型:超声.2D.A4C+面积测量法	4182948
21491843	2D US; CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Echography; ES; ES area; Heart Disease; Hrt; Hrt ventr; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; RV; Sonogram; Sonograph; Sonography; Sys; Syst; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular	4180186
21491843	RV ES area A4C	4180186
21491843	面积.收缩末期:面积:时间点:心脏.心室.右侧:定量型:超声.2D.A4C+面积测量法	4182948
21491844	2D US; CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Dias; Diast; Diastoli; Echography; ED; ED thickness; Heart Disease; Hrt; Hrt ventr; Length; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; RV; RV.ant wall; RVAW; RVAWd; RVFWd; RVWd; Sonogram; Sonograph; Sonography; Thick; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular	4180186
21491844	RV.ant wall ED thickness 2D US	4180186
21491844	厚度.舒张末期:长度:时间点:心脏.心室.右侧.前壁:定量型:超声.2D	4182948
21491845	Adenosylmethionine; Chemistry; Dementias; Depression, Emotional; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S-Adenosyl Methionine; SAMe; SAM-e; Sammy; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491845	SAMe SerPl-sCnc	4180186
21491845	S-腺苷蛋氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491846	Sedoheptulose/Creat Ur-sRto	4180186
21491846	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491846	景天庚糖/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491847	Benperidol SerPl-mCnc	4180186
21491847	Anquil; Benperidol neuraxpharm; DRUG/TOXICOLOGY; Drugs; Frenactil; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491847	苯哌利多:质量浓度:时间点:血清/血浆:定量型	4182948
21491848	NfH Ab CSF-mCnc	4180186
21491848	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Chains; Chemistry; Chn; Level; Mass concentration; NfH; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
21491848	神经丝重链 抗体:质量浓度:时间点:脑脊液:定量型	4182948
21491849	Catalytic Content; Chemistry; i; Leukocytes; PMM1; PMM-1; PMMH-22; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
21491849	PMM1 WBC-cCnt	4180186
21491849	磷酸甘露糖变位酶 1:催化含量:时间点:白细胞:定量型	4182948
21491850	Catalytic Content; Chemistry; Fib; Fibr; i; PMM1; PMM-1; PMMH-22; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491850	PMM1 Fib-cCnt	4180186
21491850	磷酸甘露糖变位酶 1:催化含量:时间点:成纤维细胞:定量型	4182948
21491851	Blood; CPC8; CYP2C8 allele; CYPIIC8; cytochrome P450, family 2, subfamily C, polypeptide 8; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; MP-12/MP-20; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491851	CYP2C8 allele Geno Bld/T	4180186
21491851	CYP2C8 基因等位基因:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
21491852	Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; CT Scanogram; Document; EXT; Extr-Bl; Finding; Findings; Imaging; LE; LE-Bl; Leg; Low; Lower extremity; Playbook; Point in time; Rad; Radiology; Random; Scanogram; without contrast	4180186
21491852	CT.scanogram LE-Bl leg meas WO contr	4180186
21491852	针对腿部测量的多层^不采用对比剂:发现:时间点:下肢.双侧:文档型:CT.定位扫描	4182948
21491854	c; CARD.PROC; Cardio; Cardiology; Contr; Contra; Contrst; Gvn; Heart Disease; IV contrast; IV contrast given; Nominal; Point in time; Rad; Radiology; Random; Typ	4180186
21491854	Contrast given Type	4180186
21491854	静脉内对比剂 给予的:类型:时间点:^患者:名义型	4182948
21491855	Cardio; Cardiology; CARDIO-PULM; Diagnosis; Dis; Diseases; Dz; Heart Disease; Hosp; Hosp admit ischemic heart dis Dx; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; PULMONARY; Random	4180186
21491855	Hosp admit ischemic heart dis Dx	4180186
21491855	医院入院缺血性心脏病诊断:印象:时间点:^患者:名义型	4182948
21491857	Cath device Guid cath prod name	4180186
21491857	Cath; Cath device; Guid cath prod name; Ident; Identifier; Nominal; Point in time; Random	4180186
21491857	导引导管产品名称:标识符:时间点:导管插入术装置:名义型	4182948
21491858	Cath device Guide wire prod name	4180186
21491858	Cath device; Guide wire prod name; Ident; Identifier; Nominal; Point in time; Random	4180186
21491858	导丝产品名称:标识符:时间点:导管插入术装置:名义型	4182948
21491860	Cor stent prod name	4180186
21491860	Angio device; Cor stent prod name; Ident; Identifier; Nominal; Point in time; Random	4180186
21491860	冠状动脉支架产品名称:标识符:时间点:血管成形术装置:名义型	4182948
21491861	3-PDGH; 3-PGDH; 3-PHGDH; 3-Phosphoglycerate Dehydrogenase; Catalytic Content; Chemistry; Dehydrog; Dehyrdogenase; Dextro; Fib; Fibr; III; PGDH; PHGDH; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491861	3-PGDH Fib-cCnt	4180186
21491861	D-3-磷酸甘油酸脱氢酶:催化含量:时间点:成纤维细胞:定量型	4182948
21491862	4OH3methoxyphenyllactate CSF-sCnc	4180186
21491862	3-Methoxy-4-Hydroxyphenylacetic Acid; 3-Methoxy-4-hydroxyphenyllactate; 4OH3methoxyphenyllactate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Hydrox; III; Level; OH; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; Vanillactate; Vanillactic acid	4180186
21491862	4-羟基-3-甲氧基苯基乳酸:物质的量浓度:时间点:脑脊液:定量型	4182948
21491863	Macroprolactin/Prolactin % SerPl	4180186
21491863	%; bbPRL; Big-big prolactin; Chemistry; IgG-bound Prolactin; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; Pl; Plasma; Plsm; Point in time; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491863	巨催乳素/催乳素:任意型分数:时间点:血清/血浆:定量型	4182948
21491867	Cortis Hair-sCnt	4180186
21491867	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; Har; hydrocortisone; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
21491867	皮质醇:物质的量含量:时间点:毛发:定量型	4182948
21491870	Bil; Bilat; Both; Dis; Diseases; Dz; EYE; EYE.HX; EYE.HX.NEI; History; Initial unilat RB dev into bilat dis; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
21491870	Initial unilat RB dev into bilat dis	4180186
21491870	后来发展为双侧疾病的最初单侧视网膜母细胞瘤:历史记录:时间点:^患者:序数型	4182948
21491871	Evid supp myopathy; EYE; EYE.HX; EYE.HX.NEI; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Typ	4180186
21491871	Type of Evid supp myopathy	4180186
21491871	支持肌病的证据:类型:时间点:^患者:名义型	4182948
21491872	CCDS susp; EYE; EYE.HX; EYE.HX.NEI; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Typ	4180186
21491872	Type of CCDS susp	4180186
21491872	所怀疑的先天性颅神经发育异常综合征:类型:时间点:^患者:名义型	4182948
21491873	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Finding; Findings; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; R; R eye; Random; RT; Vision; Visual	4180186
21491873	R eye Gross defects	4180186
21491873	大体缺陷:发现:时间点:眼睛.右侧:名义型	4182948
21491875	Corneal; DIA; Diam; EYE; EYE.PX; EYE.PX.NEI; Horiz diam; L; L cornea; Length; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491875	L cornea Horiz diam	4180186
21491875	水平直径:长度:时间点:角膜.左侧:定量型	4182948
21491877	Eye; EYE.HX; EYE.HX.NEI; Eye-rel brain MRI find; Finding; Findings; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Rad; Radiology; Random	4180186
21491877	Eye-rel brain MRI find	4180186
21491877	眼相关脑部核磁共振成像发现:发现:时间点:^患者:名义型	4182948
21491879	at init diagnosis; Dx; Eye; EYE.HX; EYE.HX.NEI; Eyeball; Intraocular RB class; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; R; R eye; Random; RT; Screen; Vision; Visual	4180186
21491879	ICRB class at init diagnosis Eye-R	4180186
21491879	眼内视网膜母细胞瘤分类^初步诊断时:分类:时间点:眼睛.右侧:序数型:ICRB	4182948
21491885	Eye; EYE.HX; EYE.HX.NEI; Eyeball; History; L; L eye; LT; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Vision; Visual	4180186
21491885	Hx of Prob Eye-L	4180186
21491885	眼睛问题:历史记录:时间点:眼睛.左侧:名义型	4182948
21491886	Corneal; EYE; EYE.HX; EYE.HX.NEI; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Typ	4180186
21491886	Type of Corneal dystrophy susp	4180186
21491886	所怀疑的角膜营养不良:类型:时间点:角膜:名义型	4182948
21491888	Eye; EYE.HX; EYE.HX.NEI; Eyeball; History; L; L eye; LT; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmologic tx; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Tx; Vision; Visual	4180186
21491888	Left eye Ophthalmologic treatment	4180186
21491888	L eye Ophthalmologic tx	4180186
21491888	眼科治疗:历史记录:时间点:眼睛.左侧:名义型	4182948
21491890	Progress of prob since birth	4180186
21491890	EYE; EYE.HX; EYE.HX.NEI; History; Nominal; Point in time; Progress of prob since birth; Random	4180186
21491890	出生以来的问题进展情况:历史记录:时间点:^患者:名义型	4182948
21491893	@ birth; EYE; EYE.HX; EYE.HX.NEI; History; Lung; New born; Newborn; O2; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; Pulmonary; Pulmonology; QL; Qual; Qualitative; Random; Respiratory; Screen; tO2; Use of suppl O2	4180186
21491893	Use of suppl O2--@ birth	4180186
21491893	Use of supplemental oxygen--at birth	4180186
21491893	辅助供氧的使用^出生时:历史记录:时间点:^患者:序数型	4182948
21491896	EYE; EYE.TONOMETRY; EYE.TONOMETRY.NEI; Glaucoma testing; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Tono device; Typ	4180186
21491896	眼压计:类型:时间点:眼压测量装置:名义型	4182948
21491897	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Typ; Vision; Visual	4180186
21491897	Type of Ocular align by Cover test	4180186
21491897	眼位:类型:时间点:眼睛:名义型:遮盖试验	4182948
21491901	Arden rto; EOG; EYE; EYE.EOG; EYE.EOG.NEI; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT	4180186
21491901	R ret Arden rto EOG	4180186
21491901	Arden 比率:电势比率:时间点:视网膜.右侧:定量型:眼电图	4182948
21491902	Arden rto; EOG; EYE; EYE.EOG; EYE.EOG.NEI; L; L ret; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491902	L ret Arden rto EOG	4180186
21491902	Arden 比率:电势比率:时间点:视网膜.左侧:定量型:眼电图	4182948
21491903	EOG; EYE; EYE.EOG; EYE.EOG.NEI; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; R; R ret; Random; RT; Screen; Study report	4180186
21491903	Overall study imp R ret EOG	4180186
21491903	检查观察结果.总体:印象:时间点:视网膜.右侧:序数型:眼电图	4182948
21491912	Atrial wave; a-wave impl time; ERG; EYE; EYE.ERG; EYE.ERG.NEI; L; L ret; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491912	a-wave impl time L ret light-adapt ERG	4180186
21491912	a-波潜伏时间^明适应型:时间:时间点:视网膜.左侧:定量型:视网膜电图	4182948
21491913	Electrical potential; ERG; EYE; EYE.ERG; EYE.ERG.NEI; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT; Voltage	4180186
21491913	b-wave amp R ret dark-adapt ERG	4180186
21491913	b-波振幅^暗适应型:电势:时间点:视网膜.右侧:定量型:视网膜电图	4182948
21491916	Electrical potential; ERG; EYE; EYE.ERG; EYE.ERG.NEI; L; L ret; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage	4180186
21491916	b-wave amp L ret light-adapt ERG	4180186
21491916	b-波振幅^明适应型:电势:时间点:视网膜.左侧:定量型:视网膜电图	4182948
21491918	b-wave impl time; ERG; EYE; EYE.ERG; EYE.ERG.NEI; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT	4180186
21491918	b-wave impl time R ret dark-adapt ERG	4180186
21491918	b-波潜伏时间^暗适应型:时间:时间点:视网膜.右侧:定量型:视网膜电图	4182948
21491919	b-wave impl time; ERG; EYE; EYE.ERG; EYE.ERG.NEI; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT	4180186
21491919	b-wave impl time R ret light-adapt ERG	4180186
21491919	b-波潜伏时间^明适应型:时间:时间点:视网膜.右侧:定量型:视网膜电图	4182948
21491920	b-wave impl time; ERG; EYE; EYE.ERG; EYE.ERG.NEI; L; L ret; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491920	b-wave impl time L ret light-adapt ERG	4180186
21491920	b-波潜伏时间^明适应型:时间:时间点:视网膜.左侧:定量型:视网膜电图	4182948
21491922	ERG; EYE; EYE.ERG; EYE.ERG.NEI; Finding; Findings; L; L ret; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random	4180186
21491922	L ret Oscillatory pot ERG	4180186
21491922	振荡电位:发现:时间点:视网膜.左侧:名义型:视网膜电图	4182948
21491924	ERG; EYE; EYE.ERG; EYE.ERG.NEI; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; R ret; Random; RT; Study report	4180186
21491924	Overall study imp R ret ERG	4180186
21491924	检查观察结果.总体:印象:时间点:视网膜.右侧:名义型:视网膜电图	4182948
21491925	ERG; EYE; EYE.ERG; EYE.ERG.NEI; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; L; L ret; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Study report	4180186
21491925	Overall study imp L ret ERG	4180186
21491925	检查观察结果.总体:印象:时间点:视网膜.左侧:名义型:视网膜电图	4182948
21491926	CVA hx	4180186
21491926	CVA; H+P; H+P.HX; History; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Stroke	4180186
21491926	脑血管意外:历史记录:时间点:^患者:序数型	4182948
21491927	Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; BZP; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Level; Mass concentration; N-Benzylpiperazine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
21491927	Benzylpiperazine Fld-mCnc	4180186
21491927	苄基哌嗪:质量浓度:时间点:体液:定量型	4182948
21491928	Addiction; Blood; BU; BUP; Bupe; Buprenex; buprenorphine HCI; Buprex; Butrans; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Finobrin; GCMS; Illicit; Norspan; Ordinal; Point in time; PotentialForAbuse; PR; Prefin; QL; Qual; Qualitative; Random; Screen; Suboxone; Subutex; Temgesic; WB; Whole blood	4180186
21491928	Buprenorphine Bld Ql Cfm	4180186
21491928	丁丙诺啡:存在情况或阈值:时间点:全血:序数型:毒理学确认试验	4182948
21491929	Addiction; Blood; BU; BUP; Bupe; Buprenex; buprenorphine HCI; Buprex; Butrans; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Finobrin; Illicit; Norspan; Ordinal; Point in time; PotentialForAbuse; PR; Prefin; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Suboxone; Subutex; Temgesic; WB; Whole blood	4180186
21491929	Buprenorphine Bld Ql Scn	4180186
21491929	丁丙诺啡:存在情况或阈值:时间点:全血:序数型:毒理学筛查试验	4182948
21491931	Addiction; benzoylethanamine; beta-keto-amphetamine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; hagigat; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
21491931	Cathinone Ur Ql Scn	4180186
21491931	卡西酮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
21491932	Bath salts; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; ephedrone; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491932	Methcathinone CtO Ur Cfm-mCnc	4180186
21491932	甲卡西酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491936	CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Nucynta; Palexia; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Tapal; UA; UR; Urn	4180186
21491936	Tapentadol CtO Ur Scn-mCnc	4180186
21491936	他喷他多 截止点:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
21491937	4-methoxymethcathinone; Bath salts; bk-PMMA; Cat; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; PMMC; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491937	Methedrone CtO Ur Cfm-mCnc	4180186
21491937	甲氧麻黄酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491938	3,4-Methylenedioxy-N-Methylcathinone; Bath salts; bk-MDMA; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; M1; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491938	Methylone CtO Ur Cfm-mCnc	4180186
21491938	亚甲基双氧甲基卡西酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491939	3,4-methylenedioxy-N-ethylcathinone; Addiction; Bath salts; bk-MDEA; Cat; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; MDEC; methylenedioxyethylcathinone; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491939	bk-MDEA Ur Cfm-mCnc	4180186
21491939	乙基卡西酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491940	Abd; Abdo; Abdomen+; Abdominal; Document; Films; Finding; Findings; GE 2V; II; Imaging; L/sp; L-spine; L-spine+Sacrum; Lumbar; Lumbo; Lumbosacral; Minimum 2 views; Pelvic; Pelvis+L-spine; Plain Films; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; View; VWS; Xray; X-ray	4180186
21491940	XR L-spine+Sacrum GE 2V	4180186
21491940	多重视图 GE 双重:发现:时间点:腹部>脊椎.腰段 & 盆腔>骶骨:文档型:X射线摄影术	4182948
21491941	Abd; Abdo; Abdomen+; Abdominal; Document; Films; Finding; Findings; GE 4V; Imaging; L/sp; L-spine; L-spine+Sacrum; Lumbar; Lumbo; Lumbosacral; Minimum 4 views; Pelvic; Pelvis+L-spine; Plain Films; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; View; VWS; Xray; X-ray	4180186
21491941	XR L-spine+Sacrum GE 4V	4180186
21491941	多重视图 GE 四重:发现:时间点:腹部>脊椎.腰段 & 盆腔>骶骨:文档型:X射线摄影术	4182948
21491943	Ab Ao; Abd; Abd Aorta; Abdo; Abdomen; Abdomen+; Abdominal; AO; Aortic; Asympt; Asymptomatic; Cardio; Cardiology; Document; Echography; Finding; Findings; Heart Disease; Imaging; Point in time; Radiology; Random; Scn; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
21491943	US Abd Aorta Screening	4180186
21491943	针对筛查的多层:发现:时间点:腹部>主动脉.腹腔段:文档型:超声	4182948
21491945	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491946	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491947	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491948	4 weeks; Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491952	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491957	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491959	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491961	4 weeks; Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491962	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491964	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491965	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491966	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491969	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491970	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491974	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491975	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491977	Chemistry; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
21491977	Melatonin Sal-mCnc	4180186
21491977	褪黑激素:质量浓度:时间点:唾液:定量型	4182948
21491981	Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Surf; Survey; SURVEY.PROMIS	4180186
21491982	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.PROMIS	4180186
21491989	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491992	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491994	Arterial Stenosis; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491995	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491996	Arterial Stenosis; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS; Upper extremity joint	4180186
21491997	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491998	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492001	Activity; EXCZ; Exercise; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492003	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492004	Finding; Findings; Liquids; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492005	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492006	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492007	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492010	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492013	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492015	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492019	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492020	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Surf; Survey; SURVEY.PROMIS	4180186
21492022	Arterial Stenosis; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492025	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492026	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS; Upper extremity	4180186
21492027	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492028	Difficulty standing up-low couch; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492029	Erect; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS; Upr; Uprt	4180186
21492030	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492033	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492034	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492035	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492036	4 weeks; Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492037	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492038	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492039	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492040	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492041	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492042	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492044	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492049	4 weeks; Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492050	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492054	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492056	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492057	1 week; Patient Reported Outcomes Information System; PEDS; promise; QNT; Quan; Quant; Quantitative; Scale; Survey; SURVEY.PROMIS	4180186
21492062	2D US; Area Ratio; CARD.US; Cardiac; Cardio; Cardiology; Echography; Exchange; FAC; Heart Disease; Hrt; Hrt ventr; Point in time; QNT; Quan; Quant; Quantitative; R; Random; Replace; RT; RV; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular	4180186
21492062	RV FAC 2D US	4180186
21492062	面积变化分数:面积比率:时间点:心脏.心室.右侧:定量型:超声.2D	4182948
21492063	2D US; AO; AO root; Aortic; CARD.US; Cardio; Cardiology; DIA; Diam; Echography; Heart Disease; Length; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional	4180186
21492063	AO root Diam 2D US	4180186
21492063	直径:长度:时间点:主动脉.根部:定量型:超声.2D	4182948
21492068	CARD.US; Cardio; Cardiology; Dias; Diast; Diastoli; DOP; DUPLEX; Echography; Heart Disease; Point in time; PV; QNT; Quan; Quant; Quantitative; Random; Regurg vel dias rapid inflow; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vel; Velocity	4180186
21492068	PV Regurg vel dias rapid inflow DOP	4180186
21492068	在舒张期快速流入期间的速度:速度:时间点:肺动脉瓣:定量型:超声.多普勒	4182948
21492071	Blood flow.diastolic.early wave.max; CARD.US; Cardio; Cardiology; DOP; DOP+TDI; DUPLEX; Early wave; Echography; e-prime Vmax; E-wave; Heart Disease; Largest; Maximal; Maximum; MV; MV ann; MV med ann; Peak; Peak E-wave; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vel; Velocity ratio	4180186
21492071	MV med ann E-wave/e-prime Vmax DOP+TDI	4180186
21492071	E 波/组织速度.E 波.最大值:速度比率:时间点:二尖瓣.环.中部:定量型:超声.多普勒+组织多普勒	4182948
21492072	Blood flow.diastolic.early wave.max; CARD.US; Cardio; Cardiology; DOP; DOP+TDI; DUPLEX; Early wave; Echography; e-prime Vmax; E-wave; Heart Disease; Largest; Lat; Maximal; Maximum; MV; MV ann; MV lat ann; Peak; Peak E-wave; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vel; Velocity ratio	4180186
21492072	MV lat ann E-wave/e-prime Vmax DOP+TDI	4180186
21492072	E 波/组织速度.E 波.最大值:速度比率:时间点:二尖瓣.环.侧部:定量型:超声.多普勒+组织多普勒	4182948
21492073	Bld flow; CARD.US; Cardio; Cardiology; Dec; DOP; DT; DUPLEX; Dynamic; Early wave; Echography; E-wave; E-wave deceleration time; Heart Disease; MV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
21492073	MV E-wave deceleration time DOP	4180186
21492073	血流.减速时间.E 波:时间:时间点:二尖瓣:定量型:超声.多普勒	4182948
21492075	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492077	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492083	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492085	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492088	Activity; EXCZ; Exercise; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492089	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.PROMIS	4180186
21492092	FCN; Func; Funct; Ordinal; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492094	Abd; Abd+Pelvis; Abdo; Abdominal; After; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; p 3D proc; Pelvic; Playbook; Point in time; PST; Rad; RADIOLOGY; Random; without contrast	4180186
21492094	CT Abd+Pelvis p 3D proc WO contr	4180186
21492094	三维后处理类多层^不采用对比剂:发现:时间点:腹部+盆腔:文档型:CT	4182948
21492095	Abd; Abdo; Abdomen+; Abdominal; After; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; p 3D proc; Playbook; Point in time; PST; Rad; RADIOLOGY; Random; without contrast	4180186
21492095	CT Abd p 3D proc WO contr	4180186
21492095	三维后处理类多层^不采用对比剂:发现:时间点:腹部:文档型:CT	4182948
21492096	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; Playbook; Point in time; Rad; Radiology; Random; Thorax; without contrast	4180186
21492096	CT Airway WO contr	4180186
21492096	多层^不采用对比剂:发现:时间点:胸部>气道:文档型:CT	4182948
21492099	Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Colonography; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; LGI; Pelvic; Playbook; Point in time; Rad; RADIOLOGY; Random; Rectal; Rectum+colon; Virtual colonoscopy; W contr IV; WC	4180186
21492099	Deprecated	4180186
21492101	CAT scan; Computed tomography; Computerized tomography; CorePlaybook; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; RT; Simulation; Spec; To be specified in another part of the message; Tx; Unspecified	4180186
21492101	CT Guided RT	4180186
21492101	旨在放射治疗的引导:发现:时间点:XXX:文档型:CT	4182948
21492103	Abd; Abd+Pelvis; Abdo; Abdominal; After; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Cystogram; Document; Finding; Findings; Imaging; Kid+Uret+Blad; Kidney; Nephric; Nephrogram; Nephrography; Nephrology; p 3D proc; Pelvic; Playbook; Point in time; PST; Pyelogram; Pyelography; Rad; Radiology; Random; Renal; Ureter+Blad; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
21492103	CT Kid+Uret+Blad p 3D proc WO+W contr IV	4180186
21492103	三维后处理类多层^不采用 & 采用静脉注射对比剂:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:CT	4182948
21492106	Ang; Angio; Angiography; Angm; Arteriogram; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; for PE; Imaging; PA; PAA; PE; Playbook; Point in time; Pulm; Rad; Radiology; Random; Thorax; W contr IV; WC	4180186
21492106	CTA PA for PE W contr IV	4180186
21492106	针对肺栓塞的多层^采用静脉注射对比剂:发现:时间点:胸部>肺动脉类:文档型:CT.血管造影术	4182948
21492107	c; C/sp; CAT scan; Cerv; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; C-spine; CT scan; Document; Finding; Findings; Imaging; Playbook; Point in time; Rad; Radiology; Random; Spinal; Spinal Cord; W contr IV; WC	4180186
21492107	CT C-spine by reconstr W contr IV	4180186
21492107	基于重建的多层^采用静脉注射对比剂:发现:时间点:颈部>脊椎.颈段:文档型:CT	4182948
21492108	c; C/sp; CAT scan; Cerv; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; C-spine; CT scan; Document; Finding; Findings; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; without contrast	4180186
21492108	CT C-spine by reconstr WO contr	4180186
21492108	基于重建的多层^不采用对比剂:发现:时间点:颈部>脊椎.颈段:文档型:CT	4182948
21492111	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Dorsal spine; Finding; Findings; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; W contr IV; WC	4180186
21492111	CT T-spine by reconstr W contr IV	4180186
21492111	基于重建的多层^采用静脉注射对比剂:发现:时间点:胸部>脊椎.胸段:文档型:CT	4182948
21492112	BON; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Playbook; Point in time; Rad; RADIOLOGY; Random; Skull; W contr IV; WC	4180186
21492112	CT Temporal bone by reconstr W contr IV	4180186
21492112	基于重建的多层^采用静脉注射对比剂:发现:时间点:头部>颞骨:文档型:CT	4182948
21492114	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; c; CAG; CAT scan; CHGM; Cholangiogram; Cholangiography; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; Playbook; Point in time; Rad; Radiology; Random; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
21492114	CT BDs WO+W contr IV	4180186
21492114	多层^不采用 & 采用静脉注射对比剂:发现:时间点:腹部>胆管类:文档型:CT	4182948
21492121	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Dorsal spine; Finding; Findings; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; without contrast	4180186
21492121	CT.Dens T-spine WO contr	4180186
21492121	多层^不采用对比剂:发现:时间点:胸部>脊椎.胸段:文档型:CT.密度测定法	4182948
21492127	Abd; Abd+Pelvis; Abdo; Abdominal; After; c; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; p 3D proc; Pelvic; Playbook; Point in time; PST; Rad; Radiology; Random; Thorax; without contrast	4180186
21492127	CT Chest+Abd+Pelvis p 3D proc WO contr	4180186
21492127	三维后处理类多层^不采用对比剂:发现:时间点:胸部+腹部+盆腔:文档型:CT	4182948
21492130	ADMIN; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
21492130	Federal employer tax ID Organization	4180186
21492130	联邦政府雇员税务标识符:标识符:时间点:组织机构:名义型	4182948
21492134	CARD.US; Cardiac; Cardio; Cardiology; Echography; Finding; Findings; Heart Disease; Hrt; Hrt ventr; Inf; L; Lat; LT; LV; LV.mid inf; LV.mid inf lat; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Segment; Segment appearance; Sonogram; Sonograph; Sonography; SWM; ULS; Ultrasound; Ventricular; WM	4180186
21492134	LV.mid inf lat SWM US	4180186
21492134	节段性壁运动:发现:时间点:心脏.心室.左侧.侧面中下部:序数型:超声	4182948
21492140	ABL; bcr/abl; Blood; Chromosom; Chromosomes; Chronic myeloid leukemia; CML; Cyto loc; Del; Deletions; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492140	9q34 Del Bld/T Ql FISH	4180186
21492140	9q34 染色体区域 缺失:存在情况或阈值:时间点:全血/组织:序数型:FISH	4182948
